ID   B2RB13_HUMAN            Unreviewed;       697 AA.
AC   B2RB13;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=cDNA, FLJ95253, highly similar to Homo sapiens acyl-CoA synthetase long-chain family member 6(ACSL6), mRNA {ECO:0000313|EMBL:BAG37060.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG37060.1};
RN   [1] {ECO:0000313|EMBL:BAG37060.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAG37060.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK314452; BAG37060.1; -; mRNA.
DR   RefSeq; NP_001192177.1; NM_001205248.1.
DR   RefSeq; NP_001192180.1; NM_001205251.1.
DR   PeptideAtlas; B2RB13; -.
DR   PRIDE; B2RB13; -.
DR   DNASU; 23305; -.
DR   GeneID; 23305; -.
DR   KEGG; hsa:23305; -.
DR   CTD; 23305; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   KO; K01897; -.
DR   GenomeRNAi; 23305; -.
DR   Genevisible; B2RB13; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0003824; F:catalytic activity; IEA:InterPro.
DR   Gene3D; 3.40.50.12780; -; 2.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; AMP-dep_Synthh-like_sf.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        21..44
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          115..562
FT                   /note="AMP-binding"
FT                   /evidence="ECO:0000259|Pfam:PF00501"
SQ   SEQUENCE   697 AA;  77681 MW;  F70492502C212FA7 CRC64;
     MQTQEILRIL RLPELGDLGQ FFRSLSATTL VSMGALAAIL AYWFTHRPKA LQPPCNLLMQ
     SEEVEDSGGA RRSVIGSGPQ LLTHYYDDAR TMYQVFRRGL SISGNGPCLG FRKPKQPYQW
     LSYQEVADRA EFLGSGLLQH NCKACTDQFI GVFAQNRPEW IIVELACYTY SMVVVPLYDT
     LGPGAIRYII NTADISTVIV DKPQKAVLLL EHVERKETPG LKLIILMDPF EEALKERGQK
     CGVVIKSMQA VEDCGQENHQ APVPPQPDDL SIVCFTSGTT GNPKGAMLTH GNVVADFSGF
     LKVTESQWAP TCADVHISYL PLAHMFERMV QSVVYCHGGR VGFFQGDIRL LSDDMKALCP
     TIFPVVPRLL NRMYDKIFSQ ANTPLKRWLL EFAAKRKQAE VRSGIIRNDS IWDELFFNKI
     QASLGGCVRM IVTGAAPASP TVLGFLRAAL GCQVYEGYGQ TECTAGCTFT TPGDWTSGHV
     GAPLPCNHIK LVDVEELNYW ACKGEGEICV RGPNVFKGYL KDPDRTKEAL DSDGWLHTGD
     IGKWLPAGTL KIIDRKKHIF KLAQGEYVAP EKIENIYIRS QPVAQIYVHG DSLKAFLVGI
     VVPDPEVMPS WAQKRGIEGT YADLCTNKDL KKAILEDMVR LGKESGLHSF EQVKAIHIHS
     DMFSVQNGLL TPTLKAKRPE LREYFKKQIE ELYSIPM
//
ID   B4DFW3_HUMAN            Unreviewed;       687 AA.
AC   B4DFW3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   26-FEB-2020, entry version 46.
DE   SubName: Full=cDNA FLJ55964, highly similar to Long-chain-fatty-acid--CoA ligase 6 {ECO:0000313|EMBL:BAG57574.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57574.1};
RN   [1] {ECO:0000313|EMBL:BAG57574.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAG57574.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK294291; BAG57574.1; -; mRNA.
DR   RefSeq; NP_001192176.1; NM_001205247.1.
DR   RefSeq; NP_056071.2; NM_015256.3.
DR   PeptideAtlas; B4DFW3; -.
DR   PRIDE; B4DFW3; -.
DR   DNASU; 23305; -.
DR   GeneID; 23305; -.
DR   CTD; 23305; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   OrthoDB; 630541at2759; -.
DR   GenomeRNAi; 23305; -.
DR   Genevisible; B4DFW3; HS.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.12780; -; 2.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; AMP-dep_Synthh-like_sf.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   2: Evidence at transcript level;
KW   Ligase {ECO:0000313|EMBL:BAG57574.1}.
FT   DOMAIN          105..552
FT                   /note="AMP-binding"
FT                   /evidence="ECO:0000259|Pfam:PF00501"
SQ   SEQUENCE   687 AA;  76660 MW;  A0C1630F6C0C593D CRC64;
     MLTFFLVSGG SLWLFVEFVL SLLEKMQTQE ILRILRLPEL GDLGQFFRSL SATTLDSGGA
     RRSVIGSGPQ LLTHYYDDAR TMYQVFRRGL SISGNGPCLG FRKPKQPYQW LSYQEVADRA
     EFLGSGLLQH NCKACTDQFI GVFAQNRPEW IIVELACYTY SMVVVPLYDT LGPGAIRYII
     NTADISTVIV DKPQKAVLLL EHVERKETPG LKLIILMDPF EEALKERGQK CGVVIKSMQA
     VEDCGQENHQ APVPPQPDDL SIVCFTSGTT GNPKGAMLTH GNVVADFSGF LKVTESQWAP
     TCADVHISYL PLAHMFERMV QSVVYCHGGR VGFFQGDIRL LSDDMKALCP TIFPVVPRLL
     NRMYDKIFSR ANTPLKRWLL EFAAKRKQAE VRSGIIRNDS IWDELFFNKI QASLGGCVRM
     IVTGAAPASP TVLGFLRAAL GCQVYEGYGQ TECTAGCTFT TPGDWTSGHV GAPLPCNHIK
     LVDVEELNYW ACKGEGEICV RGPNVFKGYL KDPDRTKEAL DSDGWLHTGD IGKWLPAGTL
     KIIDRKKHIF KLAQGEYVAP EKIENIYIRS QPVAQIYVHG DSLKAFLVGI VVPDPEVMPS
     WAQKRGIEGT YADLCTNKDL KKAILEDMVR LGKESGLHSF EQVKAIHIHS DMFSVQNGLL
     TPTLKAKRPE LREYFKKQIE ELYSISM
//
ID   ACSL6_HUMAN             Reviewed;         697 AA.
AC   Q9UKU0; J3KPG3; O94924; O95829; Q108M9; Q108N0; Q4G191; Q86TN7;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 4.
DT   22-APR-2020, entry version 178.
DE   RecName: Full=Long-chain-fatty-acid--CoA ligase 6 {ECO:0000305};
DE            EC=6.2.1.3 {ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233};
DE   AltName: Full=Arachidonate--CoA ligase {ECO:0000305};
DE            EC=6.2.1.15 {ECO:0000250|UniProtKB:P33124};
DE   AltName: Full=Long-chain acyl-CoA synthetase 6;
DE            Short=LACS 6;
GN   Name=ACSL6 {ECO:0000312|HGNC:HGNC:16496};
GN   Synonyms=ACS2, FACL6, KIAA0837, LACS5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND TISSUE SPECIFICITY.
RX   PubMed=10548543; DOI=10.1042/bj3440135;
RA   Malhotra K.T., Malhotra K., Lubin B.H., Kuypers F.A.;
RT   "Identification and molecular characterization of acyl-CoA synthetase in
RT   human red cells and erythroid precursor.";
RL   Biochem. J. 344:135-143(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND CHROMOSOMAL TRANSLOCATION WITH
RP   ETV6.
RC   TISSUE=Bone marrow;
RX   PubMed=10502316;
RX   DOI=10.1002/(sici)1098-2264(199911)26:3<192::aid-gcc2>3.0.co;2-e;
RA   Yagasaki F., Jinnai I., Yoshida S., Yokoyama Y., Matsuda A., Kusumoto S.,
RA   Kobayashi H., Terasaki H., Ohyashiki K., Asou N., Murohashi I., Bessho M.,
RA   Hirashima K.;
RT   "Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute
RT   myelogenous leukemia with t(5;12)(q31;p13).";
RL   Genes Chromosomes Cancer 26:192-202(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   253-374 (ISOFORM 5), AND ALTERNATIVE SPLICING (ISOFORM 8).
RX   PubMed=16834775; DOI=10.1186/1471-2199-7-21;
RA   Soupene E., Kuypers F.A.;
RT   "Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are
RT   produced by switch of the fatty acid gate domains.";
RL   BMC Mol. Biol. 7:21-21(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING
RP   (ISOFORM 8).
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 7 AND 9).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=22633490; DOI=10.1016/j.molcel.2012.04.033;
RA   Nakahara K., Ohkuni A., Kitamura T., Abe K., Naganuma T., Ohno Y.,
RA   Zoeller R.A., Kihara A.;
RT   "The Sjogren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of
RT   the sphingosine 1-phosphate degradation pathway.";
RL   Mol. Cell 46:461-471(2012).
RN   [9]
RP   CATALYTIC ACTIVITY, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24269233; DOI=10.1016/j.bbrc.2013.11.036;
RA   Ohkuni A., Ohno Y., Kihara A.;
RT   "Identification of acyl-CoA synthetases involved in the mammalian
RT   sphingosine 1-phosphate metabolic pathway.";
RL   Biochem. Biophys. Res. Commun. 442:195-201(2013).
CC   -!- FUNCTION: Catalyzes the conversion of long-chain fatty acids to their
CC       active form acyl-CoA for both synthesis of cellular lipids, and
CC       degradation via beta-oxidation (PubMed:22633490, PubMed:24269233).
CC       Plays an important role in fatty acid metabolism in brain and the acyl-
CC       CoAs produced may be utilized exclusively for the synthesis of the
CC       brain lipid. {ECO:0000269|PubMed:22633490,
CC       ECO:0000269|PubMed:24269233}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain fatty acid + ATP + CoA = a long-chain fatty acyl-
CC         CoA + AMP + diphosphate; Xref=Rhea:RHEA:15421, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57560,
CC         ChEBI:CHEBI:83139, ChEBI:CHEBI:456215; EC=6.2.1.3;
CC         Evidence={ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15422;
CC         Evidence={ECO:0000305|PubMed:22633490, ECO:0000305|PubMed:24269233};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:19713, ChEBI:CHEBI:30616, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:456215; EC=6.2.1.15;
CC         Evidence={ECO:0000250|UniProtKB:P33124};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19714;
CC         Evidence={ECO:0000250|UniProtKB:P33124};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + CoA + hexadecanoate = AMP + diphosphate + hexadecanoyl-
CC         CoA; Xref=Rhea:RHEA:30751, ChEBI:CHEBI:7896, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:24269233};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30752;
CC         Evidence={ECO:0000305|PubMed:24269233};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(E)-hexadec-2-enoate + ATP + CoA = (2E)-hexadecenoyl-CoA + AMP
CC         + diphosphate; Xref=Rhea:RHEA:36139, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:61526,
CC         ChEBI:CHEBI:72745, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36140;
CC         Evidence={ECO:0000305|PubMed:22633490, ECO:0000305|PubMed:24269233};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=15-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + ATP + CoA = 15-
CC         hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52116, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:78832, ChEBI:CHEBI:136409,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:P33124};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52117;
CC         Evidence={ECO:0000250|UniProtKB:P33124};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + ATP + CoA = 12-
CC         hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52112, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:90718, ChEBI:CHEBI:136408,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:P33124};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52113;
CC         Evidence={ECO:0000250|UniProtKB:P33124};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA = 5-
CC         hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52108, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:65341, ChEBI:CHEBI:136407,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:P33124};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52109;
CC         Evidence={ECO:0000250|UniProtKB:P33124};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- INTERACTION:
CC       Q9UKU0-7; Q9NV79: PCMTD2; NbExp=3; IntAct=EBI-12883224, EBI-6309018;
CC       Q9UKU0-7; Q8N720: ZNF655; NbExp=3; IntAct=EBI-12883224, EBI-625509;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250};
CC       Single-pass type III membrane protein {ECO:0000250}. Peroxisome
CC       membrane {ECO:0000250}; Single-pass type III membrane protein
CC       {ECO:0000250}. Microsome membrane {ECO:0000250}; Single-pass type III
CC       membrane protein {ECO:0000250}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:24269233}; Single-pass type III membrane protein
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC       Name=4;
CC         IsoId=Q9UKU0-4; Sequence=Displayed;
CC       Name=1; Synonyms=Long, v2;
CC         IsoId=Q9UKU0-1; Sequence=VSP_037819;
CC       Name=2; Synonyms=Short;
CC         IsoId=Q9UKU0-2; Sequence=VSP_021024, VSP_000241;
CC       Name=3;
CC         IsoId=Q9UKU0-3; Sequence=VSP_021024;
CC       Name=5; Synonyms=v4;
CC         IsoId=Q9UKU0-5; Sequence=VSP_037823;
CC       Name=6; Synonyms=v5;
CC         IsoId=Q9UKU0-6; Sequence=VSP_037821;
CC       Name=7; Synonyms=v3;
CC         IsoId=Q9UKU0-7; Sequence=VSP_037820, VSP_037822;
CC       Name=8; Synonyms=v1;
CC         IsoId=Q9UKU0-8; Sequence=VSP_037819, VSP_021024;
CC       Name=9;
CC         IsoId=Q9UKU0-9; Sequence=VSP_046954;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in erythrocyte precursors,
CC       in particular in reticulocytes, fetal blood cells derived from fetal
CC       liver, hemopoietic stem cells from cord blood, bone marrow and brain.
CC       {ECO:0000269|PubMed:10548543}.
CC   -!- DEVELOPMENTAL STAGE: Expression is low at earlier stages of erythroid
CC       development but is very high in reticulocytes.
CC   -!- DISEASE: Note=A chromosomal aberration involving ACSL6 may be a cause
CC       of myelodysplastic syndrome with basophilia. Translocation
CC       t(5;12)(q31;p13) with ETV6. {ECO:0000269|PubMed:10502316}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ACSL6 may be a cause
CC       of acute myelogenous leukemia with eosinophilia. Translocation
CC       t(5;12)(q31;p13) with ETV6. {ECO:0000269|PubMed:10502316}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ACSL6 may be a cause
CC       of acute eosinophilic leukemia (AEL). Translocation t(5;12)(q31;p13)
CC       with ETV6. {ECO:0000269|PubMed:10502316}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH26161.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA74860.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF129166; AAD47199.1; -; mRNA.
DR   EMBL; AF099740; AAD17853.1; -; mRNA.
DR   EMBL; DQ083030; AAZ30713.1; -; mRNA.
DR   EMBL; DQ083031; AAZ30714.1; -; mRNA.
DR   EMBL; AB020644; BAA74860.1; ALT_INIT; mRNA.
DR   EMBL; CR606980; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC025772; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026398; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC034228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC026161; AAH26161.1; ALT_SEQ; mRNA.
DR   EMBL; BC047453; AAH47453.1; -; mRNA.
DR   CCDS; CCDS34228.1; -. [Q9UKU0-8]
DR   CCDS; CCDS34229.1; -. [Q9UKU0-1]
DR   CCDS; CCDS56381.1; -. [Q9UKU0-3]
DR   CCDS; CCDS56382.1; -. [Q9UKU0-7]
DR   CCDS; CCDS56383.1; -. [Q9UKU0-9]
DR   RefSeq; NP_001009185.1; NM_001009185.2. [Q9UKU0-1]
DR   RefSeq; NP_001192176.1; NM_001205247.1.
DR   RefSeq; NP_001192177.1; NM_001205248.1. [Q9UKU0-3]
DR   RefSeq; NP_001192179.1; NM_001205250.1. [Q9UKU0-9]
DR   RefSeq; NP_001192180.1; NM_001205251.1. [Q9UKU0-7]
DR   RefSeq; NP_056071.2; NM_015256.3. [Q9UKU0-8]
DR   SMR; Q9UKU0; -.
DR   BioGrid; 116897; 1.
DR   IntAct; Q9UKU0; 4.
DR   STRING; 9606.ENSP00000368566; -.
DR   SwissLipids; SLP:000000203; -.
DR   iPTMnet; Q9UKU0; -.
DR   PhosphoSitePlus; Q9UKU0; -.
DR   BioMuta; ACSL6; -.
DR   DMDM; 146322303; -.
DR   jPOST; Q9UKU0; -.
DR   MassIVE; Q9UKU0; -.
DR   MaxQB; Q9UKU0; -.
DR   PaxDb; Q9UKU0; -.
DR   PeptideAtlas; Q9UKU0; -.
DR   PRIDE; Q9UKU0; -.
DR   ProteomicsDB; 84870; -. [Q9UKU0-4]
DR   ProteomicsDB; 84871; -. [Q9UKU0-1]
DR   ProteomicsDB; 84872; -. [Q9UKU0-2]
DR   ProteomicsDB; 84873; -. [Q9UKU0-3]
DR   ProteomicsDB; 84874; -. [Q9UKU0-5]
DR   ProteomicsDB; 84875; -. [Q9UKU0-6]
DR   ProteomicsDB; 84876; -. [Q9UKU0-7]
DR   ProteomicsDB; 84877; -. [Q9UKU0-8]
DR   Antibodypedia; 25915; 181 antibodies.
DR   DNASU; 23305; -.
DR   Ensembl; ENST00000357096; ENSP00000349608; ENSG00000164398. [Q9UKU0-7]
DR   Ensembl; ENST00000379240; ENSP00000368542; ENSG00000164398. [Q9UKU0-4]
DR   Ensembl; ENST00000379244; ENSP00000368546; ENSG00000164398. [Q9UKU0-3]
DR   Ensembl; ENST00000379246; ENSP00000368548; ENSG00000164398. [Q9UKU0-9]
DR   Ensembl; ENST00000379255; ENSP00000368557; ENSG00000164398. [Q9UKU0-7]
DR   Ensembl; ENST00000543479; ENSP00000442124; ENSG00000164398. [Q9UKU0-6]
DR   Ensembl; ENST00000651356; ENSP00000498260; ENSG00000164398. [Q9UKU0-8]
DR   Ensembl; ENST00000651883; ENSP00000499063; ENSG00000164398. [Q9UKU0-1]
DR   GeneID; 23305; -.
DR   KEGG; hsa:23305; -.
DR   UCSC; uc003kvv.3; human. [Q9UKU0-4]
DR   CTD; 23305; -.
DR   DisGeNET; 23305; -.
DR   GeneCards; ACSL6; -.
DR   HGNC; HGNC:16496; ACSL6.
DR   HPA; ENSG00000164398; Tissue enhanced (brain, ductus deferens, seminal vesicle, testis).
DR   MIM; 604443; gene.
DR   neXtProt; NX_Q9UKU0; -.
DR   OpenTargets; ENSG00000164398; -.
DR   PharmGKB; PA27970; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   GeneTree; ENSGT00940000162308; -.
DR   HOGENOM; CLU_000022_45_4_1; -.
DR   InParanoid; Q9UKU0; -.
DR   KO; K01897; -.
DR   OMA; KNDIATQ; -.
DR   PhylomeDB; Q9UKU0; -.
DR   TreeFam; TF313877; -.
DR   BioCyc; MetaCyc:HS15193-MONOMER; -.
DR   BRENDA; 6.2.1.3; 2681.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   ChiTaRS; ACSL6; human.
DR   GeneWiki; ACSL6; -.
DR   GenomeRNAi; 23305; -.
DR   Pharos; Q9UKU0; Tbio.
DR   PRO; PR:Q9UKU0; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9UKU0; protein.
DR   Bgee; ENSG00000164398; Expressed in corpus callosum and 149 other tissues.
DR   ExpressionAtlas; Q9UKU0; baseline and differential.
DR   Genevisible; Q9UKU0; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; NAS:UniProtKB.
DR   GO; GO:0003996; F:acyl-CoA ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047676; F:arachidonate-CoA ligase activity; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0102391; F:decanoate-CoA ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0006637; P:acyl-CoA metabolic process; NAS:UniProtKB.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   Gene3D; 3.40.50.12780; -; 2.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; AMP-dep_Synthh-like_sf.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Chromosomal rearrangement;
KW   Endoplasmic reticulum; Fatty acid metabolism; Ligase; Lipid metabolism;
KW   Magnesium; Membrane; Microsome; Mitochondrion;
KW   Mitochondrion outer membrane; Nucleotide-binding; Peroxisome;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..697
FT                   /note="Long-chain-fatty-acid--CoA ligase 6"
FT                   /id="PRO_0000193115"
FT   TRANSMEM        25..45
FT                   /note="Helical; Signal-anchor for type III membrane
FT                   protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        46..697
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1
FT                   /note="M -> MLTFFLVSGGSLWLFVEFVLSLLEKM (in isoform 1 and
FT                   isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:10048485"
FT                   /id="VSP_037819"
FT   VAR_SEQ         1
FT                   /note="M -> MPEFVLSLLEKM (in isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_046954"
FT   VAR_SEQ         31..65
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_037820"
FT   VAR_SEQ         192
FT                   /note="T -> TGLSCQEGASATASTQ (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:16834775"
FT                   /id="VSP_037821"
FT   VAR_SEQ         306..345
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_037822"
FT   VAR_SEQ         306..330
FT                   /note="KVIFPRQDDVLISFLPLAHMFERVI -> SQWAPTCADVHISYLPLAHMFER
FT                   MV (in isoform 3, isoform 2 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:10502316,
FT                   ECO:0000303|PubMed:10548543"
FT                   /id="VSP_021024"
FT   VAR_SEQ         306..312
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:16834775"
FT                   /id="VSP_037823"
FT   VAR_SEQ         653..697
FT                   /note="VKAIHIHSDMFSVQNGLLTPTLKAKRPELREYFKKQIEELYSISM -> DLP
FT                   QCLIQIKVFSKY (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10502316"
FT                   /id="VSP_000241"
FT   CONFLICT        19
FT                   /note="G -> E (in Ref. 1; AAD47199)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        46
FT                   /note="H -> Q (in Ref. 1; AAD47199)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        257
FT                   /note="E -> A (in Ref. 7; AAH47453)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        260
FT                   /note="Q -> L (in Ref. 7; AAH26161)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        356
FT                   /note="K -> R (in Ref. 3; AAZ30714)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        696
FT                   /note="S -> P (in Ref. 1; AAD47199 and 3; AAZ30714)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   697 AA;  77752 MW;  AC566177B47D0975 CRC64;
     MQTQEILRIL RLPELGDLGQ FFRSLSATTL VSMGALAAIL AYWFTHRPKA LQPPCNLLMQ
     SEEVEDSGGA RRSVIGSGPQ LLTHYYDDAR TMYQVFRRGL SISGNGPCLG FRKPKQPYQW
     LSYQEVADRA EFLGSGLLQH NCKACTDQFI GVFAQNRPEW IIVELACYTY SMVVVPLYDT
     LGPGAIRYII NTADISTVIV DKPQKAVLLL EHVERKETPG LKLIILMDPF EEALKERGQK
     CGVVIKSMQA VEDCGQENHQ APVPPQPDDL SIVCFTSGTT GNPKGAMLTH GNVVADFSGF
     LKVTEKVIFP RQDDVLISFL PLAHMFERVI QSVVYCHGGR VGFFQGDIRL LSDDMKALCP
     TIFPVVPRLL NRMYDKIFSQ ANTPLKRWLL EFAAKRKQAE VRSGIIRNDS IWDELFFNKI
     QASLGGCVRM IVTGAAPASP TVLGFLRAAL GCQVYEGYGQ TECTAGCTFT TPGDWTSGHV
     GAPLPCNHIK LVDVEELNYW ACKGEGEICV RGPNVFKGYL KDPDRTKEAL DSDGWLHTGD
     IGKWLPAGTL KIIDRKKHIF KLAQGEYVAP EKIENIYIRS QPVAQIYVHG DSLKAFLVGI
     VVPDPEVMPS WAQKRGIEGT YADLCTNKDL KKAILEDMVR LGKESGLHSF EQVKAIHIHS
     DMFSVQNGLL TPTLKAKRPE LREYFKKQIE ELYSISM
//
ID   Q5GIA7_HUMAN            Unreviewed;      1016 AA.
AC   Q5GIA7;
DT   01-MAR-2005, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2005, sequence version 1.
DT   11-DEC-2019, entry version 63.
DE   SubName: Full=Antigen MU-RMS-40.16A {ECO:0000313|EMBL:AAT44400.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAT44400.1};
RN   [1] {ECO:0000313|EMBL:AAT44400.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Embryonal rhabdomyosarcoma {ECO:0000313|EMBL:AAT44400.1};
RA   Behrends U., Gotz C., Mautner J.;
RT   "SEREX-defined rhabdomyosarcoma antigens.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY528715; AAT44400.1; -; mRNA.
DR   RefSeq; NP_005742.4; NM_005751.4.
DR   RefSeq; NP_671714.1; NM_147185.2.
DR   PeptideAtlas; Q5GIA7; -.
DR   PRIDE; Q5GIA7; -.
DR   GeneID; 10142; -.
DR   KEGG; hsa:10142; -.
DR   CTD; 10142; -.
DR   PharmGKB; PA24673; -.
DR   eggNOG; ENOG410II47; Eukaryota.
DR   eggNOG; ENOG41101YB; LUCA.
DR   KO; K16551; -.
DR   OrthoDB; 8180at2759; -.
DR   GenomeRNAi; 10142; -.
DR   Genevisible; Q5GIA7; HS.
DR   GO; GO:0060090; F:molecular adaptor activity; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   InterPro; IPR028745; AKAP9/Pericentrin.
DR   PANTHER; PTHR44981; PTHR44981; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   REGION          39..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          243..273
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          288..343
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          373..450
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          475..516
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          541..621
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          644..671
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          674..726
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          738..800
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          979..1016
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        52..72
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:AAT44400.1"
FT   NON_TER         1016
FT                   /evidence="ECO:0000313|EMBL:AAT44400.1"
SQ   SEQUENCE   1016 AA;  118199 MW;  58C4F432AF444604 CRC64;
     DNENLVSERE RVLLEELEAL KQLSLAGREK LCCELRNSST QTQNGNENQG EVEEQTFKEK
     ELDRKPEDVP PEILSNERYA LQKANNRLLK ILLEVVKTTA AVEETIGRHV LGILDRSSKS
     QSSASLIWRS EAEASVKSCV HEEHTRVTDE SIPSYSGSDM PRNDINMWSK VTEEGTELSQ
     RLVRSGFAGT EIDPENEELM LNISSRLQAA VEKLLEAISE TSSQLEHAKV TQTELMRESF
     RQKQEATESL KCQEELRERL HEESRAREQL AVELSKAEGV IDGYADEKTL FERQIQEKTD
     IIDRLEQELL CASNRLQELE AEQQQIQEER ELLSRQKEAM KAEAGPVEQQ LLQETEKLMK
     EKLEVQCQAE KVRDDLQKQV KALEIDVEEQ VSRFIELEQE KNTELMDLRQ QNQALEKQLE
     KMRKFLDEQA IDREHERDVF QQEIQKLEQQ LKVVPRFQPI SEHQTREVEQ LANHLKEKTD
     KCSELLLSKE QLQRDIQERN EEIEKLEFRV RELEQALLVS ADTFQKVEDR KHFGAVEAKP
     ELSLEVQLQA ERDAIDRKEK EITNLEEQLE QFREELENKN EEVQQLHMQL EIQKKESTTR
     LQELEQENKL FKDDMEKLGL AIKESDAMST QDQHVLFGKF AQIIQEKEVE IDQLNEQVTK
     LQQQLKITTD NKVIEEKNEL IRDLETQIEC LMSDQECVKR NREEEIEQLN EVIEKLQQEL
     ANIGQKTSMN AHSLSEEADS LKHQLDVVIA EKLALEQQVE TANEEMTFMK NVLKETNFKM
     NQLTQELFSL KRERESVEKI QSIPENSVNV AIDHLSKDKP ELEVVLTEDA LKSLENQTYF
     RSFEENGKGS IINLETRLLQ LESTVSAKDL ELTQCYKQIK DMQEQGQFET EMLQKKIVNL
     QKIVEEKVAA ALVSQIQLEA VQEYAKFCQD NQTISSEPER TNIQNLNQLR EDELGSDISA
     LTLRISELES QVVEMHTSLI LEKEQVEIAE KNVLEKEKKL LELQKLLEGN EKKQRE
//
ID   Q6PJH3_HUMAN            Unreviewed;       314 AA.
AC   Q6PJH3;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 121.
DE   SubName: Full=A kinase (PRKA) anchor protein (Yotiao) 9, isoform CRA_c {ECO:0000313|EMBL:EAW76862.1};
DE   SubName: Full=A-kinase anchor protein 9 {ECO:0000313|Ensembl:ENSP00000378065};
DE   SubName: Full=AKAP9 protein {ECO:0000313|EMBL:AAH15533.1};
GN   Name=AKAP9 {ECO:0000313|EMBL:EAW76862.1,
GN   ECO:0000313|Ensembl:ENSP00000378065};
GN   ORFNames=hCG_1812018 {ECO:0000313|EMBL:EAW76862.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH15533.1};
RN   [1] {ECO:0000313|EMBL:EAW76862.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000378065, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|EMBL:AAH15533.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus {ECO:0000313|EMBL:AAH15533.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000313|EMBL:EAW76862.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [6] {ECO:0000313|Ensembl:ENSP00000378065}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC000066; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC000120; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC003086; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004013; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458509; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015533; AAH15533.1; -; mRNA.
DR   EMBL; CH471091; EAW76862.1; -; Genomic_DNA.
DR   RefSeq; NP_005742.4; NM_005751.4.
DR   RefSeq; NP_671714.1; NM_147185.2.
DR   IntAct; Q6PJH3; 29.
DR   ProteomicsDB; 67207; -.
DR   Antibodypedia; 1376; 176 antibodies.
DR   Ensembl; ENST00000394564; ENSP00000378065; ENSG00000127914.
DR   GeneID; 10142; -.
DR   KEGG; hsa:10142; -.
DR   UCSC; uc003uld.5; human.
DR   CTD; 10142; -.
DR   EuPathDB; HostDB:ENSG00000127914.16; -.
DR   HGNC; HGNC:379; AKAP9.
DR   OpenTargets; ENSG00000127914; -.
DR   PharmGKB; PA24673; -.
DR   eggNOG; ENOG410II47; Eukaryota.
DR   eggNOG; ENOG41101YB; LUCA.
DR   GeneTree; ENSGT00730000110871; -.
DR   KO; K16551; -.
DR   OrthoDB; 8180at2759; -.
DR   ChiTaRS; AKAP9; human.
DR   GenomeRNAi; 10142; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000127914; Expressed in jejunal mucosa and 229 other tissues.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0060090; F:molecular adaptor activity; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   InterPro; IPR028745; AKAP9/Pericentrin.
DR   PANTHER; PTHR44981; PTHR44981; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils}; Kinase {ECO:0000313|EMBL:EAW76862.1};
KW   Proteomics identification {ECO:0000213|EPD:Q6PJH3,
KW   ECO:0000213|MaxQB:Q6PJH3, ECO:0000213|PeptideAtlas:Q6PJH3,
KW   ECO:0000213|ProteomicsDB:Q6PJH3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transferase {ECO:0000313|EMBL:EAW76862.1}.
FT   REGION          1..57
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          157..184
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          207..241
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          270..304
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        1..18
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   314 AA;  36171 MW;  70D4D3357B87EAEF CRC64;
     MEDEERQKKL EAGKAKLAQF RQRKAQSDGQ SPSKKQKKKR KTSSSKHDVS AHHDLNIDQS
     QCNEMYINSS QRVESTVIPE STIMRTLHSG EITSHEQGFS VELESEISTT ADDCSSEVNG
     CSFVMRTGKP TNLLREEEFG VDDSYSEQGA QDSPTHLEMM ESELAGKQHE IEELNRELEE
     MRVTYGTEGL QQLQEFEAAI KQRDGIITQL TANLQQARRE KDETMREFLE LTEQSQKLQI
     QFQQLQASET LRNSTHSSTA ADLLQAKQQI LTHQQQLEEQ DHLLEDYQKK KEDFTMQISF
     LQEKIKVYEM VCLF
//
ID   AKAP9_HUMAN             Reviewed;        3907 AA.
AC   Q99996; A4D1F0; A4D1F2; A4D1F4; O14869; O43355; O94895; Q75N20; Q9UQH3;
AC   Q9UQQ4; Q9Y6B8; Q9Y6Y2;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   25-APR-2018, sequence version 4.
DT   22-APR-2020, entry version 197.
DE   RecName: Full=A-kinase anchor protein 9;
DE            Short=AKAP-9;
DE   AltName: Full=A-kinase anchor protein 350 kDa;
DE            Short=AKAP 350;
DE            Short=hgAKAP 350;
DE   AltName: Full=A-kinase anchor protein 450 kDa;
DE            Short=AKAP 450;
DE   AltName: Full=AKAP 120-like protein;
DE   AltName: Full=Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};
DE            Short=CG-NAP {ECO:0000303|PubMed:10358086};
DE   AltName: Full=Protein hyperion {ECO:0000303|Ref.4};
DE   AltName: Full=Protein kinase A-anchoring protein 9;
DE            Short=PRKA9;
DE   AltName: Full=Protein yotiao {ECO:0000303|PubMed:9482789};
GN   Name=AKAP9; Synonyms=AKAP350, AKAP450, KIAA0803;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), FUNCTION (ISOFORM 4), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9482789; DOI=10.1523/jneurosci.18-06-02017.1998;
RA   Lin J.W., Wyszynski M., Madhavan R., Sealock R., Kim J.U., Sheng M.;
RT   "Yotiao, a novel protein of neuromuscular junction and brain that interacts
RT   with specific splice variants of NMDA receptor subunit NR1.";
RL   J. Neurosci. 18:2017-2027(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY, AND
RP   VARIANT GLN-1335 INS.
RX   PubMed=10202149; DOI=10.1093/emboj/18.7.1858;
RA   Witczak O., Skaalhegg B.S., Keryer G., Bornens M., Tasken K., Jahnsen T.,
RA   Oerstavik S.;
RT   "Cloning and characterization of a cDNA encoding an A-kinase anchoring
RT   protein located in the centrosome, AKAP450.";
RL   EMBO J. 18:1858-1868(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANTS ILE-463 AND SER-2979.
RC   TISSUE=Brain;
RX   PubMed=10358086; DOI=10.1074/jbc.274.24.17267;
RA   Takahashi M., Shibata H., Shimakawa M., Miyamoto M., Mukai H., Ono Y.;
RT   "Characterization of a novel giant scaffolding protein, CG-NAP, that
RT   anchors multiple signaling enzymes to centrosome and the Golgi apparatus.";
RL   J. Biol. Chem. 274:17267-17274(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Kemmner W.A., Deiss S., Schwarz U.;
RT   "Cloning of Hyperion.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 311-3907 (ISOFORM 2), NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 2145-3907 (ISOFORM 6), SUBCELLULAR LOCATION, AND VARIANT
RP   SER-2979.
RC   TISSUE=Gastric parietal cell, and Lung;
RX   PubMed=9915845; DOI=10.1074/jbc.274.5.3055;
RA   Schmidt P.H., Dransfield D.T., Claudio J.O., Hawley R.G., Trotter K.W.,
RA   Milgram S.L., Goldenring J.R.;
RT   "AKAP350, a multiply spliced protein kinase A-anchoring protein associated
RT   with centrosomes.";
RL   J. Biol. Chem. 274:3055-3066(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2200-3907 (ISOFORMS 2/3), AND
RP   VARIANT SER-2979.
RC   TISSUE=Brain;
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [9]
RP   INTERACTION WITH CLIC1; CLIC4 AND CLIC5.
RX   PubMed=12163479; DOI=10.1074/jbc.m112277200;
RA   Shanks R.A., Larocca M.C., Berryman M., Edwards J.C., Urushidani T.,
RA   Navarre J., Goldenring J.R.;
RT   "AKAP350 at the Golgi apparatus. II. Association of AKAP350 with a novel
RT   chloride intracellular channel (CLIC) family member.";
RL   J. Biol. Chem. 277:40973-40980(2002).
RN   [10]
RP   INTERACTION WITH CSNK1D, AND SUBCELLULAR LOCATION.
RX   PubMed=12270714; DOI=10.1016/s0022-2836(02)00857-4;
RA   Sillibourne J.E., Milne D.M., Takahashi M., Ono Y., Meek D.W.;
RT   "Centrosomal anchoring of the protein kinase CK1delta mediated by
RT   attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450.";
RL   J. Mol. Biol. 322:785-797(2002).
RN   [11]
RP   INTERACTION WITH KCNQ1.
RX   PubMed=11799244; DOI=10.1126/science.1066843;
RA   Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A.R.,
RA   Kass R.S.;
RT   "Requirement of a macromolecular signaling complex for beta adrenergic
RT   receptor modulation of the KCNQ1-KCNE1 potassium channel.";
RL   Science 295:496-499(2002).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [13]
RP   FUNCTION, INTERACTION WITH CIP4 AND FNBP1, AND SUBCELLULAR LOCATION.
RX   PubMed=15047863; DOI=10.1091/mbc.e03-10-0757;
RA   Larocca M.C., Shanks R.A., Tian L., Nelson D.L., Stewart D.M.,
RA   Goldenring J.R.;
RT   "AKAP350 interaction with cdc42 interacting protein 4 at the Golgi
RT   apparatus.";
RL   Mol. Biol. Cell 15:2771-2781(2004).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3865, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH GOLGA2.
RX   PubMed=19242490; DOI=10.1038/emboj.2009.47;
RA   Rivero S., Cardenas J., Bornens M., Rios R.M.;
RT   "Microtubule nucleation at the cis-side of the Golgi apparatus requires
RT   AKAP450 and GM130.";
RL   EMBO J. 28:1016-1028(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153 AND SER-3842, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1327; SER-1765; SER-3690;
RP   SER-3842 AND SER-3897, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   INTERACTION WITH PDE4DIP, AND SUBCELLULAR LOCATION.
RX   PubMed=25217626; DOI=10.1242/jcs.155408;
RA   Wang Z., Zhang C., Qi R.Z.;
RT   "A newly identified myomegalin isoform functions in Golgi microtubule
RT   organization and ER-Golgi transport.";
RL   J. Cell Sci. 127:4904-4917(2014).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25657325; DOI=10.1091/mbc.e14-09-1366;
RA   Ohta S., Wood L., Toramoto I., Yagyu K., Fukagawa T., Earnshaw W.C.;
RT   "CENP-32 is required to maintain centrosomal dominance in bipolar spindle
RT   assembly.";
RL   Mol. Biol. Cell 26:1225-1237(2015).
RN   [22]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PDE4DIP; GAMMA-TUBULIN
RP   RING COMPLEX AND CAMSAP2.
RX   PubMed=27666745; DOI=10.1016/j.devcel.2016.08.009;
RA   Wu J., de Heus C., Liu Q., Bouchet B.P., Noordstra I., Jiang K., Hua S.,
RA   Martin M., Yang C., Grigoriev I., Katrukha E.A., Altelaar A.F.,
RA   Hoogenraad C.C., Qi R.Z., Klumperman J., Akhmanova A.;
RT   "Molecular pathway of microtubule organization at the Golgi apparatus.";
RL   Dev. Cell 39:44-60(2016).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH PDE4DIP; MAPRE1 AND MAPRE3.
RX   PubMed=28814570; DOI=10.1083/jcb.201701024;
RA   Yang C., Wu J., de Heus C., Grigoriev I., Liv N., Yao Y., Smal I.,
RA   Meijering E., Klumperman J., Qi R.Z., Akhmanova A.;
RT   "EB1 and EB3 regulate microtubule minus end organization and Golgi
RT   morphology.";
RL   J. Cell Biol. 216:3179-3198(2017).
RN   [24]
RP   INTERACTION WITH CAMSAP3.
RX   PubMed=28089391; DOI=10.1016/j.jgg.2016.11.005;
RA   Wang J., Xu H., Jiang Y., Takahashi M., Takeichi M., Meng W.;
RT   "CAMSAP3-dependent microtubule dynamics regulates Golgi assembly in
RT   epithelial cells.";
RL   J. Genet. Genomics 44:39-49(2017).
RN   [25]
RP   FUNCTION, INTERACTION WITH CDK5RAP2; MAPRE1 AND PDE4DIP, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=29162697; DOI=10.1073/pnas.1705682114;
RA   Bouguenina H., Salaun D., Mangon A., Muller L., Baudelet E., Camoin L.,
RA   Tachibana T., Cianferani S., Audebert S., Verdier-Pinard P., Badache A.;
RT   "EB1-binding-myomegalin protein complex promotes centrosomal microtubules
RT   functions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:E10687-E10696(2017).
RN   [26]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-2409 AND GLN-3297.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [27]
RP   VARIANT LQT11 LEU-1570.
RX   PubMed=18093912; DOI=10.1073/pnas.0710527105;
RA   Chen L., Marquardt M.L., Tester D.J., Sampson K.J., Ackerman M.J.,
RA   Kass R.S.;
RT   "Mutation of an A-kinase-anchoring protein causes long-QT syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:20990-20995(2007).
CC   -!- FUNCTION: Scaffolding protein that assembles several protein kinases
CC       and phosphatases on the centrosome and Golgi apparatus. Required to
CC       maintain the integrity of the Golgi apparatus (PubMed:10202149,
CC       PubMed:15047863). Required for microtubule nucleation at the cis-side
CC       of the Golgi apparatus (PubMed:15047863, PubMed:19242490). Required for
CC       association of the centrosomes with the poles of the bipolar mitotic
CC       spindle during metaphase (PubMed:25657325). In complex with PDE4DIP
CC       isoform 13/MMG8/SMYLE, recruits CAMSAP2 to the Golgi apparatus and
CC       tethers non-centrosomal minus-end microtubules to the Golgi, an
CC       important step for polarized cell movement (PubMed:27666745,
CC       PubMed:28814570). In complex with PDE4DIP isoform 13/MMG8/SMYLE,
CC       EB1/MAPRE1 and CDK5RAP2, contributes to microtubules nucleation and
CC       extension also from the centrosome to the cell periphery
CC       (PubMed:29162697). {ECO:0000269|PubMed:10202149,
CC       ECO:0000269|PubMed:15047863, ECO:0000269|PubMed:19242490,
CC       ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:27666745,
CC       ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697}.
CC   -!- FUNCTION: [Isoform 4]: Associated with the N-methyl-D-aspartate
CC       receptor and is specifically found in the neuromuscular junction (NMJ)
CC       as well as in neuronal synapses, suggesting a role in the organization
CC       of postsynaptic specializations. {ECO:0000269|PubMed:9482789}.
CC   -!- SUBUNIT: Interacts with the regulatory region of protein kinase N
CC       (PKN), protein phosphatase 2A (PP2A), protein phosphatase 1 (PP1) and
CC       the immature non-phosphorylated form of PKC epsilon. Interacts with
CC       CIP4 and FNBP1 (PubMed:15047863). Interacts with chloride intracellular
CC       channel proteins CLIC1, CLIC4 and CLIC5 (PubMed:12163479). CSNK1D
CC       binding promotes its centrosomal subcellular location
CC       (PubMed:12270714). Interacts with GM130/GOLGA2; leading to recruitment
CC       to the Golgi apparatus (PubMed:19242490). Interacts with KCNQ1; targets
CC       protein kinase A (PKA) catalytic and regulatory subunits and protein
CC       phosphatase 1 (PP1), to the heterodimer KCNQ1-KCNE1 (PubMed:11799244).
CC       Interacts with PDE4DIP isoform 13/MMG8/SMYLE; this interaction
CC       stabilizes both proteins (PubMed:25217626, PubMed:27666745,
CC       PubMed:28814570). In complex with PDE4DIP isoform 13, recruits CAMSAP2
CC       to the Golgi apparatus (PubMed:27666745, PubMed:28814570). Forms a
CC       pericentrosomal complex with CDK5RAP2, EB1/MAPRE1 and PDE4DIP isoform
CC       13; within this complex, MAPRE1 binding to CDK5RAP2 may be mediated by
CC       PDE4DIP (PubMed:29162697). Interacts with MAPRE1 and MAPRE3
CC       (PubMed:28814570). Interacts (via C-terminus) with CAMSAP2; this
CC       interaction is much stronger in the presence of PDE4DIP isoform
CC       13/MMG8/SMYLE (PubMed:27666745). Interacts with CAMSAP3
CC       (PubMed:28089391). Interacts (via C-terminus) with the gamma-tubulin
CC       ring complex (gamma-TuRC), composed of gamma-tubulin, TUBGCP2, TUBGCP3,
CC       TUBGCP4, TUBGCP5 and TUBGCP6 (PubMed:27666745).
CC       {ECO:0000269|PubMed:11799244, ECO:0000269|PubMed:12163479,
CC       ECO:0000269|PubMed:12270714, ECO:0000269|PubMed:15047863,
CC       ECO:0000269|PubMed:19242490, ECO:0000269|PubMed:25217626,
CC       ECO:0000269|PubMed:27666745, ECO:0000269|PubMed:28089391,
CC       ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697}.
CC   -!- INTERACTION:
CC       Q99996-4; P26769: Adcy2; Xeno; NbExp=3; IntAct=EBI-15676518, EBI-1027877;
CC       Q99996-2; Q9H2G9: BLZF1; NbExp=3; IntAct=EBI-9641546, EBI-2548012;
CC       Q99996-2; Q6P1W5: C1orf94; NbExp=3; IntAct=EBI-9641546, EBI-946029;
CC       Q99996; Q08379: GOLGA2; NbExp=3; IntAct=EBI-1048311, EBI-618309;
CC       Q99996-2; P52272: HNRNPM; NbExp=3; IntAct=EBI-9641546, EBI-486809;
CC       Q99996-2; Q9UKT9: IKZF3; NbExp=3; IntAct=EBI-9641546, EBI-747204;
CC       Q99996; O60341: KDM1A; NbExp=2; IntAct=EBI-1048311, EBI-710124;
CC       Q99996-2; P43360: MAGEA6; NbExp=3; IntAct=EBI-9641546, EBI-1045155;
CC       Q99996-2; Q9Y5V3: MAGED1; NbExp=3; IntAct=EBI-9641546, EBI-716006;
CC       Q99996-2; Q9GZV8: PRDM14; NbExp=3; IntAct=EBI-9641546, EBI-3957793;
CC       Q99996-2; Q8N6K7: SAMD3; NbExp=3; IntAct=EBI-9641546, EBI-748741;
CC       Q99996-2; Q16385: SSX2B; NbExp=4; IntAct=EBI-9641546, EBI-2210673;
CC       Q99996-2; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-9641546, EBI-741515;
CC       Q99996-2; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-9641546, EBI-739895;
CC       Q99996-2; O60763: USO1; NbExp=3; IntAct=EBI-9641546, EBI-356164;
CC       Q99996-2; Q9BTA9: WAC; NbExp=3; IntAct=EBI-9641546, EBI-749118;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus {ECO:0000269|PubMed:15047863,
CC       ECO:0000269|PubMed:19242490, ECO:0000269|PubMed:25217626,
CC       ECO:0000269|PubMed:27666745}. Cytoplasm {ECO:0000269|PubMed:9915845}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:12270714, ECO:0000269|PubMed:14654843,
CC       ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:29162697,
CC       ECO:0000269|PubMed:9915845}. Note=Cytoplasmic in parietal cells
CC       (PubMed:9915845). Recruited to the Golgi apparatus by GM130/GOLGA2
CC       (PubMed:25657325). Localization at the centrosome versus Golgi
CC       apparatus may be cell line-dependent. In SKBr3 and HEK293F cells,
CC       exclusively located at the centrosome (PubMed:29162697). In HeLa, MDA-
CC       MB231 and RPE-1 cells, detected at the Golgi apparatus
CC       (PubMed:25217626, PubMed:29162697). In SK-BR-3 cells, recruited to the
CC       centrosome in the presence of CDK5RAP2 (PubMed:29162697).
CC       {ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:25657325,
CC       ECO:0000269|PubMed:29162697, ECO:0000269|PubMed:9915845}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=2;
CC         IsoId=Q99996-2; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q99996-1; Sequence=VSP_059522, VSP_059526;
CC       Name=3; Synonyms=CG-NAP;
CC         IsoId=Q99996-3; Sequence=VSP_059525;
CC       Name=4; Synonyms=Yotiao;
CC         IsoId=Q99996-4; Sequence=VSP_059522, VSP_059523, VSP_059524;
CC       Name=5;
CC         IsoId=Q99996-5; Sequence=VSP_059522, VSP_059527;
CC       Name=6; Synonyms=AKAP350;
CC         IsoId=Q99996-6; Sequence=VSP_059522, VSP_059525, VSP_059528;
CC   -!- TISSUE SPECIFICITY: Widely expressed (PubMed:10202149). Isoform 4:
CC       Highly expressed in skeletal muscle and in pancreas (PubMed:9482789).
CC       {ECO:0000269|PubMed:10202149, ECO:0000269|PubMed:9482789}.
CC   -!- DOMAIN: RII-binding site, predicted to form an amphipathic helix, could
CC       participate in protein-protein interactions with a complementary
CC       surface on the R-subunit dimer. {ECO:0000250|UniProtKB:Q28628}.
CC   -!- DISEASE: Long QT syndrome 11 (LQT11) [MIM:611820]: A heart disorder
CC       characterized by a prolonged QT interval on the ECG and polymorphic
CC       ventricular arrhythmias. They cause syncope and sudden death in
CC       response to exercise or emotional stress, and can present with a
CC       sentinel event of sudden cardiac death in infancy.
CC       {ECO:0000269|PubMed:18093912}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB86384.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAC60380.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AKAP9ID42999ch7q21.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ131693; CAB40713.1; -; mRNA.
DR   EMBL; AB019691; BAA78718.1; -; mRNA.
DR   EMBL; AJ010770; CAA09361.1; -; Genomic_DNA.
DR   EMBL; AF026245; AAB86384.1; ALT_FRAME; mRNA.
DR   EMBL; AC004013; AAB96867.2; -; Genomic_DNA.
DR   EMBL; AC000066; AAC60380.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC000120; AAS07419.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24155.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24156.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24157.1; -; Genomic_DNA.
DR   EMBL; AF083037; AAD22767.1; -; mRNA.
DR   EMBL; AF091711; AAD39719.1; -; mRNA.
DR   EMBL; AB018346; BAA34523.1; -; mRNA.
DR   CCDS; CCDS5622.1; -. [Q99996-2]
DR   PIR; T08880; T08880.
DR   RefSeq; NP_005742.4; NM_005751.4. [Q99996-2]
DR   RefSeq; NP_671714.1; NM_147185.2. [Q99996-3]
DR   SMR; Q99996; -.
DR   BioGrid; 115445; 104.
DR   CORUM; Q99996; -.
DR   DIP; DIP-29942N; -.
DR   IntAct; Q99996; 73.
DR   MINT; Q99996; -.
DR   STRING; 9606.ENSP00000348573; -.
DR   CarbonylDB; Q99996; -.
DR   iPTMnet; Q99996; -.
DR   MetOSite; Q99996; -.
DR   PhosphoSitePlus; Q99996; -.
DR   SwissPalm; Q99996; -.
DR   BioMuta; AKAP9; -.
DR   DMDM; 14194461; -.
DR   EPD; Q99996; -.
DR   jPOST; Q99996; -.
DR   MassIVE; Q99996; -.
DR   PaxDb; Q99996; -.
DR   PeptideAtlas; Q99996; -.
DR   PRIDE; Q99996; -.
DR   ProteomicsDB; 78566; -. [Q99996-1]
DR   ProteomicsDB; 78567; -. [Q99996-2]
DR   ProteomicsDB; 78568; -. [Q99996-3]
DR   ProteomicsDB; 78569; -. [Q99996-4]
DR   ProteomicsDB; 78570; -. [Q99996-5]
DR   ProteomicsDB; 78571; -. [Q99996-6]
DR   Antibodypedia; 1376; 176 antibodies.
DR   Ensembl; ENST00000356239; ENSP00000348573; ENSG00000127914. [Q99996-2]
DR   GeneID; 10142; -.
DR   KEGG; hsa:10142; -.
DR   UCSC; uc003ulg.4; human. [Q99996-2]
DR   CTD; 10142; -.
DR   DisGeNET; 10142; -.
DR   GeneCards; AKAP9; -.
DR   GeneReviews; AKAP9; -.
DR   HGNC; HGNC:379; AKAP9.
DR   HPA; ENSG00000127914; Low tissue specificity.
DR   MalaCards; AKAP9; -.
DR   MIM; 604001; gene.
DR   MIM; 611820; phenotype.
DR   neXtProt; NX_Q99996; -.
DR   OpenTargets; ENSG00000127914; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 101016; Romano-Ward syndrome.
DR   PharmGKB; PA24673; -.
DR   eggNOG; ENOG410II47; Eukaryota.
DR   eggNOG; ENOG41101YB; LUCA.
DR   GeneTree; ENSGT00730000110871; -.
DR   HOGENOM; CLU_000187_0_0_1; -.
DR   InParanoid; Q99996; -.
DR   KO; K16551; -.
DR   OrthoDB; 8180at2759; -.
DR   PhylomeDB; Q99996; -.
DR   TreeFam; TF105408; -.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5576890; Phase 3 - rapid repolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SignaLink; Q99996; -.
DR   ChiTaRS; AKAP9; human.
DR   GeneWiki; AKAP9; -.
DR   GenomeRNAi; 10142; -.
DR   Pharos; Q99996; Tbio.
DR   PRO; PR:Q99996; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q99996; protein.
DR   Bgee; ENSG00000127914; Expressed in jejunal mucosa and 229 other tissues.
DR   ExpressionAtlas; Q99996; baseline and differential.
DR   Genevisible; Q99996; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005801; C:cis-Golgi network; IDA:SYSCILIA_CCNET.
DR   GO; GO:0005856; C:cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0044307; C:dendritic branch; IEA:Ensembl.
DR   GO; GO:0099147; C:extrinsic component of postsynaptic density membrane; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005795; C:Golgi stack; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0097060; C:synaptic membrane; IBA:GO_Central.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0060090; F:molecular adaptor activity; IDA:UniProtKB.
DR   GO; GO:0015459; F:potassium channel regulator activity; IMP:BHF-UCL.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; IPI:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; TAS:ProtInc.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0071320; P:cellular response to cAMP; IMP:BHF-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0051661; P:maintenance of centrosome location; IMP:UniProtKB.
DR   GO; GO:0007020; P:microtubule nucleation; IMP:UniProtKB.
DR   GO; GO:0007194; P:negative regulation of adenylate cyclase activity; IEA:Ensembl.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:BHF-UCL.
DR   GO; GO:1901018; P:positive regulation of potassium ion transmembrane transporter activity; IMP:BHF-UCL.
DR   GO; GO:0098909; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; IMP:BHF-UCL.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:1903358; P:regulation of Golgi organization; IDA:UniProtKB.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0060306; P:regulation of membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0098962; P:regulation of postsynaptic neurotransmitter receptor activity; IDA:SynGO.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR028745; AKAP9/Pericentrin.
DR   InterPro; IPR005539; ELK_dom.
DR   InterPro; IPR019528; PACT_domain.
DR   PANTHER; PTHR44981; PTHR44981; 1.
DR   Pfam; PF10495; PACT_coil_coil; 1.
DR   SMART; SM01188; ELK; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Disease mutation; Golgi apparatus; Long QT syndrome; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN           1..3907
FT                   /note="A-kinase anchor protein 9"
FT                   /id="PRO_0000064534"
FT   REGION          2542..2555
FT                   /note="PKA-RII subunit binding domain"
FT   COILED          152..902
FT                   /evidence="ECO:0000255"
FT   COILED          932..1010
FT                   /evidence="ECO:0000255"
FT   COILED          1088..1173
FT                   /evidence="ECO:0000255"
FT   COILED          1241..1268
FT                   /evidence="ECO:0000255"
FT   COILED          1324..1380
FT                   /evidence="ECO:0000255"
FT   COILED          1422..1447
FT                   /evidence="ECO:0000255"
FT   COILED          1573..1647
FT                   /evidence="ECO:0000255"
FT   COILED          1845..2443
FT                   /evidence="ECO:0000255"
FT   COILED          2532..2549
FT                   /evidence="ECO:0000255"
FT   COILED          2591..2764
FT                   /evidence="ECO:0000255"
FT   COILED          3061..3088
FT                   /evidence="ECO:0000255"
FT   COILED          3120..3466
FT                   /evidence="ECO:0000255"
FT   COILED          3583..3685
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        191..280
FT                   /note="Gln-rich"
FT   COMPBIAS        309..998
FT                   /note="Glu-rich"
FT   COMPBIAS        1834..2760
FT                   /note="Glu-rich"
FT   COMPBIAS        3722..3726
FT                   /note="Poly-Leu"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         1327
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1765
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         3690
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         3842
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         3865
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   MOD_RES         3897
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         16
FT                   /note="K -> KIEELSLAFLVRQ (in isoform 1, isoform 4, isoform
FT                   5 and isoform 6)"
FT                   /id="VSP_059522"
FT   VAR_SEQ         1625..3900
FT                   /note="Missing (in isoform 4)"
FT                   /id="VSP_059523"
FT   VAR_SEQ         2163..2171
FT                   /note="SADTFQKVE -> E (in isoform 3 and isoform 6)"
FT                   /id="VSP_059525"
FT   VAR_SEQ         2883..2903
FT                   /note="GSSIPELAHSDAYQTREICSS -> VFGFYNMCFSTLC (in isoform
FT                   1)"
FT                   /id="VSP_059526"
FT   VAR_SEQ         2884..2945
FT                   /note="Missing (in isoform 5)"
FT                   /id="VSP_059527"
FT   VAR_SEQ         3897..3907
FT                   /note="STTQFHAGMRR -> ALSLTTSWQHHSARPTAPLFFEILSHSLG (in
FT                   isoform 6)"
FT                   /id="VSP_059528"
FT   VAR_SEQ         3901..3907
FT                   /note="FHAGMRR -> LAQVRVL (in isoform 4)"
FT                   /id="VSP_059524"
FT   VARIANT         463
FT                   /note="M -> I (in dbSNP:rs6964587)"
FT                   /evidence="ECO:0000269|PubMed:10358086"
FT                   /id="VAR_024249"
FT   VARIANT         1335
FT                   /note="K -> KQ"
FT                   /evidence="ECO:0000269|PubMed:10202149"
FT                   /id="VAR_010926"
FT   VARIANT         1570
FT                   /note="S -> L (in LQT11; dbSNP:rs121908566)"
FT                   /evidence="ECO:0000269|PubMed:18093912"
FT                   /id="VAR_043489"
FT   VARIANT         2409
FT                   /note="M -> I (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035785"
FT   VARIANT         2484
FT                   /note="K -> R (in dbSNP:rs35759833)"
FT                   /id="VAR_043490"
FT   VARIANT         2792
FT                   /note="N -> S (in dbSNP:rs6960867)"
FT                   /id="VAR_030162"
FT   VARIANT         2979
FT                   /note="P -> S (in dbSNP:rs1063242)"
FT                   /evidence="ECO:0000269|PubMed:10358086,
FT                   ECO:0000269|PubMed:9872452, ECO:0000269|PubMed:9915845"
FT                   /id="VAR_030163"
FT   VARIANT         3297
FT                   /note="E -> Q (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs756245027)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035786"
FT   VARIANT         3444
FT                   /note="Q -> R (in dbSNP:rs34956633)"
FT                   /id="VAR_043491"
FT   VARIANT         3614
FT                   /note="M -> V (in dbSNP:rs34327395)"
FT                   /id="VAR_043492"
FT   CONFLICT        64
FT                   /note="E -> Q (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        542
FT                   /note="E -> G (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        626
FT                   /note="R -> S (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        651
FT                   /note="N -> S (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        901
FT                   /note="H -> N (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        944
FT                   /note="K -> N (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        968..970
FT                   /note="QKH -> PKP (in Ref. 1; AAB86384 and 2; CAB40713)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        985
FT                   /note="Q -> P (in Ref. 1; AAB86384 and 2; CAB40713)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        989
FT                   /note="Q -> P (in Ref. 1; AAB86384 and 2; CAB40713)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1008
FT                   /note="N -> D (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1016
FT                   /note="V -> E (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1614
FT                   /note="R -> P (in Ref. 1; AAB86384 and 2; CAB40713)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1691
FT                   /note="N -> T (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1695
FT                   /note="V -> G (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1790..1791
FT                   /note="Missing (in Ref. 7; AAD22767)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1831
FT                   /note="A -> P (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1944
FT                   /note="I -> V (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2015
FT                   /note="V -> D (in Ref. 7; AAD22767)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2145..2146
FT                   /note="EI -> HE (in Ref. 7; AAD39719)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2157
FT                   /note="E -> V (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2171
FT                   /note="E -> Q (in Ref. 7; AAD39719)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2502
FT                   /note="L -> R (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2839
FT                   /note="I -> N (in Ref. 8; BAA34523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2953
FT                   /note="E -> D (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3083
FT                   /note="Q -> H (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3214
FT                   /note="Q -> H (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3303..3305
FT                   /note="ESE -> QSQ (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3747
FT                   /note="P -> A (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3829
FT                   /note="T -> S (in Ref. 3; BAA78718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        Q99996-6:2175
FT                   /note="E -> Q (in Ref. 7; AAD39719)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   3907 AA;  452987 MW;  81761B4341430CDF CRC64;
     MEDEERQKKL EAGKAKLAQF RQRKAQSDGQ SPSKKQKKKR KTSSSKHDVS AHHDLNIDQS
     QCNEMYINSS QRVESTVIPE STIMRTLHSG EITSHEQGFS VELESEISTT ADDCSSEVNG
     CSFVMRTGKP TNLLREEEFG VDDSYSEQGA QDSPTHLEMM ESELAGKQHE IEELNRELEE
     MRVTYGTEGL QQLQEFEAAI KQRDGIITQL TANLQQARRE KDETMREFLE LTEQSQKLQI
     QFQQLQASET LRNSTHSSTA ADLLQAKQQI LTHQQQLEEQ DHLLEDYQKK KEDFTMQISF
     LQEKIKVYEM EQDKKVENSN KEEIQEKETI IEELNTKIIE EEKKTLELKD KLTTADKLLG
     ELQEQIVQKN QEIKNMKLEL TNSKQKERQS SEEIKQLMGT VEELQKRNHK DSQFETDIVQ
     RMEQETQRKL EQLRAELDEM YGQQIVQMKQ ELIRQHMAQM EEMKTRHKGE MENALRSYSN
     ITVNEDQIKL MNVAINELNI KLQDTNSQKE KLKEELGLIL EEKCALQRQL EDLVEELSFS
     REQIQRARQT IAEQESKLNE AHKSLSTVED LKAEIVSASE SRKELELKHE AEVTNYKIKL
     EMLEKEKNAV LDRMAESQEA ELERLRTQLL FSHEEELSKL KEDLEIEHRI NIEKLKDNLG
     IHYKQQIDGL QNEMSQKIET MQFEKDNLIT KQNQLILEIS KLKDLQQSLV NSKSEEMTLQ
     INELQKEIEI LRQEEKEKGT LEQEVQELQL KTELLEKQMK EKENDLQEKF AQLEAENSIL
     KDEKKTLEDM LKIHTPVSQE ERLIFLDSIK SKSKDSVWEK EIEILIEENE DLKQQCIQLN
     EEIEKQRNTF SFAEKNFEVN YQELQEEYAC LLKVKDDLED SKNKQELEYK SKLKALNEEL
     HLQRINPTTV KMKSSVFDED KTFVAETLEM GEVVEKDTTE LMEKLEVTKR EKLELSQRLS
     DLSEQLKQKH GEISFLNEEV KSLKQEKEQV SLRCRELEII INHNRAENVQ SCDTQVSSLL
     DGVVTMTSRG AEGSVSKVNK SFGEESKIMV EDKVSFENMT VGEESKQEQL ILDHLPSVTK
     ESSLRATQPS ENDKLQKELN VLKSEQNDLR LQMEAQRICL SLVYSTHVDQ VREYMENEKD
     KALCSLKEEL IFAQEEKIKE LQKIHQLELQ TMKTQETGDE GKPLHLLIGK LQKAVSEECS
     YFLQTLCSVL GEYYTPALKC EVNAEDKENS GDYISENEDP ELQDYRYEVQ DFQENMHTLL
     NKVTEEYNKL LVLQTRLSKI WGQQTDGMKL EFGEENLPKE ETEFLSIHSQ MTNLEDIDVN
     HKSKLSSLQD LEKTKLEEQV QELESLISSL QQQLKETEQN YEAEIHCLQK RLQAVSESTV
     PPSLPVDSVV ITESDAQRTM YPGSCVKKNI DGTIEFSGEF GVKEETNIVK LLEKQYQEQL
     EEEVAKVIVS MSIAFAQQTE LSRISGGKEN TASSKQAHAV CQQEQHYFNE MKLSQDQIGF
     QTFETVDVKF KEEFKPLSKE LGEHGKEILL SNSDPHDIPE SKDCVLTISE EMFSKDKTFI
     VRQSIHDEIS VSSMDASRQL MLNEEQLEDM RQELVRQYQE HQQATELLRQ AHMRQMERQR
     EDQEQLQEEI KRLNRQLAQR SSIDNENLVS ERERVLLEEL EALKQLSLAG REKLCCELRN
     SSTQTQNGNE NQGEVEEQTF KEKELDRKPE DVPPEILSNE RYALQKANNR LLKILLEVVK
     TTAAVEETIG RHVLGILDRS SKSQSSASLI WRSEAEASVK SCVHEEHTRV TDESIPSYSG
     SDMPRNDINM WSKVTEEGTE LSQRLVRSGF AGTEIDPENE ELMLNISSRL QAAVEKLLEA
     ISETSSQLEH AKVTQTELMR ESFRQKQEAT ESLKCQEELR ERLHEESRAR EQLAVELSKA
     EGVIDGYADE KTLFERQIQE KTDIIDRLEQ ELLCASNRLQ ELEAEQQQIQ EERELLSRQK
     EAMKAEAGPV EQQLLQETEK LMKEKLEVQC QAEKVRDDLQ KQVKALEIDV EEQVSRFIEL
     EQEKNTELMD LRQQNQALEK QLEKMRKFLD EQAIDREHER DVFQQEIQKL EQQLKVVPRF
     QPISEHQTRE VEQLANHLKE KTDKCSELLL SKEQLQRDIQ ERNEEIEKLE FRVRELEQAL
     LVSADTFQKV EDRKHFGAVE AKPELSLEVQ LQAERDAIDR KEKEITNLEE QLEQFREELE
     NKNEEVQQLH MQLEIQKKES TTRLQELEQE NKLFKDDMEK LGLAIKESDA MSTQDQHVLF
     GKFAQIIQEK EVEIDQLNEQ VTKLQQQLKI TTDNKVIEEK NELIRDLETQ IECLMSDQEC
     VKRNREEEIE QLNEVIEKLQ QELANIGQKT SMNAHSLSEE ADSLKHQLDV VIAEKLALEQ
     QVETANEEMT FMKNVLKETN FKMNQLTQEL FSLKRERESV EKIQSIPENS VNVAIDHLSK
     DKPELEVVLT EDALKSLENQ TYFKSFEENG KGSIINLETR LLQLESTVSA KDLELTQCYK
     QIKDMQEQGQ FETEMLQKKI VNLQKIVEEK VAAALVSQIQ LEAVQEYAKF CQDNQTISSE
     PERTNIQNLN QLREDELGSD ISALTLRISE LESQVVEMHT SLILEKEQVE IAEKNVLEKE
     KKLLELQKLL EGNEKKQREK EKKRSPQDVE VLKTTTELFH SNEESGFFNE LEALRAESVA
     TKAELASYKE KAEKLQEELL VKETNMTSLQ KDLSQVRDHL AEAKEKLSIL EKEDETEVQE
     SKKACMFEPL PIKLSKSIAS QTDGTLKISS SNQTPQILVK NAGIQINLQS ECSSEEVTEI
     ISQFTEKIEK MQELHAAEIL DMESRHISET ETLKREHYVA VQLLKEECGT LKAVIQCLRS
     KEGSSIPELA HSDAYQTREI CSSDSGSDWG QGIYLTHSQG FDIASEGRGE ESESATDSFP
     KKIKGLLRAV HNEGMQVLSL TESPYSDGED HSIQQVSEPW LEERKAYINT ISSLKDLITK
     MQLQREAEVY DSSQSHESFS DWRGELLLAL QQVFLEERSV LLAAFRTELT ALGTTDAVGL
     LNCLEQRIQE QGVEYQAAME CLQKADRRSL LSEIQALHAQ MNGRKITLKR EQESEKPSQE
     LLEYNIQQKQ SQMLEMQVEL SSMKDRATEL QEQLSSEKMV VAELKSELAQ TKLELETTLK
     AQHKHLKELE AFRLEVKDKT DEVHLLNDTL ASEQKKSREL QWALEKEKAK LGRSEERDKE
     ELEDLKFSLE SQKQRNLQLN LLLEQQKQLL NESQQKIESQ RMLYDAQLSE EQGRNLELQV
     LLESEKVRIR EMSSTLDRER ELHAQLQSSD GTGQSRPPLP SEDLLKELQK QLEEKHSRIV
     ELLNETEKYK LDSLQTRQQM EKDRQVHRKT LQTEQEANTE GQKKMHELQS KVEDLQRQLE
     EKRQQVYKLD LEGQRLQGIM QEFQKQELER EEKRESRRIL YQNLNEPTTW SLTSDRTRNW
     VLQQKIEGET KESNYAKLIE MNGGGTGCNH ELEMIRQKLQ CVASKLQVLP QKASERLQFE
     TADDEDFIWV QENIDEIILQ LQKLTGQQGE EPSLVSPSTS CGSLTERLLR QNAELTGHIS
     QLTEEKNDLR NMVMKLEEQI RWYRQTGAGR DNSSRFSLNG GANIEAIIAS EKEVWNREKL
     TLQKSLKRAE AEVYKLKAEL RNDSLLQTLS PDSEHVTLKR IYGKYLRAES FRKALIYQKK
     YLLLLLGGFQ ECEDATLALL ARMGGQPAFT DLEVITNRPK GFTRFRSAVR VSIAISRMKF
     LVRRWHRVTG SVSININRDG FGLNQGAEKT DSFYHSSGGL ELYGEPRHTT YRSRSDLDYI
     RSPLPFQNRY PGTPADFNPG SLACSQLQNY DPDRALTDYI TRLEALQRRL GTIQSGSTTQ
     FHAGMRR
//
ID   A0A384NPN7_HUMAN        Unreviewed;       517 AA.
AC   A0A384NPN7;
DT   05-DEC-2018, integrated into UniProtKB/TrEMBL.
DT   05-DEC-2018, sequence version 1.
DT   22-APR-2020, entry version 9.
DE   SubName: Full=Aldehyde dehydrogenase 2 family (Mitochondrial), isoform CRA_c {ECO:0000313|EMBL:EAW97975.1};
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22228.1};
GN   Name=ALDH2 {ECO:0000313|EMBL:EAW97975.1};
GN   ORFNames=hCG_2039620 {ECO:0000313|EMBL:EAW97975.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADO22228.1};
RN   [1] {ECO:0000313|EMBL:EAW97975.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW97975.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADO22228.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C., Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000256|RuleBase:RU003345}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ891366; ADO22228.1; -; mRNA.
DR   EMBL; CH471054; EAW97975.1; -; Genomic_DNA.
DR   RefSeq; NP_000681.2; NM_000690.3.
DR   Antibodypedia; 31130; 628 antibodies.
DR   GeneID; 217; -.
DR   KEGG; hsa:217; -.
DR   CTD; 217; -.
DR   KO; K00128; -.
DR   OMA; NYIVGGL; -.
DR   ChiTaRS; ALDH2; human.
DR   GO; GO:0016620; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; IEA:InterPro.
DR   Gene3D; 3.40.309.10; -; 1.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   2: Evidence at transcript level;
KW   Oxidoreductase {ECO:0000256|RuleBase:RU003345}.
FT   DOMAIN          45..508
FT                   /note="Aldedh"
FT                   /evidence="ECO:0000259|Pfam:PF00171"
FT   ACT_SITE        285
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU10007"
FT   ACT_SITE        319
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU10008"
SQ   SEQUENCE   517 AA;  56381 MW;  E8F74D44D285A00E CRC64;
     MLRAAARFGP RLGRRLLSAA ATQAVPAPNQ QPEVFCNQIF INNEWHDAVS RKTFPTVNPS
     TGEVICQVAE GDKEDVDKAV KAARAAFQLG SPWRRMDASH RGRLLNRLAD LIERDRTYLA
     ALETLDNGKP YVISYLVDLD MVLKCLRYYA GWADKYHGKT IPIDGDFFSY TRHEPVGVCG
     QIIPWNFPLL MQAWKLGPAL ATGNVVVMKV AEQTPLTALY VANLIKEAGF PPGVVNIVPG
     FGPTAGAAIA SHEDVDKVAF TGSTEIGRVI QVAAGSSNLK RVTLELGGKS PNIIMSDADM
     DWAVEQAHFA LFFNQGQCCC AGSRTFVQED IYDEFVERSV ARAKSRVVGN PFDSKTEQGP
     QVDETQFKKI LGYINTGKQE GAKLLCGGGI AADRGYFIQP TVFGDVQDGM TIAKEEIFGP
     VMQILKFKTI EEVVGRANNS TYGLAAAVFT KDLDKANYLS QALQAGTVWV NCYDVFGAQS
     PFGGYKMSGS GRELGEYGLQ AYTEVKTVTV KVPQKNS
//
ID   ALDH2_HUMAN             Reviewed;         517 AA.
AC   P05091; B4DW54; E7EUE5; Q03639; Q6IB13; Q6IV71;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 2.
DT   22-APR-2020, entry version 237.
DE   RecName: Full=Aldehyde dehydrogenase, mitochondrial;
DE            EC=1.2.1.3;
DE   AltName: Full=ALDH class 2;
DE   AltName: Full=ALDH-E2;
DE   AltName: Full=ALDHI;
DE   Flags: Precursor;
GN   Name=ALDH2; Synonyms=ALDM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=3582651; DOI=10.1016/0014-5793(87)80152-7;
RA   Braun T., Bober E., Singh S., Agarwal D.P., Goedde H.W.;
RT   "Evidence for a signal peptide at the amino-terminal end of human
RT   mitochondrial aldehyde dehydrogenase.";
RL   FEBS Lett. 215:233-236(1987).
RN   [2]
RP   ERRATUM OF PUBMED:3582651, AND SEQUENCE REVISION TO N-TERMINUS.
RA   Braun T., Bober E., Singh S., Agarwal D.P., Goedde H.W.;
RL   FEBS Lett. 233:440-440(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=3562250; DOI=10.1093/nar/15.7.3179;
RA   Braun T., Bober E., Singh S., Agarwal D.P., Goedde H.W.;
RT   "Isolation and sequence analysis of a full length cDNA clone coding for
RT   human mitochondrial aldehyde dehydrogenase.";
RL   Nucleic Acids Res. 15:3179-3179(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2838413; DOI=10.1016/0888-7543(88)90109-7;
RA   Hsu L.C., Bendel R.E., Yoshida A.;
RT   "Genomic structure of the human mitochondrial aldehyde dehydrogenase
RT   gene.";
RL   Genomics 2:57-65(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Lassen N., Estey T., Vasiliou V.;
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 18-517 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=4065146; DOI=10.1111/j.1432-1033.1985.tb09260.x;
RA   Hempel J., Kaiser R., Joernvall H.;
RT   "Mitochondrial aldehyde dehydrogenase from human liver. Primary structure,
RT   differences in relation to the cytosolic enzyme, and functional
RT   correlations.";
RL   Eur. J. Biochem. 153:13-28(1985).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 119-517 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=2987944; DOI=10.1073/pnas.82.11.3771;
RA   Hsu L.C., Tani K., Fujiyoshi T., Kurachi K., Yoshida A.;
RT   "Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:3771-3775(1985).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 119-517 (ISOFORM 1).
RX   PubMed=4015823; DOI=10.1016/0741-8329(85)90024-2;
RA   Yoshida A., Ikawa M., Hsu L.C., Tani K.;
RT   "Molecular abnormality and cDNA cloning of human aldehyde dehydrogenases.";
RL   Alcohol 2:103-106(1985).
RN   [13]
RP   PROTEIN SEQUENCE OF 160-172 AND 325-338, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [14]
RP   PROTEIN SEQUENCE OF 196-226 AND 325-338.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/bj20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at the
RT   surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 214-500, AND VARIANT VAL-337.
RC   TISSUE=Liver;
RX   PubMed=3610592;
RA   Agarwal D.P., Goedde H.W.;
RT   "Human aldehyde dehydrogenase isozymes and alcohol sensitivity.";
RL   Isozymes Curr. Top. Biol. Med. Res. 16:21-48(1987).
RN   [16]
RP   DESCRIPTION OF ORIGIN OF CONFLICTS BETWEEN THE SEQUENCE DESCRIBED IN
RP   PUBMED:4065146 AND DNA SEQUENCES.
RX   PubMed=3653404; DOI=10.1016/0014-5793(87)80198-9;
RA   Hempel J., Hoeoeg J.-O., Joernvall H.;
RT   "Mitochondrial aldehyde dehydrogenase. Homology of putative targeting
RT   sequence to that of carbamyl phosphate synthetase I revealed by correlation
RT   of cDNA and protein data.";
RL   FEBS Lett. 222:95-98(1987).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.58 ANGSTROMS).
RX   PubMed=10631996; DOI=10.1110/ps.8.12.2784;
RA   Ni L., Zhou J., Hurley T.D., Weiner H.;
RT   "Human liver mitochondrial aldehyde dehydrogenase: three-dimensional
RT   structure and the restoration of solubility and activity of chimeric
RT   forms.";
RL   Protein Sci. 8:2784-2790(1999).
RN   [20]
RP   VARIANT LYS-504.
RX   PubMed=6582480; DOI=10.1073/pnas.81.1.258;
RA   Yoshida A., Huang I.-Y., Ikawa M.;
RT   "Molecular abnormality of an inactive aldehyde dehydrogenase variant
RT   commonly found in Orientals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:258-261(1984).
RN   [21]
RP   VARIANT LYS-496.
RX   PubMed=8561277; DOI=10.1111/j.1530-0277.1995.tb01587.x;
RA   Novoradovsky A., Tsai S.J., Goldfarb L., Peterson R., Long J.C.,
RA   Goldman D.;
RT   "Mitochondrial aldehyde dehydrogenase polymorphism in Asian and American
RT   Indian populations: detection of new ALDH2 alleles.";
RL   Alcohol. Clin. Exp. Res. 19:1105-1110(1995).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aldehyde + H2O + NAD(+) = a carboxylate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:16185, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17478, ChEBI:CHEBI:29067, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.2.1.3;
CC   -!- PATHWAY: Alcohol metabolism; ethanol degradation; acetate from ethanol:
CC       step 2/2.
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05091-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05091-2; Sequence=VSP_046715;
CC   -!- POLYMORPHISM: Genetic variation in ALDH2 is responsible for individual
CC       differences in responses to drinking alcohol [MIM:610251]. Allele
CC       ALDH2*2 is associated with a very high incidence of acute alcohol
CC       intoxication in Orientals and South American Indians, as compared to
CC       Caucasians. {ECO:0000269|PubMed:8561277}.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA62825.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAA68290.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAA68290.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ALDH2ID250.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X05409; CAA28990.1; -; mRNA.
DR   EMBL; Y00109; CAA68290.1; ALT_SEQ; mRNA.
DR   EMBL; M20456; AAA51693.1; -; Genomic_DNA.
DR   EMBL; M20444; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20445; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20446; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20447; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20448; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20449; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20450; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20451; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20452; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20453; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20454; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; AY621070; AAT41621.1; -; mRNA.
DR   EMBL; CR456991; CAG33272.1; -; mRNA.
DR   EMBL; AK301375; BAG62916.1; -; mRNA.
DR   EMBL; AC002996; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC003029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002967; AAH02967.1; -; mRNA.
DR   EMBL; BC071839; AAH71839.1; -; mRNA.
DR   EMBL; K03001; AAB59500.1; -; mRNA.
DR   EMBL; M26760; AAA51694.1; -; mRNA.
DR   EMBL; M54931; AAA62825.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS55885.1; -. [P05091-2]
DR   CCDS; CCDS9155.1; -. [P05091-1]
DR   PIR; A29975; DEHUE2.
DR   RefSeq; NP_000681.2; NM_000690.3. [P05091-1]
DR   RefSeq; NP_001191818.1; NM_001204889.1. [P05091-2]
DR   PDB; 1CW3; X-ray; 2.58 A; A/B/C/D/E/F/G/H=24-517.
DR   PDB; 1NZW; X-ray; 2.65 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1NZX; X-ray; 2.45 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1NZZ; X-ray; 2.45 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1O00; X-ray; 2.60 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1O01; X-ray; 2.15 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1O02; X-ray; 1.90 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1O04; X-ray; 1.42 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1O05; X-ray; 2.25 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1ZUM; X-ray; 2.10 A; A/B/C/D/E/F/G/H/I/J/K/L=18-517.
DR   PDB; 2ONM; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J/K/L=18-517.
DR   PDB; 2ONN; X-ray; 2.75 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 2ONO; X-ray; 2.15 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 2ONP; X-ray; 2.00 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 2VLE; X-ray; 2.40 A; A/B/C/D/E/F/G/H=24-517.
DR   PDB; 3INJ; X-ray; 1.69 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3INL; X-ray; 1.86 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3N80; X-ray; 1.50 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3N81; X-ray; 1.70 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3N82; X-ray; 2.25 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3N83; X-ray; 1.90 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3SZ9; X-ray; 2.10 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 4FQF; X-ray; 2.28 A; A/B/C/D=18-517.
DR   PDB; 4FR8; X-ray; 2.20 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 4KWF; X-ray; 2.31 A; A/B/C/D/E/F/G/H=24-517.
DR   PDB; 4KWG; X-ray; 2.10 A; A/B/C/D/E/F/G/H=24-517.
DR   PDB; 5L13; X-ray; 2.40 A; A/B/C/D/E/F/G/H=1-517.
DR   PDBsum; 1CW3; -.
DR   PDBsum; 1NZW; -.
DR   PDBsum; 1NZX; -.
DR   PDBsum; 1NZZ; -.
DR   PDBsum; 1O00; -.
DR   PDBsum; 1O01; -.
DR   PDBsum; 1O02; -.
DR   PDBsum; 1O04; -.
DR   PDBsum; 1O05; -.
DR   PDBsum; 1ZUM; -.
DR   PDBsum; 2ONM; -.
DR   PDBsum; 2ONN; -.
DR   PDBsum; 2ONO; -.
DR   PDBsum; 2ONP; -.
DR   PDBsum; 2VLE; -.
DR   PDBsum; 3INJ; -.
DR   PDBsum; 3INL; -.
DR   PDBsum; 3N80; -.
DR   PDBsum; 3N81; -.
DR   PDBsum; 3N82; -.
DR   PDBsum; 3N83; -.
DR   PDBsum; 3SZ9; -.
DR   PDBsum; 4FQF; -.
DR   PDBsum; 4FR8; -.
DR   PDBsum; 4KWF; -.
DR   PDBsum; 4KWG; -.
DR   PDBsum; 5L13; -.
DR   SMR; P05091; -.
DR   BioGrid; 106719; 79.
DR   DIP; DIP-40262N; -.
DR   IntAct; P05091; 43.
DR   MINT; P05091; -.
DR   STRING; 9606.ENSP00000261733; -.
DR   BindingDB; P05091; -.
DR   ChEMBL; CHEMBL1935; -.
DR   DrugBank; DB01612; Amyl Nitrite.
DR   DrugBank; DB06770; Benzyl alcohol.
DR   DrugBank; DB04381; Crotonaldehyde.
DR   DrugBank; DB02115; Daidzin.
DR   DrugBank; DB00822; Disulfiram.
DR   DrugBank; DB00536; Guanidine.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00435; Nitric Oxide.
DR   DrugBank; DB00727; Nitroglycerin.
DR   DrugBank; DB09117; Paraldehyde.
DR   DrugBank; DB06154; Pentaerythritol tetranitrate.
DR   DrugCentral; P05091; -.
DR   GuidetoPHARMACOLOGY; 2595; -.
DR   iPTMnet; P05091; -.
DR   PhosphoSitePlus; P05091; -.
DR   SwissPalm; P05091; -.
DR   BioMuta; ALDH2; -.
DR   DMDM; 118504; -.
DR   REPRODUCTION-2DPAGE; IPI00006663; -.
DR   REPRODUCTION-2DPAGE; P05091; -.
DR   UCD-2DPAGE; P05091; -.
DR   CPTAC; CPTAC-12; -.
DR   CPTAC; CPTAC-13; -.
DR   CPTAC; CPTAC-14; -.
DR   EPD; P05091; -.
DR   jPOST; P05091; -.
DR   MassIVE; P05091; -.
DR   MaxQB; P05091; -.
DR   PaxDb; P05091; -.
DR   PeptideAtlas; P05091; -.
DR   PRIDE; P05091; -.
DR   ProteomicsDB; 18413; -.
DR   ProteomicsDB; 51788; -. [P05091-1]
DR   Antibodypedia; 31130; 628 antibodies.
DR   DNASU; 217; -.
DR   Ensembl; ENST00000261733; ENSP00000261733; ENSG00000111275. [P05091-1]
DR   Ensembl; ENST00000416293; ENSP00000403349; ENSG00000111275. [P05091-2]
DR   GeneID; 217; -.
DR   KEGG; hsa:217; -.
DR   UCSC; uc001tst.4; human. [P05091-1]
DR   CTD; 217; -.
DR   DisGeNET; 217; -.
DR   GeneCards; ALDH2; -.
DR   HGNC; HGNC:404; ALDH2.
DR   HPA; ENSG00000111275; Tissue enhanced (liver).
DR   MalaCards; ALDH2; -.
DR   MIM; 100650; gene+phenotype.
DR   MIM; 610251; phenotype.
DR   neXtProt; NX_P05091; -.
DR   OpenTargets; ENSG00000111275; -.
DR   PharmGKB; PA24696; -.
DR   eggNOG; KOG2450; Eukaryota.
DR   eggNOG; COG1012; LUCA.
DR   GeneTree; ENSGT00940000156240; -.
DR   HOGENOM; CLU_005391_0_1_1; -.
DR   InParanoid; P05091; -.
DR   KO; K00128; -.
DR   OMA; NYIVGGL; -.
DR   OrthoDB; 153834at2759; -.
DR   PhylomeDB; P05091; -.
DR   TreeFam; TF300455; -.
DR   BioCyc; MetaCyc:MONOMER66-302; -.
DR   BRENDA; 1.2.1.3; 2681.
DR   Reactome; R-HSA-380612; Metabolism of serotonin.
DR   Reactome; R-HSA-71384; Ethanol oxidation.
DR   SABIO-RK; P05091; -.
DR   UniPathway; UPA00780; UER00768.
DR   ChiTaRS; ALDH2; human.
DR   EvolutionaryTrace; P05091; -.
DR   GeneWiki; ALDH2; -.
DR   GenomeRNAi; 217; -.
DR   Pharos; P05091; Tclin.
DR   PRO; PR:P05091; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P05091; protein.
DR   Bgee; ENSG00000111275; Expressed in liver and 230 other tissues.
DR   ExpressionAtlas; P05091; baseline and differential.
DR   Genevisible; P05091; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0004029; F:aldehyde dehydrogenase (NAD+) activity; IDA:CACAO.
DR   GO; GO:0004030; F:aldehyde dehydrogenase [NAD(P)+] activity; TAS:ProtInc.
DR   GO; GO:0009055; F:electron transfer activity; TAS:UniProtKB.
DR   GO; GO:0043878; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; IEA:UniProtKB-EC.
DR   GO; GO:0051287; F:NAD binding; ISS:CAFA.
DR   GO; GO:0006066; P:alcohol metabolic process; TAS:ProtInc.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc.
DR   GO; GO:0006068; P:ethanol catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006069; P:ethanol oxidation; TAS:Reactome.
DR   Gene3D; 3.40.309.10; -; 1.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Direct protein sequencing;
KW   Mitochondrion; NAD; Oxidoreductase; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT         1..17
FT                   /note="Mitochondrion"
FT   CHAIN           18..517
FT                   /note="Aldehyde dehydrogenase, mitochondrial"
FT                   /id="PRO_0000007168"
FT   NP_BIND         262..267
FT                   /note="NAD"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        285
FT                   /note="Proton acceptor"
FT   ACT_SITE        319
FT                   /note="Nucleophile"
FT   SITE            186
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P20000"
FT   MOD_RES         52
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P47738"
FT   MOD_RES         73
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P47738"
FT   MOD_RES         78
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P47738"
FT   MOD_RES         159
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P47738"
FT   MOD_RES         368
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P47738"
FT   MOD_RES         383
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P47738"
FT   MOD_RES         426
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P47738"
FT   MOD_RES         428
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P47738"
FT   MOD_RES         451
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P47738"
FT   VAR_SEQ         74..120
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046715"
FT   VARIANT         337
FT                   /note="E -> V (in dbSNP:rs1062136)"
FT                   /evidence="ECO:0000269|PubMed:3610592"
FT                   /id="VAR_011869"
FT   VARIANT         496
FT                   /note="E -> K (in allele ALDH2*3; dbSNP:rs769724893)"
FT                   /evidence="ECO:0000269|PubMed:8561277"
FT                   /id="VAR_011302"
FT   VARIANT         504
FT                   /note="E -> K (in allele ALDH2*2; drastic reduction of
FT                   enzyme activity; dbSNP:rs671)"
FT                   /evidence="ECO:0000269|PubMed:6582480"
FT                   /id="VAR_002248"
FT   CONFLICT        7..12
FT                   /note="RFGPRL -> ARAPP (in Ref. 1; CAA28990)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        18
FT                   /note="S -> A (in Ref. 10; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        60
FT                   /note="S -> F (in Ref. 6; CAG33272)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80..85
FT                   /note="VKAARA -> REGRPG (in Ref. 1; CAA28990)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        101
FT                   /note="R -> S (in Ref. 1; CAA28990)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        116
FT                   /note="R -> Q (in Ref. 5; AAT41621)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        216
FT                   /note="L -> S (in Ref. 15; AAA62825)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        218
FT                   /note="A -> R (in Ref. 15; AAA62825)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="A -> P (in Ref. 15; AAA62825)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        332
FT                   /note="Y -> C (in Ref. 7; BAG62916)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        362
FT                   /note="V -> L (in Ref. 6; CAG33272)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        380
FT                   /note="E -> Q (in Ref. 4; AAA51693)"
FT                   /evidence="ECO:0000305"
FT   STRAND          38..41
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          44..46
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          53..57
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   TURN            59..61
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          64..69
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           73..86
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           92..95
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           98..114
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           116..127
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           131..136
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           138..152
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   TURN            153..155
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          158..161
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          164..175
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          178..182
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          185..187
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           188..201
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          205..209
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          212..214
FT                   /evidence="ECO:0000244|PDB:4KWF"
FT   HELIX           216..228
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          234..237
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   TURN            242..244
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           245..250
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          257..262
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           264..276
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          281..285
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          290..294
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           300..312
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           313..316
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          322..328
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           329..345
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           364..379
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          383..386
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          389..391
FT                   /evidence="ECO:0000244|PDB:3INL"
FT   STRAND          393..396
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          401..405
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           411..414
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          419..427
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           430..438
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          439..441
FT                   /evidence="ECO:0000244|PDB:3INL"
FT   STRAND          444..449
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           453..462
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          465..471
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          478..480
FT                   /evidence="ECO:0000244|PDB:2ONO"
FT   HELIX           486..488
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          489..491
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   HELIX           496..502
FT                   /evidence="ECO:0000244|PDB:1O04"
FT   STRAND          503..511
FT                   /evidence="ECO:0000244|PDB:1O04"
SQ   SEQUENCE   517 AA;  56381 MW;  E8F74D44D285A00E CRC64;
     MLRAAARFGP RLGRRLLSAA ATQAVPAPNQ QPEVFCNQIF INNEWHDAVS RKTFPTVNPS
     TGEVICQVAE GDKEDVDKAV KAARAAFQLG SPWRRMDASH RGRLLNRLAD LIERDRTYLA
     ALETLDNGKP YVISYLVDLD MVLKCLRYYA GWADKYHGKT IPIDGDFFSY TRHEPVGVCG
     QIIPWNFPLL MQAWKLGPAL ATGNVVVMKV AEQTPLTALY VANLIKEAGF PPGVVNIVPG
     FGPTAGAAIA SHEDVDKVAF TGSTEIGRVI QVAAGSSNLK RVTLELGGKS PNIIMSDADM
     DWAVEQAHFA LFFNQGQCCC AGSRTFVQED IYDEFVERSV ARAKSRVVGN PFDSKTEQGP
     QVDETQFKKI LGYINTGKQE GAKLLCGGGI AADRGYFIQP TVFGDVQDGM TIAKEEIFGP
     VMQILKFKTI EEVVGRANNS TYGLAAAVFT KDLDKANYLS QALQAGTVWV NCYDVFGAQS
     PFGGYKMSGS GRELGEYGLQ AYTEVKTVTV KVPQKNS
//
ID   CO065_HUMAN             Reviewed;         121 AA.
AC   H3BRN8;
DT   18-SEP-2013, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2012, sequence version 1.
DT   22-APR-2020, entry version 48.
DE   RecName: Full=Uncharacterized protein C15orf65;
GN   Name=C15orf65;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Endometrium;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       H3BRN8; Q2TAL8: QRICH1; NbExp=3; IntAct=EBI-18394323, EBI-2798044;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX648577; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK130862; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC013355; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77489.1; -; Genomic_DNA.
DR   CCDS; CCDS58363.1; -.
DR   RefSeq; NP_001185713.1; NM_001198784.1.
DR   IntAct; H3BRN8; 1.
DR   BioMuta; C15orf65; -.
DR   MassIVE; H3BRN8; -.
DR   PaxDb; H3BRN8; -.
DR   PRIDE; H3BRN8; -.
DR   ProteomicsDB; 42122; -.
DR   Antibodypedia; 73844; 5 antibodies.
DR   Ensembl; ENST00000569691; ENSP00000456337; ENSG00000261652.
DR   GeneID; 145788; -.
DR   KEGG; hsa:145788; -.
DR   UCSC; uc002ada.4; human.
DR   CTD; 145788; -.
DR   GeneCards; C15orf65; -.
DR   HGNC; HGNC:44654; C15orf65.
DR   HPA; ENSG00000261652; Tissue enhanced (salivary).
DR   neXtProt; NX_H3BRN8; -.
DR   OpenTargets; ENSG00000261652; -.
DR   eggNOG; ENOG410J67E; Eukaryota.
DR   eggNOG; ENOG410Y12M; LUCA.
DR   GeneTree; ENSGT00940000154745; -.
DR   HOGENOM; CLU_153970_0_0_1; -.
DR   InParanoid; H3BRN8; -.
DR   OMA; MIMYKTS; -.
DR   OrthoDB; 1488437at2759; -.
DR   TreeFam; TF323876; -.
DR   ChiTaRS; C15orf65; human.
DR   GenomeRNAi; 145788; -.
DR   Pharos; H3BRN8; Tdark.
DR   PRO; PR:H3BRN8; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; H3BRN8; protein.
DR   Bgee; ENSG00000261652; Expressed in bronchial epithelial cell and 173 other tissues.
DR   Genevisible; H3BRN8; HS.
DR   InterPro; IPR026507; UPF0691.
DR   PANTHER; PTHR20899; PTHR20899; 1.
DR   Pfam; PF14892; DUF4490; 1.
PE   1: Evidence at protein level;
KW   Reference proteome.
FT   CHAIN           1..121
FT                   /note="Uncharacterized protein C15orf65"
FT                   /id="PRO_0000423417"
FT   CONFLICT        5
FT                   /note="N -> K (in Ref. 1; BX648577)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        10
FT                   /note="S -> G (in Ref. 1; BX648577)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   121 AA;  13763 MW;  7B799AC08A1B561A CRC64;
     MTDRNRDKKS TSPSNSDTEM KSEQLPPCVN PGNPVFSCML DPKTLQTATS LSKPQMIMYK
     TNSSHYGEFL PIPQFFPCNY TPKEQVFSSH IRATGFYQNN TLNTAPDRTR TLDFPNIQHT
     L
//
ID   CEP89_HUMAN             Reviewed;         783 AA.
AC   Q96ST8; B9EGA6; Q8N5J8;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   22-APR-2020, entry version 133.
DE   RecName: Full=Centrosomal protein of 89 kDa;
DE            Short=Cep89;
DE   AltName: Full=Centrosomal protein 123;
DE            Short=Cep123;
DE   AltName: Full=Coiled-coil domain-containing protein 123;
GN   Name=CEP89; Synonyms=CCDC123;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT ALA-398.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   ALA-398.
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21976302; DOI=10.1002/cm.20536;
RA   Sillibourne J.E., Specht C.G., Izeddin I., Hurbain I., Tran P., Triller A.,
RA   Darzacq X., Dahan M., Bornens M.;
RT   "Assessing the localization of centrosomal proteins by PALM/STORM
RT   nanoscopy.";
RL   Cytoskeleton 68:619-627(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=21399614; DOI=10.1038/emboj.2011.63;
RA   Jakobsen L., Vanselow K., Skogs M., Toyoda Y., Lundberg E., Poser I.,
RA   Falkenby L.G., Bennetzen M., Westendorf J., Nigg E.A., Uhlen M.,
RA   Hyman A.A., Andersen J.S.;
RT   "Novel asymmetrically localizing components of human centrosomes identified
RT   by complementary proteomics methods.";
RL   EMBO J. 30:1520-1535(2011).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23348840; DOI=10.1101/gad.207043.112;
RA   Tanos B.E., Yang H.J., Soni R., Wang W.J., Macaluso F.P., Asara J.M.,
RA   Tsou M.F.;
RT   "Centriole distal appendages promote membrane docking, leading to cilia
RT   initiation.";
RL   Genes Dev. 27:163-168(2013).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISEASE.
RX   PubMed=23575228; DOI=10.1093/hmg/ddt170;
RA   van Bon B.W., Oortveld M.A., Nijtmans L.G., Fenckova M., Nijhof B.,
RA   Besseling J., Vos M., Kramer J.M., de Leeuw N., Castells-Nobau A.,
RA   Asztalos L., Viragh E., Ruiter M., Hofmann F., Eshuis L., Collavin L.,
RA   Huynen M.A., Asztalos Z., Verstreken P., Rodenburg R.J., Smeitink J.A.,
RA   de Vries B.B., Schenck A.;
RT   "CEP89 is required for mitochondrial metabolism and neuronal function in
RT   man and fly.";
RL   Hum. Mol. Genet. 22:3138-3151(2013).
CC   -!- FUNCTION: Required for ciliogenesis. Also plays a role in mitochondrial
CC       metabolism where it may modulate complex IV activity.
CC       {ECO:0000269|PubMed:23348840, ECO:0000269|PubMed:23575228}.
CC   -!- INTERACTION:
CC       Q96ST8-3; P62166: NCS1; NbExp=4; IntAct=EBI-11144046, EBI-746987;
CC       Q96ST8-3; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-11144046, EBI-79165;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:14654843}. Cytoplasm, cytoskeleton, spindle pole.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome,
CC       centriole. Mitochondrion intermembrane space. Note=Localizes to the
CC       distal appendage region of the centriole, which anchors the mother
CC       centriole to the plasma membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96ST8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96ST8-2; Sequence=VSP_039181;
CC       Name=3;
CC         IsoId=Q96ST8-3; Sequence=VSP_039182, VSP_039183;
CC   -!- DISEASE: Note=Homozygous deletion comprising CEP89 and SLC7A9 genes has
CC       been reported in a patient with isolated complex IV deficiency,
CC       intellectual disability and multisystemic problems that include
CC       cystinuria, cataract, broad based walking pattern and deafness.
CC       {ECO:0000269|PubMed:23575228}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK027546; BAB55190.1; -; mRNA.
DR   EMBL; AC008805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC119048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011449; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032307; AAH32307.1; -; mRNA.
DR   EMBL; BC136328; AAI36329.1; -; mRNA.
DR   CCDS; CCDS32987.1; -. [Q96ST8-1]
DR   RefSeq; NP_116205.3; NM_032816.4. [Q96ST8-1]
DR   RefSeq; XP_011525727.1; XM_011527425.2.
DR   SMR; Q96ST8; -.
DR   BioGrid; 124342; 90.
DR   DIP; DIP-47325N; -.
DR   IntAct; Q96ST8; 94.
DR   STRING; 9606.ENSP00000306105; -.
DR   iPTMnet; Q96ST8; -.
DR   PhosphoSitePlus; Q96ST8; -.
DR   BioMuta; CEP89; -.
DR   DMDM; 296439414; -.
DR   EPD; Q96ST8; -.
DR   jPOST; Q96ST8; -.
DR   MassIVE; Q96ST8; -.
DR   MaxQB; Q96ST8; -.
DR   PaxDb; Q96ST8; -.
DR   PeptideAtlas; Q96ST8; -.
DR   PRIDE; Q96ST8; -.
DR   ProteomicsDB; 78147; -. [Q96ST8-1]
DR   ProteomicsDB; 78148; -. [Q96ST8-2]
DR   ProteomicsDB; 78149; -. [Q96ST8-3]
DR   Antibodypedia; 47945; 110 antibodies.
DR   Ensembl; ENST00000305768; ENSP00000306105; ENSG00000121289. [Q96ST8-1]
DR   GeneID; 84902; -.
DR   KEGG; hsa:84902; -.
DR   UCSC; uc002nty.4; human. [Q96ST8-1]
DR   CTD; 84902; -.
DR   DisGeNET; 84902; -.
DR   GeneCards; CEP89; -.
DR   HGNC; HGNC:25907; CEP89.
DR   HPA; ENSG00000121289; Low tissue specificity.
DR   MIM; 615470; gene.
DR   neXtProt; NX_Q96ST8; -.
DR   OpenTargets; ENSG00000121289; -.
DR   PharmGKB; PA147358250; -.
DR   eggNOG; ENOG410IGSG; Eukaryota.
DR   eggNOG; ENOG410ZNEI; LUCA.
DR   GeneTree; ENSGT00390000018876; -.
DR   HOGENOM; CLU_023281_0_0_1; -.
DR   InParanoid; Q96ST8; -.
DR   KO; K16543; -.
DR   OMA; KHIVHGL; -.
DR   OrthoDB; 476357at2759; -.
DR   PhylomeDB; Q96ST8; -.
DR   TreeFam; TF329234; -.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   ChiTaRS; CEP89; human.
DR   GenomeRNAi; 84902; -.
DR   Pharos; Q96ST8; Tbio.
DR   PRO; PR:Q96ST8; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q96ST8; protein.
DR   Bgee; ENSG00000121289; Expressed in tendon of biceps brachii and 166 other tissues.
DR   ExpressionAtlas; Q96ST8; baseline and differential.
DR   Genevisible; Q96ST8; HS.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0097539; C:ciliary transition fiber; IDA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:UniProtKB-SubCell.
DR   GO; GO:0031514; C:motile cilium; IEA:Ensembl.
DR   GO; GO:0097730; C:non-motile cilium; IDA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:InterPro.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0007005; P:mitochondrion organization; IEA:InterPro.
DR   GO; GO:1905515; P:non-motile cilium assembly; IMP:GO_Central.
DR   InterPro; IPR033545; CEP89.
DR   PANTHER; PTHR36170; PTHR36170; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cilium biogenesis/degradation; Coiled coil;
KW   Cytoplasm; Cytoskeleton; Mitochondrion; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..783
FT                   /note="Centrosomal protein of 89 kDa"
FT                   /id="PRO_0000288809"
FT   COILED          234..333
FT                   /evidence="ECO:0000255"
FT   COILED          369..719
FT                   /evidence="ECO:0000255"
FT   MOD_RES         50
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   VAR_SEQ         1..247
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_039181"
FT   VAR_SEQ         344..356
FT                   /note="SLNIEGLPSKGPI -> VTFPIVKISFSDF (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_039182"
FT   VAR_SEQ         357..782
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_039183"
FT   VARIANT         194
FT                   /note="R -> W (in dbSNP:rs3764633)"
FT                   /id="VAR_063122"
FT   VARIANT         398
FT                   /note="V -> A (in dbSNP:rs4805825)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_063123"
SQ   SEQUENCE   783 AA;  89590 MW;  7EE45B222951CED0 CRC64;
     MLLGFRRGRR SHFKHIIHGL LPAASVAPKA AVPRTPPPRS PNPSPERPRS ALAAAILATT
     LTGRTVAIPQ PRQRSRSESD VSSVEQDSFI EPYATTSQLR PRPNWQSEMG RRSSLPSFET
     LDYGDEEDIE TQLSSSGKEL GDVSAREDRG GHSDDLYAVP HRNQVPLLHE VNSEDDENIS
     HQDGFPGSPP APQRTQQKDG KHPVLNLKDE KPPLCEKPPP SPDITGRARQ RYTEITREKF
     EALKEENMDL NNMNQSLTLE LNTMKQAMKE LQLKLKGMEK EKRKLKEAEK ASSQEVAAPE
     LLYLRKQAQE LVDENDGLKM TVHRLNVELS RYQTKFRHLS KEESLNIEGL PSKGPIPPWL
     LDIKYLSPLL LAYEDMMKEK DELNATLKEE MRMFRMRVQE VVKENEELHQ ELNKSSAVTS
     EEWRQLQTQA KLVLEENKLL LEQLEIQQRK AKDSHQERLQ EVSKLTKQLM LLEAKTHGQE
     KELAENREQL EILRAKCQEL KTHSDGKIAV EVHKSIVNEL KSQLQKEEEK ERAEMEELME
     KLTVLQAQKK SLLLEKNSLT EQNKALEAEL ERAQKINRKS QKKIEVLKKQ VEKAMGNEMS
     AHQYLANLVG LAENITQERD SLMCLAKCLE SEKDGVLNKV IKSNIRLGKL EEKVKGYKKQ
     AALKLGDISH RLLEQQEDFA GKTAQYRQEM RHLHQVLKDK QEVLDQALQQ NREMEGELEV
     IWESTFRENR RIRELLQDTL TRTGVQDNPR ALVAPSLNGV SQADLLDGCD VCSYDLKSHA
     PTC
//
ID   CHIC2_HUMAN             Reviewed;         165 AA.
AC   Q9UKJ5; B2R639;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-APR-2020, entry version 135.
DE   RecName: Full=Cysteine-rich hydrophobic domain-containing protein 2;
DE   AltName: Full=BrX-like translocated in leukemia;
GN   Name=CHIC2; Synonyms=BTL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH ETV6.
RX   PubMed=10477709;
RA   Cools J., Bilhou-Nabera C., Wlodarska I., Cabrol C., Talmant P.,
RA   Bernard P., Hagemeijer A., Marynen P.;
RT   "Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a
RT   t(4;12)(q11-q12;p13).";
RL   Blood 94:1820-1824(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF 88-CYS--CYS-95, AND PALMITOYLATION.
RX   PubMed=11257495; DOI=10.1016/s0014-5793(01)02240-2;
RA   Cools J., Mentens N., Marynen P.;
RT   "A new family of small, palmitoylated, membrane-associated proteins,
RT   characterized by the presence of a cysteine-rich hydrophobic motif.";
RL   FEBS Lett. 492:204-209(2001).
CC   -!- INTERACTION:
CC       Q9UKJ5; Q6UY14-3: ADAMTSL4; NbExp=3; IntAct=EBI-741528, EBI-10173507;
CC       Q9UKJ5; P21549: AGXT; NbExp=3; IntAct=EBI-741528, EBI-727098;
CC       Q9UKJ5; Q9Y2T1: AXIN2; NbExp=3; IntAct=EBI-741528, EBI-4400025;
CC       Q9UKJ5; Q9BXJ5: C1QTNF2; NbExp=3; IntAct=EBI-741528, EBI-2817707;
CC       Q9UKJ5; Q9BWT7: CARD10; NbExp=3; IntAct=EBI-741528, EBI-3866279;
CC       Q9UKJ5; Q8NEC5: CATSPER1; NbExp=4; IntAct=EBI-741528, EBI-744545;
CC       Q9UKJ5; Q01850: CDR2; NbExp=7; IntAct=EBI-741528, EBI-1181367;
CC       Q9UKJ5; Q9C0F1: CEP44; NbExp=3; IntAct=EBI-741528, EBI-744115;
CC       Q9UKJ5; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-741528, EBI-3867333;
CC       Q9UKJ5; O96015: DNAL4; NbExp=3; IntAct=EBI-741528, EBI-742362;
CC       Q9UKJ5; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-741528, EBI-744099;
CC       Q9UKJ5; P23142-4: FBLN1; NbExp=3; IntAct=EBI-741528, EBI-11956479;
CC       Q9UKJ5; Q53SE7: FLJ13057; NbExp=3; IntAct=EBI-741528, EBI-10172181;
CC       Q9UKJ5; Q96IK5: GMCL1; NbExp=3; IntAct=EBI-741528, EBI-2548508;
CC       Q9UKJ5; P49639: HOXA1; NbExp=4; IntAct=EBI-741528, EBI-740785;
CC       Q9UKJ5; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-741528, EBI-2556193;
CC       Q9UKJ5; Q6A162: KRT40; NbExp=3; IntAct=EBI-741528, EBI-10171697;
CC       Q9UKJ5; Q07627: KRTAP1-1; NbExp=3; IntAct=EBI-741528, EBI-11959885;
CC       Q9UKJ5; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-741528, EBI-10172290;
CC       Q9UKJ5; P60410: KRTAP10-8; NbExp=6; IntAct=EBI-741528, EBI-10171774;
CC       Q9UKJ5; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-741528, EBI-10172052;
CC       Q9UKJ5; P60328: KRTAP12-3; NbExp=3; IntAct=EBI-741528, EBI-11953334;
CC       Q9UKJ5; Q9BYR9: KRTAP2-4; NbExp=3; IntAct=EBI-741528, EBI-14065470;
CC       Q9UKJ5; Q9BYR5: KRTAP4-2; NbExp=3; IntAct=EBI-741528, EBI-10172511;
CC       Q9UKJ5; P26371: KRTAP5-9; NbExp=6; IntAct=EBI-741528, EBI-3958099;
CC       Q9UKJ5; Q3LI66: KRTAP6-2; NbExp=3; IntAct=EBI-741528, EBI-11962084;
CC       Q9UKJ5; Q5T7P2: LCE1A; NbExp=3; IntAct=EBI-741528, EBI-11962058;
CC       Q9UKJ5; Q5T751: LCE1C; NbExp=3; IntAct=EBI-741528, EBI-12224199;
CC       Q9UKJ5; Q5T754: LCE1F; NbExp=3; IntAct=EBI-741528, EBI-11958008;
CC       Q9UKJ5; Q5TA81: LCE2C; NbExp=3; IntAct=EBI-741528, EBI-11973993;
CC       Q9UKJ5; Q5TA76: LCE3A; NbExp=3; IntAct=EBI-741528, EBI-9394625;
CC       Q9UKJ5; Q5T5A8: LCE3C; NbExp=6; IntAct=EBI-741528, EBI-10245291;
CC       Q9UKJ5; Q9BYE3: LCE3D; NbExp=3; IntAct=EBI-741528, EBI-6658837;
CC       Q9UKJ5; Q5TCM9: LCE5A; NbExp=3; IntAct=EBI-741528, EBI-11955689;
CC       Q9UKJ5; P80188: LCN2; NbExp=3; IntAct=EBI-741528, EBI-11911016;
CC       Q9UKJ5; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-741528, EBI-741037;
CC       Q9UKJ5; P50222: MEOX2; NbExp=3; IntAct=EBI-741528, EBI-748397;
CC       Q9UKJ5; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-741528, EBI-16439278;
CC       Q9UKJ5; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-741528, EBI-11522433;
CC       Q9UKJ5; P13349: MYF5; NbExp=3; IntAct=EBI-741528, EBI-17491620;
CC       Q9UKJ5; Q86VE0: MYPOP; NbExp=3; IntAct=EBI-741528, EBI-2858213;
CC       Q9UKJ5; P17568: NDUFB7; NbExp=3; IntAct=EBI-741528, EBI-1246238;
CC       Q9UKJ5; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-741528, EBI-945833;
CC       Q9UKJ5; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-741528, EBI-22310682;
CC       Q9UKJ5; P32242: OTX1; NbExp=4; IntAct=EBI-741528, EBI-740446;
CC       Q9UKJ5; Q96S99: PLEKHF1; NbExp=3; IntAct=EBI-741528, EBI-745767;
CC       Q9UKJ5; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-741528, EBI-742388;
CC       Q9UKJ5; Q58EX7: PLEKHG4; NbExp=3; IntAct=EBI-741528, EBI-949255;
CC       Q9UKJ5; Q8ND90: PNMA1; NbExp=3; IntAct=EBI-741528, EBI-302345;
CC       Q9UKJ5; Q12837: POU4F2; NbExp=3; IntAct=EBI-741528, EBI-17236143;
CC       Q9UKJ5; Q04864-2: REL; NbExp=3; IntAct=EBI-741528, EBI-10829018;
CC       Q9UKJ5; Q9BWG6: SCNM1; NbExp=3; IntAct=EBI-741528, EBI-748391;
CC       Q9UKJ5; O00560: SDCBP; NbExp=3; IntAct=EBI-741528, EBI-727004;
CC       Q9UKJ5; Q8NA61: SPERT; NbExp=3; IntAct=EBI-741528, EBI-741724;
CC       Q9UKJ5; P15884: TCF4; NbExp=3; IntAct=EBI-741528, EBI-533224;
CC       Q9UKJ5; Q9Y3S2: ZNF330; NbExp=3; IntAct=EBI-741528, EBI-373456;
CC       Q9UKJ5; Q96EG3: ZNF837; NbExp=3; IntAct=EBI-741528, EBI-11962574;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11257495}.
CC       Cytoplasmic vesicle {ECO:0000269|PubMed:11257495}. Note=Also present at
CC       a Golgi-like vesicular compartment and at scattered vesicles.
CC   -!- PTM: Palmitoylation in the CHIC motif is required for membrane
CC       association. {ECO:0000269|PubMed:11257495}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CHIC2 is found in a
CC       form of acute myeloid leukemia (AML). Translocation t(4;12)(q12;p13)
CC       with ETV6. {ECO:0000269|PubMed:10477709}.
CC   -!- SIMILARITY: Belongs to the CHIC family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CHIC2ID373.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF159423; AAD55981.1; -; mRNA.
DR   EMBL; AK312427; BAG35336.1; -; mRNA.
DR   EMBL; CH471057; EAX05453.1; -; Genomic_DNA.
DR   EMBL; BC034691; AAH34691.1; -; mRNA.
DR   CCDS; CCDS3493.1; -.
DR   RefSeq; NP_036242.1; NM_012110.3.
DR   BioGrid; 117716; 30.
DR   IntAct; Q9UKJ5; 64.
DR   STRING; 9606.ENSP00000263921; -.
DR   iPTMnet; Q9UKJ5; -.
DR   PhosphoSitePlus; Q9UKJ5; -.
DR   SwissPalm; Q9UKJ5; -.
DR   BioMuta; CHIC2; -.
DR   DMDM; 62901505; -.
DR   EPD; Q9UKJ5; -.
DR   MassIVE; Q9UKJ5; -.
DR   PaxDb; Q9UKJ5; -.
DR   PeptideAtlas; Q9UKJ5; -.
DR   PRIDE; Q9UKJ5; -.
DR   ProteomicsDB; 84809; -.
DR   Antibodypedia; 12265; 134 antibodies.
DR   DNASU; 26511; -.
DR   Ensembl; ENST00000263921; ENSP00000263921; ENSG00000109220.
DR   GeneID; 26511; -.
DR   KEGG; hsa:26511; -.
DR   UCSC; uc003haj.3; human.
DR   CTD; 26511; -.
DR   DisGeNET; 26511; -.
DR   GeneCards; CHIC2; -.
DR   HGNC; HGNC:1935; CHIC2.
DR   HPA; ENSG00000109220; Low tissue specificity.
DR   MalaCards; CHIC2; -.
DR   MIM; 604332; gene.
DR   neXtProt; NX_Q9UKJ5; -.
DR   OpenTargets; ENSG00000109220; -.
DR   PharmGKB; PA26466; -.
DR   eggNOG; KOG4101; Eukaryota.
DR   eggNOG; ENOG4111JK6; LUCA.
DR   GeneTree; ENSGT00390000003601; -.
DR   HOGENOM; CLU_100628_1_0_1; -.
DR   InParanoid; Q9UKJ5; -.
DR   OMA; ATVMRIN; -.
DR   OrthoDB; 1449345at2759; -.
DR   PhylomeDB; Q9UKJ5; -.
DR   TreeFam; TF314908; -.
DR   ChiTaRS; CHIC2; human.
DR   GenomeRNAi; 26511; -.
DR   Pharos; Q9UKJ5; Tbio.
DR   PRO; PR:Q9UKJ5; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q9UKJ5; protein.
DR   Bgee; ENSG00000109220; Expressed in testis and 209 other tissues.
DR   ExpressionAtlas; Q9UKJ5; baseline and differential.
DR   Genevisible; Q9UKJ5; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   InterPro; IPR039735; CHIC1/2.
DR   InterPro; IPR019383; Golgin_A_7/ERF4.
DR   PANTHER; PTHR13005; PTHR13005; 1.
DR   Pfam; PF10256; Erf4; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chromosomal rearrangement; Coiled coil; Cytoplasmic vesicle;
KW   Lipoprotein; Membrane; Palmitate; Reference proteome.
FT   CHAIN           1..165
FT                   /note="Cysteine-rich hydrophobic domain-containing protein
FT                   2"
FT                   /id="PRO_0000189556"
FT   COILED          1..26
FT                   /evidence="ECO:0000255"
FT   MOTIF           88..106
FT                   /note="CHIC motif (Cys-rich)"
FT   COMPBIAS        9..15
FT                   /note="Poly-Glu"
FT   SITE            111..112
FT                   /note="Breakpoint for translocation to form CHIC2-ETV6 in
FT                   AML"
FT   MUTAGEN         88..95
FT                   /note="CGCLCCCC->SGSLSSSS: Loss of palmitoylation.
FT                   Abolishes membrane association."
FT                   /evidence="ECO:0000269|PubMed:11257495"
SQ   SEQUENCE   165 AA;  19254 MW;  DC32A9C58524B55E CRC64;
     MADFDEIYEE EEDEERALEE QLLKYSPDPV VVRGSGHVTV FGLSNKFESE FPSSLTGKVA
     PEEFKASINR VNSCLKKNLP VNVRWLLCGC LCCCCTLGCS MWPVICLSKR TRRSIEKLLE
     WENNRLYHKL CLHWRLSKRK CETNNMMEYV ILIEFLPKTP IFRPD
//
ID   CLP1_HUMAN              Reviewed;         425 AA.
AC   Q92989; B2R7J6; B4DTI8;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   22-APR-2020, entry version 160.
DE   RecName: Full=Polyribonucleotide 5'-hydroxyl-kinase Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
DE            EC=2.7.1.78 {ECO:0000255|HAMAP-Rule:MF_03035};
DE   AltName: Full=Polyadenylation factor Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
DE   AltName: Full=Polynucleotide kinase Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
DE   AltName: Full=Pre-mRNA cleavage complex II protein Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
GN   Name=CLP1 {ECO:0000255|HAMAP-Rule:MF_03035}; Synonyms=HEAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8896421;
RA   Tanabe S., Bohlander S.K., Vignon C.V., Espinosa R. III, Zhao N.,
RA   Strissel P.L., Zeleznik-Le N.J., Rowley J.D.;
RT   "AF10 is split by MLL and HEAB, a human homolog to a putative
RT   Caenorhabditis elegans ATP/GTP-binding protein in an
RT   invins(10;11)(p12;q23q12).";
RL   Blood 88:3535-3545(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION AS A COMPONENT OF THE
RP   PRE-MRNA CLEAVAGE COMPLEX II, ASSOCIATION WITH THE PRE-MRNA CLEAVAGE
RP   COMPLEX I, AND SUBCELLULAR LOCATION.
RX   PubMed=11060040; DOI=10.1093/emboj/19.21.5895;
RA   de Vries H., Rueegsegger U., Huebner W., Friedlein A., Langen H.,
RA   Keller W.;
RT   "Human pre-mRNA cleavage factor II(m) contains homologs of yeast proteins
RT   and bridges two other cleavage factors.";
RL   EMBO J. 19:5895-5904(2000).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN A COMPLEX WITH
RP   TSEN2; TSEN15; TSEN34 AND TSEN54, AND INTERACTION WITH CSTF2 AND SYMPK.
RX   PubMed=15109492; DOI=10.1016/s0092-8674(04)00342-3;
RA   Paushkin S.V., Patel M., Furia B.S., Peltz S.W., Trotta C.R.;
RT   "Identification of a human endonuclease complex reveals a link between tRNA
RT   splicing and pre-mRNA 3' end formation.";
RL   Cell 117:311-321(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, IDENTIFICATION IN A COMPLEX WITH TSEN2; TSEN15; TSEN34 AND
RP   TSEN54, AND MUTAGENESIS OF 127-LYS-SER-128.
RX   PubMed=17495927; DOI=10.1038/nature05777;
RA   Weitzer S., Martinez J.;
RT   "The human RNA kinase hClp1 is active on 3' transfer RNA exons and short
RT   interfering RNAs.";
RL   Nature 447:222-226(2007).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF 127-LYS-SER-128 AND
RP   ASP-151.
RX   PubMed=18648070; DOI=10.1261/rna.1142908;
RA   Ramirez A., Shuman S., Schwer B.;
RT   "Human RNA 5'-kinase (hClp1) can function as a tRNA splicing enzyme in
RT   vivo.";
RL   RNA 14:1737-1745(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   VARIANT PCH10 HIS-140, FUNCTION, IDENTIFICATION IN THE TRNA SPLICING
RP   ENDONUCLEASE COMPLEX, MUTAGENESIS OF LYS-127, AND CHARACTERIZATION OF
RP   VARIANT PCH10 HIS-140.
RX   PubMed=24766809; DOI=10.1016/j.cell.2014.02.058;
RG   Baylor Hopkins Center for Mendelian Genomics;
RA   Karaca E., Weitzer S., Pehlivan D., Shiraishi H., Gogakos T., Hanada T.,
RA   Jhangiani S.N., Wiszniewski W., Withers M., Campbell I.M., Erdin S.,
RA   Isikay S., Franco L.M., Gonzaga-Jauregui C., Gambin T., Gelowani V.,
RA   Hunter J.V., Yesil G., Koparir E., Yilmaz S., Brown M., Briskin D.,
RA   Hafner M., Morozov P., Farazi T.A., Bernreuther C., Glatzel M.,
RA   Trattnig S., Friske J., Kronnerwetter C., Bainbridge M.N., Gezdirici A.,
RA   Seven M., Muzny D.M., Boerwinkle E., Ozen M., Clausen T., Tuschl T.,
RA   Yuksel A., Hess A., Gibbs R.A., Martinez J., Penninger J.M., Lupski J.R.;
RT   "Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and
RT   central nervous system function.";
RL   Cell 157:636-650(2014).
RN   [11]
RP   VARIANT PCH10 HIS-140, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24766810; DOI=10.1016/j.cell.2014.03.049;
RA   Schaffer A.E., Eggens V.R., Caglayan A.O., Reuter M.S., Scott E.,
RA   Coufal N.G., Silhavy J.L., Xue Y., Kayserili H., Yasuno K., Rosti R.O.,
RA   Abdellateef M., Caglar C., Kasher P.R., Cazemier J.L., Weterman M.A.,
RA   Cantagrel V., Cai N., Zweier C., Altunoglu U., Satkin N.B., Aktar F.,
RA   Tuysuz B., Yalcinkaya C., Caksen H., Bilguvar K., Fu X.D., Trotta C.R.,
RA   Gabriel S., Reis A., Gunel M., Baas F., Gleeson J.G.;
RT   "CLP1 founder mutation links tRNA splicing and maturation to cerebellar
RT   development and neurodegeneration.";
RL   Cell 157:651-663(2014).
CC   -!- FUNCTION: Polynucleotide kinase that can phosphorylate the 5'-hydroxyl
CC       groups of double-stranded RNA (dsRNA), single-stranded RNA (ssRNA),
CC       double-stranded DNA (dsDNA) and double-stranded DNA:RNA hybrids. dsRNA
CC       is phosphorylated more efficiently than dsDNA, and the RNA component of
CC       a DNA:RNA hybrid is phosphorylated more efficiently than the DNA
CC       component. Plays a key role in both tRNA splicing and mRNA 3'-end
CC       formation. Component of the tRNA splicing endonuclease complex:
CC       phosphorylates the 5'-terminus of the tRNA 3'-exon during tRNA
CC       splicing; this phosphorylation event is a prerequisite for the
CC       subsequent ligation of the two exon halves and the production of a
CC       mature tRNA (PubMed:24766809, PubMed:24766810). Its role in tRNA
CC       splicing and maturation is required for cerebellar development
CC       (PubMed:24766809, PubMed:24766810). Component of the pre-mRNA cleavage
CC       complex II (CF-II), which seems to be required for mRNA 3'-end
CC       formation. Also phosphorylates the 5'-terminus of exogenously
CC       introduced short interfering RNAs (siRNAs), which is a necessary
CC       prerequisite for their incorporation into the RNA-induced silencing
CC       complex (RISC). However, endogenous siRNAs and microRNAs (miRNAs) that
CC       are produced by the cleavage of dsRNA precursors by DICER1 already
CC       contain a 5'-phosphate group, so this protein may be dispensible for
CC       normal RNA-mediated gene silencing. {ECO:0000269|PubMed:17495927,
CC       ECO:0000269|PubMed:18648070, ECO:0000269|PubMed:24766809,
CC       ECO:0000269|PubMed:24766810}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5'-dephospho-(DNA) + ATP = ADP + H(+) + phospho-5'-(DNA);
CC         Xref=Rhea:RHEA:15669, Rhea:RHEA-COMP:13180, Rhea:RHEA-COMP:13184,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:136412,
CC         ChEBI:CHEBI:136416, ChEBI:CHEBI:456216; EC=2.7.1.78;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5'-dephospho-(RNA) + ATP = 5'-end-(RNA) + ADP + H(+);
CC         Xref=Rhea:RHEA:54580, Rhea:RHEA-COMP:13935, Rhea:RHEA-COMP:13936,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:138282,
CC         ChEBI:CHEBI:138284, ChEBI:CHEBI:456216; EC=2.7.1.78;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035,
CC         ECO:0000269|PubMed:17495927};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035,
CC         ECO:0000269|PubMed:17495927};
CC       Name=Ni(2+); Xref=ChEBI:CHEBI:49786;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035,
CC         ECO:0000269|PubMed:17495927};
CC   -!- SUBUNIT: Component of the tRNA splicing endonuclease complex, composed
CC       of CLP1, TSEN2, TSEN15, TSEN34 and TSEN54 (PubMed:24766809). Component
CC       of pre-mRNA cleavage complex II (CF-II). Also associates with numerous
CC       components of the pre-mRNA cleavage complex I (CF-I/CFIm), including
CC       NUDT21, CPSF2, CPSF3, CPSF6 and CPSF7. Interacts with CSTF2 and SYMPK.
CC       {ECO:0000269|PubMed:15109492, ECO:0000269|PubMed:17495927,
CC       ECO:0000269|PubMed:24766809}.
CC   -!- INTERACTION:
CC       Q92989; P13994: CCDC130; NbExp=3; IntAct=EBI-2559831, EBI-716093;
CC       Q92989; Q9UPV0: CEP164; NbExp=3; IntAct=EBI-2559831, EBI-3937015;
CC       Q92989; Q8NCG7: DAGLB; NbExp=3; IntAct=EBI-2559831, EBI-721948;
CC       Q92989; O43320: FGF16; NbExp=3; IntAct=EBI-2559831, EBI-11479104;
CC       Q92989; Q9C0B1-2: FTO; NbExp=3; IntAct=EBI-2559831, EBI-18138793;
CC       Q92989; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-2559831, EBI-16439278;
CC       Q92989; Q14696: MESD; NbExp=3; IntAct=EBI-2559831, EBI-6165891;
CC       Q92989; P22061-2: PCMT1; NbExp=3; IntAct=EBI-2559831, EBI-12386584;
CC       Q92989; P79522: PRR3; NbExp=3; IntAct=EBI-2559831, EBI-2803328;
CC       Q92989; P28074: PSMB5; NbExp=3; IntAct=EBI-2559831, EBI-357828;
CC       Q92989; Q96H20: SNF8; NbExp=3; IntAct=EBI-2559831, EBI-747719;
CC       Q92989; Q7Z6J9: TSEN54; NbExp=5; IntAct=EBI-2559831, EBI-2559824;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03035,
CC       ECO:0000269|PubMed:11060040, ECO:0000269|PubMed:24766810}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92989-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92989-2; Sequence=VSP_041164;
CC   -!- DISEASE: Pontocerebellar hypoplasia 10 (PCH10) [MIM:615803]: A form of
CC       pontocerebellar hypoplasia, a disorder characterized by structural
CC       defects of the pons and cerebellum, evident upon brain imaging. PCH10
CC       features include cortical dysgenesis marked by a simplified gyral
CC       pattern, cortical atrophy, mild or focal cerebellar vermian volume
CC       loss, delayed myelination, progressive microcephaly, global growth and
CC       developmental delays, severe intellectual disabilities, and seizures
CC       refractory to treatment. {ECO:0000269|PubMed:24766809,
CC       ECO:0000269|PubMed:24766810}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry. Neurodegeneration is due
CC       to defects in tRNA splicing (PubMed:24766809, PubMed:24766810).
CC       {ECO:0000269|PubMed:24766809, ECO:0000269|PubMed:24766810}.
CC   -!- SIMILARITY: Belongs to the Clp1 family. Clp1 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03035}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U73524; AAC50780.1; -; mRNA.
DR   EMBL; AK300232; BAG62000.1; -; mRNA.
DR   EMBL; AK313007; BAG35843.1; -; mRNA.
DR   EMBL; CH471076; EAW73770.1; -; Genomic_DNA.
DR   EMBL; BC000446; AAH00446.1; -; mRNA.
DR   CCDS; CCDS44600.1; -. [Q92989-2]
DR   CCDS; CCDS7964.1; -. [Q92989-1]
DR   RefSeq; NP_001136069.1; NM_001142597.1. [Q92989-2]
DR   RefSeq; NP_006822.1; NM_006831.2. [Q92989-1]
DR   SMR; Q92989; -.
DR   BioGrid; 116174; 27.
DR   CORUM; Q92989; -.
DR   IntAct; Q92989; 22.
DR   MINT; Q92989; -.
DR   STRING; 9606.ENSP00000434995; -.
DR   iPTMnet; Q92989; -.
DR   MetOSite; Q92989; -.
DR   PhosphoSitePlus; Q92989; -.
DR   BioMuta; CLP1; -.
DR   DMDM; 13431366; -.
DR   EPD; Q92989; -.
DR   jPOST; Q92989; -.
DR   MassIVE; Q92989; -.
DR   MaxQB; Q92989; -.
DR   PaxDb; Q92989; -.
DR   PeptideAtlas; Q92989; -.
DR   PRIDE; Q92989; -.
DR   ProteomicsDB; 75650; -. [Q92989-1]
DR   ProteomicsDB; 75651; -. [Q92989-2]
DR   Antibodypedia; 27467; 188 antibodies.
DR   DNASU; 10978; -.
DR   Ensembl; ENST00000302731; ENSP00000304704; ENSG00000172409. [Q92989-2]
DR   Ensembl; ENST00000525602; ENSP00000436066; ENSG00000172409. [Q92989-1]
DR   Ensembl; ENST00000533682; ENSP00000434995; ENSG00000172409. [Q92989-1]
DR   GeneID; 10978; -.
DR   KEGG; hsa:10978; -.
DR   UCSC; uc001nkw.4; human. [Q92989-1]
DR   CTD; 10978; -.
DR   DisGeNET; 10978; -.
DR   GeneCards; CLP1; -.
DR   HGNC; HGNC:16999; CLP1.
DR   HPA; ENSG00000172409; Low tissue specificity.
DR   MalaCards; CLP1; -.
DR   MIM; 608757; gene.
DR   MIM; 615803; phenotype.
DR   neXtProt; NX_Q92989; -.
DR   OpenTargets; ENSG00000172409; -.
DR   Orphanet; 411493; Pontocerebellar hypoplasia type 10.
DR   PharmGKB; PA162382477; -.
DR   eggNOG; KOG2749; Eukaryota.
DR   eggNOG; COG5623; LUCA.
DR   GeneTree; ENSGT00940000153668; -.
DR   HOGENOM; CLU_018195_1_0_1; -.
DR   KO; K14399; -.
DR   OrthoDB; 814241at2759; -.
DR   PhylomeDB; Q92989; -.
DR   TreeFam; TF105795; -.
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72187; mRNA 3'-end processing.
DR   Reactome; R-HSA-73856; RNA Polymerase II Transcription Termination.
DR   Reactome; R-HSA-77595; Processing of Intronless Pre-mRNAs.
DR   ChiTaRS; CLP1; human.
DR   GenomeRNAi; 10978; -.
DR   Pharos; Q92989; Tbio.
DR   PRO; PR:Q92989; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q92989; protein.
DR   Bgee; ENSG00000172409; Expressed in secondary oocyte and 211 other tissues.
DR   ExpressionAtlas; Q92989; baseline and differential.
DR   Genevisible; Q92989; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005849; C:mRNA cleavage factor complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000214; C:tRNA-intron endonuclease complex; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; TAS:UniProtKB.
DR   GO; GO:0046404; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0051736; F:ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity; IDA:UniProtKB.
DR   GO; GO:0051733; F:polydeoxyribonucleotide kinase activity; IDA:UniProtKB.
DR   GO; GO:0051731; F:polynucleotide 5'-hydroxyl-kinase activity; IBA:GO_Central.
DR   GO; GO:0021695; P:cerebellar cortex development; IMP:UniProtKB.
DR   GO; GO:0031124; P:mRNA 3'-end processing; TAS:UniProtKB.
DR   GO; GO:0006378; P:mRNA polyadenylation; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0006396; P:RNA processing; IBA:GO_Central.
DR   GO; GO:0035087; P:siRNA loading onto RISC involved in RNA interference; IDA:UniProtKB.
DR   GO; GO:0030423; P:targeting of mRNA for destruction involved in RNA interference; IMP:UniProtKB.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome.
DR   GO; GO:0006388; P:tRNA splicing, via endonucleolytic cleavage and ligation; IDA:UniProtKB.
DR   Gene3D; 2.60.120.1030; -; 1.
DR   Gene3D; 3.30.70.2410; -; 1.
DR   HAMAP; MF_03035; Clp1; 1.
DR   InterPro; IPR028606; Clp1.
DR   InterPro; IPR010655; Clp1_C.
DR   InterPro; IPR038238; Clp1_C_sf.
DR   InterPro; IPR032324; Clp1_N.
DR   InterPro; IPR038239; Clp1_N_sf.
DR   InterPro; IPR032319; CLP1_P.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF06807; Clp1; 1.
DR   Pfam; PF16573; CLP1_N; 1.
DR   Pfam; PF16575; CLP1_P; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Disease mutation; Kinase; Magnesium;
KW   Manganese; mRNA processing; Neurodegeneration; Nickel; Nucleotide-binding;
KW   Nucleus; Reference proteome; Transferase; tRNA processing.
FT   CHAIN           1..425
FT                   /note="Polyribonucleotide 5'-hydroxyl-kinase Clp1"
FT                   /id="PRO_0000089863"
FT   NP_BIND         124..129
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03035"
FT   BINDING         22
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03035"
FT   BINDING         62
FT                   /note="ATP; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03035"
FT   VAR_SEQ         139..202
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041164"
FT   VARIANT         140
FT                   /note="R -> H (in PCH10; decreases kinase activity, impairs
FT                   formation of the tRNA splicing endonuclease complex and
FT                   impairs ability to mediate tRNA splicing and maturation;
FT                   dbSNP:rs587777616)"
FT                   /evidence="ECO:0000269|PubMed:24766809,
FT                   ECO:0000269|PubMed:24766810"
FT                   /id="VAR_070952"
FT   MUTAGEN         127..128
FT                   /note="KS->AA: Abrogates RNA kinase activity. Abrogates
FT                   complementation of tRNA splicing activity in yeast; when
FT                   associated with A-128."
FT                   /evidence="ECO:0000269|PubMed:17495927,
FT                   ECO:0000269|PubMed:18648070"
FT   MUTAGEN         127
FT                   /note="K->A: Abrogates RNA kinase activity and tRNA
FT                   splicing activity."
FT                   /evidence="ECO:0000269|PubMed:24766809"
FT   MUTAGEN         151
FT                   /note="D->A: Abrogates complementation of tRNA splicing
FT                   activity in yeast."
FT                   /evidence="ECO:0000269|PubMed:18648070"
SQ   SEQUENCE   425 AA;  47646 MW;  640AF4768994CFE6 CRC64;
     MGEEANDDKK PTTKFELERE TELRFEVEAS QSVQLELLTG MAEIFGTELT RNKKFTFDAG
     AKVAVFTWHG CSVQLSGRTE VAYVSKDTPM LLYLNTHTAL EQMRRQAEKE EERGPRVMVV
     GPTDVGKSTV CRLLLNYAVR LGRRPTYVEL DVGQGSVSIP GTMGALYIER PADVEEGFSI
     QAPLVYHFGS TTPGTNIKLY NKITSRLADV FNQRCEVNRR ASVSGCVINT CGWVKGSGYQ
     ALVHAASAFE VDVVVVLDQE RLYNELKRDL PHFVRTVLLP KSGGVVERSK DFRRECRDER
     IREYFYGFRG CFYPHAFNVK FSDVKIYKVG APTIPDSCLP LGMSQEDNQL KLVPVTPGRD
     MVHHLLSVST AEGTEENLSE TSVAGFIVVT SVDLEHQVFT VLSPAPRPLP KNFLLIMDIR
     FMDLK
//
ID   CO3A1_HUMAN             Reviewed;        1466 AA.
AC   P02461; D2JYH5; D3DPH4; P78429; Q15112; Q16403; Q53S91; Q541P8; Q6LDB3;
AC   Q6LDJ2; Q6LDJ3; Q7KZ56; Q8N6U4; Q9UC88; Q9UC89; Q9UC90; Q9UC91; R4N3C5;
AC   V9GZI1;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   22-APR-2020, entry version 222.
DE   RecName: Full=Collagen alpha-1(III) chain;
DE   Flags: Precursor;
GN   Name=COL3A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLN-1353.
RC   TISSUE=Skin fibroblast;
RX   PubMed=2764886; DOI=10.1042/bj2600509;
RA   Ala-Kokko L., Kontusaari S., Baldwin C.T., Kuivaniemi H., Prockop D.J.;
RT   "Structure of cDNA clones coding for the entire prepro alpha 1 (III) chain
RT   of human type III procollagen. Differences in protein structure from type I
RT   procollagen and conservation of codon preferences.";
RL   Biochem. J. 260:509-516(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT GLN-1353.
RX   PubMed=11566270; DOI=10.1016/s0945-053x(01)00145-7;
RA   Valkkila M., Melkoniemi M., Kvist L., Kuivaniemi H., Tromp G.,
RA   Ala-Kokko L.;
RT   "Genomic organization of the human COL3A1 and COL5A2 genes: COL5A2 has
RT   evolved differently than the other minor fibrillar collagen genes.";
RL   Matrix Biol. 20:357-366(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ARG-726.
RA   Fang H.;
RL   Submitted (JAN-2013) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLN-1353.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT GLN-1353.
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-176.
RX   PubMed=2777083; DOI=10.1016/0378-1119(89)90228-x;
RA   Benson-Chanda V., Su M.W., Weil D., Chu M.-L., Ramirez F.;
RT   "Cloning and analysis of the 5' portion of the human type-III procollagen
RT   gene (COL3A1).";
RL   Gene 78:255-265(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-170 (ISOFORMS 1/2).
RC   TISSUE=Placenta;
RX   PubMed=3405773; DOI=10.1093/nar/16.14.7201;
RA   Toman D., Ricca G., de Crombrugghe B.;
RT   "Nucleotide sequence of a cDNA coding for the amino-terminal region of
RT   human prepro alpha 1(III) collagen.";
RL   Nucleic Acids Res. 16:7201-7201(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 149-1225 (ISOFORM 1).
RX   PubMed=2780304; DOI=10.1093/nar/17.16.6742;
RA   Janeczko R.A., Ramirez F.;
RT   "Nucleotide and amino acid sequences of the entire human alpha 1 (III)
RT   collagen.";
RL   Nucleic Acids Res. 17:6742-6742(1989).
RN   [11]
RP   PROTEIN SEQUENCE OF 168-398, AND HYDROXYLATION AT PRO-173; PRO-179;
RP   PRO-182; PRO-185; PRO-191; PRO-194; PRO-197; PRO-203; PRO-206; PRO-215;
RP   PRO-218; PRO-236; PRO-239; PRO-245; PRO-248; PRO-257; PRO-260; LYS-263;
RP   PRO-281; LYS-284; PRO-290; PRO-296; PRO-305; PRO-311; PRO-314; PRO-332;
RP   PRO-335; PRO-338; PRO-344; PRO-347; PRO-359; PRO-365; PRO-371; PRO-383;
RP   PRO-386 AND PRO-392.
RX   PubMed=557335; DOI=10.1021/bi00625a020;
RA   Seyer J.M., Kang A.H.;
RT   "Covalent structure of collagen: amino acid sequence of cyanogen bromide
RT   peptides from the amino-terminal segment of type III collagen of human
RT   liver.";
RL   Biochemistry 16:1158-1164(1977).
RN   [12]
RP   SEQUENCE REVISION.
RA   Seyer J.M.;
RL   Submitted (DEC-1977) to the PIR data bank.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 186-194 (ISOFORMS 1/2).
RX   PubMed=8317500;
RA   Milewicz D.M., Witz A.M., Smith A.C., Manchester D.K., Waldstein G.,
RA   Byers P.H.;
RT   "Parental somatic and germ-line mosaicism for a multiexon deletion with
RT   unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-
RT   Danlos syndrome type IV in the heterozygous offspring.";
RL   Am. J. Hum. Genet. 53:62-70(1993).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 302-423 (ISOFORMS 1/2).
RX   PubMed=7487954; DOI=10.1042/bj3110939;
RA   Chiodo A.A., Sillence D.O., Cole W.G., Bateman J.F.;
RT   "Abnormal type III collagen produced by an exon-17-skipping mutation of the
RT   COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the
RT   extracellular matrix.";
RL   Biochem. J. 311:939-943(1995).
RN   [15]
RP   PROTEIN SEQUENCE OF 395-416; 579-595; 800-814 AND 1064-1079.
RC   TISSUE=Colon carcinoma;
RX   PubMed=7864881; DOI=10.1006/bbrc.1995.1264;
RA   Minafra I.P., Andriolo M., Basirico L., Aquino A., Minafra S.,
RA   Boutillon M.-M., van der Rest M.;
RT   "Onco-fetal/laminin-binding collagen from colon carcinoma: detection of new
RT   sequences.";
RL   Biochem. Biophys. Res. Commun. 207:852-859(1995).
RN   [16]
RP   PROTEIN SEQUENCE OF 399-727, AND HYDROXYLATION AT PRO-404; PRO-407;
RP   PRO-416; PRO-425; PRO-434; PRO-443; PRO-455; PRO-458; PRO-470; PRO-473;
RP   PRO-479; PRO-488; PRO-500; PRO-512; PRO-524; PRO-530; PRO-533; PRO-539;
RP   PRO-542; PRO-545; PRO-551; PRO-554; PRO-563; PRO-566; PRO-575; PRO-581;
RP   PRO-590; PRO-599; PRO-602; PRO-608; PRO-620; PRO-635; PRO-644; PRO-650;
RP   PRO-656; PRO-659; PRO-661; PRO-668; PRO-671; PRO-680; PRO-686; PRO-692;
RP   PRO-701; PRO-703; PRO-713; PRO-716 AND PRO-722.
RX   PubMed=687591; DOI=10.1021/bi00609a034;
RA   Seyer J.M., Kang A.H.;
RT   "Covalent structure of collagen: amino acid sequence of five consecutive
RT   CNBr peptides from type III collagen of human liver.";
RL   Biochemistry 17:3404-3411(1978).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 537-605.
RX   PubMed=1672129;
RA   Lee B., Vitale E., Superti-Furga A., Steinmann B., Ramirez F.;
RT   "G to T transversion at position +5 of a splice donor site causes skipping
RT   of the preceding exon in the type III procollagen transcripts of a patient
RT   with Ehlers-Danlos syndrome type IV.";
RL   J. Biol. Chem. 266:5256-5259(1991).
RN   [18]
RP   PROTEIN SEQUENCE OF 728-964, AND HYDROXYLATION AT PRO-728; PRO-737;
RP   PRO-746; PRO-749; PRO-755; PRO-770; PRO-776; PRO-785; PRO-788; PRO-797;
RP   PRO-806; PRO-812; PRO-815; PRO-821; PRO-830; PRO-839; PRO-845; PRO-854;
RP   LYS-860; PRO-866; PRO-869; PRO-875; PRO-881; PRO-884; PRO-890; PRO-892;
RP   PRO-899; PRO-905; PRO-914; PRO-917; PRO-929; PRO-935; PRO-941; PRO-944 AND
RP   PRO-962.
RX   PubMed=6246925; DOI=10.1021/bi00549a008;
RA   Seyer J.M., Mainardi C., Kang A.H.;
RT   "Covalent structure of collagen: amino acid sequence of alpha 1 (III)-CB5
RT   from type III collagen of human liver.";
RL   Biochemistry 19:1583-1589(1980).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 861-1015 (ISOFORM 1).
RX   PubMed=2145268;
RA   Cole W.G., Chiodo A.A., Lamande S.R., Janeczko R., Ramirez F.,
RA   Dahl H.-H.M., Chan D., Bateman J.F.;
RT   "A base substitution at a splice site in the COL3A1 gene causes exon
RT   skipping and generates abnormal type III procollagen in a patient with
RT   Ehlers-Danlos syndrome type IV.";
RL   J. Biol. Chem. 265:17070-17077(1990).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 950-1466 (ISOFORM 1), AND VARIANT GLN-1353.
RX   PubMed=3357782; DOI=10.1093/nar/16.5.2337;
RA   Mankoo B.S., Dalgleish R.;
RT   "Human pro alpha 1(III) collagen: cDNA sequence for the 3' end.";
RL   Nucleic Acids Res. 16:2337-2337(1988).
RN   [21]
RP   SEQUENCE REVISION TO 1184.
RX   PubMed=3211760; DOI=10.1093/nar/16.24.11833;
RA   Molyneux K., Dalgleish R.;
RT   "Human type III collagen 'variant' is a cDNA cloning artefact.";
RL   Nucleic Acids Res. 16:11833-11833(1988).
RN   [22]
RP   PROTEIN SEQUENCE OF 965-1200, AND HYDROXYLATION AT PRO-965; PRO-971;
RP   LYS-977; PRO-983; PRO-995; PRO-1001; PRO-1010; PRO-1016; PRO-1022;
RP   PRO-1028; PRO-1040; PRO-1043; PRO-1046; PRO-1049; PRO-1052; PRO-1076;
RP   PRO-1085; LYS-1106; PRO-1112; PRO-1115; PRO-1118; PRO-1121; PRO-1133;
RP   PRO-1148; PRO-1157; PRO-1163; PRO-1178; PRO-1181; PRO-1184; PRO-1187;
RP   PRO-1190 AND PRO-1193.
RX   PubMed=7016180; DOI=10.1021/bi00512a040;
RA   Seyer J.M., Kang A.H.;
RT   "Covalent structure of collagen: amino acid sequence of alpha 1(III)-CB9
RT   from type III collagen of human liver.";
RL   Biochemistry 20:2621-2627(1981).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1065-1466 (ISOFORM 1).
RX   PubMed=6096827; DOI=10.1093/nar/12.24.9383;
RA   Loidl H.R., Brinker J.M., May M., Pihlajaniemi T., Morrow S.,
RA   Rosenbloom J., Myers J.C.;
RT   "Molecular cloning and carboxyl-propeptide analysis of human type III
RT   procollagen.";
RL   Nucleic Acids Res. 12:9383-9394(1984).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1161-1200 (ISOFORMS 1/2).
RX   PubMed=3754462; DOI=10.1021/bi00354a033;
RA   Miskulin M., Dalgleish R., Kluve-Beckerman B., Rennard S.I., Tolstoshev P.,
RA   Brantly M., Crystal R.G.;
RT   "Human type III collagen gene expression is coordinately modulated with the
RT   type I collagen genes during fibroblast growth.";
RL   Biochemistry 25:1408-1413(1986).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1165-1196 (ISOFORMS 1/2).
RX   PubMed=3858826; DOI=10.1073/pnas.82.10.3385;
RA   Emanuel B.S., Cannizzaro L.A., Seyer J.M., Myers J.C.;
RT   "Human alpha 1(III) and alpha 2(V) procollagen genes are located on the
RT   long arm of chromosome 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:3385-3389(1985).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1122-1466 (ISOFORMS 1/2), AND VARIANT
RP   GLN-1353.
RX   PubMed=2579949;
RA   Chu M.-L., Weil D., de Wet W.J., Bernard M.P., Sippola M., Ramirez F.;
RT   "Isolation of cDNA and genomic clones encoding human pro-alpha 1 (III)
RT   collagen. Partial characterization of the 3' end region of the gene.";
RL   J. Biol. Chem. 260:4357-4363(1985).
RN   [27]
RP   REVIEW ON VARIANTS.
RX   PubMed=9101290;
RX   DOI=10.1002/(sici)1098-1004(1997)9:4<300::aid-humu2>3.0.co;2-9;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in fibrillar collagens (types I, II, III, and XI), fibril-
RT   associated collagen (type IX), and network-forming collagen (type X) cause
RT   a spectrum of diseases of bone, cartilage, and blood vessels.";
RL   Hum. Mutat. 9:300-315(1997).
RN   [28]
RP   INVOLVEMENT IN PMGEDSV.
RX   PubMed=19455184; DOI=10.1038/ejhg.2009.76;
RA   Plancke A., Holder-Espinasse M., Rigau V., Manouvrier S., Claustres M.,
RA   Khau Van Kien P.;
RT   "Homozygosity for a null allele of COL3A1 results in recessive Ehlers-
RT   Danlos syndrome.";
RL   Eur. J. Hum. Genet. 17:1411-1416(2009).
RN   [29]
RP   INVOLVEMENT IN PMGEDSV, AND VARIANTS PMGEDSV 596-ARG--LEU-1466 DEL AND
RP   GLU-1284.
RX   PubMed=25205403; DOI=10.1038/ejhg.2014.181;
RA   Joergensen A., Fagerheim T., Rand-Hendriksen S., Lunde P.I., Vorren T.O.,
RA   Pepin M.G., Leistritz D.F., Byers P.H.;
RT   "Vascular Ehlers-Danlos Syndrome in siblings with biallelic COL3A1 sequence
RT   variants and marked clinical variability in the extended family.";
RL   Eur. J. Hum. Genet. 23:796-802(2015).
RN   [30]
RP   INVOLVEMENT IN PMGEDSV, AND VARIANTS PMGEDSV ALA-49 AND 428-ARG--LEU-1466
RP   DEL.
RX   PubMed=28742248; DOI=10.1002/ajmg.a.38345;
RA   Horn D., Siebert E., Seidel U., Rost I., Mayer K., Abou Jamra R.,
RA   Mitter D., Kornak U.;
RT   "Biallelic COL3A1 mutations result in a clinical spectrum of specific
RT   structural brain anomalies and connective tissue abnormalities.";
RL   Am. J. Med. Genet. A 173:2534-2538(2017).
RN   [31]
RP   INTERACTION WITH ADGRG1, INVOLVEMENT IN PMGEDSV, VARIANT PMGEDSV ALA-49,
RP   AND CHARACTERIZATION OF VARIANT PMGEDSV ALA-49.
RX   PubMed=28258187; DOI=10.1136/jmedgenet-2016-104421;
RA   Vandervore L., Stouffs K., Tanyalcin I., Vanderhasselt T., Roelens F.,
RA   Holder-Espinasse M., Joergensen A., Pepin M.G., Petit F., Khau Van Kien P.,
RA   Bahi-Buisson N., Lissens W., Gheldof A., Byers P.H., Jansen A.C.;
RT   "Bi-allelic variants in COL3A1 encoding the ligand to GPR56 are associated
RT   with cobblestone-like cortical malformation, white matter changes and
RT   cerebellar cysts.";
RL   J. Med. Genet. 54:432-440(2017).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S., Fischer-Posovszky P.,
RA   Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1158-1199, AND INTERCHAIN
RP   DISULFIDE BONDS.
RX   PubMed=18805790; DOI=10.1074/jbc.m805394200;
RA   Boudko S.P., Engel J., Okuyama K., Mizuno K., Bachinger H.P.,
RA   Schumacher M.A.;
RT   "Crystal structure of human type III collagen Gly991-Gly1032 cystine knot-
RT   containing peptide shows both 7/2 and 10/3 triple helical symmetries.";
RL   J. Biol. Chem. 283:32580-32589(2008).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.68 ANGSTROMS) OF 1222-1466, PROPEPTIDE, DISULFIDE
RP   BONDS, AND CALCIUM-BINDING SITES.
RX   PubMed=23001006; DOI=10.1038/nsmb.2389;
RA   Bourhis J.M., Mariano N., Zhao Y., Harlos K., Exposito J.Y., Jones E.Y.,
RA   Moali C., Aghajari N., Hulmes D.J.;
RT   "Structural basis of fibrillar collagen trimerization and related genetic
RT   disorders.";
RL   Nat. Struct. Mol. Biol. 19:1031-1036(2012).
RN   [36]
RP   VARIANT EDSVASC ARG-303, AND VARIANT THR-668.
RX   PubMed=8514866; DOI=10.1172/jci116490;
RA   Tromp G., Wu Y., Prockop D.J., Madhatheri S.L., Kleinert C., Earley J.J.,
RA   Zhuang J., Noerrgaard O., Darling R.C., Abbott W.M., Cole C.W.,
RA   Jaakkola P., Ryynaenen M., Pearce W.H., Yao J.S.T., Majamaa K.,
RA   Smullens S.N., Gatalica Z., Ferrell R.E., Jimenez S.A., Jackson C.E.,
RA   Michels V.V., Kaye M., Kuivaniemi H.;
RT   "Sequencing of cDNA from 50 unrelated patients reveals that mutations in
RT   the triple-helical domain of type III procollagen are an infrequent cause
RT   of aortic aneurysms.";
RL   J. Clin. Invest. 91:2539-2545(1993).
RN   [37]
RP   VARIANT THR-698.
RX   PubMed=2235526; DOI=10.1093/nar/18.20.6180;
RA   Zafarullah K., Kleinert C., Tromp G., Kuivaniemi H., Kontusaari S., Wu Y.,
RA   Ganguly A., Prockop D.J.;
RT   "G to A polymorphism in exon 31 of the COL3A1 gene.";
RL   Nucleic Acids Res. 18:6180-6180(1990).
RN   [38]
RP   VARIANT EDSVASC ARG-786.
RX   PubMed=2243125; DOI=10.1172/jci114863;
RA   Kontusaari S., Tromp G., Kuivaniemi H., Romanic A.M., Prockop D.J.;
RT   "A mutation in the gene for type III procollagen (COL3A1) in a family with
RT   aortic aneurysms.";
RL   J. Clin. Invest. 86:1465-1473(1990).
RN   [39]
RP   VARIANT EDSVASC 830-PRO--PRO-838 DEL.
RX   PubMed=1370809; DOI=10.1007/bf00197268;
RA   Richards A.J., Lloyd J.C., Narcisi P., Ward P.N., Nicholls A.C.,
RA   De Paepe A., Pope F.M.;
RT   "A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in
RT   a large family with Ehlers-Danlos syndrome type IV.";
RL   Hum. Genet. 88:325-330(1992).
RN   [40]
RP   VARIANT EDSVASC ARG-828.
RX   PubMed=8411057; DOI=10.1136/jmg.30.8.690;
RA   Richards A.J., Narcisi P., Lloyd J.C., Ferguson C., Pope F.M.;
RT   "The substitution of glycine 661 by arginine in type III collagen produces
RT   mutant molecules with different thermal stabilities and causes Ehlers-
RT   Danlos syndrome type IV.";
RL   J. Med. Genet. 30:690-693(1993).
RN   [41]
RP   VARIANT EDSVASC SER-957.
RX   PubMed=2492273;
RA   Tromp G., Kuivaniemi H., Shikata H., Prockop D.J.;
RT   "A single base mutation that substitutes serine for glycine 790 of the
RT   alpha 1 (III) chain of type III procollagen exposes an arginine and causes
RT   Ehlers-Danlos syndrome IV.";
RL   J. Biol. Chem. 264:1349-1352(1989).
RN   [42]
RP   VARIANT EDSVASC VAL-960.
RX   PubMed=7749417; DOI=10.1002/humu.1380050213;
RA   Tromp G., de Paepe A., Nuytinck L., Madhatheri S.L., Kuivaniemi H.;
RT   "Substitution of valine for glycine 793 in type III procollagen in Ehlers-
RT   Danlos syndrome type IV.";
RL   Hum. Mutat. 5:179-181(1995).
RN   [43]
RP   VARIANT EDSVASC GLU-1014.
RX   PubMed=1352273; DOI=10.1007/bf00194313;
RA   Richards A.J., Ward P.N., Narcisi P., Nicholls A.C., Lloyd J.C., Pope F.M.;
RT   "A single base mutation in the gene for type III collagen (COL3A1) converts
RT   glycine 847 to glutamic acid in a family with Ehlers-Danlos syndrome type
RT   IV. An unaffected family member is mosaic for the mutation.";
RL   Hum. Genet. 89:414-418(1992).
RN   [44]
RP   VARIANT EDSVASC ASP-1050.
RX   PubMed=2808425;
RA   Tromp G., Kuivaniemi H., Stolle C.A., Pope F.M., Prockop D.J.;
RT   "Single base mutation in the type III procollagen gene that converts the
RT   codon for glycine 883 to aspartate in a mild variant of Ehlers-Danlos
RT   syndrome IV.";
RL   J. Biol. Chem. 264:19313-19317(1989).
RN   [45]
RP   INVOLVEMENT IN EDSVASC.
RX   PubMed=2349939;
RA   Kontusaari S., Tromp G., Kuivaniemi H., Ladda R.L., Prockop D.J.;
RT   "Inheritance of an RNA splicing mutation (G+ 1 IVS20) in the type III
RT   procollagen gene (COL3A1) in a family having aortic aneurysms and easy
RT   bruisability: phenotypic overlap between familial arterial aneurysms and
RT   Ehlers-Danlos syndrome type IV.";
RL   Am. J. Hum. Genet. 47:112-120(1990).
RN   [46]
RP   VARIANT EDSVASC VAL-1077.
RX   PubMed=1895316; DOI=10.1136/jmg.28.7.458;
RA   Richards A.J., Lloyd J.C., Ward P.N., de Paepe A., Narcisi P., Pope F.M.;
RT   "Characterisation of a glycine to valine substitution at amino acid
RT   position 910 of the triple helical region of type III collagen in a patient
RT   with Ehlers-Danlos syndrome type IV.";
RL   J. Med. Genet. 28:458-463(1991).
RN   [47]
RP   VARIANT EDSVASC GLU-1173.
RX   PubMed=1357232; DOI=10.1007/bf02435995;
RA   Johnson P.H., Richards A.J., Pope F.M., Hopkinson D.A.;
RT   "A COL3A1 glycine 1006 to glutamic acid substitution in a patient with
RT   Ehlers-Danlos syndrome type IV detected by denaturing gradient gel
RT   electrophoresis.";
RL   J. Inherit. Metab. Dis. 15:426-430(1992).
RN   [48]
RP   VARIANT EDSVASC ASP-1185.
RX   PubMed=1496983;
RA   Kontusaari S., Tromp G., Kuivaniemi H., Stolle C.A., Pope F.M.,
RA   Prockop D.J.;
RT   "Substitution of aspartate for glycine 1018 in the type III procollagen
RT   (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the mutated allele is
RT   present in most blood leukocytes of the asymptomatic and mosaic mother.";
RL   Am. J. Hum. Genet. 51:497-507(1992).
RN   [49]
RP   VARIANT EDSVASC GLU-1188.
RX   PubMed=8098182; DOI=10.1002/ajmg.1320460308;
RA   Narcisi P., Wu Y., Tromp G., Earley J.J., Richards A.J., Pope F.M.,
RA   Kuivaniemi H.;
RT   "Single base mutation that substitutes glutamic acid for glycine 1021 in
RT   the COL3A1 gene and causes Ehlers-Danlos syndrome type IV.";
RL   Am. J. Med. Genet. 46:278-283(1993).
RN   [50]
RP   VARIANTS EDSVASC VAL-1167; ASP-1170 AND GLU-1173.
RA   Richards A.J., Narcisi P., Lloyd J.C., Johnson P.H., Hopkinson D.A.,
RA   Pope F.M.;
RT   "Substitution of glycines 1000, 1003 and 1006 in type III collagen all
RT   cause the acrogeric form of EDS-IV, and destabilise the collagen triple
RT   helix.";
RL   Matrix 13:47-47(1993).
RN   [51]
RP   VARIANTS THR-602 AND LEU-635.
RX   PubMed=8255472; DOI=10.1212/wnl.43.12.2652;
RA   Kuivaniemi H., Prockop D.J., Wu Y., Madhatheri S.L., Kleinert C.,
RA   Earley J.J., Jokinen A., Stolle C.A., Majamaa K., Mylllylae V.V.,
RA   Noerrgaard O., Schievink W.I., Mokri B., Fukawa O., Ter Berg J.W.M.,
RA   de Paepe A., Lozano A.M., Leblanc R., Ryynaenen M., Baxter B.T.,
RA   Shikata H., Ferrell R.E., Tromp G.;
RT   "Exclusion of mutations in the gene for type III collagen (COL3A1) as a
RT   common cause of intracranial aneurysms or cervical artery dissections:
RT   results from sequence analysis of the coding sequences of type III collagen
RT   from 55 unrelated patients.";
RL   Neurology 43:2652-2658(1993).
RN   [52]
RP   VARIANT EDSVASC GLU-756.
RX   PubMed=7912131; DOI=10.1093/hmg/3.3.511;
RA   Madhatheri S.L., Tromp G., Gustavson K.H., Kuivaniemi H.;
RT   "Substitution of glutamic acid for glycine 589 in the triple-helical domain
RT   of type III procollagen (COL3A1) in a family with variable phenotype of the
RT   Ehlers-Danlos syndrome type IV.";
RL   Hum. Mol. Genet. 3:511-512(1994).
RN   [53]
RP   VARIANT EDSVASC SER-804.
RX   PubMed=7833919; DOI=10.1093/hmg/3.9.1617;
RA   Narcisi P., Richards A.J., Ferguson S.D., Pope F.M.;
RT   "A family with Ehlers-Danlos syndrome type III/articular hypermobility
RT   syndrome has a glycine 637-to-serine substitution in type III collagen.";
RL   Hum. Mol. Genet. 3:1617-1620(1994).
RN   [54]
RP   VARIANT EDSVASC VAL-1176.
RX   PubMed=8019562; DOI=10.1002/humu.1380030315;
RA   Nuytinck L., De Paepe A., Renard J.P., Adriaens F., Leroy J.;
RT   "Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene
RT   detects a mutation that results in the substitution of glycine 1009 to
RT   valine and causes severe Ehlers-Danlos syndrome type IV.";
RL   Hum. Mutat. 3:268-274(1994).
RN   [55]
RP   VARIANTS EDSVASC CYS-183; ARG-201; GLU-228; ARG-540; ARG-936; GLU-996;
RP   VAL-1071; ALA-1104; GLU-1182; VAL-1185; GLU-1188 AND ARG-1188.
RA   Goldstein J.A., Schwarze U., Witz A., Byers P.H.;
RT   "Marked heterogeneity in COL3A1 mutations that produce the EDS type IV
RT   phenotype.";
RL   Matrix Biol. 14:392-393(1994).
RN   [56]
RP   VARIANTS EDSVASC ASP-909 AND ASP-939.
RX   PubMed=8680408; DOI=10.1002/humu.1380060408;
RA   Johnson P.H., Richards A.J., Lloyd J.C., Pope F.M., Hopkinson D.A.;
RT   "Efficient strategy for the detection of mutations in acrogeric Ehlers-
RT   Danlos syndrome type IV.";
RL   Hum. Mutat. 6:336-342(1995).
RN   [57]
RP   VARIANTS EDSVASC GLU-567; CYS-762 AND ASP-1170.
RX   PubMed=8884076; DOI=10.1111/j.1399-0004.1996.tb03790.x;
RA   Mackay K., Raghunath M., Superti-Furga A., Steinmann B., Dalgleish R.;
RT   "Ehlers-Danlos syndrome type IV caused by Gly400Glu, Gly595Cys and
RT   Gly1003Asp substitutions in collagen III: clinical features, biochemical
RT   screening, and molecular confirmation.";
RL   Clin. Genet. 49:286-295(1996).
RN   [58]
RP   VARIANT EDSVASC GLU-1101.
RX   PubMed=9147870; DOI=10.1111/j.1399-0004.1996.tb02709.x;
RA   McGrory J., Weksberg R., Thorner P., Cole W.G.;
RT   "Abnormal extracellular matrix in Ehlers-Danlos syndrome type IV due to the
RT   substitution of glycine 934 by glutamic acid in the triple helical domain
RT   of type III collagen.";
RL   Clin. Genet. 50:442-445(1996).
RN   [59]
RP   VARIANT EDSVASC ASP-666.
RX   PubMed=8664902;
RX   DOI=10.1002/(sici)1098-1004(1996)7:1<59::aid-humu8>3.0.co;2-k;
RA   McGrory J., Costa T., Cole W.G.;
RT   "A novel G499D substitution in the alpha 1(III) chain of type III collagen
RT   produces variable forms of Ehlers-Danlos syndrome type IV.";
RL   Hum. Mutat. 7:59-60(1996).
RN   [60]
RP   VARIANT EDSVASC SER-582.
RX   PubMed=8990011;
RX   DOI=10.1002/(sici)1098-1004(1997)9:1<62::aid-humu11>3.0.co;2-n;
RA   Anderson D.W., Thakker-Varia S., Tromp G., Kuivaniemi H., Stolle C.A.;
RT   "A glycine (415)-to-serine substitution results in impaired secretion and
RT   decreased thermal stability of type III procollagen in a patient with
RT   Ehlers-Danlos syndrome type IV.";
RL   Hum. Mutat. 9:62-63(1997).
RN   [61]
RP   VARIANTS EDSVASC CYS-183; ARG-201; GLU-228; ARG-540 AND ARG-936.
RX   PubMed=9036918; DOI=10.1111/1523-1747.ep12286441;
RA   Smith L.T., Schwarze U., Goldstein J., Byers P.H.;
RT   "Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome type IV
RT   and alterations in the size and distribution of the major collagen fibrils
RT   of the dermis.";
RL   J. Invest. Dermatol. 108:241-247(1997).
RN   [62]
RP   VARIANT EDSVASC ARG-726.
RX   PubMed=9452103; DOI=10.1002/humu.1380110182;
RA   Bateman J.F., Chiodo A.A., Weng Y.M., Chan D., Haan E.;
RT   "A type III collagen Gly559 to Arg helix mutation in Ehler's-Danlos
RT   syndrome type IV.";
RL   Hum. Mutat. Suppl. 1:S257-S259(1998).
RN   [63]
RP   VARIANT EDS-IV ARG-1173.
RX   PubMed=10819545; DOI=10.1046/j.1365-2133.2000.03266.x;
RA   Jansen T., de Paepe A., Luytinck N., Plewig G.;
RT   "COL3A1 mutation leading to acrogeria (Gottron Type).";
RL   Br. J. Dermatol. 142:178-180(2000).
RN   [64]
RP   VARIANTS EDSVASC ASP-204; ASP-210; ARG-264; ASP-327; ASP-1098 AND GLU-1173.
RX   PubMed=10923041;
RX   DOI=10.1002/1098-1004(200008)16:2<176::aid-humu12>3.0.co;2-e;
RA   Giunta C., Steinmann B.;
RT   "Characterization of 11 new mutations in COL3A1 of individuals with Ehlers-
RT   Danlos syndrome type IV: preliminary comparison of RNase cleavage, EMC and
RT   DHPLC assays.";
RL   Hum. Mutat. 16:176-177(2000).
RN   [65]
RP   VARIANTS EDSVASC.
RX   PubMed=10706896; DOI=10.1056/nejm200003093421001;
RA   Pepin M., Schwarze U., Superti-Furga A., Byers P.H.;
RT   "Clinical and genetic features of Ehlers-Danlos syndrome type IV, the
RT   vascular type.";
RL   N. Engl. J. Med. 342:673-680(2000).
RN   [66]
RP   VARIANT EDSVASC ASP-1044.
RX   PubMed=11168790; DOI=10.1046/j.1365-2796.2001.00761.x;
RA   Nishiyama Y., Nejima J., Watanabe A., Kotani E., Sakai N., Hatamochi A.,
RA   Shinkai H., Kiuchi K., Tamura K., Shimada T., Takano T., Katayama Y.;
RT   "Ehlers-Danlos syndrome type IV with a unique point mutation in COL3A1 and
RT   familial phenotype of myocardial infarction without organic coronary
RT   stenosis.";
RL   J. Intern. Med. 249:103-108(2001).
RN   [67]
RP   VARIANT EDSVASC ARG-297.
RX   PubMed=12694234; DOI=10.1034/j.1399-0004.2003.00047.x;
RA   Kroes H.Y., Pals G., van Essen A.J.;
RT   "Ehlers-Danlos syndrome type IV: unusual congenital anomalies in a mother
RT   and son with a COL3A1 mutation and a normal collagen III protein profile.";
RL   Clin. Genet. 63:224-227(2003).
RN   [68]
RP   ERRATUM OF PUBMED:12694234.
RA   Kroes H.Y., Pals G., van Essen A.J.;
RL   Clin. Genet. 64:375-375(2003).
RN   [69]
RP   VARIANT EDSVASC VAL-1050.
RX   PubMed=12786757; DOI=10.1034/j.1399-0004.2003.00075.x;
RA   Palmeri S., Mari F., Meloni I., Malandrini A., Ariani F., Villanova M.,
RA   Pompilio A., Schwarze U., Byers P.H., Renieri A.;
RT   "Neurological presentation of Ehlers-Danlos syndrome type IV in a family
RT   with parental mosaicism.";
RL   Clin. Genet. 63:510-515(2003).
RN   [70]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-420 AND CYS-1434.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [71]
RP   VARIANTS THR-679; THR-698; VAL-1205 AND GLN-1353.
RX   PubMed=18272325; DOI=10.1016/j.ygeno.2007.12.008;
RA   Chan T.F., Poon A., Basu A., Addleman N.R., Chen J., Phong A., Byers P.H.,
RA   Klein T.E., Kwok P.Y.;
RT   "Natural variation in four human collagen genes across an ethnically
RT   diverse population.";
RL   Genomics 91:307-314(2008).
CC   -!- FUNCTION: Collagen type III occurs in most soft connective tissues
CC       along with type I collagen. Involved in regulation of cortical
CC       development. Is the major ligand of ADGRG1 in the developing brain and
CC       binding to ADGRG1 inhibits neuronal migration and activates the RhoA
CC       pathway by coupling ADGRG1 to GNA13 and possibly GNA12.
CC   -!- SUBUNIT: Trimers of identical alpha 1(III) chains. The chains are
CC       linked to each other by interchain disulfide bonds. Trimers are also
CC       cross-linked via hydroxylysines. Interacts with ADGRG1
CC       (PubMed:28258187). {ECO:0000269|PubMed:28258187}.
CC   -!- INTERACTION:
CC       P02461; O01949: AAEL010235; Xeno; NbExp=2; IntAct=EBI-2431491, EBI-7685554;
CC       P02461-2; P63010-2: AP2B1; NbExp=3; IntAct=EBI-12214501, EBI-11529439;
CC       P02461-2; Q53G59: KLHL12; NbExp=3; IntAct=EBI-12214501, EBI-740929;
CC       P02461-1; P09486: SPARC; NbExp=4; IntAct=EBI-15740444, EBI-2800983;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P02461-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P02461-2; Sequence=VSP_022502;
CC   -!- DOMAIN: The C-terminal propeptide, also known as COLFI domain, have
CC       crucial roles in tissue growth and repair by controlling both the
CC       intracellular assembly of procollagen molecules and the extracellular
CC       assembly of collagen fibrils. It binds a calcium ion which is essential
CC       for its function.
CC   -!- PTM: Proline residues at the third position of the tripeptide repeating
CC       unit (G-X-Y) are hydroxylated in some or all of the chains.
CC       {ECO:0000269|PubMed:557335, ECO:0000269|PubMed:7016180}.
CC   -!- PTM: O-linked glycan consists of a Glc-Gal disaccharide bound to the
CC       oxygen atom of a post-translationally added hydroxyl group.
CC   -!- DISEASE: Ehlers-Danlos syndrome, vascular type (EDSVASC) [MIM:130050]:
CC       A severe form of Ehlers-Danlos syndrome, a group of connective tissue
CC       disorders characterized by skin hyperextensibility, articular
CC       hypermobility, and tissue fragility. EDSVASC is an autosomal dominant
CC       disease characterized by joint and dermal manifestations as in other
CC       forms of the syndrome, and by proneness to spontaneous rupture of bowel
CC       and large arteries. The vascular complications may affect all
CC       anatomical areas. {ECO:0000269|PubMed:10706896,
CC       ECO:0000269|PubMed:10923041, ECO:0000269|PubMed:11168790,
CC       ECO:0000269|PubMed:12694234, ECO:0000269|PubMed:12786757,
CC       ECO:0000269|PubMed:1352273, ECO:0000269|PubMed:1357232,
CC       ECO:0000269|PubMed:1370809, ECO:0000269|PubMed:1496983,
CC       ECO:0000269|PubMed:1895316, ECO:0000269|PubMed:2243125,
CC       ECO:0000269|PubMed:2349939, ECO:0000269|PubMed:2492273,
CC       ECO:0000269|PubMed:2808425, ECO:0000269|PubMed:7749417,
CC       ECO:0000269|PubMed:7833919, ECO:0000269|PubMed:7912131,
CC       ECO:0000269|PubMed:8019562, ECO:0000269|PubMed:8098182,
CC       ECO:0000269|PubMed:8411057, ECO:0000269|PubMed:8514866,
CC       ECO:0000269|PubMed:8664902, ECO:0000269|PubMed:8680408,
CC       ECO:0000269|PubMed:8884076, ECO:0000269|PubMed:8990011,
CC       ECO:0000269|PubMed:9036918, ECO:0000269|PubMed:9147870,
CC       ECO:0000269|PubMed:9452103, ECO:0000269|Ref.50, ECO:0000269|Ref.55}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Polymicrogyria with or without vascular-type Ehlers-Danlos
CC       syndrome (PMGEDSV) [MIM:618343]: An autosomal recessive disorder with a
CC       highly variable phenotype and onset in early childhood. Disease
CC       features include cobblestone-like malformation of the cortex,
CC       polymicrogyria, intellectual and motor developmental delay, small joint
CC       hypermobility, vascular fragility, aneurysms, thin translucent skin and
CC       easy bruising, congenital heart defects, and foot deformities. Early
CC       death due to vascular dissection may occur.
CC       {ECO:0000269|PubMed:19455184, ECO:0000269|PubMed:25205403,
CC       ECO:0000269|PubMed:28258187, ECO:0000269|PubMed:28742248}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the fibrillar collagen family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- WEB RESOURCE: Name=COL3A1; Note=Collagen type III alpha-1 chain
CC       mutations;
CC       URL="https://eds.gene.le.ac.uk/home.php?select_db=COL3A1";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Type-III collagen entry;
CC       URL="https://en.wikipedia.org/wiki/Type-III_collagen";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X14420; CAA32583.1; -; mRNA.
DR   EMBL; AY054301; AAL13167.1; -; Genomic_DNA.
DR   EMBL; AY016295; AAL13167.1; JOINED; Genomic_DNA.
DR   EMBL; KC567894; AGL34959.1; -; Genomic_DNA.
DR   EMBL; GU143397; ACZ58371.1; -; Genomic_DNA.
DR   EMBL; AC066694; AAY24164.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10910.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10911.1; -; Genomic_DNA.
DR   EMBL; BC028178; AAH28178.1; -; mRNA.
DR   EMBL; M26939; AAA52040.1; -; Genomic_DNA.
DR   EMBL; X07240; CAA30229.1; -; mRNA.
DR   EMBL; X15332; CAA33387.1; -; mRNA.
DR   EMBL; S62925; AAD13937.1; -; Genomic_DNA.
DR   EMBL; S79877; AAB35615.1; -; mRNA.
DR   EMBL; M59312; AAA52041.1; -; Genomic_DNA.
DR   EMBL; M59227; AAB59383.1; -; mRNA.
DR   EMBL; M55603; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X06700; CAA29886.1; -; mRNA.
DR   EMBL; X01655; CAA25821.1; -; mRNA.
DR   EMBL; X01742; CAA25879.1; -; mRNA.
DR   EMBL; M13146; AAA52003.1; -; mRNA.
DR   EMBL; M11134; AAA52004.1; -; mRNA.
DR   EMBL; M10795; AAA52002.1; -; Genomic_DNA.
DR   EMBL; M10615; AAA52002.1; JOINED; Genomic_DNA.
DR   EMBL; M10793; AAA52002.1; JOINED; Genomic_DNA.
DR   EMBL; M10794; AAA52002.1; JOINED; Genomic_DNA.
DR   EMBL; M10800; AAA52002.1; JOINED; Genomic_DNA.
DR   EMBL; M10801; AAA52002.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS2297.1; -. [P02461-1]
DR   PIR; S05272; CGHU7L.
DR   RefSeq; NP_000081.1; NM_000090.3. [P02461-1]
DR   PDB; 2V53; X-ray; 3.20 A; B/C/D=563-584.
DR   PDB; 3DMW; X-ray; 2.30 A; A/B/C=1158-1199.
DR   PDB; 4AE2; X-ray; 1.68 A; A/B/C=1222-1466.
DR   PDB; 4AEJ; X-ray; 2.21 A; A/B/C=1222-1466.
DR   PDB; 4AK3; X-ray; 3.50 A; A=1222-1466.
DR   PDB; 4GYX; X-ray; 1.49 A; A/B/C=1158-1200.
DR   PDB; 6FZV; X-ray; 2.70 A; A/B/C=1222-1466.
DR   PDB; 6FZW; X-ray; 2.78 A; A/B/C=1185-1466.
DR   PDBsum; 2V53; -.
DR   PDBsum; 3DMW; -.
DR   PDBsum; 4AE2; -.
DR   PDBsum; 4AEJ; -.
DR   PDBsum; 4AK3; -.
DR   PDBsum; 4GYX; -.
DR   PDBsum; 6FZV; -.
DR   PDBsum; 6FZW; -.
DR   SMR; P02461; -.
DR   BioGrid; 107678; 13.
DR   ComplexPortal; CPX-1714; Collagen type III trimer.
DR   DIP; DIP-57177N; -.
DR   IntAct; P02461; 27.
DR   MINT; P02461; -.
DR   STRING; 9606.ENSP00000304408; -.
DR   ChEMBL; CHEMBL2364188; -.
DR   DrugBank; DB00048; Collagenase clostridium histolyticum.
DR   GlyConnect; 1127; -.
DR   iPTMnet; P02461; -.
DR   PhosphoSitePlus; P02461; -.
DR   BioMuta; COL3A1; -.
DR   DMDM; 124056490; -.
DR   CPTAC; CPTAC-1180; -.
DR   jPOST; P02461; -.
DR   MassIVE; P02461; -.
DR   PaxDb; P02461; -.
DR   PeptideAtlas; P02461; -.
DR   PRIDE; P02461; -.
DR   ProteomicsDB; 51522; -. [P02461-1]
DR   ProteomicsDB; 51523; -. [P02461-2]
DR   Antibodypedia; 3392; 741 antibodies.
DR   Ensembl; ENST00000304636; ENSP00000304408; ENSG00000168542. [P02461-1]
DR   Ensembl; ENST00000317840; ENSP00000315243; ENSG00000168542. [P02461-2]
DR   GeneID; 1281; -.
DR   KEGG; hsa:1281; -.
DR   UCSC; uc002uqj.2; human. [P02461-1]
DR   CTD; 1281; -.
DR   DisGeNET; 1281; -.
DR   GeneCards; COL3A1; -.
DR   GeneReviews; COL3A1; -.
DR   HGNC; HGNC:2201; COL3A1.
DR   HPA; ENSG00000168542; Tissue enhanced (cervix, uterine, endometrium).
DR   MalaCards; COL3A1; -.
DR   MIM; 120180; gene.
DR   MIM; 130050; phenotype.
DR   MIM; 618343; phenotype.
DR   neXtProt; NX_P02461; -.
DR   OpenTargets; ENSG00000168542; -.
DR   Orphanet; 2500; Acrogeria.
DR   Orphanet; 86; Familial abdominal aortic aneurysm.
DR   Orphanet; 231160; Familial cerebral saccular aneurysm.
DR   Orphanet; 286; Vascular Ehlers-Danlos syndrome.
DR   PharmGKB; PA26716; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   eggNOG; ENOG410XNMM; LUCA.
DR   GeneTree; ENSGT00940000161229; -.
DR   HOGENOM; CLU_001074_2_3_1; -.
DR   InParanoid; P02461; -.
DR   KO; K19720; -.
DR   OMA; SPQFESY; -.
DR   OrthoDB; 1406711at2759; -.
DR   PhylomeDB; P02461; -.
DR   TreeFam; TF344135; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474244; Extracellular matrix organization.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-186797; Signaling by PDGF.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-3000480; Scavenging by Class A Receptors.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   Reactome; R-HSA-8874081; MET activates PTK2 signaling.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   SIGNOR; P02461; -.
DR   ChiTaRS; COL3A1; human.
DR   EvolutionaryTrace; P02461; -.
DR   GeneWiki; Collagen,_type_III,_alpha_1; -.
DR   GenomeRNAi; 1281; -.
DR   Pharos; P02461; Tbio.
DR   PRO; PR:P02461; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P02461; protein.
DR   Bgee; ENSG00000168542; Expressed in uterine cervix and 228 other tissues.
DR   ExpressionAtlas; P02461; baseline and differential.
DR   Genevisible; P02461; HS.
DR   GO; GO:0005586; C:collagen type III trimer; IDA:CAFA.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IMP:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IMP:UniProtKB.
DR   GO; GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; HDA:BHF-UCL.
DR   GO; GO:0005178; F:integrin binding; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; IDA:MGI.
DR   GO; GO:0002020; F:protease binding; IPI:CAFA.
DR   GO; GO:0046332; F:SMAD binding; IEA:Ensembl.
DR   GO; GO:0060414; P:aorta smooth muscle tissue morphogenesis; IEA:Ensembl.
DR   GO; GO:0007160; P:cell-matrix adhesion; IDA:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; ISS:UniProtKB.
DR   GO; GO:0030199; P:collagen fibril organization; IMP:UniProtKB.
DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0007507; P:heart development; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0050777; P:negative regulation of immune response; IMP:UniProtKB.
DR   GO; GO:2001223; P:negative regulation of neuron migration; ISS:UniProtKB.
DR   GO; GO:0018149; P:peptide cross-linking; IDA:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; NAS:UniProtKB.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0034097; P:response to cytokine; IDA:UniProtKB.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IDA:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   GO; GO:0043588; P:skin development; IMP:UniProtKB.
DR   GO; GO:0097435; P:supramolecular fiber organization; IMP:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0042060; P:wound healing; IDA:UniProtKB.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 8.
DR   Pfam; PF00093; VWC; 1.
DR   SMART; SM00038; COLFI; 1.
DR   SMART; SM00214; VWC; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Aortic aneurysm; Calcium; Collagen;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Ehlers-Danlos syndrome; Extracellular matrix; Glycoprotein; Hydroxylation;
KW   Metal-binding; Polymorphism; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..23
FT   PROPEP          24..153
FT                   /note="N-terminal propeptide"
FT                   /id="PRO_0000005740"
FT   CHAIN           154..1221
FT                   /note="Collagen alpha-1(III) chain"
FT                   /id="PRO_0000005741"
FT   PROPEP          1222..1466
FT                   /note="C-terminal propeptide"
FT                   /id="PRO_0000005742"
FT   DOMAIN          30..89
FT                   /note="VWFC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00220"
FT   DOMAIN          1232..1466
FT                   /note="Fibrillar collagen NC1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   REGION          149..167
FT                   /note="Nonhelical region (N-terminal)"
FT   REGION          168..1196
FT                   /note="Triple-helical region"
FT   REGION          1197..1205
FT                   /note="Nonhelical region (C-terminal)"
FT   METAL           1280
FT                   /note="Calcium"
FT   METAL           1282
FT                   /note="Calcium"
FT   METAL           1283
FT                   /note="Calcium; via carbonyl oxygen"
FT   METAL           1285
FT                   /note="Calcium; via carbonyl oxygen"
FT   METAL           1288
FT                   /note="Calcium"
FT   MOD_RES         173
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         179
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         182
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         185
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         191
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         194
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         197
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         203
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         206
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         215
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         218
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         236
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         239
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         245
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         248
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         257
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         260
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         263
FT                   /note="5-hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         281
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         284
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         290
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         296
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         305
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         311
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         314
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         332
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         335
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         338
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         344
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         347
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         359
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         365
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         371
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         383
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         386
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         392
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:557335"
FT   MOD_RES         404
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         407
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         416
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         425
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         434
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         443
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         455
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         458
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         470
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         473
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         479
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         488
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         500
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         512
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         524
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         530
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         533
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         539
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         542
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         545
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         551
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         554
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         563
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         566
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         575
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         581
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         590
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         599
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         602
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         608
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         620
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         635
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         644
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         650
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         656
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         659
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         661
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         668
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         671
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         680
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         686
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         692
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         701
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         703
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         713
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         716
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         722
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:687591"
FT   MOD_RES         728
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         737
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         746
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         749
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         755
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         770
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         776
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         785
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         788
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         797
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         806
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         812
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         815
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         821
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         830
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         839
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         845
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         854
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         860
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         866
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         869
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         875
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         881
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         884
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         890
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         892
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         899
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         905
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         914
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         917
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         929
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         935
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         941
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         944
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         962
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:6246925"
FT   MOD_RES         965
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         971
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         977
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         983
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         995
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1001
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1010
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1016
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1022
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1028
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1040
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1043
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1046
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1049
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1052
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1076
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1085
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1106
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1112
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1115
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1118
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1121
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1133
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1148
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1157
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1163
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1178
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1181
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1184
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1187
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1190
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   MOD_RES         1193
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7016180"
FT   CARBOHYD        263
FT                   /note="O-linked (Gal...) hydroxylysine; alternate"
FT   DISULFID        1196
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793,
FT                   ECO:0000269|PubMed:23001006"
FT   DISULFID        1197
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793,
FT                   ECO:0000269|PubMed:23001006"
FT   DISULFID        1262..1294
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793,
FT                   ECO:0000269|PubMed:23001006"
FT   DISULFID        1268
FT                   /note="Interchain (with C-1285)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793,
FT                   ECO:0000269|PubMed:23001006"
FT   DISULFID        1285
FT                   /note="Interchain (with C-1268)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793,
FT                   ECO:0000269|PubMed:23001006"
FT   DISULFID        1302..1464
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793,
FT                   ECO:0000269|PubMed:23001006"
FT   DISULFID        1372..1417
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793,
FT                   ECO:0000269|PubMed:23001006"
FT   VAR_SEQ         847..1149
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022502"
FT   VARIANT         49
FT                   /note="P -> A (in PMGEDSV; does not affect interaction with
FT                   ADGRG1; dbSNP:rs1234344050)"
FT                   /evidence="ECO:0000269|PubMed:28258187,
FT                   ECO:0000269|PubMed:28742248"
FT                   /id="VAR_082043"
FT   VARIANT         169
FT                   /note="L -> F (in dbSNP:rs111391222)"
FT                   /id="VAR_001767"
FT   VARIANT         183
FT                   /note="G -> C (in EDSVASC; dbSNP:rs121912926)"
FT                   /evidence="ECO:0000269|PubMed:9036918, ECO:0000269|Ref.55"
FT                   /id="VAR_001768"
FT   VARIANT         183
FT                   /note="G -> D (in EDSVASC; dbSNP:rs587779420)"
FT                   /id="VAR_011095"
FT   VARIANT         183
FT                   /note="G -> S (in EDSVASC; dbSNP:rs121912926)"
FT                   /id="VAR_011096"
FT   VARIANT         192
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779710)"
FT                   /id="VAR_011097"
FT   VARIANT         201
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779436)"
FT                   /evidence="ECO:0000269|PubMed:9036918, ECO:0000269|Ref.55"
FT                   /id="VAR_001769"
FT   VARIANT         204
FT                   /note="G -> D (in EDSVASC; dbSNP:rs587779626)"
FT                   /evidence="ECO:0000269|PubMed:10923041"
FT                   /id="VAR_011098"
FT   VARIANT         204
FT                   /note="G -> S (in EDSVASC; dbSNP:rs587779711)"
FT                   /id="VAR_011099"
FT   VARIANT         210
FT                   /note="G -> D (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:10923041"
FT                   /id="VAR_011100"
FT   VARIANT         219
FT                   /note="G -> C (in EDSVASC; dbSNP:rs587779624)"
FT                   /id="VAR_011101"
FT   VARIANT         225
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779533)"
FT                   /id="VAR_011102"
FT   VARIANT         228
FT                   /note="G -> E (in EDSVASC; dbSNP:rs587779555)"
FT                   /evidence="ECO:0000269|PubMed:9036918, ECO:0000269|Ref.55"
FT                   /id="VAR_001770"
FT   VARIANT         240
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779468)"
FT                   /id="VAR_011103"
FT   VARIANT         243
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779629)"
FT                   /id="VAR_011104"
FT   VARIANT         249
FT                   /note="G -> D (in EDSVASC; dbSNP:rs121912927)"
FT                   /id="VAR_011105"
FT   VARIANT         249
FT                   /note="G -> V (in EDSVASC; dbSNP:rs121912927)"
FT                   /id="VAR_011106"
FT   VARIANT         252
FT                   /note="G -> D (in EDSVASC; dbSNP:rs587779464)"
FT                   /id="VAR_011107"
FT   VARIANT         252
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779705)"
FT                   /id="VAR_011108"
FT   VARIANT         252
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779464)"
FT                   /id="VAR_011109"
FT   VARIANT         255
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779605)"
FT                   /id="VAR_011110"
FT   VARIANT         264
FT                   /note="G -> R (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:10923041"
FT                   /id="VAR_011111"
FT   VARIANT         267
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779427)"
FT                   /id="VAR_011112"
FT   VARIANT         297
FT                   /note="G -> R (in EDSVASC; dbSNP:rs1553507557)"
FT                   /evidence="ECO:0000269|PubMed:12694234"
FT                   /id="VAR_037007"
FT   VARIANT         303
FT                   /note="G -> R (in EDSVASC; dbSNP:rs121912919)"
FT                   /evidence="ECO:0000269|PubMed:8514866"
FT                   /id="VAR_001771"
FT   VARIANT         321
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779588)"
FT                   /id="VAR_011113"
FT   VARIANT         327
FT                   /note="G -> D (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:10923041"
FT                   /id="VAR_011114"
FT   VARIANT         345
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779419)"
FT                   /id="VAR_011115"
FT   VARIANT         417
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779637)"
FT                   /id="VAR_011116"
FT   VARIANT         420
FT                   /note="G -> S (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs587779692)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035738"
FT   VARIANT         428..1466
FT                   /note="Missing (in PMGEDSV)"
FT                   /evidence="ECO:0000269|PubMed:28742248"
FT                   /id="VAR_082044"
FT   VARIANT         444
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779489)"
FT                   /id="VAR_011117"
FT   VARIANT         489
FT                   /note="G -> E (in EDSVASC; dbSNP:rs587779476)"
FT                   /id="VAR_011118"
FT   VARIANT         501
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779523)"
FT                   /id="VAR_011119"
FT   VARIANT         519
FT                   /note="G -> V (in EDSVASC)"
FT                   /id="VAR_011120"
FT   VARIANT         534
FT                   /note="G -> E (in dbSNP:rs41263744)"
FT                   /id="VAR_055665"
FT   VARIANT         540
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779584)"
FT                   /evidence="ECO:0000269|PubMed:9036918, ECO:0000269|Ref.55"
FT                   /id="VAR_001772"
FT   VARIANT         549
FT                   /note="G -> E (in EDSVASC; dbSNP:rs587779679)"
FT                   /id="VAR_011121"
FT   VARIANT         552
FT                   /note="G -> E (in EDSVASC; dbSNP:rs121912928)"
FT                   /id="VAR_011122"
FT   VARIANT         567
FT                   /note="G -> E (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:8884076"
FT                   /id="VAR_001773"
FT   VARIANT         582
FT                   /note="G -> S (in EDSVASC; dbSNP:rs121912923)"
FT                   /evidence="ECO:0000269|PubMed:8990011"
FT                   /id="VAR_001774"
FT   VARIANT         588
FT                   /note="G -> D (in EDSVASC; dbSNP:rs587779691)"
FT                   /id="VAR_011123"
FT   VARIANT         596..1466
FT                   /note="Missing (in PMGEDSV)"
FT                   /evidence="ECO:0000269|PubMed:25205403"
FT                   /id="VAR_082045"
FT   VARIANT         602
FT                   /note="P -> T (in dbSNP:rs35795890)"
FT                   /evidence="ECO:0000269|PubMed:8255472"
FT                   /id="VAR_001775"
FT   VARIANT         635
FT                   /note="P -> L (in dbSNP:rs902780774)"
FT                   /evidence="ECO:0000269|PubMed:8255472"
FT                   /id="VAR_001776"
FT   VARIANT         636
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779522)"
FT                   /id="VAR_011124"
FT   VARIANT         657
FT                   /note="G -> E (in EDSVASC; dbSNP:rs587779699)"
FT                   /id="VAR_011125"
FT   VARIANT         660
FT                   /note="G -> D (in EDSVASC; dbSNP:rs587779493)"
FT                   /id="VAR_011126"
FT   VARIANT         666
FT                   /note="G -> D (in EDSVASC; dbSNP:rs121912921)"
FT                   /evidence="ECO:0000269|PubMed:8664902"
FT                   /id="VAR_001777"
FT   VARIANT         668
FT                   /note="P -> T (in dbSNP:rs1801183)"
FT                   /evidence="ECO:0000269|PubMed:8514866"
FT                   /id="VAR_011127"
FT   VARIANT         679
FT                   /note="A -> T (in dbSNP:rs41263773)"
FT                   /evidence="ECO:0000269|PubMed:18272325"
FT                   /id="VAR_055666"
FT   VARIANT         686
FT                   /note="P -> A (in dbSNP:rs41263775)"
FT                   /id="VAR_055667"
FT   VARIANT         698
FT                   /note="A -> T (in dbSNP:rs1800255)"
FT                   /evidence="ECO:0000269|PubMed:18272325,
FT                   ECO:0000269|PubMed:2235526"
FT                   /id="VAR_001778"
FT   VARIANT         699
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779668)"
FT                   /id="VAR_011128"
FT   VARIANT         726
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779638)"
FT                   /evidence="ECO:0000269|PubMed:9452103, ECO:0000269|Ref.3"
FT                   /id="VAR_001779"
FT   VARIANT         738
FT                   /note="G -> S (in EDSVASC; dbSNP:rs121912925)"
FT                   /id="VAR_011129"
FT   VARIANT         738
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779615)"
FT                   /id="VAR_011130"
FT   VARIANT         744
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779697)"
FT                   /id="VAR_011131"
FT   VARIANT         756
FT                   /note="G -> E (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:7912131"
FT                   /id="VAR_001780"
FT   VARIANT         762
FT                   /note="G -> C (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:8884076"
FT                   /id="VAR_001781"
FT   VARIANT         786
FT                   /note="G -> R (in EDSVASC; dbSNP:rs113485686)"
FT                   /evidence="ECO:0000269|PubMed:2243125"
FT                   /id="VAR_001782"
FT   VARIANT         804
FT                   /note="G -> S (in EDSVASC; dbSNP:rs121912920)"
FT                   /evidence="ECO:0000269|PubMed:7833919"
FT                   /id="VAR_001783"
FT   VARIANT         828
FT                   /note="G -> R (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:8411057"
FT                   /id="VAR_001784"
FT   VARIANT         828
FT                   /note="G -> W (in EDSVASC; dbSNP:rs587779486)"
FT                   /id="VAR_011132"
FT   VARIANT         830..838
FT                   /note="Missing (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:1370809"
FT                   /id="VAR_037008"
FT   VARIANT         852
FT                   /note="G -> C (in EDSVASC; dbSNP:rs587779690)"
FT                   /id="VAR_011133"
FT   VARIANT         879
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779645)"
FT                   /id="VAR_011134"
FT   VARIANT         882
FT                   /note="G -> D (in EDSVASC; dbSNP:rs587779622)"
FT                   /id="VAR_011135"
FT   VARIANT         900
FT                   /note="G -> D (in EDSVASC; dbSNP:rs587779599)"
FT                   /id="VAR_011136"
FT   VARIANT         903
FT                   /note="G -> E (in EDSVASC; dbSNP:rs587779505)"
FT                   /id="VAR_011137"
FT   VARIANT         909
FT                   /note="G -> D (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:8680408"
FT                   /id="VAR_001785"
FT   VARIANT         909
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779483)"
FT                   /id="VAR_011138"
FT   VARIANT         918
FT                   /note="G -> E (in EDSVASC; dbSNP:rs587779662)"
FT                   /id="VAR_011139"
FT   VARIANT         924
FT                   /note="G -> C (in EDSVASC; dbSNP:rs587779471)"
FT                   /id="VAR_011140"
FT   VARIANT         936
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779566)"
FT                   /evidence="ECO:0000269|PubMed:9036918, ECO:0000269|Ref.55"
FT                   /id="VAR_001786"
FT   VARIANT         936
FT                   /note="G -> S (in EDSVASC)"
FT                   /id="VAR_001787"
FT   VARIANT         939
FT                   /note="G -> D (in EDSVASC; dbSNP:rs112978464)"
FT                   /evidence="ECO:0000269|PubMed:8680408"
FT                   /id="VAR_001788"
FT   VARIANT         942
FT                   /note="G -> E (in EDSVASC; dbSNP:rs587779517)"
FT                   /id="VAR_011141"
FT   VARIANT         957
FT                   /note="G -> S (in EDSVASC; severe variant;
FT                   dbSNP:rs121912913)"
FT                   /evidence="ECO:0000269|PubMed:2492273"
FT                   /id="VAR_001789"
FT   VARIANT         960
FT                   /note="G -> V (in EDSVASC; severe variant;
FT                   dbSNP:rs121912922)"
FT                   /evidence="ECO:0000269|PubMed:7749417"
FT                   /id="VAR_001790"
FT   VARIANT         966
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779571)"
FT                   /id="VAR_011142"
FT   VARIANT         972
FT                   /note="G -> A (in EDSVASC; dbSNP:rs587779559)"
FT                   /id="VAR_011143"
FT   VARIANT         984
FT                   /note="G -> T (in EDSVASC; requires 2 nucleotide
FT                   substitutions)"
FT                   /id="VAR_011144"
FT   VARIANT         996
FT                   /note="G -> E (in EDSVASC; dbSNP:rs587779576)"
FT                   /evidence="ECO:0000269|Ref.55"
FT                   /id="VAR_001791"
FT   VARIANT         999
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779548)"
FT                   /id="VAR_011145"
FT   VARIANT         1011
FT                   /note="G -> E (in EDSVASC; dbSNP:rs587779552)"
FT                   /id="VAR_011146"
FT   VARIANT         1014
FT                   /note="G -> E (in EDSVASC; dbSNP:rs121912916)"
FT                   /evidence="ECO:0000269|PubMed:1352273"
FT                   /id="VAR_001792"
FT   VARIANT         1032
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779428)"
FT                   /id="VAR_011147"
FT   VARIANT         1035
FT                   /note="G -> C (in EDSVASC; dbSNP:rs587779704)"
FT                   /id="VAR_011148"
FT   VARIANT         1044
FT                   /note="G -> D (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:11168790"
FT                   /id="VAR_011149"
FT   VARIANT         1050
FT                   /note="G -> D (in EDSVASC; mild variant;
FT                   dbSNP:rs121912914)"
FT                   /evidence="ECO:0000269|PubMed:2808425"
FT                   /id="VAR_001793"
FT   VARIANT         1050
FT                   /note="G -> V (in EDSVASC; dbSNP:rs121912914)"
FT                   /evidence="ECO:0000269|PubMed:12786757"
FT                   /id="VAR_011150"
FT   VARIANT         1071
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779709)"
FT                   /evidence="ECO:0000269|Ref.55"
FT                   /id="VAR_001794"
FT   VARIANT         1077
FT                   /note="G -> V (in EDSVASC; dbSNP:rs121912915)"
FT                   /evidence="ECO:0000269|PubMed:1895316"
FT                   /id="VAR_001795"
FT   VARIANT         1089
FT                   /note="G -> D (in EDSVASC; dbSNP:rs587779672)"
FT                   /id="VAR_011151"
FT   VARIANT         1098
FT                   /note="G -> D (in EDSVASC)"
FT                   /evidence="ECO:0000269|PubMed:10923041"
FT                   /id="VAR_011152"
FT   VARIANT         1098
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779614)"
FT                   /id="VAR_011153"
FT   VARIANT         1101
FT                   /note="G -> E (in EDSVASC; dbSNP:rs121912924)"
FT                   /evidence="ECO:0000269|PubMed:9147870"
FT                   /id="VAR_001796"
FT   VARIANT         1104
FT                   /note="G -> A (in EDSVASC)"
FT                   /evidence="ECO:0000269|Ref.55"
FT                   /id="VAR_001797"
FT   VARIANT         1161
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779473)"
FT                   /id="VAR_011154"
FT   VARIANT         1164
FT                   /note="G -> E (in EDSVASC; dbSNP:rs587779431)"
FT                   /id="VAR_011155"
FT   VARIANT         1164
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779553)"
FT                   /id="VAR_011156"
FT   VARIANT         1164
FT                   /note="G -> S (in spondyloepiphyseal dysplasia)"
FT                   /id="VAR_001798"
FT   VARIANT         1167
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779578)"
FT                   /evidence="ECO:0000269|Ref.50"
FT                   /id="VAR_001799"
FT   VARIANT         1170
FT                   /note="G -> D (in EDSVASC; dbSNP:rs587779465)"
FT                   /evidence="ECO:0000269|PubMed:8884076, ECO:0000269|Ref.50"
FT                   /id="VAR_001800"
FT   VARIANT         1170
FT                   /note="G -> V (in EDSVASC; dbSNP:rs587779465)"
FT                   /id="VAR_011157"
FT   VARIANT         1173
FT                   /note="G -> E (in EDSVASC; dbSNP:rs121912918)"
FT                   /evidence="ECO:0000269|PubMed:10923041,
FT                   ECO:0000269|PubMed:1357232, ECO:0000269|Ref.50"
FT                   /id="VAR_001801"
FT   VARIANT         1173
FT                   /note="G -> R (in EDSVASC; Gottron type acrogeria;
FT                   dbSNP:rs587779521)"
FT                   /evidence="ECO:0000269|PubMed:10819545"
FT                   /id="VAR_011158"
FT   VARIANT         1176
FT                   /note="G -> V (in EDSVASC; severe)"
FT                   /evidence="ECO:0000269|PubMed:8019562"
FT                   /id="VAR_001802"
FT   VARIANT         1179
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779574)"
FT                   /id="VAR_011159"
FT   VARIANT         1182
FT                   /note="G -> E (in EDSVASC; dbSNP:rs111505097)"
FT                   /evidence="ECO:0000269|Ref.55"
FT                   /id="VAR_001803"
FT   VARIANT         1185
FT                   /note="G -> D (in EDSVASC; severe variant;
FT                   dbSNP:rs121912917)"
FT                   /evidence="ECO:0000269|PubMed:1496983"
FT                   /id="VAR_001804"
FT   VARIANT         1185
FT                   /note="G -> V (in EDSVASC; dbSNP:rs121912917)"
FT                   /evidence="ECO:0000269|Ref.55"
FT                   /id="VAR_001805"
FT   VARIANT         1188
FT                   /note="G -> E (in EDSVASC; severe variant;
FT                   dbSNP:rs112456072)"
FT                   /evidence="ECO:0000269|PubMed:8098182, ECO:0000269|Ref.55"
FT                   /id="VAR_001806"
FT   VARIANT         1188
FT                   /note="G -> R (in EDSVASC; dbSNP:rs587779504)"
FT                   /evidence="ECO:0000269|Ref.55"
FT                   /id="VAR_001807"
FT   VARIANT         1205
FT                   /note="I -> V (in dbSNP:rs2271683)"
FT                   /evidence="ECO:0000269|PubMed:18272325"
FT                   /id="VAR_020012"
FT   VARIANT         1284
FT                   /note="G -> E (in PMGEDSV; dbSNP:rs587779528)"
FT                   /evidence="ECO:0000269|PubMed:25205403"
FT                   /id="VAR_082046"
FT   VARIANT         1353
FT                   /note="H -> Q (in dbSNP:rs1516446)"
FT                   /evidence="ECO:0000269|PubMed:11566270,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:18272325,
FT                   ECO:0000269|PubMed:2579949, ECO:0000269|PubMed:2764886,
FT                   ECO:0000269|PubMed:3357782, ECO:0000269|Ref.6"
FT                   /id="VAR_030115"
FT   VARIANT         1434
FT                   /note="R -> C (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs747324731)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035739"
FT   CONFLICT        163
FT                   /note="G -> GG (in Ref. 10; CAA33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        168
FT                   /note="G -> V (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        226..228
FT                   /note="Missing (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        241
FT                   /note="E -> D (in Ref. 10; CAA33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        278
FT                   /note="T -> A (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        293..295
FT                   /note="NGA -> DGS (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        401
FT                   /note="A -> L (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        409
FT                   /note="L -> P (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        472
FT                   /note="E -> D (in Ref. 10; CAA33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        488..490
FT                   /note="PGF -> LGS (in Ref. 10; CAA33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        589
FT                   /note="A -> E (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        614
FT                   /note="T -> Y (in Ref. 10; CAA33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        635
FT                   /note="P -> R (in Ref. 10; CAA33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        664
FT                   /note="D -> E (in Ref. 10; CAA33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        676
FT                   /note="D -> N (in Ref. 16; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        803
FT                   /note="T -> P (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        896
FT                   /note="S -> A (in Ref. 18; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        980
FT                   /note="S -> A (in Ref. 22; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        985..989
FT                   /note="ANGLS -> PSGQN (in Ref. 22; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1019
FT                   /note="D -> Y (in Ref. 20; CAA29886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1067
FT                   /note="S -> P (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1070
FT                   /note="A -> P (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1097
FT                   /note="T -> P (in Ref. 22; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1153..1154
FT                   /note="TS -> AT (in Ref. 22; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1156
FT                   /note="H -> S (in Ref. 22; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1184
FT                   /note="P -> S (in Ref. 10; CAA33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1203
FT                   /note="A -> P (in Ref. 10; CAA33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1210
FT                   /note="G -> A (in Ref. 10; CAA33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1222
FT                   /note="D -> P (in Ref. 26; AAA52002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1235
FT                   /note="M -> I (in Ref. 26; AAA52002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1241
FT                   /note="V -> A (in Ref. 20; CAA29886 and 23; CAA25879)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1274
FT                   /note="S -> T (in Ref. 26; AAA52002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1332
FT                   /note="M -> I (in Ref. 26; AAA52002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1357
FT                   /note="L -> P (in Ref. 26; AAA52002)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1231..1249
FT                   /evidence="ECO:0000244|PDB:6FZV"
FT   STRAND          1253..1257
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1259..1261
FT                   /evidence="ECO:0000244|PDB:6FZV"
FT   HELIX           1262..1268
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1274..1279
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   HELIX           1286..1288
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1290..1295
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   TURN            1296..1299
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1300..1303
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1305..1307
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1309..1313
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1320..1322
FT                   /evidence="ECO:0000244|PDB:4AK3"
FT   HELIX           1328..1331
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1339..1341
FT                   /evidence="ECO:0000244|PDB:4AEJ"
FT   STRAND          1343..1345
FT                   /evidence="ECO:0000244|PDB:4AK3"
FT   HELIX           1347..1360
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1364..1374
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   TURN            1381..1384
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1391..1393
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1395..1397
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1399..1404
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   HELIX           1406..1408
FT                   /evidence="ECO:0000244|PDB:6FZV"
FT   STRAND          1411..1415
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1422..1434
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   HELIX           1436..1438
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1443..1445
FT                   /evidence="ECO:0000244|PDB:4AE2"
FT   STRAND          1451..1453
FT                   /evidence="ECO:0000244|PDB:6FZV"
FT   STRAND          1455..1465
FT                   /evidence="ECO:0000244|PDB:4AE2"
SQ   SEQUENCE   1466 AA;  138564 MW;  B904B4E05E17D339 CRC64;
     MMSFVQKGSW LLLALLHPTI ILAQQEAVEG GCSHLGQSYA DRDVWKPEPC QICVCDSGSV
     LCDDIICDDQ ELDCPNPEIP FGECCAVCPQ PPTAPTRPPN GQGPQGPKGD PGPPGIPGRN
     GDPGIPGQPG SPGSPGPPGI CESCPTGPQN YSPQYDSYDV KSGVAVGGLA GYPGPAGPPG
     PPGPPGTSGH PGSPGSPGYQ GPPGEPGQAG PSGPPGPPGA IGPSGPAGKD GESGRPGRPG
     ERGLPGPPGI KGPAGIPGFP GMKGHRGFDG RNGEKGETGA PGLKGENGLP GENGAPGPMG
     PRGAPGERGR PGLPGAAGAR GNDGARGSDG QPGPPGPPGT AGFPGSPGAK GEVGPAGSPG
     SNGAPGQRGE PGPQGHAGAQ GPPGPPGING SPGGKGEMGP AGIPGAPGLM GARGPPGPAG
     ANGAPGLRGG AGEPGKNGAK GEPGPRGERG EAGIPGVPGA KGEDGKDGSP GEPGANGLPG
     AAGERGAPGF RGPAGPNGIP GEKGPAGERG APGPAGPRGA AGEPGRDGVP GGPGMRGMPG
     SPGGPGSDGK PGPPGSQGES GRPGPPGPSG PRGQPGVMGF PGPKGNDGAP GKNGERGGPG
     GPGPQGPPGK NGETGPQGPP GPTGPGGDKG DTGPPGPQGL QGLPGTGGPP GENGKPGEPG
     PKGDAGAPGA PGGKGDAGAP GERGPPGLAG APGLRGGAGP PGPEGGKGAA GPPGPPGAAG
     TPGLQGMPGE RGGLGSPGPK GDKGEPGGPG ADGVPGKDGP RGPTGPIGPP GPAGQPGDKG
     EGGAPGLPGI AGPRGSPGER GETGPPGPAG FPGAPGQNGE PGGKGERGAP GEKGEGGPPG
     VAGPPGGSGP AGPPGPQGVK GERGSPGGPG AAGFPGARGL PGPPGSNGNP GPPGPSGSPG
     KDGPPGPAGN TGAPGSPGVS GPKGDAGQPG EKGSPGAQGP PGAPGPLGIA GITGARGLAG
     PPGMPGPRGS PGPQGVKGES GKPGANGLSG ERGPPGPQGL PGLAGTAGEP GRDGNPGSDG
     LPGRDGSPGG KGDRGENGSP GAPGAPGHPG PPGPVGPAGK SGDRGESGPA GPAGAPGPAG
     SRGAPGPQGP RGDKGETGER GAAGIKGHRG FPGNPGAPGS PGPAGQQGAI GSPGPAGPRG
     PVGPSGPPGK DGTSGHPGPI GPPGPRGNRG ERGSEGSPGH PGQPGPPGPP GAPGPCCGGV
     GAAAIAGIGG EKAGGFAPYY GDEPMDFKIN TDEIMTSLKS VNGQIESLIS PDGSRKNPAR
     NCRDLKFCHP ELKSGEYWVD PNQGCKLDAI KVFCNMETGE TCISANPLNV PRKHWWTDSS
     AEKKHVWFGE SMDGGFQFSY GNPELPEDVL DVHLAFLRLL SSRASQNITY HCKNSIAYMD
     QASGNVKKAL KLMGSNEGEF KAEGNSKFTY TVLEDGCTKH TGEWSKTVFE YRTRKAVRLP
     IVDIAPYDIG GPDQEFGVDV GPVCFL
//
ID   A0A024R9B7_HUMAN        Unreviewed;        75 AA.
AC   A0A024R9B7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 47.
DE   SubName: Full=Cytochrome c oxidase subunit VIc, isoform CRA_a {ECO:0000313|EMBL:EAW91792.1};
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22528.1};
GN   Name=COX6C {ECO:0000313|EMBL:EAW91792.1};
GN   ORFNames=hCG_1781497 {ECO:0000313|EMBL:EAW91792.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW91792.1};
RN   [1] {ECO:0000313|EMBL:EAW91792.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW91792.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADO22528.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C., Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ901011; ADO22528.1; -; mRNA.
DR   EMBL; CH471060; EAW91792.1; -; Genomic_DNA.
DR   EMBL; CH471060; EAW91793.1; -; Genomic_DNA.
DR   RefSeq; NP_004365.1; NM_004374.3.
DR   RefSeq; XP_016868509.1; XM_017013020.1.
DR   Antibodypedia; 4263; 224 antibodies.
DR   GeneID; 1345; -.
DR   KEGG; hsa:1345; -.
DR   CTD; 1345; -.
DR   EuPathDB; HostDB:ENSG00000164919.10; -.
DR   eggNOG; ENOG410J83U; Eukaryota.
DR   eggNOG; ENOG41124VH; LUCA.
DR   HOGENOM; CLU_196254_0_0_1; -.
DR   KO; K02268; -.
DR   OMA; ALMKPQM; -.
DR   OrthoDB; 1618740at2759; -.
DR   ChiTaRS; COX6C; human.
DR   GenomeRNAi; 1345; -.
DR   Bgee; ENSG00000164919; Expressed in heart and 240 other tissues.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro.
DR   CDD; cd00927; Cyt_c_Oxidase_VIc; 1.
DR   Gene3D; 4.10.93.10; -; 1.
DR   InterPro; IPR004204; COX6C.
DR   InterPro; IPR034884; Cytochrome_c_oxidase_VIc/VIIs.
DR   InterPro; IPR037169; Cytochrome_c_oxidase_VIc_sf.
DR   Pfam; PF02937; COX6C; 1.
DR   SUPFAM; SSF81415; SSF81415; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        20..37
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          6..74
FT                   /note="COX6C"
FT                   /evidence="ECO:0000259|Pfam:PF02937"
SQ   SEQUENCE   75 AA;  8781 MW;  D09FEE0C0AA7A798 CRC64;
     MAPEVLPKPR MRGLLARRLR NHMAVAFVLS LGVAALYKFR VADQRKKAYA DFYRNYDVMK
     DFEEMRKAGI FQSVK
//
ID   COX6C_HUMAN             Reviewed;          75 AA.
AC   P09669; B2R4D7;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   22-APR-2020, entry version 179.
DE   RecName: Full=Cytochrome c oxidase subunit 6C;
DE   AltName: Full=Cytochrome c oxidase polypeptide VIc;
GN   Name=COX6C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2849755; DOI=10.1093/nar/16.22.10916;
RA   Otsuka M., Mizuno Y., Yoshida M., Kagawa Y., Ohta S.;
RT   "Nucleotide sequence of cDNA encoding human cytochrome c oxidase subunit
RT   VIc.";
RL   Nucleic Acids Res. 16:10916-10916(1988).
RN   [2]
RP   SEQUENCE REVISION TO 52.
RA   Ohta S.;
RL   Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10072584; DOI=10.1159/000015185;
RA   Hofmann S., Lichtner P., Schuffenhauer S., Gerbitz K.D., Meitinger T.;
RT   "Assignment of the human genes coding for cytochrome c oxidase subunits Va
RT   (COX5A), VIc (COX6C) and VIIc (COX7C) to chromosome bands 15q25, 8q22-->q23
RT   and 5q14 and of three pseudogenes (COX5AP1, COX6CP1, COX7CP1) to 14q22,
RT   16p12 and 13q14-->q21 by FISH and radiation hybrid mapping.";
RL   Cytogenet. Cell Genet. 83:226-227(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE [LARGE SCALE ANALYSIS] OF 2-11.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19892738; DOI=10.1073/pnas.0908958106;
RA   Xu G., Shin S.B., Jaffrey S.R.;
RT   "Global profiling of protease cleavage sites by chemoselective labeling of
RT   protein N-termini.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:19310-19315(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.90 ANGSTROMS), AND SUBUNIT.
RX   PubMed=28844695; DOI=10.1016/j.cell.2017.07.050;
RA   Guo R., Zong S., Wu M., Gu J., Yang M.;
RT   "Architecture of human mitochondrial respiratory megacomplex I2III2IV2.";
RL   Cell 170:1247-1257(2017).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS) OF 3-75.
RX   PubMed=30030519; DOI=10.1038/s41422-018-0071-1;
RA   Zong S., Wu M., Gu J., Liu T., Guo R., Yang M.;
RT   "Structure of the intact 14-subunit human cytochrome c oxidase.";
RL   Cell Res. 28:1026-1034(2018).
CC   -!- FUNCTION: Component of the cytochrome c oxidase, the last enzyme in the
CC       mitochondrial electron transport chain which drives oxidative
CC       phosphorylation. The respiratory chain contains 3 multisubunit
CC       complexes succinate dehydrogenase (complex II, CII), ubiquinol-
CC       cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III,
CC       CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to
CC       transfer electrons derived from NADH and succinate to molecular oxygen,
CC       creating an electrochemical gradient over the inner membrane that
CC       drives transmembrane transport and the ATP synthase. Cytochrome c
CC       oxidase is the component of the respiratory chain that catalyzes the
CC       reduction of oxygen to water. Electrons originating from reduced
CC       cytochrome c in the intermembrane space (IMS) are transferred via the
CC       dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1
CC       to the active site in subunit 1, a binuclear center (BNC) formed by
CC       heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2
CC       water molecules using 4 electrons from cytochrome c in the IMS and 4
CC       protons from the mitochondrial matrix. {ECO:0000250|UniProtKB:P04038}.
CC   -!- PATHWAY: Energy metabolism; oxidative phosphorylation.
CC       {ECO:0000250|UniProtKB:P04038}.
CC   -!- SUBUNIT: Component of the cytochrome c oxidase (complex IV, CIV), a
CC       multisubunit enzyme composed of 14 subunits. The complex is composed of
CC       a catalytic core of 3 subunits MT-CO1, MT-CO2 and MT-CO3, encoded in
CC       the mitochondrial DNA, and 11 supernumerary subunits COX4I1 (or
CC       COX4I2), COX5A, COX5B, COX6A1 (or COX6A2), COX6B1 (or COX6B2), COX6C,
CC       COX7A2 (or COX7A1), COX7B, COX7C, COX8A and NDUFA4, which are encoded
CC       in the nuclear genome (PubMed:30030519). The complex exists as a
CC       monomer or a dimer and forms supercomplexes (SCs) in the inner
CC       mitochondrial membrane with NADH-ubiquinone oxidoreductase (complex I,
CC       CI) and ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex,
CC       complex III, CIII), resulting in different assemblies (supercomplex
CC       SCI(1)III(2)IV(1) and megacomplex MCI(2)III(2)IV(2)) (PubMed:28844695).
CC       {ECO:0000269|PubMed:28844695, ECO:0000269|PubMed:30030519}.
CC   -!- INTERACTION:
CC       P09669; P21673: SAT1; NbExp=3; IntAct=EBI-715040, EBI-711613;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:30030519}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:30030519}.
CC   -!- SIMILARITY: Belongs to the cytochrome c oxidase subunit 6c family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/COX6CID251.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X13238; CAA31624.1; -; mRNA.
DR   EMBL; AF067637; AAC73061.1; -; Genomic_DNA.
DR   EMBL; AF067636; AAC73061.1; JOINED; Genomic_DNA.
DR   EMBL; BT007007; AAP35653.1; -; mRNA.
DR   EMBL; AK311791; BAG34734.1; -; mRNA.
DR   EMBL; CH471060; EAW91791.1; -; Genomic_DNA.
DR   EMBL; BC000187; AAH00187.1; -; mRNA.
DR   CCDS; CCDS6284.1; -.
DR   PIR; S01960; OGHU6C.
DR   RefSeq; NP_004365.1; NM_004374.3.
DR   RefSeq; XP_016868509.1; XM_017013020.1.
DR   PDB; 5Z62; EM; 3.60 A; I=3-75.
DR   PDBsum; 5Z62; -.
DR   SMR; P09669; -.
DR   BioGrid; 107738; 90.
DR   CORUM; P09669; -.
DR   IntAct; P09669; 42.
DR   MINT; P09669; -.
DR   STRING; 9606.ENSP00000428895; -.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB04464; N-Formylmethionine.
DR   iPTMnet; P09669; -.
DR   PhosphoSitePlus; P09669; -.
DR   BioMuta; COX6C; -.
DR   EPD; P09669; -.
DR   jPOST; P09669; -.
DR   MassIVE; P09669; -.
DR   MaxQB; P09669; -.
DR   PaxDb; P09669; -.
DR   PeptideAtlas; P09669; -.
DR   PRIDE; P09669; -.
DR   ProteomicsDB; 52263; -.
DR   TopDownProteomics; P09669; -.
DR   Antibodypedia; 4263; 224 antibodies.
DR   DNASU; 1345; -.
DR   Ensembl; ENST00000297564; ENSP00000297564; ENSG00000164919.
DR   Ensembl; ENST00000517682; ENSP00000429714; ENSG00000164919.
DR   Ensembl; ENST00000518171; ENSP00000429755; ENSG00000164919.
DR   Ensembl; ENST00000520271; ENSP00000428150; ENSG00000164919.
DR   Ensembl; ENST00000520468; ENSP00000428895; ENSG00000164919.
DR   Ensembl; ENST00000520517; ENSP00000429991; ENSG00000164919.
DR   Ensembl; ENST00000522934; ENSP00000428702; ENSG00000164919.
DR   Ensembl; ENST00000522940; ENSP00000428965; ENSG00000164919.
DR   Ensembl; ENST00000523016; ENSP00000429707; ENSG00000164919.
DR   Ensembl; ENST00000524245; ENSP00000429410; ENSG00000164919.
DR   GeneID; 1345; -.
DR   KEGG; hsa:1345; -.
DR   UCSC; uc003yiy.3; human.
DR   CTD; 1345; -.
DR   DisGeNET; 1345; -.
DR   GeneCards; COX6C; -.
DR   HGNC; HGNC:2285; COX6C.
DR   HPA; ENSG00000164919; Tissue enhanced (skeletal).
DR   MIM; 124090; gene.
DR   neXtProt; NX_P09669; -.
DR   OpenTargets; ENSG00000164919; -.
DR   PharmGKB; PA26802; -.
DR   eggNOG; ENOG410J83U; Eukaryota.
DR   eggNOG; ENOG41124VH; LUCA.
DR   GeneTree; ENSGT00940000162275; -.
DR   HOGENOM; CLU_196254_0_0_1; -.
DR   InParanoid; P09669; -.
DR   KO; K02268; -.
DR   OMA; ALMKPQM; -.
DR   OrthoDB; 1618740at2759; -.
DR   PhylomeDB; P09669; -.
DR   TreeFam; TF353619; -.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   UniPathway; UPA00705; -.
DR   ChiTaRS; COX6C; human.
DR   GeneWiki; COX6C; -.
DR   GenomeRNAi; 1345; -.
DR   Pharos; P09669; Tbio.
DR   PRO; PR:P09669; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; P09669; protein.
DR   Bgee; ENSG00000164919; Expressed in heart and 240 other tissues.
DR   ExpressionAtlas; P09669; baseline and differential.
DR   Genevisible; P09669; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0006123; P:mitochondrial electron transport, cytochrome c to oxygen; TAS:Reactome.
DR   CDD; cd00927; Cyt_c_Oxidase_VIc; 1.
DR   Gene3D; 4.10.93.10; -; 1.
DR   InterPro; IPR004204; COX6C.
DR   InterPro; IPR034884; Cytochrome_c_oxidase_VIc/VIIs.
DR   InterPro; IPR037169; Cytochrome_c_oxidase_VIc_sf.
DR   Pfam; PF02937; COX6C; 1.
DR   SUPFAM; SSF81415; SSF81415; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..75
FT                   /note="Cytochrome c oxidase subunit 6C"
FT                   /id="PRO_0000006131"
FT   TOPO_DOM        1..13
FT                   /note="Mitochondrial matrix"
FT                   /evidence="ECO:0000269|PubMed:30030519"
FT   TRANSMEM        14..54
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P04038"
FT   TOPO_DOM        55..75
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000269|PubMed:30030519"
SQ   SEQUENCE   75 AA;  8781 MW;  D09FEE0C0AA7A798 CRC64;
     MAPEVLPKPR MRGLLARRLR NHMAVAFVLS LGVAALYKFR VADQRKKAYA DFYRNYDVMK
     DFEEMRKAGI FQSVK
//
ID   B3KRT8_HUMAN            Unreviewed;       617 AA.
AC   B3KRT8;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 70.
DE   SubName: Full=Elastin {ECO:0000313|Ensembl:ENSP00000480955};
DE   SubName: Full=Elastin (Supravalvular aortic stenosis, Williams-Beuren syndrome), isoform CRA_l {ECO:0000313|EMBL:EAW69636.1};
DE   SubName: Full=cDNA FLJ34913 fis, clone NT2RP7000311, moderately similar to ELASTIN {ECO:0000313|EMBL:BAG52500.1};
GN   Name=ELN {ECO:0000313|EMBL:EAW69636.1,
GN   ECO:0000313|Ensembl:ENSP00000480955};
GN   ORFNames=hCG_18037 {ECO:0000313|EMBL:EAW69636.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG52500.1};
RN   [1] {ECO:0000313|EMBL:EAW69636.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000480955, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|EMBL:BAG52500.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M.,
RA   Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S.,
RA   Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S.,
RA   Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H.,
RA   Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M.,
RA   Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M.,
RA   Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y.,
RA   Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N.,
RA   Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S.,
RA   Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T.,
RA   Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M.,
RA   Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y.,
RA   Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y.,
RA   Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T.,
RA   Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000313|EMBL:EAW69636.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|Ensembl:ENSP00000480955}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK092232; BAG52500.1; -; mRNA.
DR   EMBL; CH471200; EAW69636.1; -; Genomic_DNA.
DR   RefSeq; NP_001265847.1; NM_001278918.1.
DR   Antibodypedia; 4380; 401 antibodies.
DR   DNASU; 2006; -.
DR   Ensembl; ENST00000621115; ENSP00000480955; ENSG00000049540.
DR   GeneID; 2006; -.
DR   UCSC; uc003tzp.5; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   PharmGKB; PA27757; -.
DR   GeneTree; ENSGT00730000111510; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in thoracic aorta and 180 other tissues.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 3.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|MaxQB:B3KRT8,
KW   ECO:0000213|PeptideAtlas:B3KRT8, ECO:0000213|ProteomicsDB:B3KRT8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           27..617
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5014567665"
SQ   SEQUENCE   617 AA;  53630 MW;  A5244FCC64986330 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPALGPGG KPLKPVPGGL
     AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG LGVSAGAVVP
     QPGAGVKPGK VPGVGLPGVY PGGVLPGVGP FGGPQPGVPL GYPIKAPKLP GGYGLPYTTG
     KLPYGYGPGG VAGAAGKAGY PTGTGVGPQA AAAAAAKAAA KFGAGAAGVL PGVGGAGVPG
     VPGAIPGIGG IAGVGTPAAA AAAAAAAKAA KYGAAAGLVP GGPGFGPGVV GVPGAGVPGV
     GVPGAGIPVV PGAGIPGAAV PGVVSPEAAA KAAAKAAKYG ARPGVGVGGI PTYGVGAGGF
     PGFGVGVGAE AQAAAAAKAA KYGLVPGVGV APGVGVAPGV GVAPGVGLAP GVGVAPGVGV
     APGVGVAPGI GPGGVAAAAK SAAKVAAKAQ LRAAAGLGAG IPGLGVGVGV PGLGVGAGVP
     GLGVGAGVPG FGAVPGALAA AKAAKYGAAV PGVLGGLGAL GGVGIPGGVV GAGPAAAAAA
     AKAAAKAAQF GLVGAAGLGG LGVGGLGVPG VGGLGGIPPA AAAKAAKYGV AARPGFGLSP
     IFPGGACLGK ACGRKRK
//
ID   B4E3S4_HUMAN            Unreviewed;       706 AA.
AC   B4E3S4;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 38.
DE   SubName: Full=cDNA FLJ56005, highly similar to Elastin {ECO:0000313|EMBL:BAG65586.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65586.1};
RN   [1] {ECO:0000313|EMBL:BAG65586.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Uterus {ECO:0000313|EMBL:BAG65586.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK304845; BAG65586.1; -; mRNA.
DR   RefSeq; NP_001265841.1; NM_001278912.1.
DR   Allergome; 11040; Hom s Elastin.
DR   PeptideAtlas; B4E3S4; -.
DR   PRIDE; B4E3S4; -.
DR   GeneID; 2006; -.
DR   CTD; 2006; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GenomeRNAi; 2006; -.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 1.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           27..706
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002801176"
SQ   SEQUENCE   706 AA;  61182 MW;  84D3B457CED67CA5 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPVPGGL AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG
     LGVSAGAVVP QPGAGVKPGK VPGVGLPGVY PGGVLPGARF PGVGVLPGVP TGAGVKPKAP
     GVGGAFAGIP GVGPFGGPQP GVPLGYPIKA PKLPGGYGLP YTTGKLPYGY GPGGVAGAAG
     KAGYPTGTGV GPQAVAAAAA KAAAKFGAGA AGVLPGVGGA GVPGVPGAIP GIGGIAGVGT
     PAAAAAAAAA AKAAKYGAAA GLVPGGPGFG PGVVGVPGAG VPGVGVPGAG IPVVPGAGIP
     GAAVPGVVSP EAAAKAAAKA AKYGARPGVG VGGIPTYGVG AGGFPGFGVG VGGIPGVAGV
     PGVGGVPGVG GVPGVGISPE AQAAAAAKAA KYGVGTPAAA AAKAAAKAAQ FGLVPGVGVA
     PGVGVAPGVG VAPGVGLAPG VGVAPGVGVA PGVGVAPGIG PGGVAAAAKS AAKVAAKAQL
     RAAAGLGAGI PGLGVGVGVP GLGVGAGVPG LGVGAGVPGF GAVPGALAAA KAAKYGAAVP
     GVLGGLGALG GVGIPGGVVG AGPAAAAAAA KAAAKAAQFG LVGAAGLGGL GVGGLGVPGV
     GGLGGIPPAA AAKAAKYGVA ARPGFGLSPI FPGGACLGKA CGRKRK
//
ID   E7EN65_HUMAN            Unreviewed;       714 AA.
AC   E7EN65;
DT   08-MAR-2011, integrated into UniProtKB/TrEMBL.
DT   08-MAR-2011, sequence version 1.
DT   22-APR-2020, entry version 55.
DE   SubName: Full=Elastin {ECO:0000313|Ensembl:ENSP00000403162};
GN   Name=ELN {ECO:0000313|Ensembl:ENSP00000403162};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000403162, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000403162, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000403162}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001265846.1; NM_001278917.1.
DR   Allergome; 11040; Hom s Elastin.
DR   jPOST; E7EN65; -.
DR   PeptideAtlas; E7EN65; -.
DR   PRIDE; E7EN65; -.
DR   ProteomicsDB; 17090; -.
DR   Antibodypedia; 4380; 401 antibodies.
DR   Ensembl; ENST00000458204; ENSP00000403162; ENSG00000049540.
DR   GeneID; 2006; -.
DR   UCSC; uc003tzx.5; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GeneTree; ENSGT00730000111510; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in thoracic aorta and 180 other tissues.
DR   ExpressionAtlas; E7EN65; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 1.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|MaxQB:E7EN65,
KW   ECO:0000213|PeptideAtlas:E7EN65, ECO:0000213|ProteomicsDB:E7EN65};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           27..714
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5003217306"
SQ   SEQUENCE   714 AA;  61923 MW;  0159DB68B68BAAFB CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPALGPGG KPLKPVPGGL
     AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG LGVSAGAVVP
     QPGAGVKPGK VPGVGLPGVY PGGVLPGARF PGVGVLPGVP TGAGVKPKAP GVGGAFAGIP
     GVGPFGGPQP GVPLGYPIKA PKLPGGYGLP YTTGKLPYGY GPGGVAGAAG KAGYPTGTGV
     GPQAAAAAAA KAAAKFGAGA AGVLPGVGGA GVPGVPGAIP GIGGIAGVGT PAAAAAAAAA
     AKAAKYGAAA GLVPGGPGFG PGVVGVPGAG VPGVGVPGAG IPVVPGAGIP GAAVPGVVSP
     EAAAKAAAKA AKYGARPGVG VGGIPTYGVG AGGFPGFGVG VGGIPGVAGV PGVGGVPGVG
     GVPGVGISPE AQAAAAAKAA KYGVGTPAAA AAKAAAKAAQ FGLVPGVGVA PGVGVAPGVG
     VAPGVGLAPG VGVAPGVGVA PGVGVAPGIG PGGVAAAAKS AAKVAAKAQL RAAAGLGAGI
     PGLGVGVGVP GLGVGAGVPG LGVGAGVPGF GAVPGALAAA KAAKYGAAVP GVLGGLGALG
     GVGIPGGVVG AGPAAAAAAA KAAAKAAQFG LVGAAGLGGL GVGGLGVPGV GGLGGIPPAA
     AAKAAKYGAA GLGGVLGGAG QFPLGGVAAR PGFGLSPIFP GGACLGKACG RKRK
//
ID   E7ENM0_HUMAN            Unreviewed;       706 AA.
AC   E7ENM0;
DT   08-MAR-2011, integrated into UniProtKB/TrEMBL.
DT   08-MAR-2011, sequence version 1.
DT   22-APR-2020, entry version 54.
DE   SubName: Full=Elastin {ECO:0000313|Ensembl:ENSP00000389857};
GN   Name=ELN {ECO:0000313|Ensembl:ENSP00000389857};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000389857, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000389857, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000389857}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001265841.1; NM_001278912.1.
DR   Allergome; 11040; Hom s Elastin.
DR   jPOST; E7ENM0; -.
DR   PeptideAtlas; E7ENM0; -.
DR   PRIDE; E7ENM0; -.
DR   ProteomicsDB; 17182; -.
DR   Antibodypedia; 4380; 401 antibodies.
DR   Ensembl; ENST00000445912; ENSP00000389857; ENSG00000049540.
DR   GeneID; 2006; -.
DR   UCSC; uc011kff.4; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GeneTree; ENSGT00730000111510; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in thoracic aorta and 180 other tissues.
DR   ExpressionAtlas; E7ENM0; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 1.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|MaxQB:E7ENM0,
KW   ECO:0000213|PeptideAtlas:E7ENM0, ECO:0000213|ProteomicsDB:E7ENM0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           27..706
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5003219423"
SQ   SEQUENCE   706 AA;  61154 MW;  34BF630B341E2F50 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPVPGGL AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG
     LGVSAGAVVP QPGAGVKPGK VPGVGLPGVY PGGVLPGARF PGVGVLPGVP TGAGVKPKAP
     GVGGAFAGIP GVGPFGGPQP GVPLGYPIKA PKLPGGYGLP YTTGKLPYGY GPGGVAGAAG
     KAGYPTGTGV GPQAAAAAAA KAAAKFGAGA AGVLPGVGGA GVPGVPGAIP GIGGIAGVGT
     PAAAAAAAAA AKAAKYGAAA GLVPGGPGFG PGVVGVPGAG VPGVGVPGAG IPVVPGAGIP
     GAAVPGVVSP EAAAKAAAKA AKYGARPGVG VGGIPTYGVG AGGFPGFGVG VGGIPGVAGV
     PGVGGVPGVG GVPGVGISPE AQAAAAAKAA KYGVGTPAAA AAKAAAKAAQ FGLVPGVGVA
     PGVGVAPGVG VAPGVGLAPG VGVAPGVGVA PGVGVAPGIG PGGVAAAAKS AAKVAAKAQL
     RAAAGLGAGI PGLGVGVGVP GLGVGAGVPG LGVGAGVPGF GAVPGALAAA KAAKYGAAVP
     GVLGGLGALG GVGIPGGVVG AGPAAAAAAA KAAAKAAQFG LVGAAGLGGL GVGGLGVPGV
     GGLGGIPPAA AAKAAKYGVA ARPGFGLSPI FPGGACLGKA CGRKRK
//
ID   G3V0G6_HUMAN            Unreviewed;       700 AA.
AC   G3V0G6;
DT   16-NOV-2011, integrated into UniProtKB/TrEMBL.
DT   16-NOV-2011, sequence version 1.
DT   22-APR-2020, entry version 83.
DE   SubName: Full=Elastin {ECO:0000313|Ensembl:ENSP00000392575};
DE   SubName: Full=Elastin (Supravalvular aortic stenosis, Williams-Beuren syndrome), isoform CRA_e {ECO:0000313|EMBL:EAW69628.1};
GN   Name=ELN {ECO:0000313|EMBL:EAW69628.1,
GN   ECO:0000313|Ensembl:ENSP00000392575};
GN   ORFNames=hCG_18037 {ECO:0000313|EMBL:EAW69628.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000392575, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW69628.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000392575, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|EMBL:EAW69628.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000392575}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471200; EAW69628.1; -; Genomic_DNA.
DR   RefSeq; NP_001265843.1; NM_001278914.1.
DR   Allergome; 11040; Hom s Elastin.
DR   ProteomicsDB; 32191; -.
DR   Antibodypedia; 4380; 401 antibodies.
DR   Ensembl; ENST00000414324; ENSP00000392575; ENSG00000049540.
DR   GeneID; 2006; -.
DR   UCSC; uc003tzy.5; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GeneTree; ENSGT00730000111510; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in thoracic aorta and 180 other tissues.
DR   ExpressionAtlas; G3V0G6; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 2.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|MaxQB:G3V0G6,
KW   ECO:0000213|PeptideAtlas:G3V0G6, ECO:0000213|ProteomicsDB:G3V0G6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           27..700
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5015091584"
SQ   SEQUENCE   700 AA;  60721 MW;  B611796F2E23E1F4 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPALGPGG KPLKPVPGGL
     AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG LGVSAAPSVP
     GAVVPQPGAG VKPGKVPGVG LPGVYPGGVL PGARFPGVGV LPGVPTGAGV KPKAPGVGGA
     FAGIPGVGPF GGPQPGVPLG YPIKAPKLPG GYGLPYTTGK LPYGYGPGGV AGAAGKAGYP
     TGTGVGPQAA AAAAAKAAAK FGAGAAGVLP GVGGAGVPGV PGAIPGIGGI AGVGTPAAAA
     AAAAAAKAAK YGAAAGLVPG GPGFGPGVVG VPGAGVPGVG VPGAGIPVVP GAGIPGAAVP
     GVVSPEAAAK AAAKAAKYGA RPGVGVGGIP TYGVGAGGFP GFGVGVGGIP GVAGVPGVGG
     VPGVGGVPGV GISPEAQAAA AAKAAKYGLV PGVGVAPGVG VAPGVGVAPG VGLAPGVGVA
     PGVGVAPGVG VAPGIGPGGV AAAAKSAAKV AAKAQLRAAA GLGAGIPGLG VGVGVPGLGV
     GAGVPGLGVG AGVPGFGAVP GALAAAKAAK YGAAVPGVLG GLGALGGVGI PGGVVGAGPA
     AAAAAAKAAA KAAQFGLVGA AGLGGLGVGG LGVPGVGGLG GIPPAAAAKA AKYGAAGLGG
     VLGGAGQFPL GGVAARPGFG LSPIFPGGAC LGKACGRKRK
//
ID   G5E950_HUMAN            Unreviewed;       643 AA.
AC   G5E950;
DT   14-DEC-2011, integrated into UniProtKB/TrEMBL.
DT   14-DEC-2011, sequence version 1.
DT   22-APR-2020, entry version 69.
DE   SubName: Full=Elastin {ECO:0000313|Ensembl:ENSP00000315607};
DE   SubName: Full=Elastin (Supravalvular aortic stenosis, Williams-Beuren syndrome), isoform CRA_h {ECO:0000313|EMBL:EAW69632.1};
GN   Name=ELN {ECO:0000313|EMBL:EAW69632.1,
GN   ECO:0000313|Ensembl:ENSP00000315607};
GN   ORFNames=hCG_18037 {ECO:0000313|EMBL:EAW69632.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000315607, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW69632.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000315607, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|EMBL:EAW69632.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000315607}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (OCT-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471200; EAW69632.1; -; Genomic_DNA.
DR   RefSeq; NP_001265842.1; NM_001278913.1.
DR   ProteomicsDB; 33830; -.
DR   Antibodypedia; 4380; 401 antibodies.
DR   Ensembl; ENST00000320492; ENSP00000315607; ENSG00000049540.
DR   GeneID; 2006; -.
DR   UCSC; uc003tzz.5; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GeneTree; ENSGT00730000111510; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in thoracic aorta and 180 other tissues.
DR   ExpressionAtlas; G5E950; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 2.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|MaxQB:G5E950,
KW   ECO:0000213|PeptideAtlas:G5E950, ECO:0000213|ProteomicsDB:G5E950};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           27..643
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5014571900"
SQ   SEQUENCE   643 AA;  55643 MW;  F9AD070710972A69 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPGLGAF PAVTFPGALV PGGVADAAAA YKAAKAGAGL GGVPGVGGLG VSAGAVVPQP
     GAGVKPGKVP GVGLPGVYPG GVLPGARFPG VGVLPGVPTG AGVKPKAPGV GPFGGPQPGV
     PLGYPIKAPK LPGYGPGGVA GAAGKAGYPT GTGVGPQAAA AAAAKAAAKF GAGAAGVLPG
     VGGAGVPGVP GAIPGIGGIA GVGTPAAAAA AAAAAKAAKY GAAAGLVPGG PGFGPGVVGV
     PGAGVPGVGV PGAGIPVVPG AGIPGAAVPG VVSPEAAAKA AAKAAKYGAR PGVGVGGIPT
     YGVGAGGFPG FGVGVGAEAQ AAAAAKAAKY GLVPGVGVAP GVGVAPGVGV APGVGLAPGV
     GVAPGVGVAP GVGVAPGIGP GGVAAAAKSA AKVAAKAQLR AAAGLGAGIP GLGVGVGVPG
     LGVGAGVPGL GVGAGVPGFG AVPGALAAAK AAKYGAAVPG VLGGLGALGG VGIPGGVVGA
     GPAAAAAAAK AAAKAAQFGL VGAAGLGGLG VGGLGVPGVG GLGGIPPAAA AKAAKYGAAG
     LGGVLGGAGQ FPLGGVAARP GFGLSPIFPG GACLGKACGR KRK
//
ID   ELN_HUMAN               Reviewed;         786 AA.
AC   P15502; B3KTS6; O15336; O15337; Q14233; Q14234; Q14235; Q14238; Q6P0L4;
AC   Q6ZWJ6; Q75MU5; Q7Z316; Q7Z3F5; Q9UMF5;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   18-JUL-2018, sequence version 4.
DT   22-APR-2020, entry version 208.
DE   RecName: Full=Elastin;
DE   AltName: Full=Tropoelastin;
DE   Flags: Precursor;
GN   Name=ELN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2; 3; 4 AND 6), AND VARIANT
RP   SER-422.
RX   PubMed=3039501; DOI=10.1073/pnas.84.16.5680;
RA   Indik Z., Yeh H., Ornstein-Goldstein N., Sheppard P., Anderson N.,
RA   Rosenbloom J.C., Peltonen L., Rosenbloom J.;
RT   "Alternative splicing of human elastin mRNA indicated by sequence analysis
RT   of cloned genomic and complementary DNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:5680-5684(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-422.
RC   TISSUE=Skin fibroblast;
RX   PubMed=3171221; DOI=10.1111/1523-1747.ep12476591;
RA   Fazio M.J., Olsen D.R., Kauh E.A., Baldwin C.T., Indik Z.,
RA   Ornstein-Goldstein N., Yeh H., Rosenbloom J., Uitto J.;
RT   "Cloning of full-length elastin cDNAs from a human skin fibroblast
RT   recombinant cDNA library: further elucidation of alternative splicing
RT   utilizing exon-specific oligonucleotides.";
RL   J. Invest. Dermatol. 91:458-464(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 11 AND 12), AND VARIANT
RP   SER-422.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 7).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 13).
RC   TISSUE=Gastric mucosa;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 8), AND VARIANTS SER-422
RP   AND ARG-610.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-27.
RX   PubMed=2722804;
RA   Bashir M.M., Indik Z., Yeh H., Ornstein-Goldstein N., Rosenbloom J.C.,
RA   Abrams W., Fazio M., Uitto J., Rosenbloom J.;
RT   "Characterization of the complete human elastin gene. Delineation of
RT   unusual features in the 5'-flanking region.";
RL   J. Biol. Chem. 264:8887-8891(1989).
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 1-27.
RA   Bressan G.M.;
RL   Submitted (JUN-1989) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   SEQUENCE REVISION.
RA   Bressan G.M.;
RL   Submitted (OCT-1991) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-657 (ISOFORMS 9 AND 10), AND
RP   VARIANTS SER-422 AND ARG-610.
RX   PubMed=9215670; DOI=10.1093/hmg/6.7.1021;
RA   Li D.Y., Toland A.E., Boak B.B., Atkinson D.L., Ensing G.J., Morris C.A.,
RA   Keating M.T.;
RT   "Elastin point mutations cause an obstructive vascular disease,
RT   supravalvular aortic stenosis.";
RL   Hum. Mol. Genet. 6:1021-1028(1997).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 164-724 (ISOFORM 2), AND VARIANT SER-422.
RC   TISSUE=Placenta;
RX   PubMed=2831431;
RA   Fazio M.J., Olsen D.R., Kuivaniemi H., Chu M.L., Davidson J.M.,
RA   Rosenbloom J., Uitto J.;
RT   "Isolation and characterization of human elastin cDNAs, and age-associated
RT   variation in elastin gene expression in cultured skin fibroblasts.";
RL   Lab. Invest. 58:270-277(1988).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 496-786 (ISOFORM 1/10), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8812460; DOI=10.1006/geno.1996.0469;
RA   Osborne L.R., Martindale D.W., Scherer S.W., Shi X.-M., Huizenga J.,
RA   Heng H.H.Q., Costa T., Pober B., Lew L., Brinkman J., Rommens J.,
RA   Koop B.F., Tsui L.-C.;
RT   "Identification of genes from a 500-kb region at 7q11.23 that is commonly
RT   deleted in Williams syndrome patients.";
RL   Genomics 36:328-336(1996).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 659-786, AND VARIANT SER-422.
RC   TISSUE=Hippocampus, and Placenta;
RX   PubMed=8689688; DOI=10.1016/s0092-8674(00)80077-x;
RA   Frangiskakis J.M., Ewart A.K., Morris C.A., Mervis C.B., Bertrand J.,
RA   Robinson B.F., Klein B.P., Ensing G.J., Everett L.A., Green E.D.,
RA   Proeschel C., Gutowski N.J., Noble M., Atkinson D.L., Odelberg S.J.,
RA   Keating M.T.;
RT   "LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive
RT   cognition.";
RL   Cell 86:59-69(1996).
RN   [16]
RP   INVOLVEMENT IN ADCL1.
RX   PubMed=9873040; DOI=10.1074/jbc.274.2.981;
RA   Zhang M.-C., He L., Giro M., Yong S.L., Tiller G.E., Davidson J.M.;
RT   "Cutis laxa arising from frameshift mutations in exon 30 of the elastin
RT   gene (ELN).";
RL   J. Biol. Chem. 274:981-986(1999).
RN   [17]
RP   INVOLVEMENT IN SVAS.
RX   PubMed=10942104; DOI=10.1007/s004390000285;
RA   Urban Z., Michels V.V., Thibodeau S.N., Davis E.C., Bonnefont J.-P.,
RA   Munnich A., Eyskens B., Gewillig M., Devriendt K., Boyd C.D.;
RT   "Isolated supravalvular aortic stenosis: functional haploinsufficiency of
RT   the elastin gene as a result of nonsense-mediated decay.";
RL   Hum. Genet. 106:577-588(2000).
RN   [18]
RP   INTERACTION WITH FBN1 AND FBLN5.
RX   PubMed=15790312; DOI=10.1042/bj20050368;
RA   Freeman L.J., Lomas A., Hodson N., Sherratt M.J., Mellody K.T., Weiss A.S.,
RA   Shuttleworth A., Kielty C.M.;
RT   "Fibulin-5 interacts with fibrillin-1 molecules and microfibrils.";
RL   Biochem. J. 388:1-5(2005).
RN   [19]
RP   HYDROXYLATION AT PRO-65; PRO-67; PRO-88; PRO-116; PRO-156; PRO-177;
RP   PRO-190; PRO-286; PRO-290; PRO-415; PRO-427; PRO-465; PRO-481; PRO-522;
RP   PRO-580; PRO-607; PRO-646; PRO-677; PRO-769 AND PRO-772, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=16078697; DOI=10.1016/j.chroma.2005.06.034;
RA   Schmelzer C.E.H., Getie M., Neubert R.H.H.;
RT   "Mass spectrometric characterization of human skin elastin peptides
RT   produced by proteolytic digestion with pepsin and thermitase.";
RL   J. Chromatogr. A 1083:120-126(2005).
RN   [20]
RP   HYDROXYLATION AT PRO-34; PRO-167; PRO-170; PRO-190; PRO-283; PRO-286;
RP   PRO-327; PRO-342; PRO-347; PRO-352; PRO-355; PRO-360; PRO-421; PRO-427;
RP   PRO-550; PRO-580; PRO-589; PRO-598 AND PRO-677, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16161116; DOI=10.1002/prot.20643;
RA   Getie M., Schmelzer C.E.H., Neubert R.H.H.;
RT   "Characterization of peptides resulting from digestion of human skin
RT   elastin with elastase.";
RL   Proteins 61:649-657(2005).
RN   [21]
RP   INTERACTION WITH FBLN5, AND SUBCELLULAR LOCATION.
RX   PubMed=17035250; DOI=10.1093/hmg/ddl414;
RA   Hu Q., Loeys B.L., Coucke P.J., De Paepe A., Mecham R.P., Choi J.,
RA   Davis E.C., Urban Z.;
RT   "Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in
RT   recessive cutis laxa.";
RL   Hum. Mol. Genet. 15:3379-3386(2006).
RN   [22]
RP   INTERACTION WITH FBN1; FBLN2 AND FBLN5.
RX   PubMed=17255108; DOI=10.1074/jbc.m608204200;
RA   El-Hallous E., Sasaki T., Hubmacher D., Getie M., Tiedemann K.,
RA   Brinckmann J., Baetge B., Davis E.C., Reinhardt D.P.;
RT   "Fibrillin-1 interactions with fibulins depend on the first hybrid domain
RT   and provide an adaptor function to tropoelastin.";
RL   J. Biol. Chem. 282:8935-8946(2007).
RN   [23]
RP   VARIANT SER-211.
RX   PubMed=19194475; DOI=10.1038/jid.2008.450;
RA   Megarbane H., Florence J., Sass J.O., Schwonbeck S., Foglio M., de Cid R.,
RA   Cure S., Saker S., Megarbane A., Fischer J.;
RT   "An autosomal-recessive form of cutis laxa is due to homozygous elastin
RT   mutations, and the phenotype may be modified by a heterozygous fibulin 5
RT   polymorphism.";
RL   J. Invest. Dermatol. 129:1650-1655(2009).
CC   -!- FUNCTION: Major structural protein of tissues such as aorta and nuchal
CC       ligament, which must expand rapidly and recover completely. Molecular
CC       determinant of the late arterial morphogenesis, stabilizing arterial
CC       structure by regulating proliferation and organization of vascular
CC       smooth muscle (By similarity). {ECO:0000250|UniProtKB:P54320}.
CC   -!- SUBUNIT: The polymeric elastin chains are cross-linked together into an
CC       extensible 3D network. Forms a ternary complex with BGN and MFAP2.
CC       Interacts with MFAP2 via divalent cations (calcium > magnesium >
CC       manganese) in a dose-dependent and saturating manner. Interacts with
CC       FBLN5 (PubMed:15790312, PubMed:17035250). Interacts with FBN1
CC       (PubMed:15790312). Forms a ternary complex with FBN1 and FBLN2 or FBLN5
CC       (PubMed:17255108). Interacts with MFAP4 in a Ca (2+)-dependent manner;
CC       this interaction promotes ELN self-assembly (By similarity).
CC       {ECO:0000250|UniProtKB:P04985, ECO:0000269|PubMed:15790312,
CC       ECO:0000269|PubMed:17035250, ECO:0000269|PubMed:17255108}.
CC   -!- INTERACTION:
CC       P15502; O95967: EFEMP2; NbExp=5; IntAct=EBI-1222108, EBI-743414;
CC       P15502; Q9UBX5: FBLN5; NbExp=3; IntAct=EBI-1222108, EBI-947897;
CC       P15502; P28300: LOX; NbExp=2; IntAct=EBI-1222108, EBI-3893481;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:17035250}. Note=Extracellular matrix of
CC       elastic fibers. {ECO:0000269|PubMed:17035250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=13;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=3;
CC         IsoId=P15502-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=P15502-1; Sequence=VSP_012484, VSP_012485, VSP_012487;
CC       Name=2;
CC         IsoId=P15502-2; Sequence=VSP_012484, VSP_012487;
CC       Name=4;
CC         IsoId=P15502-4; Sequence=VSP_012484;
CC       Name=5;
CC         IsoId=P15502-5; Sequence=VSP_012481, VSP_012484, VSP_012487,
CC                                  VSP_012488;
CC       Name=6;
CC         IsoId=P15502-6; Sequence=VSP_012483, VSP_012487, VSP_012488;
CC       Name=7;
CC         IsoId=P15502-7; Sequence=VSP_012479, VSP_012483, VSP_012487,
CC                                  VSP_012488;
CC       Name=8;
CC         IsoId=P15502-8; Sequence=VSP_012482, VSP_012483, VSP_012486,
CC                                  VSP_012487, VSP_012488;
CC       Name=9;
CC         IsoId=P15502-9; Sequence=VSP_012485;
CC       Name=10;
CC         IsoId=P15502-10; Sequence=VSP_012485, VSP_012487;
CC       Name=11;
CC         IsoId=P15502-11; Sequence=VSP_012480, VSP_012482, VSP_012483,
CC                                   VSP_012487, VSP_012488;
CC       Name=12;
CC         IsoId=P15502-12; Sequence=VSP_012481, VSP_012483, VSP_012487,
CC                                   VSP_012488;
CC       Name=13;
CC         IsoId=P15502-13; Sequence=VSP_012483, VSP_012487;
CC   -!- TISSUE SPECIFICITY: Expressed within the outer myometrial smooth muscle
CC       and throughout the arteriolar tree of uterus (at protein level). Also
CC       expressed in the large arteries, lung and skin.
CC       {ECO:0000269|PubMed:8812460}.
CC   -!- PTM: Elastin is formed through the cross-linking of its soluble
CC       precursor tropoelastin. Cross-linking is initiated through the action
CC       of lysyl oxidase on exposed lysines to form allysine. Subsequent
CC       spontaneous condensation reactions with other allysine or unmodified
CC       lysine residues result in various bi-, tri-, and tetrafunctional cross-
CC       links. The most abundant cross-links in mature elastin fibers are
CC       lysinonorleucine, allysine aldol, desmosine, and isodesmosine.
CC   -!- PTM: Hydroxylation on proline residues within the sequence motif, GXPG,
CC       is most likely 4-hydroxy as this fits the requirement for 4-
CC       hydroxylation in vertebrates. {ECO:0000250}.
CC   -!- DISEASE: Cutis laxa, autosomal dominant, 1 (ADCL1) [MIM:123700]: A
CC       connective tissue disorder characterized by loose, hyperextensible skin
CC       with decreased resilience and elasticity leading to a premature aged
CC       appearance. Face, hands, feet, joints, and torso may be differentially
CC       affected. Additional variable clinical features are gastrointestinal
CC       diverticula, hernia, and genital prolapse. Rare manifestations are
CC       pulmonary artery stenosis, aortic aneurysm, bronchiectasis, and
CC       emphysema. {ECO:0000269|PubMed:9873040}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Supravalvular aortic stenosis (SVAS) [MIM:185500]: Congenital
CC       narrowing of the ascending aorta which can occur sporadically, as an
CC       autosomal dominant condition, or as one component of Williams-Beuren
CC       syndrome. {ECO:0000269|PubMed:10942104}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=ELN is located in the Williams-Beuren syndrome (WBS)
CC       critical region. WBS results from a hemizygous deletion of several
CC       genes on chromosome 7q11.23, thought to arise as a consequence of
CC       unequal crossing over between highly homologous low-copy repeat
CC       sequences flanking the deleted region. Haploinsufficiency of ELN may be
CC       the cause of certain cardiovascular and musculo-skeletal abnormalities
CC       observed in the disease (PubMed:8812460). {ECO:0000269|PubMed:8812460}.
CC   -!- SIMILARITY: Belongs to the elastin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD98065.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Elastin entry;
CC       URL="https://en.wikipedia.org/wiki/Elastin";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M17282; AAC98393.1; -; Genomic_DNA.
DR   EMBL; M16983; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17265; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17266; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17267; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17268; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17271; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17272; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17273; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17275; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17276; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17277; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17278; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17279; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17281; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17282; AAC98394.1; -; Genomic_DNA.
DR   EMBL; M16983; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17265; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17266; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17267; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17268; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17270; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17271; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17272; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17273; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17275; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17276; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17277; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17278; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17279; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17280; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17281; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17282; AAC98395.1; -; Genomic_DNA.
DR   EMBL; M16983; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17265; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17266; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17267; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17268; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17270; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17271; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17272; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17273; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17274; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17275; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17276; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17277; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17278; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17279; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17280; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17281; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M36860; AAA52382.1; -; mRNA.
DR   EMBL; AK095990; BAG53188.1; -; mRNA.
DR   EMBL; AK122731; BAC85506.1; -; mRNA.
DR   EMBL; BX537939; CAD97910.1; -; mRNA.
DR   EMBL; BX538199; CAD98065.1; ALT_INIT; mRNA.
DR   EMBL; AK225659; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC005056; AAS07435.1; -; Genomic_DNA.
DR   EMBL; CH471200; EAW69627.1; -; Genomic_DNA.
DR   EMBL; BC065566; AAH65566.1; -; mRNA.
DR   EMBL; X15603; CAA33627.1; -; Genomic_DNA.
DR   EMBL; U93037; AAB65620.1; -; Genomic_DNA.
DR   EMBL; U93034; AAB65620.1; JOINED; Genomic_DNA.
DR   EMBL; U93035; AAB65620.1; JOINED; Genomic_DNA.
DR   EMBL; U93036; AAB65620.1; JOINED; Genomic_DNA.
DR   EMBL; U93037; AAB65621.1; -; Genomic_DNA.
DR   EMBL; U93034; AAB65621.1; JOINED; Genomic_DNA.
DR   EMBL; U93035; AAB65621.1; JOINED; Genomic_DNA.
DR   EMBL; U93036; AAB65621.1; JOINED; Genomic_DNA.
DR   EMBL; M24782; AAA53190.1; -; mRNA.
DR   EMBL; U63721; AAC13884.1; -; Genomic_DNA.
DR   EMBL; U62292; AAB17544.1; -; Genomic_DNA.
DR   CCDS; CCDS43598.1; -. [P15502-5]
DR   CCDS; CCDS43599.1; -. [P15502-7]
DR   CCDS; CCDS47611.1; -. [P15502-12]
DR   CCDS; CCDS47612.1; -. [P15502-13]
DR   CCDS; CCDS5562.2; -. [P15502-2]
DR   CCDS; CCDS64673.1; -. [P15502-1]
DR   CCDS; CCDS64675.1; -. [P15502-8]
DR   CCDS; CCDS75616.1; -. [P15502-3]
DR   PIR; A32707; EAHU.
DR   RefSeq; NP_000492.2; NM_000501.3. [P15502-2]
DR   RefSeq; NP_001075221.1; NM_001081752.2. [P15502-7]
DR   RefSeq; NP_001075222.1; NM_001081753.2. [P15502-12]
DR   RefSeq; NP_001075223.1; NM_001081754.2. [P15502-5]
DR   RefSeq; NP_001075224.1; NM_001081755.2. [P15502-13]
DR   RefSeq; NP_001265844.1; NM_001278915.1. [P15502-1]
DR   RefSeq; NP_001265845.1; NM_001278916.1. [P15502-8]
DR   RefSeq; NP_001265868.1; NM_001278939.1. [P15502-3]
DR   BioGrid; 108321; 15.
DR   CORUM; P15502; -.
DR   IntAct; P15502; 12.
DR   STRING; 9606.ENSP00000351807; -.
DR   ChEMBL; CHEMBL3713712; -.
DR   DrugBank; DB00533; Rofecoxib.
DR   Allergome; 11040; Hom s Elastin.
DR   iPTMnet; P15502; -.
DR   PhosphoSitePlus; P15502; -.
DR   BioMuta; ELN; -.
DR   DMDM; 306526276; -.
DR   jPOST; P15502; -.
DR   MassIVE; P15502; -.
DR   PaxDb; P15502; -.
DR   PeptideAtlas; P15502; -.
DR   PRIDE; P15502; -.
DR   ProteomicsDB; 53144; -. [P15502-3]
DR   ProteomicsDB; 53145; -. [P15502-1]
DR   ProteomicsDB; 53146; -. [P15502-10]
DR   ProteomicsDB; 53147; -. [P15502-11]
DR   ProteomicsDB; 53148; -. [P15502-12]
DR   ProteomicsDB; 53149; -. [P15502-13]
DR   ProteomicsDB; 53150; -. [P15502-2]
DR   ProteomicsDB; 53151; -. [P15502-4]
DR   ProteomicsDB; 53152; -. [P15502-5]
DR   ProteomicsDB; 53153; -. [P15502-6]
DR   ProteomicsDB; 53154; -. [P15502-7]
DR   ProteomicsDB; 53155; -. [P15502-8]
DR   ProteomicsDB; 53156; -. [P15502-9]
DR   Antibodypedia; 4380; 401 antibodies.
DR   DNASU; 2006; -.
DR   Ensembl; ENST00000252034; ENSP00000252034; ENSG00000049540. [P15502-2]
DR   Ensembl; ENST00000320399; ENSP00000313565; ENSG00000049540. [P15502-4]
DR   Ensembl; ENST00000357036; ENSP00000349540; ENSG00000049540. [P15502-5]
DR   Ensembl; ENST00000358929; ENSP00000351807; ENSG00000049540. [P15502-3]
DR   Ensembl; ENST00000380553; ENSP00000369926; ENSG00000049540. [P15502-11]
DR   Ensembl; ENST00000380562; ENSP00000369936; ENSG00000049540. [P15502-1]
DR   Ensembl; ENST00000380575; ENSP00000369949; ENSG00000049540. [P15502-7]
DR   Ensembl; ENST00000380576; ENSP00000369950; ENSG00000049540. [P15502-13]
DR   Ensembl; ENST00000380584; ENSP00000369958; ENSG00000049540. [P15502-8]
DR   Ensembl; ENST00000429192; ENSP00000391129; ENSG00000049540. [P15502-12]
DR   GeneID; 2006; -.
DR   KEGG; hsa:2006; -.
DR   UCSC; uc003tzn.5; human. [P15502-3]
DR   CTD; 2006; -.
DR   DisGeNET; 2006; -.
DR   GeneCards; ELN; -.
DR   GeneReviews; ELN; -.
DR   HGNC; HGNC:3327; ELN.
DR   HPA; ENSG00000049540; Low tissue specificity.
DR   MalaCards; ELN; -.
DR   MIM; 123700; phenotype.
DR   MIM; 130160; gene.
DR   MIM; 185500; phenotype.
DR   neXtProt; NX_P15502; -.
DR   OpenTargets; ENSG00000049540; -.
DR   Orphanet; 90348; Autosomal dominant cutis laxa.
DR   Orphanet; 91387; Familial thoracic aortic aneurysm and aortic dissection.
DR   Orphanet; 3193; Supravalvular aortic stenosis.
DR   Orphanet; 904; Williams syndrome.
DR   PharmGKB; PA27757; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GeneTree; ENSGT00730000111510; -.
DR   HOGENOM; CLU_021236_0_0_1; -.
DR   InParanoid; P15502; -.
DR   KO; K14211; -.
DR   OMA; MDIQVIP; -.
DR   TreeFam; TF338594; -.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-1566948; Elastic fibre formation.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   SIGNOR; P15502; -.
DR   ChiTaRS; ELN; human.
DR   GeneWiki; Elastin; -.
DR   GenomeRNAi; 2006; -.
DR   Pharos; P15502; Tbio.
DR   PRO; PR:P15502; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P15502; protein.
DR   Bgee; ENSG00000049540; Expressed in thoracic aorta and 180 other tissues.
DR   ExpressionAtlas; P15502; baseline and differential.
DR   Genevisible; P15502; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0071953; C:elastic fiber; IDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; TAS:ProtInc.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0050840; F:extracellular matrix binding; IEA:Ensembl.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0003180; P:aortic valve morphogenesis; IC:BHF-UCL.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0003151; P:outflow tract morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IEA:Ensembl.
DR   GO; GO:0048660; P:regulation of smooth muscle cell proliferation; TAS:GO_Central.
DR   GO; GO:0007585; P:respiratory gaseous exchange by respiratory system; TAS:ProtInc.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0043149; P:stress fiber assembly; IEA:Ensembl.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 1.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disulfide bond; Extracellular matrix; Hydroxylation;
KW   Polymorphism; Reference proteome; Repeat; Secreted; Signal;
KW   Williams-Beuren syndrome.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000250|UniProtKB:Q99372"
FT   CHAIN           27..786
FT                   /note="Elastin"
FT                   /id="PRO_0000021163"
FT   COMPBIAS        97..102
FT                   /note="Poly-Ala"
FT   COMPBIAS        236..742
FT                   /note="Ala-rich"
FT   MOD_RES         34
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         65
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         67
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         88
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         104
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         107
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         116
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         156
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         167
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         170
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         177
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         190
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697,
FT                   ECO:0000269|PubMed:16161116"
FT   MOD_RES         241
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         261
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         265
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         283
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         286
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697,
FT                   ECO:0000269|PubMed:16161116"
FT   MOD_RES         290
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         312
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         315
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         327
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         342
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         347
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         352
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         355
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         360
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         375
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         379
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         382
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         415
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         421
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         427
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697,
FT                   ECO:0000269|PubMed:16161116"
FT   MOD_RES         448
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         451
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         465
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         481
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         492
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         496
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         522
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         550
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16161116"
FT   MOD_RES         558
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         562
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         566
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         580
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697,
FT                   ECO:0000269|PubMed:16161116"
FT   MOD_RES         589
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000305|PubMed:16161116"
FT   MOD_RES         598
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000305|PubMed:16161116"
FT   MOD_RES         607
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         646
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         653
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         656
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         677
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697,
FT                   ECO:0000269|PubMed:16161116"
FT   MOD_RES         693
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         697
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         735
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         738
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         769
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   MOD_RES         772
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:16078697"
FT   DISULFID        776..781
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         45..54
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_012479"
FT   VAR_SEQ         78..180
FT                   /note="Missing (in isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_012480"
FT   VAR_SEQ         125
FT                   /note="A -> AAPSVP (in isoform 5 and isoform 12)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_012481"
FT   VAR_SEQ         215..228
FT                   /note="Missing (in isoform 8 and isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012482"
FT   VAR_SEQ         453..500
FT                   /note="Missing (in isoform 6, isoform 7, isoform 8, isoform
FT                   11, isoform 12 and isoform 13)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|Ref.5"
FT                   /id="VSP_012483"
FT   VAR_SEQ         453..481
FT                   /note="Missing (in isoform 1, isoform 2, isoform 4 and
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|PubMed:2831431, ECO:0000303|PubMed:3171221"
FT                   /id="VSP_012484"
FT   VAR_SEQ         500
FT                   /note="F -> FALLNLA (in isoform 1, isoform 9 and isoform
FT                   10)"
FT                   /evidence="ECO:0000303|PubMed:3171221"
FT                   /id="VSP_012485"
FT   VAR_SEQ         555..570
FT                   /note="AAAKSAAKVAAKAQLR -> G (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012486"
FT   VAR_SEQ         612..644
FT                   /note="Missing (in isoform 1, isoform 2, isoform 5, isoform
FT                   6, isoform 7, isoform 8, isoform 10, isoform 11, isoform 12
FT                   and isoform 13)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|PubMed:2831431, ECO:0000303|PubMed:3171221,
FT                   ECO:0000303|Ref.5"
FT                   /id="VSP_012487"
FT   VAR_SEQ         740..757
FT                   /note="Missing (in isoform 5, isoform 6, isoform 7, isoform
FT                   8, isoform 11 and isoform 12)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_012488"
FT   VARIANT         211
FT                   /note="P -> S (found as homozygous mutation in a patient
FT                   with autosomal recessive cutis laxa also carrying a
FT                   mutation in FBLN5; unknown pathological significance;
FT                   dbSNP:rs1064793880)"
FT                   /evidence="ECO:0000269|PubMed:19194475"
FT                   /id="VAR_072395"
FT   VARIANT         422
FT                   /note="G -> S (in dbSNP:rs2071307)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2831431,
FT                   ECO:0000269|PubMed:3039501, ECO:0000269|PubMed:3171221,
FT                   ECO:0000269|PubMed:8689688, ECO:0000269|PubMed:9215670"
FT                   /id="VAR_020882"
FT   VARIANT         610
FT                   /note="G -> R (in dbSNP:rs17855988)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9215670"
FT                   /id="VAR_056869"
FT   CONFLICT        317
FT                   /note="G -> E (in Ref. 4; CAD97910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        553
FT                   /note="V -> I (in Ref. 3; BAC85506)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        691
FT                   /note="A -> T (in Ref. 4; CAD98065)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        773
FT                   /note="G -> D (in Ref. 4; CAD97910)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   786 AA;  68398 MW;  4A128EC9EA2CC29F CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPVPGGL AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG
     LGVSAGAVVP QPGAGVKPGK VPGVGLPGVY PGGVLPGARF PGVGVLPGVP TGAGVKPKAP
     GVGGAFAGIP GVGPFGGPQP GVPLGYPIKA PKLPGGYGLP YTTGKLPYGY GPGGVAGAAG
     KAGYPTGTGV GPQAAAAAAA KAAAKFGAGA AGVLPGVGGA GVPGVPGAIP GIGGIAGVGT
     PAAAAAAAAA AKAAKYGAAA GLVPGGPGFG PGVVGVPGAG VPGVGVPGAG IPVVPGAGIP
     GAAVPGVVSP EAAAKAAAKA AKYGARPGVG VGGIPTYGVG AGGFPGFGVG VGGIPGVAGV
     PGVGGVPGVG GVPGVGISPE AQAAAAAKAA KYGAAGAGVL GGLVPGAPGA VPGVPGTGGV
     PGVGTPAAAA AKAAAKAAQF GLVPGVGVAP GVGVAPGVGV APGVGLAPGV GVAPGVGVAP
     GVGVAPGIGP GGVAAAAKSA AKVAAKAQLR AAAGLGAGIP GLGVGVGVPG LGVGAGVPGL
     GVGAGVPGFG AGADEGVRRS LSPELREGDP SSSQHLPSTP SSPRVPGALA AAKAAKYGAA
     VPGVLGGLGA LGGVGIPGGV VGAGPAAAAA AAKAAAKAAQ FGLVGAAGLG GLGVGGLGVP
     GVGGLGGIPP AAAAKAAKYG AAGLGGVLGG AGQFPLGGVA ARPGFGLSPI FPGGACLGKA
     CGRKRK
//
ID   Q59H17_HUMAN            Unreviewed;       106 AA.
AC   Q59H17;
DT   26-APR-2005, integrated into UniProtKB/TrEMBL.
DT   26-APR-2005, sequence version 1.
DT   11-DEC-2019, entry version 29.
DE   SubName: Full=Elastin variant {ECO:0000313|EMBL:BAD92179.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD92179.1};
RN   [1] {ECO:0000313|EMBL:BAD92179.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAD92179.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB208942; BAD92179.1; -; mRNA.
DR   RefSeq; NP_001265846.1; NM_001278917.1.
DR   GeneID; 2006; -.
DR   CTD; 2006; -.
DR   GenomeRNAi; 2006; -.
PE   2: Evidence at transcript level;
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:BAD92179.1"
SQ   SEQUENCE   106 AA;  11629 MW;  228761EADB87A94A CRC64;
     RRRPRGPESS CSCCPSSTPL GLEGSLGPFL VEFLEESFIQ RWGLEANLLS QFPEGLRVLA
     LGQGSAPSPQ LPFRGLWCLV EWLTLLQPIK LLRLALGLVV SQELVA
//
ID   Q6ZUN2_HUMAN            Unreviewed;       559 AA.
AC   Q6ZUN2;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   11-DEC-2019, entry version 56.
DE   SubName: Full=cDNA FLJ43523 fis, clone PLACE5000282, weakly similar to Homo sapiens elastin (supravalvular aortic stenosis, Williams-Beuren syndrome) (ELN) {ECO:0000313|EMBL:BAC86188.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAC86188.1};
RN   [1] {ECO:0000313|EMBL:BAC86188.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAC86188.1};
RA   Oshima A., Takahashi-Fujii A., Tanase T., Imose N., Takeuchi K., Arita M.,
RA   Musashino K., Yuuki H., Hara H., Sugiyama T., Irie R., Otsuki T., Sato H.,
RA   Wakamatsu A., Ishii S., Yamamoto J., Isono Y., Kawai-Hio Y., Saito K.,
RA   Nishikawa T., Kimura K., Yamashita H., Matsuo K., Nakamura Y., Sekine M.,
RA   Kikuchi H., Kanda K., Wagatsuma M., Murakawa K., Kanehori K., Sugiyama A.,
RA   Kawakami B., Suzuki Y., Sugano S., Nagahari K., Masuho Y., Nagai K.,
RA   Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK125511; BAC86188.1; -; mRNA.
DR   RefSeq; NP_001265843.1; NM_001278914.1.
DR   SMR; Q6ZUN2; -.
DR   PeptideAtlas; Q6ZUN2; -.
DR   PRIDE; Q6ZUN2; -.
DR   GeneID; 2006; -.
DR   CTD; 2006; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GenomeRNAi; 2006; -.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 1.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           27..559
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5004283926"
SQ   SEQUENCE   559 AA;  53787 MW;  20938FFEC5492A01 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPALGPGG KPLKPVPGGL
     AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG LGVSAAPSVP
     GAVVPQPGAG VKPGKVPGVG LPGVYPGGVL PGARFPGVGV LPGVPTGAGV KPKAPGVGGA
     FAGIPGVGPF GGPQPGVPLG YPIKAPKLPG GYGLPYTTGK LPYGYGPGGV AGAAGKAGYP
     TGTGVGPQAA AAAAAKAAAK FGAGAAGVLP GVGGAGVPGV PGAIPGIGGI AGVGTPAAAA
     AAAAAAKAAK YGAAAGLVPG GPGFGPGVVG VPGAGVPGVG VPGAGIPVVP GAGIPGAAVP
     GVVSPEAAAK AAAKAAKYGA RPGVGVGGIP TYGVGAGGFP GFGVGVGGIP GVAGVPGVGG
     SRSRRCPGSW HFPRSSGSSC RQGCQVRVSS WCRRGSWSWR GSWCRCGSWS WLGSWSWRGS
     WSWCGSWRWR GSRHWPWWSC SCSKIRCQGG CQSPAPSCSW AWCWHPWTWS WCRRPWTWSW
     CWCSWTWSWC WCSWLRGST
//
ID   Q8NBI4_HUMAN            Unreviewed;       643 AA.
AC   Q8NBI4;
DT   01-OCT-2002, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2002, sequence version 1.
DT   11-DEC-2019, entry version 71.
DE   SubName: Full=cDNA PSEC0254 fis, clone NT2RP3003474, moderately similar to ELASTIN {ECO:0000313|EMBL:BAC11696.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAC11696.1};
RN   [1] {ECO:0000313|EMBL:BAC11696.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK075554; BAC11696.1; -; mRNA.
DR   RefSeq; NP_001265842.1; NM_001278913.1.
DR   PeptideAtlas; Q8NBI4; -.
DR   PRIDE; Q8NBI4; -.
DR   GeneID; 2006; -.
DR   CTD; 2006; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GenomeRNAi; 2006; -.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 2.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           27..643
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5004312895"
SQ   SEQUENCE   643 AA;  55629 MW;  FDFC042617E72A69 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPGLGAF PAVTFPGALV PGGVADAAAA YKAAKAGAGL GGVPGVGGLG VSAGAVVPQP
     GAGVKPGKVP GVGLPGVYPG GVLPGARFPG VGVLPGVPTG AGVKPKAPGV GPFGGPQPGV
     PLGYPIKAPK LPGYGPGGVA GAAGKAGYPT GTGVGPQAAA AAAAKAAAKF GAGAAGVLPG
     VGGAGVPGVP GAIPGIGGIA GVGTPAAAAA AAAAAKAAKY GAAAGLVPGG PGFGPGVVGV
     PGAGVPGVGV PGAGIPVVPG AGIPGAAVPG VVSPEAAAKA AAKAAKYGAR PGVGVGGIPT
     YGVGAGGFPG FGVGVGAEAQ AAAAAKAAKY GLVPGVGVAP GVGVAPGVGV APGVGLAPGV
     GVAPGVGVAP GVGVAPGIGP GGVAAAAKSA AKVAAKAQLR AAAGLGAGIP GLGVGVGVPG
     LGVGAGVPGL GVGAGVPGFG AVPGALAAAK AANYGAAVPG VLGGLGALGG VGIPGGVVGA
     GPAAAAAAAK AAAKAAQFGL VGAAGLGGLG VGGLGVPGVG GLGGIPPAAA AKAAKYGAAG
     LGGVLGGAGQ FPLGGVAARP GFGLSPIFPG GACLGKACGR KRK
//
ID   O94871_HUMAN            Unreviewed;       336 AA.
AC   O94871;
DT   01-MAY-1999, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 2.
DT   22-APR-2020, entry version 83.
DE   SubName: Full=KIAA0773 protein {ECO:0000313|EMBL:BAA34493.2};
DE   Flags: Fragment;
GN   Name=KIAA0773 {ECO:0000313|EMBL:BAA34493.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAA34493.2};
RN   [1] {ECO:0000313|EMBL:BAA34493.2}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAA34493.2};
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB018316; BAA34493.2; -; mRNA.
DR   RefSeq; NP_001265226.1; NM_001278297.1.
DR   MaxQB; O94871; -.
DR   PeptideAtlas; O94871; -.
DR   PRIDE; O94871; -.
DR   ProteomicsDB; 50508; -.
DR   GeneID; 9715; -.
DR   CTD; 9715; -.
DR   eggNOG; ENOG410IECV; Eukaryota.
DR   eggNOG; ENOG4111H79; LUCA.
DR   GenomeRNAi; 9715; -.
DR   InterPro; IPR026782; FAM131.
DR   PANTHER; PTHR15736; PTHR15736; 1.
DR   Pfam; PF15010; FAM131; 1.
PE   2: Evidence at transcript level;
FT   REGION          99..118
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          226..336
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        274..311
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        313..336
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:BAA34493.2"
SQ   SEQUENCE   336 AA;  36496 MW;  189A7E6BD2774DE6 CRC64;
     FLLGRHQRTV STHVLNLCPS FPEHWGYIPP WDSWLSMEDT TSILPKLKRN SNAYGIGALA
     KSSFSGISRS MKDHVTKPTA MGQGRVAHMI EWQGWGKTPA VQPQHSHESV RRDTDAYSDL
     SDGEKEARFL AGVMEQFAIS EATLMAWSSM DGEDMSVNST QEPLGCNYSD NYQELMDSQD
     ALAQAPMDGW PHSYVSQGMY CLGSSDAWEA SDQSLIASPA TGSYLGPAFD DSQPSLHEMG
     PSQPASGYSA LEPPPLLGGD TDWAPGVGAV DLARGPAEEE KRPLAPEEEE DAGCRDLESL
     SPREDPEMST ALSRKVSDVT SSGVQSFDEE EGEANN
//
ID   F131B_HUMAN             Reviewed;         332 AA.
AC   Q86XD5; A4D2H6; A6NDW3; A8K605; B8ZZN2; D3DXE3; J3KQX2; Q7L0D6; Q86T97;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   22-APR-2020, entry version 120.
DE   RecName: Full=Protein FAM131B;
GN   Name=FAM131B; Synonyms=KIAA0773;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Spinal cord;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT THR-307.
RC   TISSUE=Brain, and Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   MYRISTOYLATION AT GLY-2 (ISOFORM 2).
RX   PubMed=20213681; DOI=10.1002/pmic.200900783;
RA   Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,
RA   Tsunasawa S., Utsumi T.;
RT   "Strategy for comprehensive identification of human N-myristoylated
RT   proteins using an insect cell-free protein synthesis system.";
RL   Proteomics 10:1780-1793(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-117, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- INTERACTION:
CC       Q86XD5; Q9BSI4: TINF2; NbExp=2; IntAct=EBI-11308812, EBI-717399;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q86XD5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86XD5-2; Sequence=VSP_041633;
CC       Name=3;
CC         IsoId=Q86XD5-3; Sequence=VSP_046798;
CC   -!- SIMILARITY: Belongs to the FAM131 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAS07501.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK291470; BAF84159.1; -; mRNA.
DR   EMBL; AL832579; CAD89938.1; -; mRNA.
DR   EMBL; AC093673; AAS07501.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH236959; EAL23787.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51853.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51854.1; -; Genomic_DNA.
DR   EMBL; BC045611; AAH45611.2; -; mRNA.
DR   EMBL; BC050543; AAH50543.2; -; mRNA.
DR   CCDS; CCDS47734.1; -. [Q86XD5-3]
DR   CCDS; CCDS5882.1; -. [Q86XD5-1]
DR   RefSeq; NP_001026860.2; NM_001031690.2. [Q86XD5-3]
DR   RefSeq; NP_001265226.1; NM_001278297.1.
DR   RefSeq; NP_055505.3; NM_014690.4. [Q86XD5-1]
DR   RefSeq; XP_005250130.1; XM_005250073.3.
DR   RefSeq; XP_006716249.1; XM_006716186.2.
DR   BioGrid; 115064; 34.
DR   IntAct; Q86XD5; 31.
DR   STRING; 9606.ENSP00000410603; -.
DR   iPTMnet; Q86XD5; -.
DR   PhosphoSitePlus; Q86XD5; -.
DR   SwissPalm; Q86XD5; -.
DR   BioMuta; FAM131B; -.
DR   EPD; Q86XD5; -.
DR   jPOST; Q86XD5; -.
DR   MassIVE; Q86XD5; -.
DR   MaxQB; Q86XD5; -.
DR   PaxDb; Q86XD5; -.
DR   PeptideAtlas; Q86XD5; -.
DR   PRIDE; Q86XD5; -.
DR   ProteomicsDB; 70264; -. [Q86XD5-1]
DR   ProteomicsDB; 70265; -. [Q86XD5-2]
DR   Antibodypedia; 18478; 41 antibodies.
DR   DNASU; 9715; -.
DR   Ensembl; ENST00000409222; ENSP00000387147; ENSG00000159784. [Q86XD5-1]
DR   Ensembl; ENST00000409346; ENSP00000386984; ENSG00000159784. [Q86XD5-1]
DR   Ensembl; ENST00000409408; ENSP00000387017; ENSG00000159784. [Q86XD5-1]
DR   Ensembl; ENST00000409578; ENSP00000386568; ENSG00000159784. [Q86XD5-2]
DR   Ensembl; ENST00000443739; ENSP00000410603; ENSG00000159784. [Q86XD5-3]
DR   GeneID; 9715; -.
DR   KEGG; hsa:9715; -.
DR   UCSC; uc003wct.4; human. [Q86XD5-1]
DR   CTD; 9715; -.
DR   DisGeNET; 9715; -.
DR   GeneCards; FAM131B; -.
DR   HGNC; HGNC:22202; FAM131B.
DR   HPA; ENSG00000159784; Tissue enriched (brain).
DR   neXtProt; NX_Q86XD5; -.
DR   NIAGADS; ENSG00000159784; -.
DR   OpenTargets; ENSG00000159784; -.
DR   PharmGKB; PA162386065; -.
DR   eggNOG; ENOG410IECV; Eukaryota.
DR   eggNOG; ENOG4111H79; LUCA.
DR   GeneTree; ENSGT00950000183106; -.
DR   HOGENOM; CLU_047357_1_0_1; -.
DR   InParanoid; Q86XD5; -.
DR   OMA; LMESQEH; -.
DR   OrthoDB; 864510at2759; -.
DR   PhylomeDB; Q86XD5; -.
DR   TreeFam; TF331537; -.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   ChiTaRS; FAM131B; human.
DR   GenomeRNAi; 9715; -.
DR   Pharos; Q86XD5; Tdark.
DR   PRO; PR:Q86XD5; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q86XD5; protein.
DR   Bgee; ENSG00000159784; Expressed in C1 segment of cervical spinal cord and 135 other tissues.
DR   ExpressionAtlas; Q86XD5; baseline and differential.
DR   Genevisible; Q86XD5; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   InterPro; IPR026782; FAM131.
DR   PANTHER; PTHR15736; PTHR15736; 1.
DR   Pfam; PF15010; FAM131; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Lipoprotein; Myristate; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..332
FT                   /note="Protein FAM131B"
FT                   /id="PRO_0000253032"
FT   COMPBIAS        283..286
FT                   /note="Poly-Glu"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TY60"
FT   MOD_RES         114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TY60"
FT   MOD_RES         117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         295
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TY60"
FT   MOD_RES         297
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TY60"
FT   MOD_RES         313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TY60"
FT   MOD_RES         316
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TY60"
FT   MOD_RES         317
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TY60"
FT   MOD_RES         318
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TY60"
FT   MOD_RES         322
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TY60"
FT   VAR_SEQ         1..30
FT                   /note="MDSTSSLHGSSLHRPSTEQTRTDFSWDGIN -> MGCIGSRTVGNEVIAVDW
FT                   KGLKDVDQINMDSTSSLHGSSLHRPSTE (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_041633"
FT   VAR_SEQ         1
FT                   /note="M -> MGCIGSRTVGNEVIAVDWKGLKDVDQINM (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_046798"
FT   VARIANT         307
FT                   /note="A -> T (in dbSNP:rs17854363)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_053920"
FT   CONFLICT        47
FT                   /note="S -> F (in Ref. 2; CAD89938)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        141
FT                   /note="M -> T (in Ref. 2; CAD89938)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        285
FT                   /note="E -> G (in Ref. 6; AAH45611)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        291
FT                   /note="R -> Q (in Ref. 6; AAH45611)"
FT                   /evidence="ECO:0000305"
FT   INIT_MET        Q86XD5-2:1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   LIPID           Q86XD5-2:2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:20213681"
SQ   SEQUENCE   332 AA;  35769 MW;  35FE42189855034F CRC64;
     MDSTSSLHGS SLHRPSTEQT RTDFSWDGIN LSMEDTTSIL PKLKRNSNAY GIGALAKSSF
     SGISRSMKDH VTKPTAMGQG RVAHMIEWQG WGKTPAVQPQ HSHESVRRDT DAYSDLSDGE
     KEARFLAGVM EQFAISEATL MAWSSMDGED MSVNSTQEPL GCNYSDNYQE LMDSQDALAQ
     APMDGWPHSY VSQGMYCLGS SDAWEASDQS LIASPATGSY LGPAFDDSQP SLHEMGPSQP
     ASGYSALEPP PLLGGDTDWA PGVGAVDLAR GPAEEEKRPL APEEEEDAGC RDLESLSPRE
     DPEMSTALSR KVSDVTSSGV QSFDEEEGEA NN
//
ID   B7ZL13_HUMAN            Unreviewed;       607 AA.
AC   B7ZL13;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   26-FEB-2020, entry version 70.
DE   SubName: Full=FNBP1 protein {ECO:0000313|EMBL:AAI43515.1};
GN   Name=FNBP1 {ECO:0000313|EMBL:AAI43515.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI43515.1};
RN   [1] {ECO:0000313|EMBL:AAI43515.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver {ECO:0000313|EMBL:AAI43515.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC143514; AAI43515.1; -; mRNA.
DR   RefSeq; XP_005251883.1; XM_005251826.2.
DR   PeptideAtlas; B7ZL13; -.
DR   PRIDE; B7ZL13; -.
DR   GeneID; 23048; -.
DR   CTD; 23048; -.
DR   eggNOG; ENOG410INNY; Eukaryota.
DR   eggNOG; ENOG410ZU0I; LUCA.
DR   OrthoDB; 348563at2759; -.
DR   ChiTaRS; FNBP1; human.
DR   GenomeRNAi; 23048; -.
DR   GO; GO:0006897; P:endocytosis; IEA:InterPro.
DR   CDD; cd07676; F-BAR_FBP17; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR028532; FNBP1/FBP17.
DR   InterPro; IPR037449; FNBP1_F-BAR.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR15735:SF13; PTHR15735:SF13; 1.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU01077, ECO:0000256|SAM:Coils};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS00989295}.
FT   DOMAIN          1..264
FT                   /note="F-BAR"
FT                   /evidence="ECO:0000259|PROSITE:PS51741"
FT   DOMAIN          540..601
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
FT   REGION          280..356
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          476..521
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          155..175
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          401..428
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        291..305
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        326..341
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        485..521
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   607 AA;  70198 MW;  17B8BD7F171A49B8 CRC64;
     MSWGTELWDQ FDNLEKHTQW GIDILEKYIK FVKERTEIEL SYAKQLRNLS KKYQPKKNSK
     EEEEYKYTSC KAFISNLNEM NDYAGQHEVI SENMASQIIV DLARYVQELK QERKSNFHDG
     RKAQQHIETC WKQLESSKRR FERDCKEADR AQQYFEKMDA DINVTKADVE KARQQAQIRH
     QMAEDSKADY SSILQKFNHE QHEYYHTHIP NIFQKIQEME ERRIVRMGES MKTYAEVDRQ
     VIPIIGKCLD GIVKAAESID QKNDSQLVIE AYKSGFEPPG DIEFEDYTQP MKRTVSDNSL
     SNSRGEGKPD LKFGGKSKGK LWPFIKKNKP PPPPPASASP SAVPNGPQSP KQQKEPLSHR
     FNEFMTSKPK IHCFRSLKRG LSLKLGATPE DFSNLPPEQR RKKLQQKVDE LNKEIQKEMD
     QRDAITKMKD VYLKNPQMGD PASLDHKLAE VSQNIEKLRV ETQKFEAWLA EVEGRLPARS
     EQARRQSGLY DSQNPPTVNN CAQDRESPDG SYTEEQSQES EMKVLATDFD DEFDDEEPLP
     AIGTCKALYT FEGQNEGTIS VVEGETLYVI EEDKGDGWTR IRRNEDEEGY VPTSYVEVCL
     DKNAKDS
//
ID   B7ZL14_HUMAN            Unreviewed;       551 AA.
AC   B7ZL14; E7EPB7;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   22-APR-2020, entry version 91.
DE   SubName: Full=FNBP1 protein {ECO:0000313|EMBL:AAI43516.1};
DE   SubName: Full=Formin-binding protein 1 {ECO:0000313|Ensembl:ENSP00000389117};
GN   Name=FNBP1 {ECO:0000313|EMBL:AAI43516.1,
GN   ECO:0000313|Ensembl:ENSP00000389117};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI43516.1};
RN   [1] {ECO:0000213|PubMed:15144186}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [2] {ECO:0000313|EMBL:AAI43516.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver {ECO:0000313|EMBL:AAI43516.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000389117, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [5] {ECO:0000213|PubMed:19367720}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [6] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13] {ECO:0000313|Ensembl:ENSP00000389117}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [14] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL136141; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC143515; AAI43516.1; -; mRNA.
DR   RefSeq; XP_005251891.1; XM_005251834.2.
DR   ProteomicsDB; 17324; -.
DR   Antibodypedia; 31452; 177 antibodies.
DR   Ensembl; ENST00000443566; ENSP00000389117; ENSG00000187239.
DR   GeneID; 23048; -.
DR   UCSC; uc004bza.2; human.
DR   CTD; 23048; -.
DR   EuPathDB; HostDB:ENSG00000187239.16; -.
DR   HGNC; HGNC:17069; FNBP1.
DR   OpenTargets; ENSG00000187239; -.
DR   GeneTree; ENSGT00950000183047; -.
DR   HOGENOM; CLU_023320_2_0_1; -.
DR   OrthoDB; 348563at2759; -.
DR   ChiTaRS; FNBP1; human.
DR   GenomeRNAi; 23048; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000187239; Expressed in corpus callosum and 238 other tissues.
DR   GO; GO:0006897; P:endocytosis; IEA:InterPro.
DR   CDD; cd07676; F-BAR_FBP17; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR028532; FNBP1/FBP17.
DR   InterPro; IPR037449; FNBP1_F-BAR.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR15735:SF13; PTHR15735:SF13; 2.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU01077, ECO:0000256|SAM:Coils};
KW   Proteomics identification {ECO:0000213|EPD:B7ZL14,
KW   ECO:0000213|MaxQB:B7ZL14, ECO:0000213|PeptideAtlas:B7ZL14,
KW   ECO:0000213|ProteomicsDB:B7ZL14};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS00989295}.
FT   DOMAIN          1..264
FT                   /note="F-BAR"
FT                   /evidence="ECO:0000259|PROSITE:PS51741"
FT   DOMAIN          484..545
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
FT   REGION          422..465
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          155..175
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          345..372
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        429..465
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   551 AA;  64071 MW;  CCA04989BE12E604 CRC64;
     MSWGTELWDQ FDNLEKHTQW GIDILEKYIK FVKERTEIEL SYAKQLRNLS KKYQPKKNSK
     EEEEYKYTSC KAFISNLNEM NDYAGQHEVI SENMASQIIV DLARYVQELK QERKSNFHDG
     RKAQQHIETC WKQLESSKRR FERDCKEADR AQQYFEKMDA DINVTKADVE KARQQAQIRH
     QMAEDSKADY SSILQKFNHE QHEYYHTHIP NIFQKIQEME ERRIVRMGES MKTYAEVDRQ
     VIPIIGKCLD GIVKAAESID QKNDSQLVIE AYKSGFEPPG DIEFEDYTQP MKRTVSDNSL
     SNSRGEGKPD LKFGGKSKGK LWPFIKKNKG ATPEDFSNLP PEQRRKKLQQ KVDELNKEIQ
     KEMDQRDAIT KMKDVYLKNP QMGDPASLDH KLAEVSQNIE KLRVETQKFE AWLAEVEGRL
     PARSEQARRQ SGLYDSQNPP TVNNCAQDRE SPDGSYTEEQ SQESEMKVLA TDFDDEFDDE
     EPLPAIGTCK ALYTFEGQNE GTISVVEGET LYVIEEDKGD GWTRIRRNED EEGYVPTSYV
     EVCLDKNAKD S
//
ID   FNBP1_HUMAN             Reviewed;         617 AA.
AC   Q96RU3; B7ZL12; E9PGQ4; O60301; Q3MIN8; Q5TC87; Q5TC88; Q6P658; Q7LGG2;
AC   Q9H8H8; Q9NWD1;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   22-APR-2020, entry version 159.
DE   RecName: Full=Formin-binding protein 1;
DE   AltName: Full=Formin-binding protein 17;
DE            Short=hFBP17;
GN   Name=FNBP1; Synonyms=FBP17, KIAA0554;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH SNX2, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND CHROMOSOMAL TRANSLOCATION WITH
RP   KMT2A/MLL1.
RX   PubMed=11438682; DOI=10.1073/pnas.121433898;
RA   Fuchs U., Rehkamp G.F., Haas O.A., Slany R., Koenig M., Bojesen S.,
RA   Bohle R.M., Damm-Welk C., Ludwig W.-D., Harbott J., Borkhardt A.;
RT   "The human formin-binding protein 17 (FBP17) interacts with sorting nexin,
RT   SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8756-8761(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 36-617 (ISOFORM 2), AND VARIANT ASN-490.
RC   TISSUE=Embryo, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-409 (ISOFORM 4).
RC   TISSUE=Liver, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH ARHGAP17.
RX   PubMed=11431473; DOI=10.1074/jbc.m103540200;
RA   Richnau N., Aspenstroem P.;
RT   "Rich, a rho GTPase-activating protein domain-containing protein involved
RT   in signaling by Cdc42 and Rac1.";
RL   J. Biol. Chem. 276:35060-35070(2001).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH FASLG.
RX   PubMed=12023017; DOI=10.1016/s0014-5793(02)02709-6;
RA   Ghadimi M.P., Sanzenbacher R., Thiede B., Wenzel J., Jing Q., Plomann M.,
RA   Borkhardt A., Kabelitz D., Janssen O.;
RT   "Identification of interaction partners of the cytosolic polyproline region
RT   of CD95 ligand (CD178).";
RL   FEBS Lett. 519:50-58(2002).
RN   [8]
RP   INTERACTION WITH SNX2 AND TNKS, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ARG-515; ASP-519 AND 515-ARG--GLY-520.
RX   PubMed=14596906; DOI=10.1016/s0014-5793(03)01063-9;
RA   Fuchs U., Rehkamp G.F., Slany R., Follo M., Borkhardt A.;
RT   "The formin-binding protein 17, FBP17, binds via a TNKS binding motif to
RT   tankyrase, a protein involved in telomere maintenance.";
RL   FEBS Lett. 554:10-16(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [10]
RP   FUNCTION, SELF-ASSOCIATION, INTERACTION WITH DNM1; DNM2 AND DNM3,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF PRO-602.
RX   PubMed=15252009; DOI=10.1074/jbc.m404899200;
RA   Kamioka Y., Fukuhara S., Sawa H., Nagashima K., Masuda M., Matsuda M.,
RA   Mochizuki N.;
RT   "A novel dynamin-associating molecule, formin-binding protein 17, induces
RT   tubular membrane invaginations and participates in endocytosis.";
RL   J. Biol. Chem. 279:40091-40099(2004).
RN   [11]
RP   INTERACTION WITH AKAP9, AND SUBCELLULAR LOCATION.
RX   PubMed=15047863; DOI=10.1091/mbc.e03-10-0757;
RA   Larocca M.C., Shanks R.A., Tian L., Nelson D.L., Stewart D.M.,
RA   Goldenring J.R.;
RT   "AKAP350 interaction with cdc42 interacting protein 4 at the Golgi
RT   apparatus.";
RL   Mol. Biol. Cell 15:2771-2781(2004).
RN   [12]
RP   FUNCTION, SELF-ASSOCIATION, INTERACTION WITH DNM1 AND WASL, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF LEU-7.
RX   PubMed=16326391; DOI=10.1016/j.devcel.2005.11.005;
RA   Itoh T., Erdmann K.S., Roux A., Habermann B., Werner H., De Camilli P.;
RT   "Dynamin and the actin cytoskeleton cooperatively regulate plasma membrane
RT   invagination by BAR and F-BAR proteins.";
RL   Dev. Cell 9:791-804(2005).
RN   [13]
RP   FUNCTION, INTERACTION WITH FASLG, AND SUBCELLULAR LOCATION.
RX   PubMed=16318909; DOI=10.1016/j.cellsig.2005.10.015;
RA   Qian J., Chen W., Lettau M., Podda G., Zoernig M., Kabelitz D., Janssen O.;
RT   "Regulation of FasL expression: a SH3 domain containing protein family
RT   involved in the lysosomal association of FasL.";
RL   Cell. Signal. 18:1327-1337(2006).
RN   [14]
RP   INTERACTION WITH DAAM1; DIAPH1 AND DIAPH2.
RX   PubMed=16630611; DOI=10.1016/j.yexcr.2006.03.013;
RA   Aspenstroem P., Richnau N., Johansson A.-S.;
RT   "The diaphanous-related formin DAAM1 collaborates with the Rho GTPases RhoA
RT   and Cdc42, CIP4 and Src in regulating cell morphogenesis and actin
RT   dynamics.";
RL   Exp. Cell Res. 312:2180-2194(2006).
RN   [15]
RP   FUNCTION, INTERACTION WITH DNM2 AND WASL, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF LYS-33; ARG-35; 51-LYS-LYS-52 AND 113-ARG-LYS-114.
RX   PubMed=16418535; DOI=10.1083/jcb.200508091;
RA   Tsujita K., Suetsugu S., Sasaki N., Furutani M., Oikawa T., Takenawa T.;
RT   "Coordination between the actin cytoskeleton and membrane deformation by a
RT   novel membrane tubulation domain of PCH proteins is involved in
RT   endocytosis.";
RL   J. Cell Biol. 172:269-279(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296; SER-299; SER-349 AND
RP   SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-359, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-66 AND LYS-110, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296 AND SER-359, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296 AND SER-299, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296 AND SER-359, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.61 ANGSTROMS) OF 1-300, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, DOMAIN F-BAR, COILED-COIL DOMAIN, AND MUTAGENESIS OF
RP   LYS-33; THR-165; LYS-166; ASP-168 AND PRO-210.
RX   PubMed=17512409; DOI=10.1016/j.cell.2007.03.040;
RA   Shimada A., Niwa H., Tsujita K., Suetsugu S., Nitta K., Hanawa-Suetsugu K.,
RA   Akasaka R., Nishino Y., Toyama M., Chen L., Liu Z.-J., Wang B.C.,
RA   Yamamoto M., Terada T., Miyazawa A., Tanaka A., Sugano S., Shirouzu M.,
RA   Nagayama K., Takenawa T., Yokoyama S.;
RT   "Curved EFC/F-BAR-domain dimers are joined end to end into a filament for
RT   membrane invagination in endocytosis.";
RL   Cell 129:761-772(2007).
CC   -!- FUNCTION: May act as a link between RND2 signaling and regulation of
CC       the actin cytoskeleton (By similarity). Required to coordinate membrane
CC       tubulation with reorganization of the actin cytoskeleton during the
CC       late stage of clathrin-mediated endocytosis. Binds to lipids such as
CC       phosphatidylinositol 4,5-bisphosphate and phosphatidylserine and
CC       promotes membrane invagination and the formation of tubules. Also
CC       enhances actin polymerization via the recruitment of WASL/N-WASP, which
CC       in turn activates the Arp2/3 complex. Actin polymerization may promote
CC       the fission of membrane tubules to form endocytic vesicles. May be
CC       required for the lysosomal retention of FASLG/FASL. {ECO:0000250,
CC       ECO:0000269|PubMed:15252009, ECO:0000269|PubMed:16318909,
CC       ECO:0000269|PubMed:16326391, ECO:0000269|PubMed:16418535,
CC       ECO:0000269|PubMed:17512409}.
CC   -!- SUBUNIT: Interacts specifically with GTP-bound RND2 and CDC42.
CC       Interacts with PDE6G and microtubules (By similarity). Homodimerizes,
CC       the dimers can polymerize end-to-end to form filamentous structures.
CC       Interacts with AKAP9, ARHGAP17, DAAM1, DIAPH1, DIAPH2, DNM1, DNM2,
CC       DNM3, FASLG/FASL, SNX2 and WASL/N-WASP. May interact with TNKS.
CC       {ECO:0000250, ECO:0000269|PubMed:11431473, ECO:0000269|PubMed:11438682,
CC       ECO:0000269|PubMed:12023017, ECO:0000269|PubMed:14596906,
CC       ECO:0000269|PubMed:15047863, ECO:0000269|PubMed:15252009,
CC       ECO:0000269|PubMed:16318909, ECO:0000269|PubMed:16326391,
CC       ECO:0000269|PubMed:16418535, ECO:0000269|PubMed:16630611,
CC       ECO:0000269|PubMed:17512409}.
CC   -!- INTERACTION:
CC       Q96RU3; Q96RU3; NbExp=3; IntAct=EBI-1111248, EBI-1111248;
CC       Q96RU3; Q05193: DNM1; NbExp=5; IntAct=EBI-1111248, EBI-713135;
CC       Q96RU3; P48023: FASLG; NbExp=4; IntAct=EBI-1111248, EBI-495538;
CC       Q96RU3; O95166: GABARAP; NbExp=2; IntAct=EBI-1111248, EBI-712001;
CC       Q96RU3; P97573: Inpp5d; Xeno; NbExp=2; IntAct=EBI-1111248, EBI-8008869;
CC       Q96RU3; O60749: SNX2; NbExp=4; IntAct=EBI-1111248, EBI-1046690;
CC       Q96RU3; O95271: TNKS; NbExp=4; IntAct=EBI-1111248, EBI-1105254;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton. Cytoplasm,
CC       cell cortex. Lysosome. Cytoplasmic vesicle. Cell membrane; Peripheral
CC       membrane protein; Cytoplasmic side. Membrane, clathrin-coated pit.
CC       Note=Enriched in cortical regions coincident with F-actin. Also
CC       localizes to endocytic vesicles and lysosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q96RU3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96RU3-2; Sequence=VSP_021695, VSP_021696;
CC       Name=3;
CC         IsoId=Q96RU3-3; Sequence=VSP_021694, VSP_021696;
CC       Name=4;
CC         IsoId=Q96RU3-4; Sequence=VSP_021693;
CC       Name=5;
CC         IsoId=Q96RU3-5; Sequence=VSP_021695;
CC   -!- TISSUE SPECIFICITY: Very highly expressed in the epithelial cells of
CC       the gastrointestinal tract, respiratory, reproductive and urinary
CC       systems. Also highly expressed in brown adipose tissue, cardiomyocytes,
CC       enteric ganglia and glucagon producing cells of the pancreas. Expressed
CC       in germ cells of the testis and all regions of the brain.
CC       {ECO:0000269|PubMed:11438682, ECO:0000269|PubMed:15252009}.
CC   -!- DOMAIN: The F-BAR domain binds the phospholipid membrane with its
CC       concave surface. The end-to-end polymerization of dimers of these
CC       domains provides a curved surface that fits best membranes with around
CC       600 A diameter, and may drive tubulation.
CC       {ECO:0000269|PubMed:17512409}.
CC   -!- DISEASE: Note=A chromosomal aberration involving FNBP1 is found in
CC       acute leukemias. Translocation t(9;11)(q34;q23) with KMT2A/MLL1. The
CC       relatively low incidence of the KMT2A/MLL1-FNBP1 fusion protein in
CC       acute leukemia may reflect the marginal capacity of this fusion protein
CC       to induce cellular transformation.
CC   -!- SIMILARITY: Belongs to the FNBP1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH62463.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAK49824.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA25480.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA91451.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FBP17ID353.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF265550; AAK49824.1; ALT_INIT; mRNA.
DR   EMBL; AB011126; BAA25480.1; ALT_INIT; mRNA.
DR   EMBL; AK000975; BAA91451.1; ALT_INIT; mRNA.
DR   EMBL; AK023681; BAB14638.1; -; mRNA.
DR   EMBL; AL136141; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC062463; AAH62463.1; ALT_SEQ; mRNA.
DR   EMBL; BC101755; AAI01756.1; -; mRNA.
DR   EMBL; BC143513; AAI43514.1; -; mRNA.
DR   CCDS; CCDS48040.1; -. [Q96RU3-1]
DR   CCDS; CCDS87699.1; -. [Q96RU3-3]
DR   RefSeq; NP_055848.1; NM_015033.2. [Q96RU3-1]
DR   RefSeq; XP_005251880.1; XM_005251823.2. [Q96RU3-2]
DR   RefSeq; XP_005251881.1; XM_005251824.2. [Q96RU3-5]
DR   RefSeq; XP_005251886.1; XM_005251829.2.
DR   PDB; 2EFL; X-ray; 2.61 A; A=1-300.
DR   PDBsum; 2EFL; -.
DR   SMR; Q96RU3; -.
DR   BioGrid; 116686; 29.
DR   DIP; DIP-35355N; -.
DR   ELM; Q96RU3; -.
DR   IntAct; Q96RU3; 29.
DR   MINT; Q96RU3; -.
DR   STRING; 9606.ENSP00000413625; -.
DR   iPTMnet; Q96RU3; -.
DR   MetOSite; Q96RU3; -.
DR   PhosphoSitePlus; Q96RU3; -.
DR   BioMuta; FNBP1; -.
DR   DMDM; 118572321; -.
DR   EPD; Q96RU3; -.
DR   jPOST; Q96RU3; -.
DR   MassIVE; Q96RU3; -.
DR   MaxQB; Q96RU3; -.
DR   PaxDb; Q96RU3; -.
DR   PeptideAtlas; Q96RU3; -.
DR   PRIDE; Q96RU3; -.
DR   ProteomicsDB; 20367; -.
DR   ProteomicsDB; 78035; -. [Q96RU3-1]
DR   ProteomicsDB; 78036; -. [Q96RU3-2]
DR   ProteomicsDB; 78037; -. [Q96RU3-3]
DR   ProteomicsDB; 78038; -. [Q96RU3-4]
DR   Antibodypedia; 31452; 177 antibodies.
DR   Ensembl; ENST00000355681; ENSP00000347907; ENSG00000187239. [Q96RU3-3]
DR   Ensembl; ENST00000420781; ENSP00000407548; ENSG00000187239. [Q96RU3-5]
DR   Ensembl; ENST00000446176; ENSP00000413625; ENSG00000187239. [Q96RU3-1]
DR   GeneID; 23048; -.
DR   KEGG; hsa:23048; -.
DR   UCSC; uc004byw.2; human. [Q96RU3-1]
DR   CTD; 23048; -.
DR   DisGeNET; 23048; -.
DR   GeneCards; FNBP1; -.
DR   HGNC; HGNC:17069; FNBP1.
DR   HPA; ENSG00000187239; Low tissue specificity.
DR   MIM; 606191; gene.
DR   neXtProt; NX_Q96RU3; -.
DR   OpenTargets; ENSG00000187239; -.
DR   PharmGKB; PA128394597; -.
DR   eggNOG; ENOG410INNY; Eukaryota.
DR   eggNOG; ENOG410ZU0I; LUCA.
DR   GeneTree; ENSGT00950000183047; -.
DR   InParanoid; Q96RU3; -.
DR   KO; K20121; -.
DR   OMA; IPMNEGE; -.
DR   OrthoDB; 348563at2759; -.
DR   PhylomeDB; Q96RU3; -.
DR   TreeFam; TF351162; -.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   ChiTaRS; FNBP1; human.
DR   EvolutionaryTrace; Q96RU3; -.
DR   GeneWiki; FNBP1; -.
DR   GenomeRNAi; 23048; -.
DR   Pharos; Q96RU3; Tbio.
DR   PRO; PR:Q96RU3; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q96RU3; protein.
DR   Bgee; ENSG00000187239; Expressed in corpus callosum and 238 other tissues.
DR   ExpressionAtlas; Q96RU3; baseline and differential.
DR   Genevisible; Q96RU3; HS.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   CDD; cd07676; F-BAR_FBP17; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR028532; FNBP1/FBP17.
DR   InterPro; IPR037449; FNBP1_F-BAR.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR15735:SF13; PTHR15735:SF13; 1.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS51860; REM_1; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane;
KW   Chromosomal rearrangement; Coated pit; Coiled coil; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; Endocytosis; Lipid-binding; Lysosome;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome; SH3 domain.
FT   CHAIN           1..617
FT                   /note="Formin-binding protein 1"
FT                   /id="PRO_0000261430"
FT   DOMAIN          1..264
FT                   /note="F-BAR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01077"
FT   DOMAIN          404..481
FT                   /note="REM-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01207"
FT   DOMAIN          550..611
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          1..335
FT                   /note="Interaction with microtubules"
FT                   /evidence="ECO:0000250"
FT   REGION          1..79
FT                   /note="Required for self-association and induction of
FT                   membrane tubulation"
FT   REGION          251..617
FT                   /note="Required for self-association and induction of
FT                   membrane tubulation"
FT   REGION          400..552
FT                   /note="Interaction with RND2"
FT                   /evidence="ECO:0000250"
FT   REGION          495..617
FT                   /note="Interaction with PDE6G"
FT                   /evidence="ECO:0000250"
FT   REGION          514..617
FT                   /note="Required for interaction with TNKS"
FT                   /evidence="ECO:0000269|PubMed:14596906"
FT   REGION          535..617
FT                   /note="Interaction with DNM1 and DNM3"
FT                   /evidence="ECO:0000269|PubMed:15252009"
FT   REGION          550..617
FT                   /note="Interaction with ARHGAP17, DAAM1, DIAPH1 and DIAPH2"
FT                   /evidence="ECO:0000269|PubMed:11431473,
FT                   ECO:0000269|PubMed:16630611"
FT   REGION          553..610
FT                   /note="Interaction with FASLG"
FT   REGION          553..609
FT                   /note="Interaction with DNM2 and WASL"
FT   COILED          67..259
FT                   /evidence="ECO:0000269|PubMed:17512409"
FT   COILED          398..490
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        340..345
FT                   /note="Poly-Pro"
FT   SITE            166
FT                   /note="Mediates end-to-end attachment of dimers"
FT   MOD_RES         66
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         110
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         296
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692"
FT   MOD_RES         349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         359
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         497
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TY0"
FT   MOD_RES         500
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TY0"
FT   MOD_RES         521
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8R511"
FT   VAR_SEQ         329..394
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_021693"
FT   VAR_SEQ         330..358
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_021694"
FT   VAR_SEQ         391..395
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_021695"
FT   VAR_SEQ         616..617
FT                   /note="DS -> GAKTYI (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_021696"
FT   VARIANT         490
FT                   /note="S -> N (in dbSNP:rs1023000)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_029388"
FT   MUTAGEN         7
FT                   /note="L->E: Impairs membrane tubulation but does not
FT                   affect lipid-binding."
FT                   /evidence="ECO:0000269|PubMed:16326391"
FT   MUTAGEN         33
FT                   /note="K->E: Abolishes membrane invagination."
FT                   /evidence="ECO:0000269|PubMed:16418535,
FT                   ECO:0000269|PubMed:17512409"
FT   MUTAGEN         33
FT                   /note="K->Q: Impairs lipid-binding and induction of
FT                   membrane tubulation; when associated with Q-35."
FT                   /evidence="ECO:0000269|PubMed:16418535,
FT                   ECO:0000269|PubMed:17512409"
FT   MUTAGEN         35
FT                   /note="R->Q: Impairs lipid-binding and induction of
FT                   membrane tubulation; when associated with Q-33."
FT                   /evidence="ECO:0000269|PubMed:16418535"
FT   MUTAGEN         51..52
FT                   /note="KK->QQ: Impairs lipid-binding and induction of
FT                   membrane tubulation."
FT                   /evidence="ECO:0000269|PubMed:16418535"
FT   MUTAGEN         113..114
FT                   /note="RK->QQ: Impairs lipid-binding and induction of
FT                   membrane tubulation."
FT                   /evidence="ECO:0000269|PubMed:16418535"
FT   MUTAGEN         165
FT                   /note="T->A: Abolishes membrane invagination."
FT                   /evidence="ECO:0000269|PubMed:17512409"
FT   MUTAGEN         166
FT                   /note="K->A: Abolishes membrane invagination."
FT                   /evidence="ECO:0000269|PubMed:17512409"
FT   MUTAGEN         168
FT                   /note="D->A,N,R: No significant effect."
FT                   /evidence="ECO:0000269|PubMed:17512409"
FT   MUTAGEN         210
FT                   /note="P->A: Disrupts helix kink and moderately increases
FT                   diameter of the induced tubular membrane."
FT                   /evidence="ECO:0000269|PubMed:17512409"
FT   MUTAGEN         515..520
FT                   /note="Missing: Abrogates interaction with TNKS."
FT                   /evidence="ECO:0000269|PubMed:14596906"
FT   MUTAGEN         515
FT                   /note="R->A: Impairs interaction with TNKS."
FT                   /evidence="ECO:0000269|PubMed:14596906"
FT   MUTAGEN         519
FT                   /note="D->A: Impairs interaction with TNKS; when associated
FT                   with A-515."
FT                   /evidence="ECO:0000269|PubMed:14596906"
FT   MUTAGEN         602
FT                   /note="P->L: Abrogates interaction with DNM1, DNM2 and
FT                   DNM3."
FT                   /evidence="ECO:0000269|PubMed:15252009"
FT   CONFLICT        388
FT                   /note="K -> E (in Ref. 3; BAA91451)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..6
FT                   /evidence="ECO:0000244|PDB:2EFL"
FT   TURN            7..9
FT                   /evidence="ECO:0000244|PDB:2EFL"
FT   HELIX           11..52
FT                   /evidence="ECO:0000244|PDB:2EFL"
FT   HELIX           68..160
FT                   /evidence="ECO:0000244|PDB:2EFL"
FT   HELIX           166..206
FT                   /evidence="ECO:0000244|PDB:2EFL"
FT   HELIX           208..238
FT                   /evidence="ECO:0000244|PDB:2EFL"
FT   HELIX           241..257
FT                   /evidence="ECO:0000244|PDB:2EFL"
FT   HELIX           261..272
FT                   /evidence="ECO:0000244|PDB:2EFL"
SQ   SEQUENCE   617 AA;  71307 MW;  F06E847C6E631EC3 CRC64;
     MSWGTELWDQ FDNLEKHTQW GIDILEKYIK FVKERTEIEL SYAKQLRNLS KKYQPKKNSK
     EEEEYKYTSC KAFISNLNEM NDYAGQHEVI SENMASQIIV DLARYVQELK QERKSNFHDG
     RKAQQHIETC WKQLESSKRR FERDCKEADR AQQYFEKMDA DINVTKADVE KARQQAQIRH
     QMAEDSKADY SSILQKFNHE QHEYYHTHIP NIFQKIQEME ERRIVRMGES MKTYAEVDRQ
     VIPIIGKCLD GIVKAAESID QKNDSQLVIE AYKSGFEPPG DIEFEDYTQP MKRTVSDNSL
     SNSRGEGKPD LKFGGKSKGK LWPFIKKNKL MSLLTSPHQP PPPPPASASP SAVPNGPQSP
     KQQKEPLSHR FNEFMTSKPK IHCFRSLKRG LSLKLGATPE DFSNLPPEQR RKKLQQKVDE
     LNKEIQKEMD QRDAITKMKD VYLKNPQMGD PASLDHKLAE VSQNIEKLRV ETQKFEAWLA
     EVEGRLPARS EQARRQSGLY DSQNPPTVNN CAQDRESPDG SYTEEQSQES EMKVLATDFD
     DEFDDEEPLP AIGTCKALYT FEGQNEGTIS VVEGETLYVI EEDKGDGWTR IRRNEDEEGY
     VPTSYVEVCL DKNAKDS
//
ID   A0A140VJK6_HUMAN        Unreviewed;       693 AA.
AC   A0A140VJK6;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   22-APR-2020, entry version 19.
DE   SubName: Full=Testicular tissue protein Li 82 {ECO:0000313|EMBL:AEE60993.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE60993.1};
RN   [1] {ECO:0000313|EMBL:AEE60993.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HM005395; AEE60993.1; -; mRNA.
DR   RefSeq; NP_003866.1; NM_003875.2.
DR   SMR; A0A140VJK6; -.
DR   PRIDE; A0A140VJK6; -.
DR   Antibodypedia; 33632; 244 antibodies.
DR   GeneID; 8833; -.
DR   KEGG; hsa:8833; -.
DR   CTD; 8833; -.
DR   KO; K01951; -.
DR   OMA; KRKIIGH; -.
DR   OrthoDB; 392369at2759; -.
DR   PhylomeDB; A0A140VJK6; -.
DR   GenomeRNAi; 8833; -.
DR   ExpressionAtlas; A0A140VJK6; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003922; F:GMP synthase (glutamine-hydrolyzing) activity; IEA:InterPro.
DR   GO; GO:0016462; F:pyrophosphatase activity; IEA:InterPro.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-UniRule.
DR   CDD; cd01742; GATase1_GMP_Synthase; 1.
DR   CDD; cd01997; GMP_synthase_C; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR001674; GMP_synth_C.
DR   InterPro; IPR004739; GMP_synth_GATase.
DR   InterPro; IPR025777; GMPS_ATP_PPase_dom.
DR   InterPro; IPR022310; NAD/GMP_synthase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00117; GATase; 1.
DR   Pfam; PF00958; GMP_synt_C; 1.
DR   Pfam; PF02540; NAD_synthase; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   TIGRFAMs; TIGR00888; guaA_Nterm; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
DR   PROSITE; PS51553; GMPS_ATP_PPASE; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|PROSITE-ProRule:PRU00886};
KW   Glutamine amidotransferase {ECO:0000256|PROSITE-ProRule:PRU00605};
KW   GMP biosynthesis {ECO:0000256|PROSITE-ProRule:PRU00886};
KW   Nucleotide-binding {ECO:0000256|PROSITE-ProRule:PRU00886};
KW   Purine biosynthesis {ECO:0000256|PROSITE-ProRule:PRU00886}.
FT   DOMAIN          27..216
FT                   /note="Glutamine amidotransferase type-1"
FT                   /evidence="ECO:0000259|PROSITE:PS51273"
FT   DOMAIN          217..435
FT                   /note="GMPS ATP-PPase"
FT                   /evidence="ECO:0000259|PROSITE:PS51553"
FT   NP_BIND         244..250
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00886"
FT   ACT_SITE        104
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00605"
FT   ACT_SITE        190
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00605"
FT   ACT_SITE        192
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00605"
SQ   SEQUENCE   693 AA;  76715 MW;  1CDA0DD3B244728D CRC64;
     MALCNGDSKL ENAGGDLKDG HHHYEGAVVI LDAGAQYGKV IDRRVRELFV QSEIFPLETP
     AFAIKEQGFR AIIISGGPNS VYAEDAPWFD PAIFTIGKPV LGICYGMQMM NKVFGGTVHK
     KSVREDGVFN ISVDNTCSLF RGLQKEEVVL LTHGDSVDKV ADGFKVVARS GNIVAGIANE
     SKKLYGAQFH PEVGLTENGK VILKNFLYDI AGCSGTFTVQ NRELECIREI KERVGTSKVL
     VLLSGGVDST VCTALLNRAL NQEQVIAVHI DNGFMRKRES QSVEEALKKL GIQVKVINAA
     HSFYNGTTTL PISDEDRTPR KRISKTLNMT TSPEEKRKII GDTFVKIANE VIGEMNLKPE
     EVFLAQGTLR PDLIESASLV ASGKAELIKT HHNDTELIRK LREEGKVIEP LKDFHKDEVR
     ILGRELGLPE ELVSRHPFPG PGLAIRVICA EEPYICKDFP ETNNILKIVA DFSASVKKPH
     TLLQRVKACT TEEDQEKLMQ ITSLHSLNAF LLPIKTVGVQ GDCRSYSYVC GISSKDEPDW
     ESLIFLARLI PRMCHNVNRV VYIFGPPVKE PPTDVTPTFL TTGVLSTLRQ ADFEAHNILR
     ESGYAGKISQ MPVILTPLHF DRDPLQKQPS CQRSVVIRTF ITSDFMTGIP ATPGNEIPVE
     VVLKMVTEIK KIPGISRIMY DLTSKPPGTT EWE
//
ID   GUAA_HUMAN              Reviewed;         693 AA.
AC   P49915; A8K639; B4DXV7; F8W720;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-APR-2020, entry version 200.
DE   RecName: Full=GMP synthase [glutamine-hydrolyzing];
DE            EC=6.3.5.2;
DE   AltName: Full=GMP synthetase;
DE   AltName: Full=Glutamine amidotransferase;
GN   Name=GMPS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=8089153;
RA   Hirst M., Haliday E., Nakamura J., Lou L.;
RT   "Human GMP synthetase. Protein purification, cloning, and functional
RT   expression of cDNA.";
RL   J. Biol. Chem. 269:23830-23837(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH KMT2A/MLL1.
RX   PubMed=11110714;
RA   Pegram L.D., Megonigal M.D., Lange B.J., Nowell P.C., Rowley J.D.,
RA   Rappaport E.F., Felix C.A.;
RT   "t(3;11) translocation in treatment-related acute myeloid leukemia fuses
RT   MLL with the GMPS (guanosine 5-prime monophosphate synthetase) gene.";
RL   Blood 96:4360-4362(2000).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-9, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-318 AND SER-332, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8 AND SER-332, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 20-693, SUBSTRATE-BINDING SITES,
RP   ACTIVE SITE, AND SUBUNIT.
RX   PubMed=23816837; DOI=10.1016/j.jmb.2013.06.032;
RA   Welin M., Lehtio L., Johansson A., Flodin S., Nyman T., Tresaugues L.,
RA   Hammarstrom M., Graslund S., Nordlund P.;
RT   "Substrate specificity and oligomerization of human GMP synthetase.";
RL   J. Mol. Biol. 425:4323-4333(2013).
CC   -!- FUNCTION: Involved in the de novo synthesis of guanine nucleotides
CC       which are not only essential for DNA and RNA synthesis, but also
CC       provide GTP, which is involved in a number of cellular processes
CC       important for cell division.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + L-glutamine + XMP = AMP + diphosphate + GMP + 2
CC         H(+) + L-glutamate; Xref=Rhea:RHEA:11680, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57464, ChEBI:CHEBI:58115,
CC         ChEBI:CHEBI:58359, ChEBI:CHEBI:456215; EC=6.3.5.2;
CC   -!- PATHWAY: Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln
CC       route): step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:23816837}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49915-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49915-2; Sequence=VSP_053933;
CC   -!- DISEASE: Note=A chromosomal aberration involving GMPS is found in acute
CC       myeloid leukemias. Translocation t(3,11)(q25,q23) with KMT2A/MLL1.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GMPSID229.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10860; AAA60331.1; -; mRNA.
DR   EMBL; AK291504; BAF84193.1; -; mRNA.
DR   EMBL; AK302148; BAG63519.1; -; mRNA.
DR   EMBL; AK315832; BAF98723.1; -; mRNA.
DR   EMBL; AC067721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104472; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC140753; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78741.1; -; Genomic_DNA.
DR   EMBL; BC012178; AAH12178.1; -; mRNA.
DR   CCDS; CCDS46941.1; -. [P49915-1]
DR   PIR; A54847; A54847.
DR   RefSeq; NP_003866.1; NM_003875.2. [P49915-1]
DR   PDB; 2VPI; X-ray; 2.40 A; A/B=25-219.
DR   PDB; 2VXO; X-ray; 2.50 A; A/B=20-693.
DR   PDBsum; 2VPI; -.
DR   PDBsum; 2VXO; -.
DR   SMR; P49915; -.
DR   BioGrid; 114360; 91.
DR   IntAct; P49915; 28.
DR   MINT; P49915; -.
DR   STRING; 9606.ENSP00000419851; -.
DR   ChEMBL; CHEMBL5721; -.
DR   DrugBank; DB00142; Glutamic acid.
DR   DrugBank; DB00130; L-Glutamine.
DR   MEROPS; C26.950; -.
DR   iPTMnet; P49915; -.
DR   MetOSite; P49915; -.
DR   PhosphoSitePlus; P49915; -.
DR   SwissPalm; P49915; -.
DR   BioMuta; GMPS; -.
DR   DMDM; 1708072; -.
DR   REPRODUCTION-2DPAGE; IPI00029079; -.
DR   EPD; P49915; -.
DR   jPOST; P49915; -.
DR   MassIVE; P49915; -.
DR   MaxQB; P49915; -.
DR   PaxDb; P49915; -.
DR   PeptideAtlas; P49915; -.
DR   PRIDE; P49915; -.
DR   ProteomicsDB; 29873; -.
DR   ProteomicsDB; 56180; -. [P49915-1]
DR   Antibodypedia; 33632; 244 antibodies.
DR   DNASU; 8833; -.
DR   Ensembl; ENST00000295920; ENSP00000295920; ENSG00000163655. [P49915-2]
DR   Ensembl; ENST00000496455; ENSP00000419851; ENSG00000163655. [P49915-1]
DR   GeneID; 8833; -.
DR   KEGG; hsa:8833; -.
DR   UCSC; uc003faq.4; human. [P49915-1]
DR   CTD; 8833; -.
DR   DisGeNET; 8833; -.
DR   GeneCards; GMPS; -.
DR   HGNC; HGNC:4378; GMPS.
DR   HPA; ENSG00000163655; Low tissue specificity.
DR   MIM; 600358; gene.
DR   neXtProt; NX_P49915; -.
DR   OpenTargets; ENSG00000163655; -.
DR   PharmGKB; PA28763; -.
DR   eggNOG; KOG1622; Eukaryota.
DR   eggNOG; COG0518; LUCA.
DR   eggNOG; COG0519; LUCA.
DR   GeneTree; ENSGT00390000006591; -.
DR   HOGENOM; CLU_014340_0_2_1; -.
DR   InParanoid; P49915; -.
DR   KO; K01951; -.
DR   OMA; KRKIIGH; -.
DR   OrthoDB; 392369at2759; -.
DR   PhylomeDB; P49915; -.
DR   TreeFam; TF106132; -.
DR   BRENDA; 6.3.5.2; 2681.
DR   Reactome; R-HSA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   SIGNOR; P49915; -.
DR   UniPathway; UPA00189; UER00296.
DR   ChiTaRS; GMPS; human.
DR   EvolutionaryTrace; P49915; -.
DR   GeneWiki; GMP_synthase; -.
DR   GenomeRNAi; 8833; -.
DR   Pharos; P49915; Tbio.
DR   PRO; PR:P49915; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P49915; protein.
DR   Bgee; ENSG00000163655; Expressed in testis and 183 other tissues.
DR   ExpressionAtlas; P49915; baseline and differential.
DR   Genevisible; P49915; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003922; F:GMP synthase (glutamine-hydrolyzing) activity; EXP:Reactome.
DR   GO; GO:0003921; F:GMP synthase activity; IDA:MGI.
DR   GO; GO:0016462; F:pyrophosphatase activity; IEA:InterPro.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006177; P:GMP biosynthetic process; IDA:MGI.
DR   GO; GO:0009113; P:purine nucleobase biosynthetic process; TAS:ProtInc.
DR   GO; GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome.
DR   CDD; cd01742; GATase1_GMP_Synthase; 1.
DR   CDD; cd01997; GMP_synthase_C; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR001674; GMP_synth_C.
DR   InterPro; IPR004739; GMP_synth_GATase.
DR   InterPro; IPR025777; GMPS_ATP_PPase_dom.
DR   InterPro; IPR022310; NAD/GMP_synthase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00117; GATase; 1.
DR   Pfam; PF00958; GMP_synt_C; 1.
DR   Pfam; PF02540; NAD_synthase; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   TIGRFAMs; TIGR00888; guaA_Nterm; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
DR   PROSITE; PS51553; GMPS_ATP_PPASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Chromosomal rearrangement; Cytoplasm; Direct protein sequencing;
KW   Glutamine amidotransferase; GMP biosynthesis; Ligase; Nucleotide-binding;
KW   Phosphoprotein; Proto-oncogene; Purine biosynthesis; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   CHAIN           2..693
FT                   /note="GMP synthase [glutamine-hydrolyzing]"
FT                   /id="PRO_0000140257"
FT   DOMAIN          27..216
FT                   /note="Glutamine amidotransferase type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00605"
FT   DOMAIN          217..435
FT                   /note="GMPS ATP-PPase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00886"
FT   NP_BIND         244..250
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00886"
FT   ACT_SITE        104
FT                   /note="For GATase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00605,
FT                   ECO:0000269|PubMed:23816837"
FT   ACT_SITE        190
FT                   /note="For GATase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00605,
FT                   ECO:0000269|PubMed:23816837"
FT   ACT_SITE        192
FT                   /note="For GATase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00605,
FT                   ECO:0000269|PubMed:23816837"
FT   BINDING         337
FT                   /note="Substrate"
FT   BINDING         522
FT                   /note="Substrate"
FT   BINDING         610
FT                   /note="Substrate"
FT   BINDING         685
FT                   /note="Substrate"
FT   BINDING         691
FT                   /note="Substrate"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         8
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         9
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         318
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         10..108
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_053933"
FT   CONFLICT        261
FT                   /note="N -> D (in Ref. 2; BAG63519)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        415
FT                   /note="H -> I (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          28..32
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   TURN            35..38
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   HELIX           39..47
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          52..54
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   HELIX           61..67
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          70..76
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   HELIX           91..94
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          100..104
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   HELIX           105..113
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          118..123
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          127..133
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   HELIX           138..140
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          145..151
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          153..159
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          165..170
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          173..179
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   TURN            180..183
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          184..189
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   STRAND          193..196
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           199..207
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   TURN            208..211
FT                   /evidence="ECO:0000244|PDB:2VPI"
FT   HELIX           219..234
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          238..242
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           247..259
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           262..264
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          265..271
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           281..289
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          294..298
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           300..304
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           327..329
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           333..354
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          361..365
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           377..382
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           387..389
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           396..403
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           410..413
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           416..425
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           430..433
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           442..446
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          450..452
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           459..470
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           472..475
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           481..489
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           492..504
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          507..520
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          523..536
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           540..553
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          557..563
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           582..601
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           605..607
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          613..617
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           624..626
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          633..637
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          643..649
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   TURN            654..656
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   HELIX           659..671
FT                   /evidence="ECO:0000244|PDB:2VXO"
FT   STRAND          675..681
FT                   /evidence="ECO:0000244|PDB:2VXO"
SQ   SEQUENCE   693 AA;  76715 MW;  1CDA0DD3B244728D CRC64;
     MALCNGDSKL ENAGGDLKDG HHHYEGAVVI LDAGAQYGKV IDRRVRELFV QSEIFPLETP
     AFAIKEQGFR AIIISGGPNS VYAEDAPWFD PAIFTIGKPV LGICYGMQMM NKVFGGTVHK
     KSVREDGVFN ISVDNTCSLF RGLQKEEVVL LTHGDSVDKV ADGFKVVARS GNIVAGIANE
     SKKLYGAQFH PEVGLTENGK VILKNFLYDI AGCSGTFTVQ NRELECIREI KERVGTSKVL
     VLLSGGVDST VCTALLNRAL NQEQVIAVHI DNGFMRKRES QSVEEALKKL GIQVKVINAA
     HSFYNGTTTL PISDEDRTPR KRISKTLNMT TSPEEKRKII GDTFVKIANE VIGEMNLKPE
     EVFLAQGTLR PDLIESASLV ASGKAELIKT HHNDTELIRK LREEGKVIEP LKDFHKDEVR
     ILGRELGLPE ELVSRHPFPG PGLAIRVICA EEPYICKDFP ETNNILKIVA DFSASVKKPH
     TLLQRVKACT TEEDQEKLMQ ITSLHSLNAF LLPIKTVGVQ GDCRSYSYVC GISSKDEPDW
     ESLIFLARLI PRMCHNVNRV VYIFGPPVKE PPTDVTPTFL TTGVLSTLRQ ADFEAHNILR
     ESGYAGKISQ MPVILTPLHF DRDPLQKQPS CQRSVVIRTF ITSDFMTGIP ATPGNEIPVE
     VVLKMVTEIK KIPGISRIMY DLTSKPPGTT EWE
//
ID   JAZF1_HUMAN             Reviewed;         243 AA.
AC   Q86VZ6; A4D195; Q8N3L7;
DT   11-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2003, sequence version 2.
DT   22-APR-2020, entry version 152.
DE   RecName: Full=Juxtaposed with another zinc finger protein 1;
DE   AltName: Full=TAK1-interacting protein 27;
DE   AltName: Full=Zinc finger protein 802;
GN   Name=JAZF1; Synonyms=TIP27, ZNF802;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH NR2C2,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF LYS-47;
RP   TYR-60; ALA-69 AND LEU-76.
RX   PubMed=15302918; DOI=10.1093/nar/gkh741;
RA   Nakajima T., Fujino S., Nakanishi G., Kim Y.S., Jetten A.M.;
RT   "TIP27: a novel repressor of the nuclear orphan receptor TAK1/TR4.";
RL   Nucleic Acids Res. 32:4194-4204(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH SUZ12.
RX   PubMed=11371647; DOI=10.1073/pnas.101132598;
RA   Koontz J.I., Soreng A.L., Nucci M., Kuo F.C., Pauwels P.,
RA   van Den Berghe H., Cin P.D., Fletcher J.A., Sklar J.;
RT   "Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal
RT   tumors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:6348-6353(2001).
RN   [7]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH PHF1.
RX   PubMed=16397222; DOI=10.1158/0008-5472.can-05-2485;
RA   Micci F., Panagopoulos I., Bjerkehagen B., Heim S.;
RT   "Consistent rearrangement of chromosomal band 6p21 with generation of
RT   fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma.";
RL   Cancer Res. 66:107-112(2006).
RN   [8]
RP   TRANS-SPLICING.
RX   PubMed=18772439; DOI=10.1126/science.1156725;
RA   Li H., Wang J., Mor G., Sklar J.;
RT   "A neoplastic gene fusion mimics trans-splicing of RNAs in normal human
RT   cells.";
RL   Science 321:1357-1361(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-113, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Acts as a transcriptional corepressor of orphan nuclear
CC       receptor NR2C2 (PubMed:15302918). Inhibits expression of the
CC       gluconeogenesis enzyme PCK2 through inhibition of NR2C2 activity (By
CC       similarity). Also involved in transcriptional activation of NAMPT by
CC       promoting expression of PPARA and PPARD (By similarity). Plays a role
CC       in lipid metabolism by suppressing lipogenesis, increasing lipolysis
CC       and decreasing lipid accumulation in adipose tissue (By similarity).
CC       Plays a role in glucose homeostasis by improving glucose metabolism and
CC       insulin sensitivity (By similarity). {ECO:0000250|UniProtKB:Q80ZQ5,
CC       ECO:0000269|PubMed:15302918}.
CC   -!- SUBUNIT: Interacts with NR2C2 (via ligand-binding region).
CC       {ECO:0000269|PubMed:15302918}.
CC   -!- INTERACTION:
CC       Q86VZ6; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-11023753, EBI-10175124;
CC       Q86VZ6; P49116: NR2C2; NbExp=6; IntAct=EBI-11023753, EBI-2652582;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15302918}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86VZ6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86VZ6-2; Sequence=VSP_007755;
CC   -!- TISSUE SPECIFICITY: Highest expression in testis with moderate levels
CC       in colon, placenta, prostate and ovary and low levels in brain, spleen,
CC       liver and small intestine. {ECO:0000269|PubMed:15302918}.
CC   -!- DISEASE: Note=A chromosomal aberration involving JAZF1 may be a cause
CC       of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with
CC       SUZ12. The translocation generates the JAZF1-SUZ12 oncogene consisting
CC       of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is
CC       frequently found in all cases of endometrial stromal tumors, except in
CC       endometrial stromal sarcomas, where it is rarer. Translocation
CC       t(6;7)(p21;p22) with PHF1. {ECO:0000269|PubMed:11371647,
CC       ECO:0000269|PubMed:16397222}.
CC   -!- MISCELLANEOUS: Under hypoxic conditions, the precursor SUZ12 RNA
CC       undergoes regulated trans-splicing with the JAZF1 RNA, resulting in a
CC       chimeric isoform which may be protective against apoptosis. The
CC       chimeric transcript is characterized by JAZF1 exons 1-3 joined to SUZ12
CC       exon 2-16. The chimeric transcript is expressed primarily in the
CC       endometrium from late secretory and early proliferative phases of the
CC       menstrual cycle, but not in normal myometrium at any phase of the
CC       cycle. Its expression is slightly induced by low levels of
CC       progesterone, but suppressed by both estrogen and high levels of
CC       progesterone (PubMed:18772439). {ECO:0000305|PubMed:18772439}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Incomplete sequence. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/JAZF1ID41036ch7p15.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY372319; AAQ74874.1; -; mRNA.
DR   EMBL; AK091311; BAG52333.1; -; mRNA.
DR   EMBL; CH236948; EAL24212.1; -; Genomic_DNA.
DR   EMBL; BC042441; AAH42441.1; -; mRNA.
DR   EMBL; AL834234; CAD38912.1; -; mRNA.
DR   CCDS; CCDS5416.1; -. [Q86VZ6-1]
DR   RefSeq; NP_778231.2; NM_175061.3. [Q86VZ6-1]
DR   BioGrid; 128764; 13.
DR   IntAct; Q86VZ6; 10.
DR   STRING; 9606.ENSP00000283928; -.
DR   iPTMnet; Q86VZ6; -.
DR   PhosphoSitePlus; Q86VZ6; -.
DR   BioMuta; JAZF1; -.
DR   DMDM; 32699538; -.
DR   EPD; Q86VZ6; -.
DR   jPOST; Q86VZ6; -.
DR   MassIVE; Q86VZ6; -.
DR   MaxQB; Q86VZ6; -.
DR   PaxDb; Q86VZ6; -.
DR   PeptideAtlas; Q86VZ6; -.
DR   PRIDE; Q86VZ6; -.
DR   ProteomicsDB; 70098; -. [Q86VZ6-1]
DR   ProteomicsDB; 70099; -. [Q86VZ6-2]
DR   Antibodypedia; 26034; 113 antibodies.
DR   DNASU; 221895; -.
DR   Ensembl; ENST00000283928; ENSP00000283928; ENSG00000153814. [Q86VZ6-1]
DR   GeneID; 221895; -.
DR   KEGG; hsa:221895; -.
DR   UCSC; uc003szn.4; human. [Q86VZ6-1]
DR   CTD; 221895; -.
DR   DisGeNET; 221895; -.
DR   GeneCards; JAZF1; -.
DR   HGNC; HGNC:28917; JAZF1.
DR   HPA; ENSG00000153814; Low tissue specificity.
DR   MalaCards; JAZF1; -.
DR   MIM; 606246; gene.
DR   neXtProt; NX_Q86VZ6; -.
DR   OpenTargets; ENSG00000153814; -.
DR   Orphanet; 213711; Endometrial stromal sarcoma.
DR   Orphanet; 536; Systemic lupus erythematosus.
DR   PharmGKB; PA162392484; -.
DR   eggNOG; KOG4124; Eukaryota.
DR   eggNOG; COG5189; LUCA.
DR   GeneTree; ENSGT00390000003635; -.
DR   HOGENOM; CLU_077501_0_0_1; -.
DR   InParanoid; Q86VZ6; -.
DR   KO; K19495; -.
DR   OMA; QHIEDNH; -.
DR   OrthoDB; 1617085at2759; -.
DR   PhylomeDB; Q86VZ6; -.
DR   TreeFam; TF324161; -.
DR   SIGNOR; Q86VZ6; -.
DR   ChiTaRS; JAZF1; human.
DR   GeneWiki; JAZF1; -.
DR   GenomeRNAi; 221895; -.
DR   Pharos; Q86VZ6; Tbio.
DR   PRO; PR:Q86VZ6; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q86VZ6; protein.
DR   Bgee; ENSG00000153814; Expressed in trabecular bone tissue and 196 other tissues.
DR   ExpressionAtlas; Q86VZ6; baseline and differential.
DR   Genevisible; Q86VZ6; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0017053; C:transcriptional repressor complex; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:MGI.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00355; ZnF_C2H2; 3.
DR   SUPFAM; SSF57667; SSF57667; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Lipid metabolism;
KW   Metal-binding; Nucleus; Phosphoprotein; Proto-oncogene; Reference proteome;
KW   Repeat; Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..243
FT                   /note="Juxtaposed with another zinc finger protein 1"
FT                   /id="PRO_0000046985"
FT   ZN_FING         12..37
FT                   /note="C2H2-type 1"
FT   ZN_FING         173..198
FT                   /note="C2H2-type 2"
FT   ZN_FING         208..230
FT                   /note="C2H2-type 3; degenerate"
FT   REGION          39..79
FT                   /note="Required for interaction with NR2C2"
FT                   /evidence="ECO:0000269|PubMed:15302918"
FT   SITE            129..130
FT                   /note="Breakpoint for translocation to form JAZF1-SUZ12
FT                   oncogene"
FT   MOD_RES         109
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80ZQ5"
FT   MOD_RES         113
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..38
FT                   /note="MTGIAAASFFSNTCRFGGCGLHFPTLADLIEHIEDNHI -> YFVLGSLIYS
FT                   DAKSKKNRNCVFIT (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_007755"
FT   MUTAGEN         47
FT                   /note="K->P: Little effect on interaction with NR2C2."
FT                   /evidence="ECO:0000269|PubMed:15302918"
FT   MUTAGEN         60
FT                   /note="Y->D: Abolishes interaction with NR2C2."
FT                   /evidence="ECO:0000269|PubMed:15302918"
FT   MUTAGEN         69
FT                   /note="A->P: Little effect on interaction with NR2C2."
FT                   /evidence="ECO:0000269|PubMed:15302918"
FT   MUTAGEN         76
FT                   /note="L->P: Reduces interaction with NR2C2."
FT                   /evidence="ECO:0000269|PubMed:15302918"
FT   CONFLICT        133
FT                   /note="D -> G (in Ref. 4; AAH42441)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   243 AA;  27079 MW;  878A6EE3D82C0588 CRC64;
     MTGIAAASFF SNTCRFGGCG LHFPTLADLI EHIEDNHIDT DPRVLEKQEL QQPTYVALSY
     INRFMTDAAR REQESLKKKI QPKLSLTLSS SVSRGNVSTP PRHSSGSLTP PVTPPITPSS
     SFRSSTPTGS EYDEEEVDYE ESDSDESWTT ESAISSEAIL SSMCMNGGEE KPFACPVPGC
     KKRYKNVNGI KYHAKNGHRT QIRVRKPFKC RCGKSYKTAQ GLRHHTINFH PPVSAEIIRK
     MQQ
//
ID   K1549_HUMAN             Reviewed;        1950 AA.
AC   Q9HCM3; B6HY55; B6HY56; B6HY58; B6HY60; B6HY61; B6HY62; B6HY63; B6HY64;
AC   B6HY65; B6HY66; Q5BJD6; Q8IY15; Q9H0M3;
DT   01-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 4.
DT   22-APR-2020, entry version 123.
DE   RecName: Full=UPF0606 protein KIAA1549;
GN   Name=KIAA1549;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2; 3 AND 4), DISEASE,
RP   AND CHROMOSOMAL REARRANGEMENT.
RC   TISSUE=Brain;
RX   PubMed=18974108; DOI=10.1158/0008-5472.can-08-2097;
RA   Jones D.T.W., Kocialkowski S., Liu L., Pearson D.M., Backlund L.M.,
RA   Ichimura K., Collins V.P.;
RT   "Tandem duplication producing a novel oncogenic BRAF fusion gene defines
RT   the majority of pilocytic astrocytomas.";
RL   Cancer Res. 68:8673-8677(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 70-1950 (ISOFORM 2), AND VARIANT
RP   LEU-652.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1128-1950 (ISOFORM 1).
RC   TISSUE=Brain, and Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1811-1950 (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1395, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   GLYCOSYLATION.
RX   PubMed=28512129; DOI=10.1074/jbc.m117.794487;
RA   Larsen I.S.B., Narimatsu Y., Joshi H.J., Yang Z., Harrison O.J., Brasch J.,
RA   Shapiro L., Honig B., Vakhrushev S.Y., Clausen H., Halim A.;
RT   "Mammalian O-mannosylation of cadherins and plexins is independent of
RT   protein O-mannosyltransferases 1 and 2.";
RL   J. Biol. Chem. 292:11586-11598(2017).
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=v2 long-form;
CC         IsoId=Q9HCM3-1; Sequence=Displayed;
CC       Name=2; Synonyms=v1 long-form;
CC         IsoId=Q9HCM3-2; Sequence=VSP_034448;
CC       Name=3; Synonyms=v1 short-form;
CC         IsoId=Q9HCM3-3; Sequence=VSP_040885, VSP_040886, VSP_034448;
CC       Name=4; Synonyms=v2 short-form;
CC         IsoId=Q9HCM3-4; Sequence=VSP_040885, VSP_040886;
CC   -!- PTM: O-glycosylated. O-mannosylated by POMT1 and POMT2 and elongated by
CC       POMGNT1. {ECO:0000269|PubMed:28512129}.
CC   -!- DISEASE: Note=A chromosomal aberration involving KIAA1549 is found in
CC       pilocytic astrocytoma. A tandem duplication of 2 Mb at 7q34 leads to
CC       the expression of a KIAA1549-BRAF fusion protein with a constitutive
CC       kinase activity and inducing cell transformation.
CC       {ECO:0000269|PubMed:18974108}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Produced by alternative promoter usage.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Produced by alternative promoter usage.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the UPF0606 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH38232.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AM989467; CAQ43105.1; -; Genomic_DNA.
DR   EMBL; AM989467; CAQ43106.1; -; Genomic_DNA.
DR   EMBL; AM989468; CAQ43107.1; -; mRNA.
DR   EMBL; AM989469; CAQ43108.1; -; mRNA.
DR   EMBL; AM989470; CAQ43109.1; -; mRNA.
DR   EMBL; AM989471; CAQ43110.1; -; mRNA.
DR   EMBL; AM989472; CAQ43111.1; ALT_TERM; mRNA.
DR   EMBL; AM989473; CAQ43112.1; ALT_TERM; mRNA.
DR   EMBL; AM989474; CAQ43113.1; ALT_TERM; mRNA.
DR   EMBL; AM989475; CAQ43114.1; ALT_TERM; mRNA.
DR   EMBL; AM989476; CAQ43115.1; ALT_TERM; mRNA.
DR   EMBL; AM989477; CAQ43116.1; ALT_TERM; mRNA.
DR   EMBL; AC018663; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083868; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093144; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB046769; BAB13375.2; -; mRNA.
DR   EMBL; BC038232; AAH38232.1; ALT_INIT; mRNA.
DR   EMBL; BC091523; AAH91523.1; -; mRNA.
DR   EMBL; AL136736; CAB66670.2; -; mRNA.
DR   CCDS; CCDS47723.2; -. [Q9HCM3-2]
DR   CCDS; CCDS56513.1; -. [Q9HCM3-1]
DR   RefSeq; NP_001158137.1; NM_001164665.1. [Q9HCM3-1]
DR   RefSeq; NP_065961.2; NM_020910.2. [Q9HCM3-2]
DR   BioGrid; 121702; 28.
DR   IntAct; Q9HCM3; 20.
DR   MINT; Q9HCM3; -.
DR   STRING; 9606.ENSP00000416040; -.
DR   iPTMnet; Q9HCM3; -.
DR   PhosphoSitePlus; Q9HCM3; -.
DR   BioMuta; KIAA1549; -.
DR   DMDM; 327478603; -.
DR   jPOST; Q9HCM3; -.
DR   MassIVE; Q9HCM3; -.
DR   MaxQB; Q9HCM3; -.
DR   PaxDb; Q9HCM3; -.
DR   PeptideAtlas; Q9HCM3; -.
DR   PRIDE; Q9HCM3; -.
DR   ProteomicsDB; 81759; -. [Q9HCM3-1]
DR   ProteomicsDB; 81760; -. [Q9HCM3-2]
DR   ProteomicsDB; 81761; -. [Q9HCM3-3]
DR   ProteomicsDB; 81762; -. [Q9HCM3-4]
DR   Antibodypedia; 9863; 24 antibodies.
DR   Ensembl; ENST00000422774; ENSP00000416040; ENSG00000122778. [Q9HCM3-1]
DR   Ensembl; ENST00000440172; ENSP00000406661; ENSG00000122778. [Q9HCM3-2]
DR   GeneID; 57670; -.
DR   KEGG; hsa:57670; -.
DR   UCSC; uc011kqj.3; human. [Q9HCM3-1]
DR   CTD; 57670; -.
DR   DisGeNET; 57670; -.
DR   GeneCards; KIAA1549; -.
DR   HGNC; HGNC:22219; KIAA1549.
DR   HPA; ENSG00000122778; Tissue enhanced (ductus deferens, seminal vesicle).
DR   MalaCards; KIAA1549; -.
DR   MIM; 613344; gene.
DR   neXtProt; NX_Q9HCM3; -.
DR   OpenTargets; ENSG00000122778; -.
DR   Orphanet; 251615; Pilomyxoid astrocytoma.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA162393138; -.
DR   eggNOG; ENOG410IFU4; Eukaryota.
DR   eggNOG; ENOG410XX42; LUCA.
DR   GeneTree; ENSGT00530000063472; -.
DR   HOGENOM; CLU_002218_0_0_1; -.
DR   InParanoid; Q9HCM3; -.
DR   OMA; MWRRATI; -.
DR   OrthoDB; 33154at2759; -.
DR   PhylomeDB; Q9HCM3; -.
DR   TreeFam; TF332690; -.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   ChiTaRS; KIAA1549; human.
DR   GenomeRNAi; 57670; -.
DR   Pharos; Q9HCM3; Tbio.
DR   PRO; PR:Q9HCM3; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q9HCM3; protein.
DR   Bgee; ENSG00000122778; Expressed in neocortex and 159 other tissues.
DR   Genevisible; Q9HCM3; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   InterPro; IPR024606; DUF3827.
DR   PANTHER; PTHR21590; PTHR21590; 1.
DR   Pfam; PF12877; DUF3827; 1.
PE   1: Evidence at protein level;
KW   Alternative promoter usage; Alternative splicing;
KW   Chromosomal rearrangement; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..1950
FT                   /note="UPF0606 protein KIAA1549"
FT                   /id="PRO_0000342405"
FT   TRANSMEM        998..1018
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1299..1319
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        494..764
FT                   /note="Ser-rich"
FT   SITE            1643..1644
FT                   /note="Breakpoint for translocation to form KIAA1549-BRAF
FT                   fusion protein"
FT   SITE            1749..1750
FT                   /note="Breakpoint for translocation to form KIAA1549-BRAF
FT                   fusion protein"
FT   MOD_RES         1388
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD9"
FT   MOD_RES         1395
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983"
FT   MOD_RES         1554
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD9"
FT   MOD_RES         1555
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD9"
FT   MOD_RES         1622
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD9"
FT   MOD_RES         1624
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD9"
FT   VAR_SEQ         1..1216
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:18974108"
FT                   /id="VSP_040885"
FT   VAR_SEQ         1217..1222
FT                   /note="AGNSVV -> MVSAIF (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:18974108"
FT                   /id="VSP_040886"
FT   VAR_SEQ         1867..1882
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10997877,
FT                   ECO:0000303|PubMed:11230166, ECO:0000303|PubMed:18974108"
FT                   /id="VSP_034448"
FT   VARIANT         448
FT                   /note="A -> P (in dbSNP:rs2718131)"
FT                   /id="VAR_044187"
FT   VARIANT         652
FT                   /note="P -> L (in dbSNP:rs2774960)"
FT                   /evidence="ECO:0000269|PubMed:10997877"
FT                   /id="VAR_057812"
FT   VARIANT         851
FT                   /note="V -> G (in dbSNP:rs2354336)"
FT                   /id="VAR_044188"
FT   CONFLICT        486
FT                   /note="P -> A (in Ref. 3; BAB13375)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        617
FT                   /note="R -> G (in Ref. 3; BAB13375)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        849
FT                   /note="S -> L (in Ref. 3; BAB13375)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1950 AA;  210755 MW;  3F7FD3A94CE4EE93 CRC64;
     MPGARRRRRG AAMEGKPRAG VALAPGPSGR RPSARCARRR RPGLLLPGLW LLLLARPASC
     APDELSPEQH NLSLYSMELV LKKSTGHSAA QVALTETAPG SQHSSPLHVT APPSATTFDT
     AFFNQGKQTK STADPSIFVA TYVSVTSKEV AVNDDEMDNF LPDTHWTTPR MVSPIQYITV
     SPPGLPREAL EPMLTPSLPM VSLQDEEVTS GWQNTTRQPA AYAESASHFH TFRSAFRTSE
     GIVPTPGRNL VLYPTDAYSH LSSRTLPEIV ASLTEGVETT LFLSSRSLMP QPLGDGITIP
     LPSLGEVSQP PEEVWATSAD RYTDVTTVLS QSLEETISPR TYPTVTASHA ALAFSRTHSP
     LLSTPLAFAS SASPTDVSSN PFLPSDSSKT SELHSNSALP GPVDNTHILS PVSSFRPYTW
     CAACTVPSPQ QVLATSLMEK DVGSGDGAET LCMTVLEESS ISLMSSVVAD FSEFEEDPQV
     FNTLFPSRPI VPLSSRSMEI SETSVGISAE VDMSSVTTTQ VPPAHGRLSV PASLDPTAGS
     LSVAETQVTP SSVTTAFFSV ITSILLDSSF SVIANKNTPS LAVRDPSVFT PYSLVPSVES
     SLFSDQERSS FSEHKPRGAL DFASSFFSTP PLELSGSISS PSEAPASLSL MPSDLSPFTS
     QSFSPLVETF TLFDSSDLQS SQLSLPSSTN LEFSQLQPSS ELPLNTIMLL PSRSEVSPWS
     SFPSDSLEFV EASTVSLTDS EAHFTSAFIE TTSYLESSLI SHESAVTALV PPGSESFDIL
     TAGIQATSPL TTVHTTPILT ESSLFSTLTP PDDQISALDG HVSVLASFSK AIPTGTVLIT
     DAYLPSGSSF VSEATPFPLP TELTVVGPSL TPTEVPLNTS TEVSTTSTGA ATGGPLDSTL
     MGDAASQSPP ESSAAPPLPS LRPVTAFTLE ATVDTPTLAT AKPPYVCDIT VPDAYLITTV
     LARRAVQEYI ITAIKEVLRI HFNRAVELKV YELFTDFTFL VTSGPFVYTA ISVINVLINS
     KLVRDQTPLI LSVKPSFLVP ESRFQVQTVL QFVPPSVDTG FCNFTQRIEK GLMTALFEVR
     KHHQGTYNLT VQILNITISS SRVTPRRGPV NIIFAVKSTQ GFLNGSEVSE LLRNLSVVEF
     SFYLGYPVLQ IAEPFQYPQL NLSQLLKSSW VRTVLLGVME KQLQNEVFQA EMERKLAQLL
     SEVSTRRRMW RRATVAAGNS VVQVVNVSRL EGDDNPVQLI YFVEDQDGER LSAVKSSDLI
     NKMDLQRAAI ILGYRIQGVI AQPVDRVKRP SPESQSNNLW VIVGVVIPVL VVMVIVVILY
     WKLCRTDKLD FQPDTVANIQ QRQKLQIPSV KGFDFAKQHL GQHNKDDILI IHEPAPLPGP
     LKDHTTPSEN GDVPSPKSKI PSKNVRHRGR VSPSDADSTV SEESSERDAG DKTPGAVNDG
     RSHRAPQSGP PLPSSGNEQH SSASIFEHVD RISRPPEASR RVPSKIQLIA MQPIPAPPVQ
     RPSPADRVAE SNKINKEIQT ALRHKSEIEH HRNKIRLRAK RRGHYEFPVV DDLSSGDTKE
     RHRVYRRAQM QIDKILDPTA SVPSVFIEPR KSSRIKRSPK PRRKHQVNGC PADAEKDRLI
     TTDSDGTYRR PPGVHNSAYI GCPSDPDLPA DVQTPSSVEL GRYPALPFPA SQYIPPQPSI
     EEARQTMHSL LDDAFALVAP SSQPASTAGV GPGVPPGLPA NSTPSQEERR ATQWGSFYSP
     AQTANNPCSR YEDYGMTPPT GPLPRPGFGP GLLQSTELVP PDPQQPQASA EAPFAARGIY
     SEEMPSVARP RPVGGTTGSQ IQHLTQVGIA SRIGAQPVEI PPSRGSQYGG PGWPSYGEDE
     AGRREATHML GHQEYSSSPL FQVPRTSGRE PSAPSGNLPH RGLQGPGLGY PTSSTEDLQP
     GHSSASLIKA IREELLRLSQ KQSTVQNFHS
//
ID   A0A024RDT4_HUMAN        Unreviewed;       627 AA.
AC   A0A024RDT4;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 41.
DE   SubName: Full=Lymphocyte cytosolic protein 1 (L-plastin), isoform CRA_a {ECO:0000313|EMBL:EAX08758.1};
GN   Name=LCP1 {ECO:0000313|EMBL:EAX08758.1};
GN   ORFNames=hCG_2020552 {ECO:0000313|EMBL:EAX08758.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX08758.1};
RN   [1] {ECO:0000313|EMBL:EAX08758.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX08758.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471075; EAX08758.1; -; Genomic_DNA.
DR   RefSeq; NP_002289.2; NM_002298.4.
DR   RefSeq; XP_005266431.1; XM_005266374.1.
DR   SMR; A0A024RDT4; -.
DR   PRIDE; A0A024RDT4; -.
DR   Antibodypedia; 9112; 362 antibodies.
DR   GeneID; 3936; -.
DR   KEGG; hsa:3936; -.
DR   CTD; 3936; -.
DR   EuPathDB; HostDB:ENSG00000136167.13; -.
DR   eggNOG; KOG0046; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   HOGENOM; CLU_015284_2_0_1; -.
DR   KO; K17276; -.
DR   OMA; MVRWAND; -.
DR   OrthoDB; 312506at2759; -.
DR   PhylomeDB; A0A024RDT4; -.
DR   ChiTaRS; LCP1; human.
DR   GenomeRNAi; 3936; -.
DR   Bgee; ENSG00000136167; Expressed in blood and 175 other tissues.
DR   ExpressionAtlas; A0A024RDT4; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005884; C:actin filament; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001891; C:phagocytic cup; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0001726; C:ruffle; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0051017; P:actin filament bundle assembly; IEA:Ensembl.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   CDD; cd00014; CH; 2.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 1.10.418.10; -; 4.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR039959; Fimbrin/Plastin.
DR   InterPro; IPR039956; PLS2/3.
DR   PANTHER; PTHR19961; PTHR19961; 1.
DR   PANTHER; PTHR19961:SF32; PTHR19961:SF32; 1.
DR   Pfam; PF00307; CH; 4.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00033; CH; 4.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 2.
DR   PROSITE; PS50021; CH; 4.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   4: Predicted;
KW   Actin-binding {ECO:0000256|SAAS:SAAS00782879};
KW   Calcium {ECO:0000256|PROSITE-ProRule:PRU00448};
KW   Repeat {ECO:0000256|SAAS:SAAS00782917}.
FT   DOMAIN          9..44
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000259|PROSITE:PS50222"
FT   DOMAIN          49..84
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000259|PROSITE:PS50222"
FT   DOMAIN          120..236
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000259|PROSITE:PS50021"
FT   DOMAIN          264..375
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000259|PROSITE:PS50021"
FT   DOMAIN          394..503
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000259|PROSITE:PS50021"
FT   DOMAIN          515..624
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000259|PROSITE:PS50021"
FT   CA_BIND         22..33
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00448"
FT   CA_BIND         62..73
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00448"
SQ   SEQUENCE   627 AA;  70288 MW;  668E4AA6A3FC7B58 CRC64;
     MARGSVSDEE MMELREAFAK VDTDGNGYIS FNELNDLFKA ACLPLPGYRV REITENLMAT
     GDLDQDGRIS FDEFIKIFHG LKSTDVAKTF RKAINKKEGI CAIGGTSEQS SVGTQHSYSE
     EEKYAFVNWI NKALENDPDC RHVIPMNPNT NDLFNAVGDG IVLCKMINLS VPDTIDERTI
     NKKKLTPFTI QENLNLALNS ASAIGCHVVN IGAEDLKEGK PYLVLGLLWQ VIKIGLFADI
     ELSRNEALIA LLREGESLED LMKLSPEELL LRWANYHLEN AGCNKIGNFS TDIKDSKAYY
     HLLEQVAPKG DEEGVPAVVI DMSGLREKDD IQRAECMLQQ AERLGCRQFV TATDVVRGNP
     KLNLAFIANL FNRYPALHKP ENQDIDWGAL EGETREERTF RNWMNSLGVN PRVNHLYSDL
     SDALVIFQLY EKIKVPVDWN RVNKPPYPKL GGNMKKLENC NYAVELGKNQ AKFSLVGIGG
     QDLNEGNRTL TLALIWQLMR RYTLNILEEI GGGQKVNDDI IVNWVNETLR EAKKSSSISS
     FKDPKISTSL PVLDLIDAIQ PGSINYDLLK TENLNDDEKL NNAKYAISMA RKIGARVYAL
     PEDLVEVNPK MVMTVFACLM GKGMKRV
//
ID   PLSL_HUMAN              Reviewed;         627 AA.
AC   P13796; B2R613; B4DUA0; Q5TBN4;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 6.
DT   22-APR-2020, entry version 224.
DE   RecName: Full=Plastin-2;
DE   AltName: Full=L-plastin;
DE   AltName: Full=LC64P;
DE   AltName: Full=Lymphocyte cytosolic protein 1;
DE            Short=LCP-1;
GN   Name=LCP1; Synonyms=PLS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLU-533.
RX   PubMed=2252891; DOI=10.1021/bi00488a017;
RA   Zu Y., Shigesada K., Nishida E., Kubota I., Kohno M., Hanaoka M., Namba Y.;
RT   "65-kilodalton protein phosphorylated by interleukin 2 stimulation bears
RT   two putative actin-binding sites and two calcium-binding sites.";
RL   Biochemistry 29:8319-8324(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   GLU-533.
RC   TISSUE=Amygdala, and Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLU-533.
RC   TISSUE=Lymph, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 58-627 (ISOFORM 1), PARTIAL PROTEIN SEQUENCE,
RP   AND VARIANT GLU-533.
RX   PubMed=3211125; DOI=10.1128/mcb.8.11.4659;
RA   Lin C.-S., Aebersold R.H., Kent S.B., Varma M., Leavitt J.;
RT   "Molecular cloning and characterization of plastin, a human leukocyte
RT   protein expressed in transformed human fibroblasts.";
RL   Mol. Cell. Biol. 8:4659-4668(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-140 (ISOFORM 1), AND SEQUENCE REVISION.
RX   PubMed=2378651; DOI=10.1128/mcb.10.4.1818;
RA   Lin C.-S., Aebersold R.H., Leavitt J.;
RT   "Correction of the N-terminal sequences of the human plastin isoforms by
RT   using anchored polymerase chain reaction: identification of a potential
RT   calcium-binding domain.";
RL   Mol. Cell. Biol. 10:1818-1821(1990).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-14; 20-31; 184-192 AND 534-541, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=T-cell;
RA   Bienvenut W.V., Kanor S., Tissot J.-D., Quadroni M.;
RL   Submitted (MAY-2006) to UniProtKB.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 585-627.
RX   PubMed=8428952;
RA   Lin C.-S., Park T., Chen Z.P., Leavitt J.;
RT   "Human plastin genes. Comparative gene structure, chromosome location, and
RT   differential expression in normal and neoplastic cells.";
RL   J. Biol. Chem. 268:2781-2792(1993).
RN   [10]
RP   PROTEIN SEQUENCE OF 264-283; 517-533 AND 593-609, AND VARIANT GLU-533.
RX   PubMed=2111166; DOI=10.1021/bi00456a030;
RA   Zu Y., Kohno M., Kubota I., Nishida E., Hanaoka M., Namba Y.;
RT   "Characterization of interleukin 2 stimulated 65-kilodalton phosphoprotein
RT   in human T cells.";
RL   Biochemistry 29:1055-1062(1990).
RN   [11]
RP   PROTEIN SEQUENCE OF 590-611, AND TISSUE SPECIFICITY.
RX   PubMed=3261603; DOI=10.1021/bi00410a037;
RA   Matsushima K., Shiroo M., Kung H.F., Copeland T.D.;
RT   "Purification and characterization of a cytosolic 65-kilodalton
RT   phosphoprotein in human leukocytes whose phosphorylation is augmented by
RT   stimulation with interleukin 1.";
RL   Biochemistry 27:3765-3770(1988).
RN   [12]
RP   INVOLVEMENT IN B-CELL NON-HODGKIN LYMPHOMA, AND CHROMOSOMAL TRANSLOCATION
RP   WITH BCL6.
RX   PubMed=10469447;
RX   DOI=10.1002/(sici)1098-2264(199910)26:2<97::aid-gcc1>3.0.co;2-9;
RA   Galiegue-Zouitina S., Quief S., Hildebrand M.P., Denis C.,
RA   Detourmignies L., Lai J.L., Kerckaert J.P.;
RT   "Nonrandom fusion of L-plastin(LCP1) and LAZ3(BCL6) genes by
RT   t(3;13)(q27;q14) chromosome translocation in two cases of B-cell non-
RT   Hodgkin lymphoma.";
RL   Genes Chromosomes Cancer 26:97-105(1999).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-124, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [15]
RP   FUNCTION, ACTIN-BINDING, INTERACTION WITH ACTIN FIBERS, SUBCELLULAR
RP   LOCATION, MUTAGENESIS OF SER-5, AND PHOSPHORYLATION AT SER-5.
RX   PubMed=16636079; DOI=10.1242/jcs.02874;
RA   Janji B., Giganti A., De Corte V., Catillon M., Bruyneel E., Lentz D.,
RA   Plastino J., Gettemans J., Friederich E.;
RT   "Phosphorylation on Ser5 increases the F-actin-binding activity of L-
RT   plastin and promotes its targeting to sites of actin assembly in cells.";
RL   J. Cell Sci. 119:1947-1960(2006).
RN   [16]
RP   SUBCELLULAR LOCATION, FUNCTION, MUTAGENESIS OF SER-5, PHOSPHORYLATION AT
RP   SER-5, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17294403; DOI=10.1002/eji.200636320;
RA   Wabnitz G.H., Koecher T., Lohneis P., Stober C., Konstandin M.H., Funk B.,
RA   Sester U., Wilm M., Klemke M., Samstag Y.;
RT   "Costimulation induced phosphorylation of L-plastin facilitates surface
RT   transport of the T cell activation molecules CD69 and CD25.";
RL   Eur. J. Immunol. 37:649-662(2007).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; TYR-28; SER-30; SER-257
RP   AND SER-323, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-76; LYS-88; LYS-294; LYS-297;
RP   LYS-361; LYS-472; LYS-542 AND LYS-579, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-257; SER-290; THR-291;
RP   THR-353; SER-406 AND SER-474, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [25]
RP   STRUCTURE BY NMR OF 513-627.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the fourth CH domain from human L-plastin.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [26]
RP   VARIANT SER-608, CHARACTERIZATION OF VARIANT SER-608, FUNCTION, AND
RP   INTERACTION WITH ACTIN.
RX   PubMed=28493397; DOI=10.1002/humu.23246;
RG   UK10K;
RA   Rainger J., Williamson K.A., Soares D.C., Truch J., Kurian D.,
RA   Gillessen-Kaesbach G., Seawright A., Prendergast J., Halachev M.,
RA   Wheeler A., McTeir L., Gill A.C., van Heyningen V., Davey M.G.,
RA   FitzPatrick D.R.;
RT   "A recurrent de novo mutation in ACTG1 causes isolated ocular coloboma.";
RL   Hum. Mutat. 38:942-946(2017).
CC   -!- FUNCTION: Actin-binding protein (PubMed:16636079, PubMed:17294403,
CC       PubMed:28493397). Plays a role in the activation of T-cells in response
CC       to costimulation through TCR/CD3 and CD2 or CD28 (PubMed:17294403).
CC       Modulates the cell surface expression of IL2RA/CD25 and CD69
CC       (PubMed:17294403). {ECO:0000269|PubMed:16636079,
CC       ECO:0000269|PubMed:17294403, ECO:0000269|PubMed:28493397}.
CC   -!- SUBUNIT: Monomer. Interacts with AIF1 (By similarity). Interacts with
CC       actin (PubMed:28493397). {ECO:0000250|UniProtKB:Q61233,
CC       ECO:0000269|PubMed:16636079, ECO:0000269|PubMed:28493397}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:16636079}. Cell junction
CC       {ECO:0000269|PubMed:17294403}. Cell projection
CC       {ECO:0000269|PubMed:16636079}. Cell projection, ruffle membrane
CC       {ECO:0000250|UniProtKB:Q61233, ECO:0000269|PubMed:16636079}; Peripheral
CC       membrane protein {ECO:0000250|UniProtKB:Q61233}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q61233}. Note=Relocalizes to the immunological
CC       synapse between peripheral blood T-lymphocytes and antibody-presenting
CC       cells in response to costimulation through TCR/CD3 and CD2 or CD28
CC       (PubMed:17294403). Associated with the actin cytoskeleton at membrane
CC       ruffles. Relocalizes to actin-rich cell projections upon serine
CC       phosphorylation (PubMed:16636079). {ECO:0000250|UniProtKB:Q61233,
CC       ECO:0000269|PubMed:16636079, ECO:0000269|PubMed:17294403}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P13796-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13796-2; Sequence=VSP_056450, VSP_056451;
CC   -!- TISSUE SPECIFICITY: Detected in intestinal microvilli, hair cell
CC       stereocilia, and fibroblast filopodia, in spleen and other lymph node-
CC       containing organs. Expressed in peripheral blood T-lymphocytes,
CC       neutrophils, monocytes, B-lymphocytes, and myeloid cells.
CC       {ECO:0000269|PubMed:3261603}.
CC   -!- PTM: Phosphorylated on a serine residue in response to costimulation
CC       through TCR/CD3 and CD2 or CD28. Serine phosphorylation promotes
CC       association with the actin cytoskeleton and targeting to peripheral
CC       cell projections. {ECO:0000269|PubMed:16636079,
CC       ECO:0000269|PubMed:17294403}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving LCP1 is a cause of B-
CC       cell non-Hodgkin lymphomas (B-cell NHL). Translocation
CC       t(3;13)(q27;q14), with BCL6. {ECO:0000269|PubMed:10469447}.
CC   -!- DISEASE: Note=Defects in LCP1 has been found in a patient with isolated
CC       coloboma, a defect of the eye characterized by the absence of ocular
CC       structures due to abnormal morphogenesis of the optic cup and stalk,
CC       and the fusion of the fetal fissure (optic fissure). Isolated colobomas
CC       may be associated with an abnormally small eye (microphthalmia) or
CC       small cornea. {ECO:0000269|PubMed:28493397}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/LCP1ID95.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02923; AAA63236.1; -; mRNA.
DR   EMBL; AK300556; BAG62262.1; -; mRNA.
DR   EMBL; AK312393; BAG35310.1; -; mRNA.
DR   EMBL; AL137141; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08757.1; -; Genomic_DNA.
DR   EMBL; BC007673; AAH07673.1; -; mRNA.
DR   EMBL; BC010271; AAH10271.1; -; mRNA.
DR   EMBL; M22300; AAB02845.1; -; mRNA.
DR   EMBL; AH002870; AAA59529.1; -; Genomic_DNA.
DR   EMBL; M34426; AAA36184.1; -; mRNA.
DR   CCDS; CCDS9403.1; -. [P13796-1]
DR   PIR; A35836; A35836.
DR   RefSeq; NP_002289.2; NM_002298.4. [P13796-1]
DR   RefSeq; XP_005266431.1; XM_005266374.1. [P13796-1]
DR   PDB; 2D85; NMR; -; A=517-627.
DR   PDB; 5JOJ; NMR; -; A=1-97.
DR   PDB; 5JOL; NMR; -; A=1-82.
DR   PDBsum; 2D85; -.
DR   PDBsum; 5JOJ; -.
DR   PDBsum; 5JOL; -.
DR   SMR; P13796; -.
DR   BioGrid; 110128; 37.
DR   DIP; DIP-34767N; -.
DR   ELM; P13796; -.
DR   IntAct; P13796; 16.
DR   MINT; P13796; -.
DR   STRING; 9606.ENSP00000381581; -.
DR   iPTMnet; P13796; -.
DR   MetOSite; P13796; -.
DR   PhosphoSitePlus; P13796; -.
DR   SwissPalm; P13796; -.
DR   BioMuta; LCP1; -.
DR   DMDM; 308153685; -.
DR   CPTAC; CPTAC-88; -.
DR   CPTAC; CPTAC-89; -.
DR   EPD; P13796; -.
DR   jPOST; P13796; -.
DR   MassIVE; P13796; -.
DR   MaxQB; P13796; -.
DR   PaxDb; P13796; -.
DR   PeptideAtlas; P13796; -.
DR   PRIDE; P13796; -.
DR   ProteomicsDB; 5167; -.
DR   ProteomicsDB; 52986; -. [P13796-1]
DR   Antibodypedia; 9112; 362 antibodies.
DR   DNASU; 3936; -.
DR   Ensembl; ENST00000323076; ENSP00000315757; ENSG00000136167. [P13796-1]
DR   Ensembl; ENST00000398576; ENSP00000381581; ENSG00000136167. [P13796-1]
DR   GeneID; 3936; -.
DR   KEGG; hsa:3936; -.
DR   UCSC; uc001vba.5; human. [P13796-1]
DR   CTD; 3936; -.
DR   DisGeNET; 3936; -.
DR   GeneCards; LCP1; -.
DR   HGNC; HGNC:6528; LCP1.
DR   HPA; ENSG00000136167; Tissue enhanced (blood, lymphoid tissue).
DR   MIM; 153430; gene.
DR   neXtProt; NX_P13796; -.
DR   OpenTargets; ENSG00000136167; -.
DR   PharmGKB; PA30312; -.
DR   eggNOG; KOG0046; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00950000183097; -.
DR   HOGENOM; CLU_015284_2_0_1; -.
DR   InParanoid; P13796; -.
DR   KO; K17276; -.
DR   OMA; MVRWAND; -.
DR   PhylomeDB; P13796; -.
DR   TreeFam; TF300680; -.
DR   Reactome; R-HSA-8950505; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation.
DR   SIGNOR; P13796; -.
DR   ChiTaRS; LCP1; human.
DR   EvolutionaryTrace; P13796; -.
DR   GeneWiki; LCP1; -.
DR   GenomeRNAi; 3936; -.
DR   Pharos; P13796; Tbio.
DR   PRO; PR:P13796; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; P13796; protein.
DR   Bgee; ENSG00000136167; Expressed in blood and 175 other tissues.
DR   ExpressionAtlas; P13796; baseline and differential.
DR   Genevisible; P13796; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005884; C:actin filament; IMP:UniProtKB.
DR   GO; GO:0032432; C:actin filament bundle; IMP:UniProtKB.
DR   GO; GO:0030054; C:cell junction; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IMP:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IMP:UniProtKB.
DR   GO; GO:0001891; C:phagocytic cup; ISS:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0002102; C:podosome; IDA:UniProtKB.
DR   GO; GO:0001726; C:ruffle; IMP:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003779; F:actin binding; NAS:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IMP:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; NAS:UniProtKB.
DR   GO; GO:0051020; F:GTPase binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0005178; F:integrin binding; IPI:ARUK-UCL.
DR   GO; GO:0051017; P:actin filament bundle assembly; IMP:UniProtKB.
DR   GO; GO:0051639; P:actin filament network formation; IBA:GO_Central.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0022617; P:extracellular matrix disassembly; IMP:UniProtKB.
DR   GO; GO:0035722; P:interleukin-12-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0071803; P:positive regulation of podosome assembly; IMP:UniProtKB.
DR   GO; GO:0010737; P:protein kinase A signaling; IMP:UniProtKB.
DR   GO; GO:0033157; P:regulation of intracellular protein transport; IDA:UniProtKB.
DR   GO; GO:0002286; P:T cell activation involved in immune response; IDA:UniProtKB.
DR   CDD; cd00014; CH; 2.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 1.10.418.10; -; 4.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR039959; Fimbrin/Plastin.
DR   InterPro; IPR039956; PLS2/3.
DR   PANTHER; PTHR19961; PTHR19961; 1.
DR   PANTHER; PTHR19961:SF32; PTHR19961:SF32; 1.
DR   Pfam; PF00307; CH; 4.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00033; CH; 4.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS00019; ACTININ_1; 2.
DR   PROSITE; PS00020; ACTININ_2; 2.
DR   PROSITE; PS50021; CH; 4.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing; Calcium;
KW   Cell junction; Cell membrane; Cell projection; Chromosomal rearrangement;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; Disease mutation;
KW   Membrane; Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.8"
FT   CHAIN           2..627
FT                   /note="Plastin-2"
FT                   /id="PRO_0000073743"
FT   DOMAIN          9..44
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          49..84
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          120..236
FT                   /note="Calponin-homology (CH) 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          264..375
FT                   /note="Calponin-homology (CH) 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          394..503
FT                   /note="Calponin-homology (CH) 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          515..624
FT                   /note="Calponin-homology (CH) 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   CA_BIND         22..33
FT                   /note="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   CA_BIND         62..73
FT                   /note="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          106..379
FT                   /note="Actin-binding 1"
FT   REGION          380..624
FT                   /note="Actin-binding 2"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.8"
FT   MOD_RES         5
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:16636079,
FT                   ECO:0000269|PubMed:17294403"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         28
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         76
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         88
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         124
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:15592455"
FT   MOD_RES         257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         291
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         294
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         297
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         353
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         361
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         406
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         472
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         474
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         542
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         579
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   VAR_SEQ         1..25
FT                   /note="MARGSVSDEEMMELREAFAKVDTDG -> MCAEDGDSKFSMSISMNSPFLEI
FT                   LH (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056450"
FT   VAR_SEQ         26..456
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056451"
FT   VARIANT         24
FT                   /note="D -> E"
FT                   /id="VAR_001371"
FT   VARIANT         533
FT                   /note="K -> E (in dbSNP:rs4941543)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2111166,
FT                   ECO:0000269|PubMed:2252891, ECO:0000269|PubMed:3211125"
FT                   /id="VAR_024398"
FT   VARIANT         544
FT                   /note="P -> A (in dbSNP:rs17067725)"
FT                   /id="VAR_030826"
FT   VARIANT         608
FT                   /note="N -> S (found in a patient with isolated coloboma;
FT                   increases interaction with actin)"
FT                   /evidence="ECO:0000269|PubMed:28493397"
FT                   /id="VAR_079850"
FT   MUTAGEN         5
FT                   /note="S->A: Abolishes phosphorylation and reduces the cell
FT                   surface expression of CD69 and IL2RA. Reduces association
FT                   with the actin cytoskeleton."
FT                   /evidence="ECO:0000269|PubMed:16636079,
FT                   ECO:0000269|PubMed:17294403"
FT   MUTAGEN         5
FT                   /note="S->E: Promotes association with the actin
FT                   cytoskeleton."
FT                   /evidence="ECO:0000269|PubMed:16636079,
FT                   ECO:0000269|PubMed:17294403"
FT   CONFLICT        611
FT                   /note="M -> T (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   HELIX           8..21
FT                   /evidence="ECO:0000244|PDB:5JOJ"
FT   STRAND          27..29
FT                   /evidence="ECO:0000244|PDB:5JOJ"
FT   HELIX           31..40
FT                   /evidence="ECO:0000244|PDB:5JOJ"
FT   HELIX           47..59
FT                   /evidence="ECO:0000244|PDB:5JOJ"
FT   STRAND          61..63
FT                   /evidence="ECO:0000244|PDB:5JOL"
FT   TURN            64..66
FT                   /evidence="ECO:0000244|PDB:5JOL"
FT   HELIX           71..80
FT                   /evidence="ECO:0000244|PDB:5JOJ"
FT   HELIX           85..94
FT                   /evidence="ECO:0000244|PDB:5JOJ"
FT   HELIX           520..532
FT                   /evidence="ECO:0000244|PDB:2D85"
FT   HELIX           545..548
FT                   /evidence="ECO:0000244|PDB:2D85"
FT   HELIX           550..559
FT                   /evidence="ECO:0000244|PDB:2D85"
FT   TURN            566..568
FT                   /evidence="ECO:0000244|PDB:2D85"
FT   HELIX           576..593
FT                   /evidence="ECO:0000244|PDB:2D85"
FT   HELIX           601..604
FT                   /evidence="ECO:0000244|PDB:2D85"
FT   TURN            605..607
FT                   /evidence="ECO:0000244|PDB:2D85"
FT   HELIX           609..612
FT                   /evidence="ECO:0000244|PDB:2D85"
FT   HELIX           615..620
FT                   /evidence="ECO:0000244|PDB:2D85"
FT   TURN            621..623
FT                   /evidence="ECO:0000244|PDB:2D85"
SQ   SEQUENCE   627 AA;  70288 MW;  668E4AA6A3FC7B58 CRC64;
     MARGSVSDEE MMELREAFAK VDTDGNGYIS FNELNDLFKA ACLPLPGYRV REITENLMAT
     GDLDQDGRIS FDEFIKIFHG LKSTDVAKTF RKAINKKEGI CAIGGTSEQS SVGTQHSYSE
     EEKYAFVNWI NKALENDPDC RHVIPMNPNT NDLFNAVGDG IVLCKMINLS VPDTIDERTI
     NKKKLTPFTI QENLNLALNS ASAIGCHVVN IGAEDLKEGK PYLVLGLLWQ VIKIGLFADI
     ELSRNEALIA LLREGESLED LMKLSPEELL LRWANYHLEN AGCNKIGNFS TDIKDSKAYY
     HLLEQVAPKG DEEGVPAVVI DMSGLREKDD IQRAECMLQQ AERLGCRQFV TATDVVRGNP
     KLNLAFIANL FNRYPALHKP ENQDIDWGAL EGETREERTF RNWMNSLGVN PRVNHLYSDL
     SDALVIFQLY EKIKVPVDWN RVNKPPYPKL GGNMKKLENC NYAVELGKNQ AKFSLVGIGG
     QDLNEGNRTL TLALIWQLMR RYTLNILEEI GGGQKVNDDI IVNWVNETLR EAKKSSSISS
     FKDPKISTSL PVLDLIDAIQ PGSINYDLLK TENLNDDEKL NNAKYAISMA RKIGARVYAL
     PEDLVEVNPK MVMTVFACLM GKGMKRV
//
ID   A0A024RDR1_HUMAN        Unreviewed;       200 AA.
AC   A0A024RDR1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 32.
DE   SubName: Full=Lipoma HMGIC fusion partner, isoform CRA_a {ECO:0000313|EMBL:EAX08617.1};
GN   Name=LHFP {ECO:0000313|EMBL:EAX08617.1};
GN   ORFNames=hCG_32195 {ECO:0000313|EMBL:EAX08617.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX08617.1};
RN   [1] {ECO:0000313|EMBL:EAX08617.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX08617.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471075; EAX08617.1; -; Genomic_DNA.
DR   RefSeq; NP_005771.1; NM_005780.2.
DR   RefSeq; XP_011533163.1; XM_011534861.1.
DR   PRIDE; A0A024RDR1; -.
DR   Antibodypedia; 67484; 84 antibodies.
DR   GeneID; 10186; -.
DR   KEGG; hsa:10186; -.
DR   CTD; 10186; -.
DR   EuPathDB; HostDB:ENSG00000183722.7; -.
DR   eggNOG; KOG4026; Eukaryota.
DR   eggNOG; ENOG410XSUB; LUCA.
DR   HOGENOM; CLU_084868_2_0_1; -.
DR   KO; K23893; -.
DR   OMA; CEIGWAF; -.
DR   OrthoDB; 1383327at2759; -.
DR   PhylomeDB; A0A024RDR1; -.
DR   ChiTaRS; LHFPL6; human.
DR   GenomeRNAi; 10186; -.
DR   Bgee; ENSG00000183722; Expressed in female reproductive system and 230 other tissues.
DR   ExpressionAtlas; A0A024RDR1; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR019372; LHFPL.
DR   PANTHER; PTHR12489; PTHR12489; 1.
DR   Pfam; PF10242; L_HMGIC_fpl; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           22..200
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5001536767"
FT   TRANSMEM        87..108
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        120..141
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        168..190
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
SQ   SEQUENCE   200 AA;  21598 MW;  49D1161602966423 CRC64;
     MASSLTCTGV IWALLSFLCA ATSCVGFFMP YWLWGSQLGK PVSFGTFRRC SYPVHDESRQ
     MMVMVEECGR YASFQGIPSA EWRICTIVTG LGCGLLLLVA LTALMGCCVS DLISRTVGRV
     AGGIQFLGGL LIGAGCALYP LGWDSEEVRQ TCGYTSGQFD LGKCEIGWAY YCTGAGATAA
     MLLCTWLACF SGKKQKHYPY
//
ID   LHPL6_HUMAN             Reviewed;         200 AA.
AC   Q9Y693; B2R7M2; Q53FC0; Q96SH5;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-APR-2020, entry version 133.
DE   RecName: Full=LHFPL tetraspan subfamily member 6 protein {ECO:0000312|HGNC:HGNC:6586};
DE   AltName: Full=Lipoma HMGIC fusion partner {ECO:0000312|HGNC:HGNC:6586};
DE   Flags: Precursor;
GN   Name=LHFPL6 {ECO:0000312|HGNC:HGNC:6586};
GN   Synonyms=LHFP {ECO:0000312|HGNC:HGNC:6586};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DISEASE.
RX   PubMed=10329012; DOI=10.1006/geno.1999.5778;
RA   Petit M.M.R., Schoenmakers E.F.P.M., Huysmans C., Geurts J.M.W.,
RA   Mandahl N., Van de Ven W.J.M.;
RT   "LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member
RT   of a new family of LHFP-like genes.";
RL   Genomics 57:438-441(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 141-200.
RC   TISSUE=Dermoid cancer;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Pancreas, kidney, skeletal muscle, liver, lung
CC       brain, heart, colon, small intestine, uterus, testis, prostate, thymus,
CC       spleen and placenta. {ECO:0000269|PubMed:10329012}.
CC   -!- DISEASE: Note=A chromosomal aberration involving LHFP is associated
CC       with a subclass of benign mesenchymal tumors known as lipomas.
CC       Translocation t(12;13)(q13-q15;q12) with HMGA2 is shown in lipomas.
CC       {ECO:0000269|PubMed:10329012}.
CC   -!- SIMILARITY: Belongs to the LHFP family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/LHFPID248ch13q12.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF098807; AAD31386.1; -; mRNA.
DR   EMBL; AL138685; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136358; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158194; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08616.1; -; Genomic_DNA.
DR   EMBL; BC017824; AAH17824.1; -; mRNA.
DR   EMBL; AK223369; BAD97089.1; -; mRNA.
DR   EMBL; AK313036; BAG35869.1; -; mRNA.
DR   CCDS; CCDS9369.1; -.
DR   RefSeq; NP_005771.1; NM_005780.2.
DR   RefSeq; XP_011533163.1; XM_011534861.1.
DR   STRING; 9606.ENSP00000368908; -.
DR   TCDB; 1.A.82.1.6; the lhfpl tetraspan protein (ltsp) family.
DR   iPTMnet; Q9Y693; -.
DR   PhosphoSitePlus; Q9Y693; -.
DR   SwissPalm; Q9Y693; -.
DR   BioMuta; LHFPL6; -.
DR   DMDM; 74753519; -.
DR   jPOST; Q9Y693; -.
DR   MassIVE; Q9Y693; -.
DR   MaxQB; Q9Y693; -.
DR   PaxDb; Q9Y693; -.
DR   PeptideAtlas; Q9Y693; -.
DR   PRIDE; Q9Y693; -.
DR   ProteomicsDB; 86627; -.
DR   Antibodypedia; 67484; 84 antibodies.
DR   DNASU; 10186; -.
DR   Ensembl; ENST00000379589; ENSP00000368908; ENSG00000183722.
DR   Ensembl; ENST00000648377; ENSP00000496801; ENSG00000183722.
DR   GeneID; 10186; -.
DR   KEGG; hsa:10186; -.
DR   UCSC; uc001uxf.4; human.
DR   CTD; 10186; -.
DR   DisGeNET; 10186; -.
DR   GeneCards; LHFPL6; -.
DR   HGNC; HGNC:6586; LHFPL6.
DR   HPA; ENSG00000183722; Low tissue specificity.
DR   MIM; 606710; gene.
DR   neXtProt; NX_Q9Y693; -.
DR   OpenTargets; ENSG00000183722; -.
DR   PharmGKB; PA30358; -.
DR   eggNOG; KOG4026; Eukaryota.
DR   eggNOG; ENOG410XSUB; LUCA.
DR   GeneTree; ENSGT00950000182669; -.
DR   HOGENOM; CLU_084868_2_0_1; -.
DR   InParanoid; Q9Y693; -.
DR   KO; K23893; -.
DR   OMA; CEIGWAF; -.
DR   OrthoDB; 1383327at2759; -.
DR   PhylomeDB; Q9Y693; -.
DR   TreeFam; TF321143; -.
DR   ChiTaRS; LHFPL6; human.
DR   GeneWiki; LHFP; -.
DR   GenomeRNAi; 10186; -.
DR   Pharos; Q9Y693; Tdark.
DR   PRO; PR:Q9Y693; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9Y693; protein.
DR   Bgee; ENSG00000183722; Expressed in female reproductive system and 230 other tissues.
DR   ExpressionAtlas; Q9Y693; baseline and differential.
DR   Genevisible; Q9Y693; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR019372; LHFPL.
DR   PANTHER; PTHR12489; PTHR12489; 1.
DR   Pfam; PF10242; L_HMGIC_fpl; 1.
PE   2: Evidence at transcript level;
KW   Chromosomal rearrangement; Membrane; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..200
FT                   /note="LHFPL tetraspan subfamily member 6 protein"
FT                   /id="PRO_0000244756"
FT   TRANSMEM        84..104
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        123..143
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        166..186
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   200 AA;  21598 MW;  49D1161602966423 CRC64;
     MASSLTCTGV IWALLSFLCA ATSCVGFFMP YWLWGSQLGK PVSFGTFRRC SYPVHDESRQ
     MMVMVEECGR YASFQGIPSA EWRICTIVTG LGCGLLLLVA LTALMGCCVS DLISRTVGRV
     AGGIQFLGGL LIGAGCALYP LGWDSEEVRQ TCGYTSGQFD LGKCEIGWAY YCTGAGATAA
     MLLCTWLACF SGKKQKHYPY
//
ID   LS14A_HUMAN             Reviewed;         463 AA.
AC   Q8ND56; B4DTG6; Q76LX7; Q96AR3; Q96K73; Q96SN5; Q9UFR3;
DT   02-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2005, sequence version 3.
DT   22-APR-2020, entry version 155.
DE   RecName: Full=Protein LSM14 homolog A;
DE   AltName: Full=Protein FAM61A;
DE   AltName: Full=Protein SCD6 homolog;
DE   AltName: Full=Putative alpha-synuclein-binding protein;
DE            Short=AlphaSNBP;
DE   AltName: Full=RNA-associated protein 55A;
DE            Short=hRAP55;
DE            Short=hRAP55A;
GN   Name=LSM14A; Synonyms=C19orf13, FAM61A, RAP55, RAP55A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Takeda K., Araki W., Tabira T.;
RT   "Possible alpha synuclein binding protein.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   GLN-238.
RC   TISSUE=Mammary gland, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLN-238.
RC   TISSUE=Brain, and Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17074753; DOI=10.1074/jbc.m609059200;
RA   Tanaka K.J., Ogawa K., Takagi M., Imamoto N., Matsumoto K., Tsujimoto M.;
RT   "RAP55, a cytoplasmic mRNP component, represses translation in Xenopus
RT   oocytes.";
RL   J. Biol. Chem. 281:40096-40106(2006).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=16484376; DOI=10.1261/rna.2302706;
RA   Yang W.H., Yu J.H., Gulick T., Bloch K.D., Bloch D.B.;
RT   "RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and
RT   stress granules.";
RL   RNA 12:547-554(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-182; SER-183; SER-192;
RP   THR-194 AND SER-216, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   REVIEW.
RX   PubMed=18723115; DOI=10.1016/j.biocel.2008.06.015;
RA   Marnef A., Sommerville J., Ladomery M.R.;
RT   "RAP55: insights into an evolutionarily conserved protein family.";
RL   Int. J. Biochem. Cell Biol. 41:977-981(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183; SER-192 AND SER-216, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-192 AND SER-216, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; SER-183; SER-192;
RP   SER-216 AND SER-227, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Essential for formation of P-bodies, cytoplasmic structures
CC       that provide storage sites for non-translating mRNAs.
CC       {ECO:0000269|PubMed:16484376, ECO:0000269|PubMed:17074753}.
CC   -!- SUBUNIT: Component of a ribonucleoprotein (RNP) complex. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:16484376,
CC       ECO:0000269|PubMed:17074753}. Cytoplasm, Stress granule
CC       {ECO:0000269|PubMed:16484376}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=AlphaSNBP(A);
CC         IsoId=Q8ND56-1; Sequence=Displayed;
CC       Name=2; Synonyms=AlphaSNBP(B);
CC         IsoId=Q8ND56-2; Sequence=VSP_014650;
CC       Name=3;
CC         IsoId=Q8ND56-3; Sequence=VSP_057232;
CC   -!- DOMAIN: The LSM14 domain and the RGG repeats are required for
CC       accumulation in P-bodies, and the region containing the FDF motif is
CC       responsible for cytoplasmic retention. {ECO:0000269|PubMed:16484376}.
CC   -!- SIMILARITY: Belongs to the LSM14 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB55066.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB069974; BAC99045.1; -; mRNA.
DR   EMBL; AB069975; BAC99046.1; -; mRNA.
DR   EMBL; AK027369; BAB55066.1; ALT_INIT; mRNA.
DR   EMBL; AK027643; BAB55259.1; -; mRNA.
DR   EMBL; AK300208; BAG61978.1; -; mRNA.
DR   EMBL; AL834398; CAD39060.2; -; mRNA.
DR   EMBL; AL117499; CAB55964.1; -; mRNA.
DR   EMBL; AC010614; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016842; AAH16842.1; -; mRNA.
DR   CCDS; CCDS12435.1; -. [Q8ND56-2]
DR   CCDS; CCDS46040.1; -. [Q8ND56-1]
DR   PIR; T17274; T17274.
DR   RefSeq; NP_001107565.1; NM_001114093.1. [Q8ND56-1]
DR   RefSeq; NP_056393.2; NM_015578.2. [Q8ND56-2]
DR   PDB; 6F9W; X-ray; 2.62 A; A=1-84.
DR   PDBsum; 6F9W; -.
DR   SMR; Q8ND56; -.
DR   BioGrid; 117527; 49.
DR   IntAct; Q8ND56; 15.
DR   MINT; Q8ND56; -.
DR   STRING; 9606.ENSP00000446271; -.
DR   iPTMnet; Q8ND56; -.
DR   PhosphoSitePlus; Q8ND56; -.
DR   BioMuta; LSM14A; -.
DR   EPD; Q8ND56; -.
DR   jPOST; Q8ND56; -.
DR   MassIVE; Q8ND56; -.
DR   MaxQB; Q8ND56; -.
DR   PaxDb; Q8ND56; -.
DR   PeptideAtlas; Q8ND56; -.
DR   PRIDE; Q8ND56; -.
DR   ProteomicsDB; 5108; -.
DR   ProteomicsDB; 72979; -. [Q8ND56-1]
DR   ProteomicsDB; 72980; -. [Q8ND56-2]
DR   Antibodypedia; 47950; 155 antibodies.
DR   Ensembl; ENST00000433627; ENSP00000413964; ENSG00000257103. [Q8ND56-1]
DR   Ensembl; ENST00000540746; ENSP00000446451; ENSG00000257103. [Q8ND56-3]
DR   Ensembl; ENST00000544216; ENSP00000446271; ENSG00000257103. [Q8ND56-2]
DR   Ensembl; ENST00000570462; ENSP00000459843; ENSG00000262860. [Q8ND56-1]
DR   Ensembl; ENST00000575811; ENSP00000461225; ENSG00000262860. [Q8ND56-2]
DR   GeneID; 26065; -.
DR   KEGG; hsa:26065; -.
DR   UCSC; uc002nva.5; human. [Q8ND56-1]
DR   CTD; 26065; -.
DR   DisGeNET; 26065; -.
DR   GeneCards; LSM14A; -.
DR   HGNC; HGNC:24489; LSM14A.
DR   HPA; ENSG00000257103; Low tissue specificity.
DR   MIM; 610677; gene.
DR   neXtProt; NX_Q8ND56; -.
DR   OpenTargets; ENSG00000257103; -.
DR   PharmGKB; PA134989467; -.
DR   eggNOG; KOG1073; Eukaryota.
DR   eggNOG; ENOG41122RA; LUCA.
DR   GeneTree; ENSGT00940000154415; -.
DR   InParanoid; Q8ND56; -.
DR   KO; K18749; -.
DR   OMA; GNAMDNL; -.
DR   OrthoDB; 1569369at2759; -.
DR   PhylomeDB; Q8ND56; -.
DR   TreeFam; TF313514; -.
DR   ChiTaRS; LSM14A; human.
DR   GenomeRNAi; 26065; -.
DR   Pharos; Q8ND56; Tbio.
DR   PRO; PR:Q8ND56; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8ND56; protein.
DR   Bgee; ENSG00000257103; Expressed in female gonad and 235 other tissues.
DR   ExpressionAtlas; Q8ND56; baseline and differential.
DR   Genevisible; Q8ND56; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000932; C:P-body; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IEA:Ensembl.
DR   GO; GO:0003725; F:double-stranded RNA binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:Ensembl.
DR   GO; GO:0033962; P:cytoplasmic mRNA processing body assembly; IDA:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0006417; P:regulation of translation; IEA:UniProtKB-KW.
DR   GO; GO:0039529; P:RIG-I signaling pathway; IEA:Ensembl.
DR   CDD; cd01736; LSm14_N; 1.
DR   InterPro; IPR025762; DFDF.
DR   InterPro; IPR019050; FDF_dom.
DR   InterPro; IPR025761; FFD_box.
DR   InterPro; IPR025609; Lsm14-like_N.
DR   InterPro; IPR010920; LSM_dom_sf.
DR   InterPro; IPR025768; TFG_box.
DR   Pfam; PF09532; FDF; 1.
DR   Pfam; PF12701; LSM14; 1.
DR   SMART; SM01199; FDF; 1.
DR   SMART; SM01271; LSM14; 1.
DR   SUPFAM; SSF50182; SSF50182; 1.
DR   PROSITE; PS51512; DFDF; 1.
DR   PROSITE; PS51513; FFD; 1.
DR   PROSITE; PS51536; TFG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm;
KW   Developmental protein; Methylation; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repressor; Ribonucleoprotein; Translation regulation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895"
FT   CHAIN           2..463
FT                   /note="Protein LSM14 homolog A"
FT                   /id="PRO_0000187090"
FT   DOMAIN          284..320
FT                   /note="DFDF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00845"
FT   MOTIF           361..377
FT                   /note="FFD box"
FT   MOTIF           380..400
FT                   /note="TFG box"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895"
FT   MOD_RES         178
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         182
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         183
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         192
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         194
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:19367720, ECO:0000244|PubMed:19369195,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         227
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         401
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2F8"
FT   VAR_SEQ         139..179
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057232"
FT   VAR_SEQ         458..463
FT                   /note="TTAFGP -> DNKVAA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.1"
FT                   /id="VSP_014650"
FT   VARIANT         238
FT                   /note="R -> Q (in dbSNP:rs36006556)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17974005"
FT                   /id="VAR_057532"
FT   VARIANT         448
FT                   /note="R -> Q (in dbSNP:rs2274896)"
FT                   /id="VAR_022884"
FT   CONFLICT        17
FT                   /note="K -> Q (in Ref. 3; CAD39060)"
FT                   /evidence="ECO:0000305"
FT   STRAND          11..16
FT                   /evidence="ECO:0000244|PDB:6F9W"
FT   STRAND          21..30
FT                   /evidence="ECO:0000244|PDB:6F9W"
FT   TURN            31..34
FT                   /evidence="ECO:0000244|PDB:6F9W"
FT   STRAND          35..46
FT                   /evidence="ECO:0000244|PDB:6F9W"
FT   STRAND          61..68
FT                   /evidence="ECO:0000244|PDB:6F9W"
FT   HELIX           69..71
FT                   /evidence="ECO:0000244|PDB:6F9W"
FT   STRAND          72..77
FT                   /evidence="ECO:0000244|PDB:6F9W"
SQ   SEQUENCE   463 AA;  50530 MW;  703BE8E8C54799DF CRC64;
     MSGGTPYIGS KISLISKAEI RYEGILYTID TENSTVALAK VRSFGTEDRP TDRPIPPRDE
     VFEYIIFRGS DIKDLTVCEP PKPQCSLPQD PAIVQSSLGS STSSFQSMGS YGPFGRMPTY
     SQFSPSSLVG QQFGAVGVAG SSLTSFGTET SNSGTLPQSS AVGSAFTQDT RSLKTQLSQG
     RSSPQLDPLR KSPTMEQAVQ TASAHLPAPA AVGRRSPVST RPLPSASQKA GENQEHRRAE
     VHKVSRPENE QLRNDNKRQV APGAPSAPRR GRGGHRGGRG RFGIRRDGPM KFEKDFDFES
     ANAQFNKEEI DREFHNKLKL KEDKLEKQEK PVNGEDKGDS GVDTQNSEGN ADEEDPLGPN
     CYYDKTKSFF DNISCDDNRE RRPTWAEERR LNAETFGIPL RPNRGRGGYR GRGGLGFRGG
     RGRGGGRGGT FTAPRGFRGG FRGGRGGREF ADFEYRKTTA FGP
//
ID   MNX1_HUMAN              Reviewed;         401 AA.
AC   P50219; F5H401; Q9Y648;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 3.
DT   22-APR-2020, entry version 169.
DE   RecName: Full=Motor neuron and pancreas homeobox protein 1;
DE   AltName: Full=Homeobox protein HB9;
GN   Name=MNX1; Synonyms=HLXB9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=7914194;
RA   Harrison K.A., Druey K.M., Deguchi Y., Tuscano J.M., Kehrl J.H.;
RT   "A novel human homeobox gene distantly related to proboscipedia is
RT   expressed in lymphoid and pancreatic tissues.";
RL   J. Biol. Chem. 269:19968-19975(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-353 (ISOFORM 1).
RX   PubMed=10329000; DOI=10.1006/geno.1999.5796;
RA   Heus H.C., Hing A., van Baren M.J., Joosse M., Breedveld G.J., Wang J.C.,
RA   Burgess A., Donnis-Keller H., Berglund C., Zguricas J., Scherer S.W.,
RA   Rommens J.M., Oostra B.A., Heutink P.;
RT   "A physical and transcriptional map of the preaxial polydactyly locus on
RT   chromosome 7q36.";
RL   Genomics 57:342-351(1999).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77 AND SER-79, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   VARIANTS CURRAS SER-246 AND TRP-293.
RX   PubMed=10631160; DOI=10.1086/302723;
RA   Belloni E., Martucciello G., Verderio D., Ponti E., Seri M., Jasonni V.,
RA   Torre M., Ferrari M., Tsui L.-C., Scherer S.W.;
RT   "Involvement of the HLXB9 homeobox gene in Currarino syndrome.";
RL   Am. J. Hum. Genet. 66:312-319(2000).
RN   [8]
RP   VARIANTS CURRAS HIS-245; GLY-245; GLY-288; LEU-288; PRO-290; TRP-292 AND
RP   GLN-293.
RX   PubMed=10749657; DOI=10.1086/302899;
RA   Hagan D.M., Ross A.J., Strachan T., Lynch S.A., Ruiz-Perez V., Wang Y.M.,
RA   Scambler P., Custard E., Reardon W., Hassan S., Nixon P., Papapetrou C.,
RA   Winter R.M., Edwards Y., Morrison K., Barrow M., Cordier-Alex M.P.,
RA   Correia P., Galvin-Parton P.A., Gaskill S., Gaskin K.J., Garcia-Minaur S.,
RA   Gereige R., Hayward R., Homfray T., McKeown C., Murday V., Plauchu H.,
RA   Shannon N., Spitz L., Lindsay S.;
RT   "Mutation analysis and embryonic expression of the HLXB9 Currarino syndrome
RT   gene.";
RL   Am. J. Hum. Genet. 66:1504-1515(2000).
RN   [9]
RP   ERRATUM OF PUBMED:10749657.
RA   Hagan D.M., Ross A.J., Strachan T., Lynch S.A., Ruiz-Perez V., Wang Y.M.,
RA   Scambler P., Custard E., Reardon W., Hassan S., Nixon P., Papapetrou C.,
RA   Winter R.M., Edwards Y., Morrison K., Barrow M., Cordier-Alex M.P.,
RA   Correia P., Galvin-Parton P.A., Gaskill S., Gaskin K.J., Garcia-Minaur S.,
RA   Gereige R., Hayward R., Homfray T., McKeown C., Murday V., Plauchu H.,
RA   Shannon N., Spitz L., Lindsay S.;
RL   Am. J. Hum. Genet. 67:769-769(2000).
RN   [10]
RP   VARIANTS CURRAS TRP-243 AND GLY-288.
RX   PubMed=19853743; DOI=10.1016/j.jpedsurg.2009.03.039;
RA   Garcia-Barcelo M.M., Lui V.C., So M.T., Miao X., Leon T.Y., Yuan Z.W.,
RA   Ngan E.S., Ehsan T., Chung P.H., Khong P.L., Wong K.K., Tam P.K.;
RT   "MNX1 (HLXB9) mutations in Currarino patients.";
RL   J. Pediatr. Surg. 44:1892-1898(2009).
RN   [11]
RP   VARIANT CURRAS SER-289.
RX   PubMed=22820079; DOI=10.1016/j.gene.2012.06.096;
RA   Markljung E., Adamovic T., Cao J., Naji H., Kaiser S., Wester T.,
RA   Nordenskjold A.;
RT   "Novel mutations in the MNX1 gene in two families with Currarino syndrome
RT   and variable phenotype.";
RL   Gene 507:50-53(2012).
CC   -!- FUNCTION: Putative transcription factor involved in pancreas
CC       development and function.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P50219-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50219-2; Sequence=VSP_046773, VSP_046774;
CC   -!- TISSUE SPECIFICITY: Expressed in lymphoid and pancreatic tissues.
CC   -!- DISEASE: Currarino syndrome (CURRAS) [MIM:176450]: The triad of a
CC       presacral tumor, sacral agenesis and anorectal malformation constitutes
CC       the Currarino syndrome which is caused by dorsal-ventral patterning
CC       defects during embryonic development. The syndrome occurs in the
CC       majority of patients as an autosomal dominant trait.
CC       {ECO:0000269|PubMed:10631160, ECO:0000269|PubMed:10749657,
CC       ECO:0000269|PubMed:19853743, ECO:0000269|PubMed:22820079}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HLXB9ID393.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U07664; AAB60647.1; -; Genomic_DNA.
DR   EMBL; U07663; AAB60647.1; JOINED; Genomic_DNA.
DR   EMBL; AC006357; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AH007909; AAD41467.1; -; Genomic_DNA.
DR   CCDS; CCDS34788.1; -. [P50219-1]
DR   CCDS; CCDS55187.1; -. [P50219-2]
DR   RefSeq; NP_001158727.1; NM_001165255.1. [P50219-2]
DR   RefSeq; NP_005506.3; NM_005515.3. [P50219-1]
DR   SMR; P50219; -.
DR   BioGrid; 109355; 4.
DR   IntAct; P50219; 3.
DR   STRING; 9606.ENSP00000252971; -.
DR   iPTMnet; P50219; -.
DR   PhosphoSitePlus; P50219; -.
DR   BioMuta; MNX1; -.
DR   DMDM; 259016336; -.
DR   EPD; P50219; -.
DR   jPOST; P50219; -.
DR   MassIVE; P50219; -.
DR   MaxQB; P50219; -.
DR   PaxDb; P50219; -.
DR   PeptideAtlas; P50219; -.
DR   PRIDE; P50219; -.
DR   ProteomicsDB; 26426; -.
DR   ProteomicsDB; 56203; -. [P50219-1]
DR   Antibodypedia; 33173; 192 antibodies.
DR   DNASU; 3110; -.
DR   Ensembl; ENST00000252971; ENSP00000252971; ENSG00000130675. [P50219-1]
DR   Ensembl; ENST00000543409; ENSP00000438552; ENSG00000130675. [P50219-2]
DR   GeneID; 3110; -.
DR   KEGG; hsa:3110; -.
DR   UCSC; uc003wnc.1; human. [P50219-1]
DR   CTD; 3110; -.
DR   DisGeNET; 3110; -.
DR   GeneCards; MNX1; -.
DR   HGNC; HGNC:4979; MNX1.
DR   HPA; ENSG00000130675; Tissue enriched (pancreas).
DR   MalaCards; MNX1; -.
DR   MIM; 142994; gene.
DR   MIM; 176450; phenotype.
DR   neXtProt; NX_P50219; -.
DR   OpenTargets; ENSG00000130675; -.
DR   Orphanet; 1552; Currarino syndrome.
DR   PharmGKB; PA162396041; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00940000160059; -.
DR   HOGENOM; CLU_049543_4_0_1; -.
DR   InParanoid; P50219; -.
DR   KO; K08025; -.
DR   OMA; TCGLIPK; -.
DR   OrthoDB; 1327265at2759; -.
DR   PhylomeDB; P50219; -.
DR   TreeFam; TF351530; -.
DR   SIGNOR; P50219; -.
DR   GeneWiki; MNX1; -.
DR   GenomeRNAi; 3110; -.
DR   Pharos; P50219; Tbio.
DR   PRO; PR:P50219; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P50219; protein.
DR   Bgee; ENSG00000130675; Expressed in body of pancreas and 83 other tissues.
DR   ExpressionAtlas; P50219; baseline and differential.
DR   Genevisible; P50219; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0031018; P:endocrine pancreas development; IBA:GO_Central.
DR   GO; GO:0006959; P:humoral immune response; TAS:ProtInc.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0021520; P:spinal cord motor neuron cell fate specification; IBA:GO_Central.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR042768; MNX1/Ceh-12.
DR   PANTHER; PTHR24335; PTHR24335; 1.
DR   Pfam; PF00046; Homeodomain; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Disease mutation; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..401
FT                   /note="Motor neuron and pancreas homeobox protein 1"
FT                   /id="PRO_0000048905"
FT   DNA_BIND        241..300
FT                   /note="Homeobox"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108"
FT   COMPBIAS        35..38
FT                   /note="Poly-Ala"
FT   COMPBIAS        40..49
FT                   /note="Poly-Gly"
FT   COMPBIAS        98..112
FT                   /note="Poly-Gly"
FT   COMPBIAS        121..134
FT                   /note="Poly-Ala"
FT   COMPBIAS        168..176
FT                   /note="Poly-Ala"
FT   COMPBIAS        315..324
FT                   /note="Poly-Gly"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         77
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         79
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..212
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_046773"
FT   VAR_SEQ         213..231
FT                   /note="WLRASTAGMILPKMPDFNS -> MGGLSTVGACPGILGAQQA (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_046774"
FT   VARIANT         243
FT                   /note="R -> W (in CURRAS)"
FT                   /evidence="ECO:0000269|PubMed:19853743"
FT                   /id="VAR_068473"
FT   VARIANT         245
FT                   /note="R -> G (in CURRAS)"
FT                   /evidence="ECO:0000269|PubMed:10749657"
FT                   /id="VAR_017874"
FT   VARIANT         245
FT                   /note="R -> H (in CURRAS)"
FT                   /evidence="ECO:0000269|PubMed:10749657"
FT                   /id="VAR_017875"
FT   VARIANT         246
FT                   /note="T -> S (in CURRAS; dbSNP:rs121912548)"
FT                   /evidence="ECO:0000269|PubMed:10631160"
FT                   /id="VAR_017876"
FT   VARIANT         288
FT                   /note="W -> G (in CURRAS)"
FT                   /evidence="ECO:0000269|PubMed:10749657,
FT                   ECO:0000269|PubMed:19853743"
FT                   /id="VAR_017877"
FT   VARIANT         288
FT                   /note="W -> L (in CURRAS)"
FT                   /evidence="ECO:0000269|PubMed:10749657"
FT                   /id="VAR_017878"
FT   VARIANT         289
FT                   /note="F -> S (in CURRAS)"
FT                   /evidence="ECO:0000269|PubMed:22820079"
FT                   /id="VAR_068474"
FT   VARIANT         290
FT                   /note="Q -> P (in CURRAS)"
FT                   /evidence="ECO:0000269|PubMed:10749657"
FT                   /id="VAR_017879"
FT   VARIANT         292
FT                   /note="R -> W (in CURRAS)"
FT                   /evidence="ECO:0000269|PubMed:10749657"
FT                   /id="VAR_017880"
FT   VARIANT         293
FT                   /note="R -> Q (in CURRAS)"
FT                   /evidence="ECO:0000269|PubMed:10749657"
FT                   /id="VAR_017881"
FT   VARIANT         293
FT                   /note="R -> W (in CURRAS)"
FT                   /evidence="ECO:0000269|PubMed:10631160"
FT                   /id="VAR_017882"
FT   CONFLICT        10..37
FT                   /note="DALLAVDPPRAASAQSAPLALVTSLAAA -> EPCWRWTPHEPPLAERALAK
FT                   VTSPPVP (in Ref. 1; AAB60647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        121
FT                   /note="A -> AAA (in Ref. 1; AAB60647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        121
FT                   /note="A -> ARA (in Ref. 3; AAD41467)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        262
FT                   /note="L -> F (in Ref. 1; AAB60647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        340
FT                   /note="G -> R (in Ref. 1; AAB60647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        346..349
FT                   /note="RRLR -> PPA (in Ref. 1; AAB60647)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   401 AA;  40569 MW;  67527C8F789DFFDB CRC64;
     MEKSKNFRID ALLAVDPPRA ASAQSAPLAL VTSLAAAASG TGGGGGGGGA SGGTSGSCSP
     ASSEPPAAPA DRLRAESPSP PRLLAAHCAL LPKPGFLGAG GGGGGTGGGH GGPHHHAHPG
     AAAAAAAAAA AAAAGGLALG LHPGGAQGGA GLPAQAALYG HPVYGYSAAA AAAALAGQHP
     ALSYSYPQVQ GAHPAHPADP IKLGAGTFQL DQWLRASTAG MILPKMPDFN SQAQSNLLGK
     CRRPRTAFTS QQLLELEHQF KLNKYLSRPK RFEVATSLML TETQVKIWFQ NRRMKWKRSK
     KAKEQAAQEA EKQKGGGGGA GKGGAEEPGA EELLGPPAPG DKGSGRRLRD LRDSDPEEDE
     DEDDEDHFPY SNGASVHAAS SDCSSEDDSP PPRPSHQPAP Q
//
ID   A0A024RB41_HUMAN        Unreviewed;       215 AA.
AC   A0A024RB41;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 36.
DE   SubName: Full=HCG2016482, isoform CRA_b {ECO:0000313|EMBL:EAW96961.1};
GN   ORFNames=hCG_2016482 {ECO:0000313|EMBL:EAW96961.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW96961.1};
RN   [1] {ECO:0000313|EMBL:EAW96961.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW96961.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471054; EAW96961.1; -; Genomic_DNA.
DR   RefSeq; NP_001106672.1; NM_001113201.2.
DR   RefSeq; NP_001106673.1; NM_001113202.1.
DR   RefSeq; NP_001307122.1; NM_001320193.1.
DR   RefSeq; NP_005585.1; NM_005594.5.
DR   SMR; A0A024RB41; -.
DR   PRIDE; A0A024RB41; -.
DR   Antibodypedia; 28384; 84 antibodies.
DR   GeneID; 4666; -.
DR   KEGG; hsa:4666; -.
DR   CTD; 4666; -.
DR   EuPathDB; HostDB:ENSG00000196531.10; -.
DR   eggNOG; KOG2239; Eukaryota.
DR   eggNOG; COG1308; LUCA.
DR   HOGENOM; CLU_057806_1_2_1; -.
DR   KO; K03626; -.
DR   OrthoDB; 1331328at2759; -.
DR   PhylomeDB; A0A024RB41; -.
DR   GenomeRNAi; 4666; -.
DR   Bgee; ENSG00000196531; Expressed in testis and 240 other tissues.
DR   ExpressionAtlas; A0A024RB41; baseline and differential.
DR   GO; GO:0005854; C:nascent polypeptide-associated complex; IEA:InterPro.
DR   Gene3D; 2.20.70.30; -; 1.
DR   InterPro; IPR016641; EGD2/NACA.
DR   InterPro; IPR038187; NAC_A/B_dom_sf.
DR   InterPro; IPR002715; Nas_poly-pep-assoc_cplx_dom.
DR   PANTHER; PTHR21713; PTHR21713; 1.
DR   Pfam; PF01849; NAC; 1.
DR   PIRSF; PIRSF015901; NAC_alpha; 1.
DR   SMART; SM01407; NAC; 1.
DR   PROSITE; PS51151; NAC_AB; 1.
PE   4: Predicted;
FT   DOMAIN          70..135
FT                   /note="NAC-A/B"
FT                   /evidence="ECO:0000259|PROSITE:PS51151"
FT   REGION          1..81
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11..31
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        40..54
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        61..80
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   215 AA;  23384 MW;  05DC563A8BEF307C CRC64;
     MPGEATETVP ATEQELPQPQ AETGSGTESD SDESVPELEE QDSTQATTQQ AQLAAAAEID
     EEPVSKAKQS RSEKKARKAM SKLGLRQVTG VTRVTIRKSK NILFVITKPD VYKSPASDTY
     IVFGEAKIED LSQQAQLAAA EKFKVQGEAV SNIQENTQTP TVQEESEEEE VDETGVEVKD
     IELVMSQANV SRAKAVRALK NNSNDIVNAI MELTM
//
ID   NACA_HUMAN              Reviewed;         215 AA.
AC   Q13765; A8MTN7; B2R4P8; F8VU71; Q3KQV4; Q53A18; Q53G46;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-APR-2020, entry version 180.
DE   RecName: Full=Nascent polypeptide-associated complex subunit alpha;
DE            Short=NAC-alpha;
DE   AltName: Full=Alpha-NAC;
DE   AltName: Allergen=Hom s 2;
GN   Name=NACA; ORFNames=HSD48;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Neuroblastoma;
RX   PubMed=12209604; DOI=10.1002/ijc.10550;
RA   Behrends U., Jandl T., Golbeck A., Lechner B., Mueller-Weihrich S.,
RA   Schmid I., Till H., Berthold F., Voltz R., Mautner J.M.;
RT   "Novel products of the HuD, HuC, NNP-1 and alpha-internexin genes
RT   identified by autologous antibody screening of a pediatric neuroblastoma
RT   library.";
RL   Int. J. Cancer 100:669-677(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=15196207; DOI=10.1111/j.1365-2567.2004.01893.x;
RA   Al-Shanti N., Steward C.G., Garland R.J., Rowbottom A.W.;
RT   "Investigation of alpha nascent polypeptide-associated complex functions in
RT   a human CD8(+) T cell ex vivo expansion model using antisense
RT   oligonucleotides.";
RL   Immunology 112:397-403(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Sakai H., Chew C., Wang S., Wiedmann B., Geromanos S., Tempst P.,
RA   Wiedmann M.;
RT   "Nascent polypeptide-associate complex (NAC): a novel type of polypeptide
RT   binding protein.";
RL   Submitted (AUG-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for 300
RT   previously undefined genes expressed in CD34+ hematopoietic stem/progenitor
RT   cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-173 (ISOFORM 1).
RC   TISSUE=Testis;
RA   Yuan L.G., Tian Y.Q., Qiao Y., Miao S.Y., Wang L.F.;
RT   "A new spermatogenesis-related gene.";
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   PROTEIN SEQUENCE OF 101-142 AND 180-192, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [13]
RP   PROTEIN SEQUENCE OF 101-142; 145-192 AND 201-215, PHOSPHORYLATION AT
RP   SER-166, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [14]
RP   ALLERGEN.
RX   PubMed=9806765; DOI=10.1096/fasebj.12.14.1559;
RA   Natter S., Seiberler S., Hufnagl P., Binder B.R., Hirschl A.M., Ring J.,
RA   Abeck D., Schmidt T., Valent P., Valenta R.;
RT   "Isolation of cDNA clones coding for IgE autoantigens with serum IgE from
RT   atopic dermatitis patients.";
RL   FASEB J. 12:1559-1569(1998).
RN   [15]
RP   FUNCTION.
RX   PubMed=9877153; DOI=10.1016/s0014-5793(98)01440-9;
RA   Moeller I., Beatrix B., Kreibich G., Sakai H., Lauring B., Wiedmann M.;
RT   "Unregulated exposure of the ribosomal M-site caused by NAC depletion
RT   results in delivery of non-secretory polypeptides to the Sec61 complex.";
RL   FEBS Lett. 441:1-5(1998).
RN   [16]
RP   FUNCTION, INTERACTION WITH BTF3, ASSOCIATION WITH RIBOSOMES, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=10982809; DOI=10.1074/jbc.m006368200;
RA   Beatrix B., Sakai H., Wiedmann M.;
RT   "The alpha and beta subunit of the nascent polypeptide-associated complex
RT   have distinct functions.";
RL   J. Biol. Chem. 275:37838-37845(2000).
RN   [17]
RP   INTERACTION WITH FADD.
RX   PubMed=12684039; DOI=10.1016/s0006-291x(03)00487-x;
RA   Stilo R., Liguoro D., di Jeso B., Leonardi A., Vito P.;
RT   "The alpha-chain of the nascent polypeptide-associated complex binds to and
RT   regulates FADD function.";
RL   Biochem. Biophys. Res. Commun. 303:1034-1041(2003).
RN   [18]
RP   SUBCELLULAR LOCATION, AND POSSIBLE INVOLVEMENT IN OSTEOSARCOMA.
RX   PubMed=12689679; DOI=10.1016/s8756-3282(03)00026-7;
RA   Papachristou D.J., Batistatou A., Sykiotis G.P., Varakis I.,
RA   Papavassiliou A.G.;
RT   "Activation of the JNK-AP-1 signal transduction pathway is associated with
RT   pathogenesis and progression of human osteosarcomas.";
RL   Bone 32:364-371(2003).
RN   [19]
RP   PHOSPHORYLATION AT SER-43, AND SUBCELLULAR LOCATION.
RX   PubMed=15299025; DOI=10.1074/jbc.m406310200;
RA   Quelo I., Gauthier C., Hannigan G.E., Dedhar S., St-Arnaud R.;
RT   "Integrin-linked kinase regulates the nuclear entry of the c-Jun
RT   coactivator alpha-NAC and its coactivation potency.";
RL   J. Biol. Chem. 279:43893-43899(2004).
RN   [20]
RP   FUNCTION.
RX   PubMed=15784678; DOI=10.1242/jcs.02295;
RA   Lopez S., Stuhl L., Fichelson S., Dubart-Kupperschmitt A., St Arnaud R.,
RA   Galindo J.-R., Murati A., Berda N., Dubreuil P., Gomez S.;
RT   "NACA is a positive regulator of human erythroid-cell differentiation.";
RL   J. Cell Sci. 118:1595-1605(2005).
RN   [21]
RP   TISSUE SPECIFICITY.
RX   PubMed=16201836; DOI=10.1371/journal.pbio.0030357;
RA   Marques A.C., Dupanloup I., Vinckenbosch N., Reymond A., Kaessmann H.;
RT   "Emergence of young human genes after a burst of retroposition in
RT   primates.";
RL   PLoS Biol. 3:E357-E357(2005).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161; SER-166 AND SER-191, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-142, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186; SER-191 AND SER-203, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [35]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-142, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 84-136, SUBUNIT, DNA/RNA-BINDING
RP   REGION, AND SUBCELLULAR LOCATION.
RX   PubMed=20214399; DOI=10.1021/bi902050p;
RA   Liu Y., Hu Y., Li X., Niu L., Teng M.;
RT   "The crystal structure of the human nascent polypeptide-associated complex
RT   domain reveals a nucleic acid-binding region on the NACA subunit.";
RL   Biochemistry 49:2890-2896(2010).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 79-132, AND SUBUNIT.
RX   PubMed=21203952; DOI=10.1007/s13238-010-0049-3;
RA   Wang L., Zhang W., Wang L., Zhang X.C., Li X., Rao Z.;
RT   "Crystal structures of NAC domains of human nascent polypeptide-associated
RT   complex (NAC) and its alphaNAC subunit.";
RL   Protein Cell 1:406-416(2010).
CC   -!- FUNCTION: Prevents inappropriate targeting of non-secretory
CC       polypeptides to the endoplasmic reticulum (ER). Binds to nascent
CC       polypeptide chains as they emerge from the ribosome and blocks their
CC       interaction with the signal recognition particle (SRP), which normally
CC       targets nascent secretory peptides to the ER. Also reduces the inherent
CC       affinity of ribosomes for protein translocation sites in the ER
CC       membrane (M sites). May act as a specific coactivator for JUN, binding
CC       to DNA and stabilizing the interaction of JUN homodimers with target
CC       gene promoters. {ECO:0000269|PubMed:10982809,
CC       ECO:0000269|PubMed:15784678, ECO:0000269|PubMed:9877153}.
CC   -!- SUBUNIT: Interacts with TBP and JUN (By similarity). Part of the
CC       nascent polypeptide-associated complex (NAC), which is a heterodimer of
CC       NACA and BTF3 (via NAC-A/B domains). NAC associates with ribosomes
CC       through the BTF3/NACB subunit and contacts the ribosomal protein L23,
CC       which is positioned near the exiting site. Both subunits can contact
CC       nascent polypeptide chains. NACA may also form homodimers, and only
CC       this form binds DNA. {ECO:0000250, ECO:0000269|PubMed:10982809,
CC       ECO:0000269|PubMed:12684039, ECO:0000269|PubMed:20214399,
CC       ECO:0000269|PubMed:21203952}.
CC   -!- INTERACTION:
CC       Q13765; P40222: TXLNA; NbExp=2; IntAct=EBI-712216, EBI-359793;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=The heterodimer is
CC       located mainly in the cytosol, and the homodimer in the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q13765-1; Sequence=Displayed;
CC       Name=skNAC-2; Synonyms=2;
CC         IsoId=E9PAV3-2; Sequence=External;
CC       Name=skNAC;
CC         IsoId=E9PAV3-1; Sequence=External;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:16201836}.
CC   -!- DOMAIN: The positively charged inner surface of the NAC-A/B domain is
CC       crucial for NACA localization in the nucleus and DNA-binding. This
CC       region is blocked from binding nucleic acids in the heterodimeric
CC       complex by a helix region in the beta-subunit, it also displays much
CC       higher affinity for RNA than DNA.
CC   -!- PTM: Phosphorylation of Thr-159 by GSK3B may promote proteasome
CC       mediated degradation (By similarity). Phosphorylation of Ser-43 by ILK
CC       during cell adhesion may promote nuclear localization. {ECO:0000250,
CC       ECO:0000269|PubMed:15299025, ECO:0000269|Ref.13}.
CC   -!- ALLERGEN: Causes an allergic reaction in human. Binds to IgE from
CC       atopic dermatitis (AD) patients. Identified as an IgE autoantigen in
CC       atopic dermatitis (AD) patients with severe skin manifestations.
CC       {ECO:0000269|PubMed:9806765}.
CC   -!- SIMILARITY: Belongs to the NAC-alpha family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAV83778.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY034001; AAK57544.1; -; mRNA.
DR   EMBL; AY911673; AAX14393.1; -; mRNA.
DR   EMBL; X80909; CAA56869.1; -; mRNA.
DR   EMBL; AF054187; AAC99403.1; -; mRNA.
DR   EMBL; AK090650; BAG52208.1; -; mRNA.
DR   EMBL; AK311904; BAG34845.1; -; mRNA.
DR   EMBL; CR450295; CAG29291.1; -; mRNA.
DR   EMBL; AK223085; BAD96805.1; -; mRNA.
DR   EMBL; AC117378; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW96960.1; -; Genomic_DNA.
DR   EMBL; BC105120; AAI05121.1; -; mRNA.
DR   EMBL; BC105122; AAI05123.1; -; mRNA.
DR   EMBL; BC106041; AAI06042.1; -; mRNA.
DR   EMBL; AY605660; AAV83778.1; ALT_INIT; mRNA.
DR   CCDS; CCDS31837.1; -. [Q13765-1]
DR   PIR; S49326; S49326.
DR   RefSeq; NP_001106672.1; NM_001113201.2. [Q13765-1]
DR   RefSeq; NP_001106673.1; NM_001113202.1. [Q13765-1]
DR   RefSeq; NP_001106674.2; NM_001113203.2.
DR   RefSeq; NP_001307122.1; NM_001320193.1. [Q13765-1]
DR   RefSeq; NP_001307123.1; NM_001320194.1.
DR   RefSeq; NP_005585.1; NM_005594.5. [Q13765-1]
DR   PDB; 3LKX; X-ray; 2.50 A; B=84-136.
DR   PDB; 3MCB; X-ray; 1.90 A; A=79-132.
DR   PDB; 3MCE; X-ray; 2.40 A; A/B/C/D=81-133.
DR   PDBsum; 3LKX; -.
DR   PDBsum; 3MCB; -.
DR   PDBsum; 3MCE; -.
DR   SMR; Q13765; -.
DR   BioGrid; 110748; 80.
DR   DIP; DIP-43878N; -.
DR   IntAct; Q13765; 39.
DR   MINT; Q13765; -.
DR   Allergome; 3323; Hom s 2.0101.
DR   Allergome; 412; Hom s 2.
DR   iPTMnet; Q13765; -.
DR   MetOSite; Q13765; -.
DR   SwissPalm; Q13765; -.
DR   BioMuta; NACA; -.
DR   DMDM; 71151996; -.
DR   EPD; Q13765; -.
DR   jPOST; Q13765; -.
DR   MassIVE; Q13765; -.
DR   MaxQB; Q13765; -.
DR   PeptideAtlas; Q13765; -.
DR   PRIDE; Q13765; -.
DR   ProteomicsDB; 28706; -.
DR   ProteomicsDB; 59679; -. [Q13765-1]
DR   TopDownProteomics; Q13765-1; -. [Q13765-1]
DR   Antibodypedia; 28384; 84 antibodies.
DR   Ensembl; ENST00000356769; ENSP00000349212; ENSG00000196531. [Q13765-1]
DR   Ensembl; ENST00000393891; ENSP00000377469; ENSG00000196531. [Q13765-1]
DR   Ensembl; ENST00000546392; ENSP00000446801; ENSG00000196531. [Q13765-1]
DR   Ensembl; ENST00000552540; ENSP00000447821; ENSG00000196531. [Q13765-1]
DR   GeneID; 4666; -.
DR   KEGG; hsa:4666; -.
DR   UCSC; uc001sly.3; human. [Q13765-1]
DR   CTD; 4666; -.
DR   DisGeNET; 4666; -.
DR   GeneCards; NACA; -.
DR   HGNC; HGNC:7629; NACA.
DR   HPA; ENSG00000196531; Low tissue specificity.
DR   MIM; 601234; gene.
DR   neXtProt; NX_Q13765; -.
DR   OpenTargets; ENSG00000196531; -.
DR   PharmGKB; PA31433; -.
DR   eggNOG; KOG2239; Eukaryota.
DR   eggNOG; COG1308; LUCA.
DR   GeneTree; ENSGT00440000033468; -.
DR   HOGENOM; CLU_057806_1_2_1; -.
DR   InParanoid; Q13765; -.
DR   KO; K03626; -.
DR   OrthoDB; 1331328at2759; -.
DR   PhylomeDB; Q13765; -.
DR   TreeFam; TF313348; -.
DR   SIGNOR; Q13765; -.
DR   ChiTaRS; NACA; human.
DR   EvolutionaryTrace; Q13765; -.
DR   GeneWiki; NACA_(gene); -.
DR   GenomeRNAi; 4666; -.
DR   Pharos; Q13765; Tbio.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000196531; Expressed in testis and 240 other tissues.
DR   ExpressionAtlas; Q13765; baseline and differential.
DR   Genevisible; Q13765; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005854; C:nascent polypeptide-associated complex; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; NAS:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL.
DR   GO; GO:0003231; P:cardiac ventricle development; ISS:BHF-UCL.
DR   GO; GO:0061384; P:heart trabecula morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0010664; P:negative regulation of striated muscle cell apoptotic process; ISS:BHF-UCL.
DR   GO; GO:1901227; P:negative regulation of transcription from RNA polymerase II promoter involved in heart development; ISS:BHF-UCL.
DR   GO; GO:2000138; P:positive regulation of cell proliferation involved in heart morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0048633; P:positive regulation of skeletal muscle tissue growth; ISS:BHF-UCL.
DR   GO; GO:1901228; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; ISS:BHF-UCL.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0048742; P:regulation of skeletal muscle fiber development; ISS:BHF-UCL.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; ISS:BHF-UCL.
DR   GO; GO:0006412; P:translation; TAS:ProtInc.
DR   Gene3D; 2.20.70.30; -; 1.
DR   InterPro; IPR016641; EGD2/NACA.
DR   InterPro; IPR038187; NAC_A/B_dom_sf.
DR   InterPro; IPR002715; Nas_poly-pep-assoc_cplx_dom.
DR   PANTHER; PTHR21713; PTHR21713; 1.
DR   Pfam; PF01849; NAC; 1.
DR   PIRSF; PIRSF015901; NAC_alpha; 1.
DR   SMART; SM01407; NAC; 1.
DR   PROSITE; PS51151; NAC_AB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allergen; Alternative splicing; Chaperone;
KW   Cytoplasm; Direct protein sequencing; DNA-binding; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Protein transport; Reference proteome;
KW   Transcription; Transport; Ubl conjugation.
FT   CHAIN           1..215
FT                   /note="Nascent polypeptide-associated complex subunit
FT                   alpha"
FT                   /id="PRO_0000135576"
FT   DOMAIN          70..135
FT                   /note="NAC-A/B"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00507"
FT   DOMAIN          176..213
FT                   /note="UBA"
FT   REGION          69..80
FT                   /note="Required for DNA-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          93..108
FT                   /note="RNA/DNA-binding"
FT   MOD_RES         43
FT                   /note="Phosphoserine; by ILK1"
FT                   /evidence="ECO:0000269|PubMed:15299025"
FT   MOD_RES         132
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         142
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         159
FT                   /note="Phosphothreonine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q60817"
FT   MOD_RES         161
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         166
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:21406692, ECO:0000269|Ref.13"
FT   MOD_RES         186
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         191
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         203
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   CROSSLNK        142
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CONFLICT        213
FT                   /note="L -> S (in Ref. 7; BAD96805)"
FT                   /evidence="ECO:0000305"
FT   HELIX           80..83
FT                   /evidence="ECO:0000244|PDB:3MCB"
FT   STRAND          86..88
FT                   /evidence="ECO:0000244|PDB:3LKX"
FT   STRAND          91..108
FT                   /evidence="ECO:0000244|PDB:3MCB"
FT   STRAND          110..113
FT                   /evidence="ECO:0000244|PDB:3MCB"
FT   STRAND          117..124
FT                   /evidence="ECO:0000244|PDB:3MCB"
FT   STRAND          126..130
FT                   /evidence="ECO:0000244|PDB:3MCB"
SQ   SEQUENCE   215 AA;  23384 MW;  05DC563A8BEF307C CRC64;
     MPGEATETVP ATEQELPQPQ AETGSGTESD SDESVPELEE QDSTQATTQQ AQLAAAAEID
     EEPVSKAKQS RSEKKARKAM SKLGLRQVTG VTRVTIRKSK NILFVITKPD VYKSPASDTY
     IVFGEAKIED LSQQAQLAAA EKFKVQGEAV SNIQENTQTP TVQEESEEEE VDETGVEVKD
     IELVMSQANV SRAKAVRALK NNSNDIVNAI MELTM
//
ID   SPN90_HUMAN             Reviewed;         722 AA.
AC   Q9NZQ3; B4DFL5; Q6GU34; Q6SPF3; Q8TC10; Q9UGM8;
DT   05-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-APR-2020, entry version 176.
DE   RecName: Full=NCK-interacting protein with SH3 domain;
DE   AltName: Full=54 kDa VacA-interacting protein;
DE   AltName: Full=54 kDa vimentin-interacting protein;
DE            Short=VIP54;
DE   AltName: Full=90 kDa SH3 protein interacting with Nck;
DE   AltName: Full=AF3p21;
DE   AltName: Full=Dia-interacting protein 1;
DE            Short=DIP-1;
DE   AltName: Full=Diaphanous protein-interacting protein;
DE   AltName: Full=SH3 adapter protein SPIN90;
DE   AltName: Full=WASP-interacting SH3-domain protein;
DE            Short=WISH;
DE   AltName: Full=Wiskott-Aldrich syndrome protein-interacting protein;
GN   Name=NCKIPSD; Synonyms=AF3P21, SPIN90;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION WITH
RP   KMT2A/MLL1.
RC   TISSUE=Leukemia;
RX   PubMed=10648423;
RA   Sano K., Hayakawa A., Piao J.-H., Kosaka Y., Nakamura H.;
RT   "Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage
RT   leukemia protein in a therapy-related leukemia with t(3;11)(p21;q23).";
RL   Blood 95:1066-1068(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INTERACTION WITH VACA, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10619843; DOI=10.1093/emboj/19.1.48;
RA   de Bernard M., Moschioni M., Napolitani G., Rappuoli R., Montecucco C.;
RT   "The VacA toxin of Helicobacter pylori identifies a new intermediate
RT   filament-interacting protein.";
RL   EMBO J. 19:48-56(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Cervix carcinoma;
RX   PubMed=11241789; DOI=10.1002/gcc.1102;
RA   Hayakawa A., Matsuda Y., Daibata M., Nakamura H., Sano K.;
RT   "Genomic organization, tissue expression and cellular localization of
RT   AF3p21, a fusion partner of MLL in therapy-related leukemia.";
RL   Genes Chromosomes Cancer 30:364-374(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=11278500; DOI=10.1074/jbc.m009411200;
RA   Lim C.S., Park E.S., Kim D.J., Song Y.H., Eom S.H., Chun J.-S., Kim J.H.,
RA   Kim J.-K., Park D., Song W.K.;
RT   "SPIN90 (SH3 protein interacting with Nck, 90 kDa), an adapter protein that
RT   is developmentally regulated during cardiac myocyte differentiation.";
RL   J. Biol. Chem. 276:12871-12878(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORMS 1 AND
RP   2).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=11509578; DOI=10.1074/jbc.m107026200;
RA   Satoh S., Tominaga T.;
RT   "mDia-interacting protein acts downstream of rho-mDia and modifies src
RT   activation and stress fiber formation.";
RL   J. Biol. Chem. 276:39290-39294(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND INTERACTION WITH FHOD1.
RC   TISSUE=Bone marrow;
RX   PubMed=15095401; DOI=10.1002/jcb.20031;
RA   Westendorf J.J., Koka S.;
RT   "Identification of FHOD1-binding proteins and mechanisms of FHOD1-regulated
RT   actin dynamics.";
RL   J. Cell. Biochem. 92:29-41(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT SER-660.
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 448-722 (ISOFORM 5).
RC   TISSUE=Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [11]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   FUNCTION IN ANGIOGENESIS, AND INTERACTION WITH TMIGD2.
RX   PubMed=22419821; DOI=10.1091/mbc.e11-11-0934;
RA   Rahimi N., Rezazadeh K., Mahoney J.E., Hartsough E., Meyer R.D.;
RT   "Identification of IGPR-1 as a novel adhesion molecule involved in
RT   angiogenesis.";
RL   Mol. Biol. Cell 23:1646-1656(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-181, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Has an important role in stress fiber formation induced by
CC       active diaphanous protein homolog 1 (DRF1). Induces microspike
CC       formation, in vivo (By similarity). In vitro, stimulates N-WASP-induced
CC       ARP2/3 complex activation in the absence of CDC42 (By similarity). May
CC       play an important role in the maintenance of sarcomeres and/or in the
CC       assembly of myofibrils into sarcomeres. Implicated in regulation of
CC       actin polymerization and cell adhesion. Plays a role in angiogenesis.
CC       {ECO:0000250, ECO:0000269|PubMed:22419821}.
CC   -!- SUBUNIT: Associates with the intermediate filaments, vimentin and
CC       desmin. Binds the first and third SH3 domains of NCK. Binds the
CC       proline-rich domains of N-WASP through its SH3 domain (By similarity).
CC       Similarly, binds diaphanous protein homolog 1 (DRF1). Binds the SH3
CC       domains of GRB2 through its proline-rich domains. Interacts with
CC       Helicobacter pylori toxin vacA. Isoform 4 interacts with FHOD1.
CC       Interacts with FASLG. Interacts with TMIGD2. {ECO:0000250,
CC       ECO:0000269|PubMed:10619843, ECO:0000269|PubMed:15095401,
CC       ECO:0000269|PubMed:19807924, ECO:0000269|PubMed:22419821}.
CC   -!- INTERACTION:
CC       Q9NZQ3-3; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-10963850, EBI-11096309;
CC       Q9NZQ3; Q60437: BAIAP2; Xeno; NbExp=3; IntAct=EBI-745080, EBI-7010040;
CC       Q9NZQ3; Q9UQB8: BAIAP2; NbExp=2; IntAct=EBI-745080, EBI-525456;
CC       Q9NZQ3-3; Q96FN4: CPNE2; NbExp=3; IntAct=EBI-10963850, EBI-7097057;
CC       Q9NZQ3-3; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-10963850, EBI-744099;
CC       Q9NZQ3; P06241: FYN; NbExp=2; IntAct=EBI-745080, EBI-515315;
CC       Q9NZQ3-3; O60861-1: GAS7; NbExp=5; IntAct=EBI-10963850, EBI-11745923;
CC       Q9NZQ3-3; P56470: LGALS4; NbExp=3; IntAct=EBI-10963850, EBI-720805;
CC       Q9NZQ3-3; Q71SY5: MED25; NbExp=3; IntAct=EBI-10963850, EBI-394558;
CC       Q9NZQ3-3; Q8IVT4: MGC50722; NbExp=3; IntAct=EBI-10963850, EBI-14086479;
CC       Q9NZQ3-3; O43639: NCK2; NbExp=3; IntAct=EBI-10963850, EBI-713635;
CC       Q9NZQ3; Q9Z0W5: Pacsin1; Xeno; NbExp=6; IntAct=EBI-745080, EBI-1550185;
CC       Q9NZQ3; Q9QY17: Pacsin2; Xeno; NbExp=2; IntAct=EBI-745080, EBI-491201;
CC       Q9NZQ3-3; Q13526: PIN1; NbExp=3; IntAct=EBI-10963850, EBI-714158;
CC       Q9NZQ3-3; Q99959-2: PKP2; NbExp=3; IntAct=EBI-10963850, EBI-10987518;
CC       Q9NZQ3-3; Q9BUI4: POLR3C; NbExp=3; IntAct=EBI-10963850, EBI-5452779;
CC       Q9NZQ3-3; Q8WWY3: PRPF31; NbExp=3; IntAct=EBI-10963850, EBI-1567797;
CC       Q9NZQ3; O00233: PSMD9; NbExp=4; IntAct=EBI-745080, EBI-750973;
CC       Q9NZQ3-3; Q9UIG4: PSORS1C2; NbExp=3; IntAct=EBI-10963850, EBI-11974061;
CC       Q9NZQ3-3; Q9NW64: RBM22; NbExp=5; IntAct=EBI-10963850, EBI-2602260;
CC       Q9NZQ3-3; Q96R05: RBP7; NbExp=3; IntAct=EBI-10963850, EBI-2856326;
CC       Q9NZQ3-3; P09234: SNRPC; NbExp=3; IntAct=EBI-10963850, EBI-766589;
CC       Q9NZQ3; O60504: SORBS3; NbExp=3; IntAct=EBI-745080, EBI-741237;
CC       Q9NZQ3-3; Q99469: STAC; NbExp=3; IntAct=EBI-10963850, EBI-2652799;
CC       Q9NZQ3-3; Q7Z6J9: TSEN54; NbExp=3; IntAct=EBI-10963850, EBI-2559824;
CC       Q9NZQ3-3; Q14119: VEZF1; NbExp=3; IntAct=EBI-10963850, EBI-11980193;
CC       Q9NZQ3-3; Q9UFB7: ZBTB47; NbExp=3; IntAct=EBI-10963850, EBI-7781767;
CC       Q9NZQ3-3; Q53FD0-2: ZC2HC1C; NbExp=3; IntAct=EBI-10963850, EBI-14104088;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=Colocalizes with DRF1 at membrane
CC       ruffles, and with Nck at Z-disks in mature cardiac myocytes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9NZQ3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NZQ3-2; Sequence=VSP_003971;
CC       Name=3;
CC         IsoId=Q9NZQ3-3; Sequence=VSP_039422;
CC       Name=4; Synonyms=WISH-B;
CC         IsoId=Q9NZQ3-4; Sequence=VSP_039422, VSP_039425, VSP_039426;
CC       Name=5;
CC         IsoId=Q9NZQ3-5; Sequence=VSP_039423, VSP_039424;
CC   -!- TISSUE SPECIFICITY: Highest expression in heart, brain, skeletal
CC       muscle, kidney and liver. Lower levels in placenta, lung, small
CC       intestine and leukocytes. Weak expression in colon, thymus and spleen.
CC       {ECO:0000269|PubMed:10619843}.
CC   -!- DISEASE: Note=A chromosomal aberration involving NCKIPSD/AF3p21 is
CC       found in therapy-related leukemia. Translocation t(3;11)(p21;q23) with
CC       KMT2A/MLL1. {ECO:0000269|PubMed:10648423}.
CC   -!- MISCELLANEOUS: [Isoform 5]: Found in a brain affected by Alzheimer
CC       disease. May be due to intron retention. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG57476.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF3p21ID228.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF178432; AAF35985.1; -; mRNA.
DR   EMBL; AJ242655; CAB65089.2; -; mRNA.
DR   EMBL; AF303581; AAK09094.1; -; mRNA.
DR   EMBL; AB069981; BAB63204.1; -; Genomic_DNA.
DR   EMBL; AB069982; BAB63205.1; -; Genomic_DNA.
DR   EMBL; AY453794; AAR83735.1; -; mRNA.
DR   EMBL; AC141002; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016052; AAH16052.1; -; mRNA.
DR   EMBL; BC026280; AAH26280.1; -; mRNA.
DR   EMBL; AK294151; BAG57476.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2776.1; -. [Q9NZQ3-1]
DR   CCDS; CCDS46827.1; -. [Q9NZQ3-3]
DR   RefSeq; NP_057537.1; NM_016453.3. [Q9NZQ3-1]
DR   RefSeq; NP_909119.1; NM_184231.2. [Q9NZQ3-3]
DR   PDB; 6DEC; X-ray; 4.60 A; M/P=269-722.
DR   PDB; 6DED; X-ray; 2.20 A; A/B=350-722.
DR   PDB; 6DEE; X-ray; 3.04 A; A=306-722.
DR   PDBsum; 6DEC; -.
DR   PDBsum; 6DED; -.
DR   PDBsum; 6DEE; -.
DR   SMR; Q9NZQ3; -.
DR   BioGrid; 119583; 56.
DR   IntAct; Q9NZQ3; 80.
DR   MINT; Q9NZQ3; -.
DR   STRING; 9606.ENSP00000294129; -.
DR   iPTMnet; Q9NZQ3; -.
DR   MetOSite; Q9NZQ3; -.
DR   PhosphoSitePlus; Q9NZQ3; -.
DR   BioMuta; NCKIPSD; -.
DR   DMDM; 17433253; -.
DR   EPD; Q9NZQ3; -.
DR   jPOST; Q9NZQ3; -.
DR   MassIVE; Q9NZQ3; -.
DR   MaxQB; Q9NZQ3; -.
DR   PaxDb; Q9NZQ3; -.
DR   PeptideAtlas; Q9NZQ3; -.
DR   PRIDE; Q9NZQ3; -.
DR   ProteomicsDB; 83478; -. [Q9NZQ3-1]
DR   ProteomicsDB; 83479; -. [Q9NZQ3-2]
DR   ProteomicsDB; 83480; -. [Q9NZQ3-3]
DR   ProteomicsDB; 83481; -. [Q9NZQ3-4]
DR   ProteomicsDB; 83482; -. [Q9NZQ3-5]
DR   Antibodypedia; 30227; 126 antibodies.
DR   DNASU; 51517; -.
DR   Ensembl; ENST00000294129; ENSP00000294129; ENSG00000213672. [Q9NZQ3-1]
DR   Ensembl; ENST00000416649; ENSP00000389059; ENSG00000213672. [Q9NZQ3-3]
DR   GeneID; 51517; -.
DR   KEGG; hsa:51517; -.
DR   UCSC; uc003cum.5; human. [Q9NZQ3-1]
DR   CTD; 51517; -.
DR   DisGeNET; 51517; -.
DR   GeneCards; NCKIPSD; -.
DR   HGNC; HGNC:15486; NCKIPSD.
DR   HPA; ENSG00000213672; Group enriched (brain, parathyroid gland).
DR   MIM; 606671; gene.
DR   neXtProt; NX_Q9NZQ3; -.
DR   OpenTargets; ENSG00000213672; -.
DR   PharmGKB; PA134872724; -.
DR   eggNOG; KOG4035; Eukaryota.
DR   eggNOG; ENOG410Y8WT; LUCA.
DR   GeneTree; ENSGT00390000015725; -.
DR   HOGENOM; CLU_012978_1_0_1; -.
DR   InParanoid; Q9NZQ3; -.
DR   OMA; CKNDTEQ; -.
DR   OrthoDB; 649314at2759; -.
DR   PhylomeDB; Q9NZQ3; -.
DR   TreeFam; TF324522; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   SignaLink; Q9NZQ3; -.
DR   SIGNOR; Q9NZQ3; -.
DR   ChiTaRS; NCKIPSD; human.
DR   GeneWiki; NCKIPSD; -.
DR   GenomeRNAi; 51517; -.
DR   Pharos; Q9NZQ3; Tbio.
DR   PRO; PR:Q9NZQ3; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9NZQ3; protein.
DR   Bgee; ENSG00000213672; Expressed in anterior cingulate cortex and 211 other tissues.
DR   ExpressionAtlas; Q9NZQ3; baseline and differential.
DR   Genevisible; Q9NZQ3; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005882; C:intermediate filament; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0008092; F:cytoskeletal protein binding; NAS:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0007010; P:cytoskeleton organization; NAS:UniProtKB.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   CDD; cd11849; SH3_SPIN90; 1.
DR   InterPro; IPR018556; DUF2013.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR035514; SPIN90_SH3.
DR   Pfam; PF09431; DUF2013; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement; Nucleus;
KW   Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome;
KW   SH3 domain; SH3-binding.
FT   CHAIN           1..722
FT                   /note="NCK-interacting protein with SH3 domain"
FT                   /id="PRO_0000072130"
FT   DOMAIN          1..58
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   MOTIF           175..192
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        171..275
FT                   /note="Pro-rich"
FT   COMPBIAS        197..240
FT                   /note="Ser/Thr-rich"
FT   COMPBIAS        442..487
FT                   /note="Leu-rich"
FT   COMPBIAS        534..601
FT                   /note="Leu-rich"
FT   SITE            57..58
FT                   /note="Breakpoint for translocation to form KMT2A/MLL1-
FT                   AF3P21 oncogene"
FT   MOD_RES         120
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ESJ4"
FT   MOD_RES         181
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ESJ4"
FT   VAR_SEQ         165..171
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15095401,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_039422"
FT   VAR_SEQ         567..596
FT                   /note="AADQNVIMAALSKHANVKIFSEKLLLLLNR -> GGVGPGWAVAEHMVALRL
FT                   STLSIPMSFLSC (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_039423"
FT   VAR_SEQ         597..722
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_039424"
FT   VAR_SEQ         656..722
FT                   /note="LRMEYLSLMHAIVRTTPYLQHRHRLPDLQAILRRILNEEETSPQCQMDRMIV
FT                   REMCKEFLVLGEAPS -> GPFGAGQRPWPGVPRLLEPGSTPSREPHPVERSGVPALTS
FT                   SWASGCPRPLHPALQLVIDSAFGGRSV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10619843"
FT                   /id="VSP_003971"
FT   VAR_SEQ         656..658
FT                   /note="LRM -> GVH (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15095401"
FT                   /id="VSP_039425"
FT   VAR_SEQ         659..722
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15095401"
FT                   /id="VSP_039426"
FT   VARIANT         324
FT                   /note="T -> S (in dbSNP:rs6785620)"
FT                   /id="VAR_051378"
FT   VARIANT         660
FT                   /note="Y -> S (in dbSNP:rs17855516)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_063400"
FT   HELIX           312..324
FT                   /evidence="ECO:0000244|PDB:6DEE"
FT   HELIX           328..345
FT                   /evidence="ECO:0000244|PDB:6DEE"
FT   HELIX           350..359
FT                   /evidence="ECO:0000244|PDB:6DEE"
FT   HELIX           377..390
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           401..404
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           407..423
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           426..450
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           454..470
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           472..480
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           483..493
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           498..511
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   TURN            512..514
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           520..524
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           528..539
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           550..562
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   STRAND          568..570
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           572..578
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           584..596
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           613..621
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           625..628
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           633..649
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           657..670
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           673..676
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           680..691
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           698..713
FT                   /evidence="ECO:0000244|PDB:6DED"
FT   HELIX           715..717
FT                   /evidence="ECO:0000244|PDB:6DED"
SQ   SEQUENCE   722 AA;  78960 MW;  7683046B94647332 CRC64;
     MYRALYAFRS AEPNALAFAA GETFLVLERS SAHWWLAARA RSGETGYVPP AYLRRLQGLE
     QDVLQAIDRA IEAVHNTAMR DGGKYSLEQR GVLQKLIHHR KETLSRRGPS ASSVAVMTSS
     TSDHHLDAAA ARQPNGVCRA GFERQHSLPS SEHLGADGGL YQIPLPSSQI PPQPRRAAPT
     TPPPPVKRRD REALMASGSG GHNTMPSGGN SVSSGSSVSS TSLDTLYTSS SPSEPGSSCS
     PTPPPVPRRG THTTVSQVQP PPSKASAPEP PAEEEVATGT TSASDDLEAL GTLSLGTTEE
     KAAAEAAVPR TIGAELMELV RRNTGLSHEL CRVAIGIIVG HIQASVPASS PVMEQVLLSL
     VEGKDLSMAL PSGQVCHDQQ RLEVIFADLA RRKDDAQQRS WALYEDEGVI RCYLEELLHI
     LTDADPEVCK KMCKRNEFES VLALVAYYQM EHRASLRLLL LKCFGAMCSL DAAIISTLVS
     SVLPVELARD MQTDTQDHQK LCYSALILAM VFSMGEAVPY AHYEHLGTPF AQFLLNIVED
     GLPLDTTEQL PDLCVNLLLA LNLHLPAADQ NVIMAALSKH ANVKIFSEKL LLLLNRGDDP
     VRIFKHEPQP PHSVLKFLQD VFGSPATAAI FYHTDMMALI DITVRHIADL SPGDKLRMEY
     LSLMHAIVRT TPYLQHRHRL PDLQAILRRI LNEEETSPQC QMDRMIVREM CKEFLVLGEA
     PS
//
ID   OMD_HUMAN               Reviewed;         421 AA.
AC   Q99983; Q5TBF4;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   22-APR-2020, entry version 171.
DE   RecName: Full=Osteomodulin;
DE   AltName: Full=Keratan sulfate proteoglycan osteomodulin;
DE            Short=KSPG osteomodulin;
DE   AltName: Full=Osteoadherin;
DE            Short=OSAD;
DE   Flags: Precursor;
GN   Name=OMD; Synonyms=SLRR2C; ORFNames=UNQ190/PRO216;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Osteoblast;
RA   Ohno I., Hashimoto J., Takaoka K., Ochi T., Okubo K., Matsubara K.;
RT   "The cloning of a cDNA for novel genes expressed in human osteoblast.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Ohno I., Matsubara K., Okubo K.;
RT   "Human osteomodulin gene: intron-exon junctions and chromosomal
RT   localization.";
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SULFATION AT TYR-22; TYR-25; TYR-31; TYR-39; TYR-51; TYR-58; TYR-77;
RP   TYR-416 AND TYR-417, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=14551184; DOI=10.1074/jbc.m308689200;
RA   Onnerfjord P., Heathfield T.F., Heinegaard D.;
RT   "Identification of tyrosine sulfation in extracellular leucine-rich repeat
RT   proteins using mass spectrometry.";
RL   J. Biol. Chem. 279:26-33(2004).
CC   -!- FUNCTION: May be implicated in biomineralization processes. Has a
CC       function in binding of osteoblasts via the alpha(V)beta(3)-integrin (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Binds the alpha(V)beta(3)-integrin. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Bone specific.
CC   -!- PTM: Binds keratan sulfate chains. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the small leucine-rich proteoglycan (SLRP)
CC       family. SLRP class II subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB000114; BAA19055.1; -; mRNA.
DR   EMBL; AB009589; BAA23982.1; -; Genomic_DNA.
DR   EMBL; AY358872; AAQ89231.1; -; mRNA.
DR   EMBL; AL137848; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471089; EAW62821.1; -; Genomic_DNA.
DR   EMBL; BC046356; AAH46356.1; -; mRNA.
DR   CCDS; CCDS6696.1; -.
DR   RefSeq; NP_005005.1; NM_005014.2.
DR   PDB; 5YQ5; X-ray; 2.17 A; A/B/C/D=21-421.
DR   PDBsum; 5YQ5; -.
DR   SMR; Q99983; -.
DR   BioGrid; 111011; 4.
DR   IntAct; Q99983; 5.
DR   STRING; 9606.ENSP00000364700; -.
DR   GlyConnect; 1588; -.
DR   iPTMnet; Q99983; -.
DR   PhosphoSitePlus; Q99983; -.
DR   BioMuta; OMD; -.
DR   DMDM; 20138850; -.
DR   jPOST; Q99983; -.
DR   MassIVE; Q99983; -.
DR   PaxDb; Q99983; -.
DR   PeptideAtlas; Q99983; -.
DR   PRIDE; Q99983; -.
DR   ProteomicsDB; 78561; -.
DR   Antibodypedia; 28259; 170 antibodies.
DR   Ensembl; ENST00000375550; ENSP00000364700; ENSG00000127083.
DR   GeneID; 4958; -.
DR   KEGG; hsa:4958; -.
DR   UCSC; uc004asd.5; human.
DR   CTD; 4958; -.
DR   DisGeNET; 4958; -.
DR   GeneCards; OMD; -.
DR   HGNC; HGNC:8134; OMD.
DR   HPA; ENSG00000127083; Low tissue specificity.
DR   neXtProt; NX_Q99983; -.
DR   OpenTargets; ENSG00000127083; -.
DR   PharmGKB; PA31921; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; COG4886; LUCA.
DR   GeneTree; ENSGT00940000160986; -.
DR   HOGENOM; CLU_000288_186_4_1; -.
DR   InParanoid; Q99983; -.
DR   KO; K08124; -.
DR   OMA; NVGHNKL; -.
DR   OrthoDB; 826997at2759; -.
DR   PhylomeDB; Q99983; -.
DR   TreeFam; TF334562; -.
DR   Reactome; R-HSA-2022854; Keratan sulfate biosynthesis.
DR   Reactome; R-HSA-2022857; Keratan sulfate degradation.
DR   Reactome; R-HSA-3656225; Defective CHST6 causes MCDC1.
DR   Reactome; R-HSA-3656243; Defective ST3GAL3 causes MCT12 and EIEE15.
DR   Reactome; R-HSA-3656244; Defective B4GALT1 causes B4GALT1-CDG (CDG-2d).
DR   SIGNOR; Q99983; -.
DR   ChiTaRS; OMD; human.
DR   GeneWiki; OMD_(gene); -.
DR   GenomeRNAi; 4958; -.
DR   Pharos; Q99983; Tbio.
DR   PRO; PR:Q99983; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q99983; protein.
DR   Bgee; ENSG00000127083; Expressed in periodontal ligament and 160 other tissues.
DR   Genevisible; Q99983; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome.
DR   GO; GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome.
DR   GO; GO:0030500; P:regulation of bone mineralization; IEA:InterPro.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR000372; LRRNT.
DR   InterPro; IPR030705; Osteomodulin.
DR   PANTHER; PTHR45712:SF3; PTHR45712:SF3; 1.
DR   Pfam; PF13855; LRR_8; 3.
DR   SMART; SM00369; LRR_TYP; 7.
DR   SMART; SM00013; LRRNT; 1.
DR   PROSITE; PS51450; LRR; 8.
PE   1: Evidence at protein level;
KW   3D-structure; Cell adhesion; Disulfide bond; Extracellular matrix;
KW   Glycoprotein; Leucine-rich repeat; Polymorphism; Proteoglycan;
KW   Reference proteome; Repeat; Secreted; Signal; Sulfation.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..421
FT                   /note="Osteomodulin"
FT                   /id="PRO_0000032754"
FT   DOMAIN          53..91
FT                   /note="LRRNT"
FT   REPEAT          92..113
FT                   /note="LRR 1"
FT   REPEAT          116..129
FT                   /note="LRR 2"
FT   REPEAT          142..164
FT                   /note="LRR 3"
FT   REPEAT          165..184
FT                   /note="LRR 4"
FT   REPEAT          187..210
FT                   /note="LRR 5"
FT   REPEAT          213..233
FT                   /note="LRR 6"
FT   REPEAT          234..255
FT                   /note="LRR 7"
FT   REPEAT          258..280
FT                   /note="LRR 8"
FT   REPEAT          281..294
FT                   /note="LRR 9"
FT   REPEAT          301..321
FT                   /note="LRR 10"
FT   REPEAT          331..353
FT                   /note="LRR 11"
FT   COMPBIAS        62..78
FT                   /note="Cys-rich"
FT   COMPBIAS        385..409
FT                   /note="Asp/Glu-rich (acidic)"
FT   MOD_RES         22
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000305|PubMed:14551184"
FT   MOD_RES         25
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000305|PubMed:14551184"
FT   MOD_RES         31
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000305|PubMed:14551184"
FT   MOD_RES         39
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000269|PubMed:14551184"
FT   MOD_RES         51
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000305|PubMed:14551184"
FT   MOD_RES         58
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000305|PubMed:14551184"
FT   MOD_RES         77
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000305|PubMed:14551184"
FT   MOD_RES         416
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000269|PubMed:14551184"
FT   MOD_RES         417
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000269|PubMed:14551184"
FT   CARBOHYD        113
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        121
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        187
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        242
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        316
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        321..353
FT                   /evidence="ECO:0000250"
FT   VARIANT         200
FT                   /note="D -> G (in dbSNP:rs34069871)"
FT                   /id="VAR_052014"
FT   VARIANT         212
FT                   /note="E -> G (in dbSNP:rs34413259)"
FT                   /id="VAR_052015"
FT   VARIANT         221
FT                   /note="S -> N (in dbSNP:rs34860658)"
FT                   /id="VAR_052016"
FT   VARIANT         282
FT                   /note="I -> T (in dbSNP:rs35779901)"
FT                   /id="VAR_052017"
FT   VARIANT         353
FT                   /note="C -> W (in dbSNP:rs34059114)"
FT                   /id="VAR_052018"
FT   STRAND          75..77
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          95..97
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   HELIX           108..111
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          119..121
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   HELIX           129..131
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   TURN            134..139
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          145..147
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          166..168
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   TURN            179..184
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          190..192
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   HELIX           200..203
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   TURN            204..210
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          216..218
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          237..239
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   HELIX           252..255
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          261..263
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   TURN            274..277
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          284..286
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          304..306
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   HELIX           317..320
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          334..336
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   HELIX           350..353
FT                   /evidence="ECO:0000244|PDB:5YQ5"
FT   STRAND          359..361
FT                   /evidence="ECO:0000244|PDB:5YQ5"
SQ   SEQUENCE   421 AA;  49492 MW;  CED47B2BC33BB872 CRC64;
     MGFLSPIYVI FFFFGVKVHC QYETYQWDED YDQEPDDDYQ TGFPFRQNVD YGVPFHQYTL
     GCVSECFCPT NFPSSMYCDN RKLKTIPNIP MHIQQLYLQF NEIEAVTANS FINATHLKEI
     NLSHNKIKSQ KIDYGVFAKL PNLLQLHLEH NNLEEFPFPL PKSLERLLLG YNEISKLQTN
     AMDGLVNLTM LDLCYNYLHD SLLKDKIFAK MEKLMQLNLC SNRLESMPPG LPSSLMYLSL
     ENNSISSIPE KYFDKLPKLH TLRMSHNKLQ DIPYNIFNLP NIVELSVGHN KLKQAFYIPR
     NLEHLYLQNN EIEKMNLTVM CPSIDPLHYH HLTYIRVDQN KLKEPISSYI FFCFPHIHTI
     YYGEQRSTNG QTIQLKTQVF RRFPDDDDES EDHDDPDNAH ESPEQEGAEG HFDLHYYENQ
     E
//
ID   PWP2A_HUMAN             Reviewed;         755 AA.
AC   Q96N64; G5EA07; Q2HJJ2; Q8IYR3; Q96PV3;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   22-APR-2020, entry version 128.
DE   RecName: Full=PWWP domain-containing protein 2A;
GN   Name=PWWP2A; Synonyms=KIAA1935, MST101;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-435.
RC   TISSUE=Brain;
RX   PubMed=11572484; DOI=10.1093/dnares/8.4.179;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXI. The
RT   complete sequences of 60 new cDNA clones from brain which code for large
RT   proteins.";
RL   DNA Res. 8:179-187(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 241-755.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116 AND SER-119, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81; SER-116 AND SER-119, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102 AND SER-119, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-208, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [14]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH H2AZ1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=28645917; DOI=10.15252/embj.201695757;
RA   Puenzeler S., Link S., Wagner G., Keilhauer E.C., Kronbeck N.,
RA   Spitzer R.M., Leidescher S., Markaki Y., Mentele E., Regnard C.,
RA   Schneider K., Takahashi D., Kusakabe M., Vardabasso C., Zink L.M.,
RA   Straub T., Bernstein E., Harata M., Leonhardt H., Mann M., Rupp R.A.,
RA   Hake S.B.;
RT   "Multivalent binding of PWWP2A to H2A.Z regulates mitosis and neural crest
RT   differentiation.";
RL   EMBO J. 36:2263-2279(2017).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-208, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: H2A.Z-specific chromatin binding protein which may play an
CC       important role in the neural crest stem cell migration and
CC       differentiation during early development. Also required for proper
CC       mitosis progression. {ECO:0000269|PubMed:28645917}.
CC   -!- SUBUNIT: Interacts with H2A.Z/H2AZ1. {ECO:0000269|PubMed:28645917}.
CC   -!- INTERACTION:
CC       Q96N64; Q13547: HDAC1; NbExp=5; IntAct=EBI-6597774, EBI-301834;
CC       Q96N64-2; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-18924849, EBI-742388;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28645917}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96N64-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96N64-2; Sequence=VSP_029547, VSP_029548;
CC       Name=3;
CC         IsoId=Q96N64-3; Sequence=VSP_054064, VSP_054065;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH35076.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB67828.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB71045.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB067522; BAB67828.1; ALT_INIT; mRNA.
DR   EMBL; AK055921; BAB71045.1; ALT_INIT; mRNA.
DR   EMBL; AC008706; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61567.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61568.1; -; Genomic_DNA.
DR   EMBL; BC035076; AAH35076.2; ALT_INIT; mRNA.
DR   EMBL; BC105110; AAI05111.1; -; mRNA.
DR   CCDS; CCDS47331.1; -. [Q96N64-2]
DR   CCDS; CCDS47332.1; -. [Q96N64-1]
DR   CCDS; CCDS58990.1; -. [Q96N64-3]
DR   RefSeq; NP_001124336.1; NM_001130864.1. [Q96N64-1]
DR   RefSeq; NP_001253964.1; NM_001267035.1. [Q96N64-3]
DR   RefSeq; NP_443159.1; NM_052927.2. [Q96N64-2]
DR   SMR; Q96N64; -.
DR   BioGrid; 125375; 10.
DR   IntAct; Q96N64; 17.
DR   STRING; 9606.ENSP00000305151; -.
DR   iPTMnet; Q96N64; -.
DR   MetOSite; Q96N64; -.
DR   PhosphoSitePlus; Q96N64; -.
DR   BioMuta; PWWP2A; -.
DR   DMDM; 160419226; -.
DR   EPD; Q96N64; -.
DR   jPOST; Q96N64; -.
DR   MassIVE; Q96N64; -.
DR   MaxQB; Q96N64; -.
DR   PaxDb; Q96N64; -.
DR   PeptideAtlas; Q96N64; -.
DR   PRIDE; Q96N64; -.
DR   ProteomicsDB; 34103; -.
DR   ProteomicsDB; 77468; -. [Q96N64-1]
DR   ProteomicsDB; 77469; -. [Q96N64-2]
DR   Antibodypedia; 28516; 32 antibodies.
DR   Ensembl; ENST00000307063; ENSP00000305151; ENSG00000170234. [Q96N64-1]
DR   Ensembl; ENST00000456329; ENSP00000390462; ENSG00000170234. [Q96N64-2]
DR   Ensembl; ENST00000523662; ENSP00000428143; ENSG00000170234. [Q96N64-3]
DR   GeneID; 114825; -.
DR   KEGG; hsa:114825; -.
DR   UCSC; uc003lxv.5; human. [Q96N64-1]
DR   CTD; 114825; -.
DR   DisGeNET; 114825; -.
DR   GeneCards; PWWP2A; -.
DR   HGNC; HGNC:29406; PWWP2A.
DR   HPA; ENSG00000170234; Tissue enhanced (brain).
DR   MIM; 617823; gene.
DR   neXtProt; NX_Q96N64; -.
DR   OpenTargets; ENSG00000170234; -.
DR   PharmGKB; PA162400500; -.
DR   eggNOG; ENOG410IXQI; Eukaryota.
DR   eggNOG; ENOG4111IWH; LUCA.
DR   GeneTree; ENSGT00940000157692; -.
DR   HOGENOM; CLU_035885_0_0_1; -.
DR   InParanoid; Q96N64; -.
DR   OMA; HRRPKDQ; -.
DR   OrthoDB; 326248at2759; -.
DR   PhylomeDB; Q96N64; -.
DR   TreeFam; TF331271; -.
DR   ChiTaRS; PWWP2A; human.
DR   GenomeRNAi; 114825; -.
DR   Pharos; Q96N64; Tdark.
DR   PRO; PR:Q96N64; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q96N64; protein.
DR   Bgee; ENSG00000170234; Expressed in corpus callosum and 198 other tissues.
DR   ExpressionAtlas; Q96N64; baseline and differential.
DR   Genevisible; Q96N64; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IPI:UniProtKB.
DR   InterPro; IPR000313; PWWP_dom.
DR   Pfam; PF00855; PWWP; 1.
DR   SMART; SM00293; PWWP; 1.
DR   PROSITE; PS50812; PWWP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..755
FT                   /note="PWWP domain-containing protein 2A"
FT                   /id="PRO_0000311363"
FT   DOMAIN          655..715
FT                   /note="PWWP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00162"
FT   REGION          423..574
FT                   /note="Interaction with the H2A.Z/H2AZ1"
FT                   /evidence="ECO:0000269|PubMed:28645917"
FT   COMPBIAS        61..146
FT                   /note="Pro-rich"
FT   COMPBIAS        240..291
FT                   /note="Pro-rich"
FT   COMPBIAS        575..632
FT                   /note="Ser-rich"
FT   MOD_RES         81
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         102
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569"
FT   CROSSLNK        208
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         517..520
FT                   /note="GEAP -> AQRH (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054064"
FT   VAR_SEQ         518..560
FT                   /note="EAPSENQSPSKGPEEASSEVQDTNEVHVPGDQDEPQTLGKKGS -> LNKWQ
FT                   LLHQTVTSPAAPLQCLTDHCGFRLGALKLTVKRAAQRH (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029547"
FT   VAR_SEQ         521..755
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054065"
FT   VAR_SEQ         561..755
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029548"
FT   CONFLICT        154
FT                   /note="S -> L (in Ref. 5; AAH35076)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   755 AA;  81960 MW;  6BF89E9C8D68EAA0 CRC64;
     MAAVAAEAAA TAASPGEGGA GEAEPEMEPI PGSEAGTDPL PVTATEASVP DGETDGQQSA
     PQADEPPLPP PPPPPGELAR SPEAVGPELE AEEKLSVRVA ESAAAAPQGG PELPPSPASP
     PEQPPAPEER EEPPLPQPVA PALVPPAGGD STVSQLIPGS EVRVTLDHII EDALVVSFRF
     GEKLFSGVLM DLSKRFGPHG IPVTVFPKRE YKDKPEAMPL QSNTFQEGTE VKCEANGAVP
     DDPSPVPHPE LSLAESLWTS KPPPLFHEGA PYPPPLFIRD TYNQSIPQPP PRKIKRPKRK
     MYREEPTSIM NAIKLRPRQV LCDKCKNSVV AEKKEIRKGS SATDSSKYED KKRRNESVTT
     VNKKLKTDHK VDGKNQNESQ KRNAVVKVSN IAHSRGRVVK VSAQANTSKA QLSTKKVLQS
     KNMDHAKARE VLKIAKEKAQ KKQNETSTSK NAHSKVHFTR RYQNPSSGSL PPRVRLKPQR
     YRNEENDSSL KTGLEKMRSG KMAPKPQSRC TSTRSAGEAP SENQSPSKGP EEASSEVQDT
     NEVHVPGDQD EPQTLGKKGS KNNISVYMTL NQKKSDSSSA SVCSIDSTDD LKSSNSECSS
     SESFDFPPGS MHAPSTSSTS SSSKEEKKLS NSLKMKVFSK NVSKCVTPDG RTICVGDIVW
     AKIYGFPWWP ARILTITVSR KDNGLLVRQE ARISWFGSPT TSFLALSQLS PFLENFQSRF
     NKKRKGLYRK AITEAAKAAK QLTPEVRALL TQFET
//
ID   GNDS_HUMAN              Reviewed;         914 AA.
AC   Q12967; B7Z753; E7ER93; E7ERZ0; Q5T7V4; Q6KH11; Q6PCE1; Q6ZSD5; Q9HAX7;
AC   Q9HAY1; Q9HCT1; Q9P2N8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2001, sequence version 2.
DT   22-APR-2020, entry version 187.
DE   RecName: Full=Ral guanine nucleotide dissociation stimulator;
DE            Short=RalGDS;
DE   AltName: Full=Ral guanine nucleotide exchange factor;
DE            Short=RalGEF;
GN   Name=RALGDS; Synonyms=KIAA1308, RGF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9365783; DOI=10.1046/j.1469-1809.1997.6140299.x;
RA   Humphrey D., Kwiatkowska J., Henske E.P., Haines J.L., Halley D.,
RA   van Slegtenhorst M., Kwiatkowski D.J.;
RT   "Cloning and evaluation of RALGDS as a candidate for the tuberous sclerosis
RT   gene TSC1.";
RL   Ann. Hum. Genet. 61:299-305(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Yu L., Zhao S.Y.;
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 205-912 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI. The
RT   complete sequences of 150 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 587-914 (ISOFORM 1).
RX   PubMed=7972015; DOI=10.1073/pnas.91.23.11089;
RA   Hofer F., Fields S., Schneider C., Martin G.S.;
RT   "Activated Ras interacts with the Ral guanine nucleotide dissociation
RT   stimulator.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:11089-11093(1994).
RN   [9]
RP   STRUCTURE BY NMR OF 788-884.
RX   PubMed=9302994; DOI=10.1038/nsb0997-694;
RA   Geyer M., Herrmann C., Wohlgemuth S., Wittinghofer A., Kalbitzer H.R.;
RT   "Structure of the Ras-binding domain of RalGEF and implications for Ras
RT   binding and signalling.";
RL   Nat. Struct. Biol. 4:694-699(1997).
RN   [10]
RP   STRUCTURE BY NMR OF 771-886.
RA   Mueller T.D., Handel L., Schmieder P., Oschkinat H.;
RT   "High-resolution structure of the RA-domain of human RalGDS and a dynamics
RT   study of its binding loop to Ras.";
RL   Submitted (MAR-1999) to the PDB data bank.
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-496.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Stimulates the dissociation of GDP from the Ras-related RalA
CC       and RalB GTPases which allows GTP binding and activation of the
CC       GTPases. Interacts and acts as an effector molecule for R-Ras, H-Ras,
CC       K-Ras, and Rap.
CC   -!- SUBUNIT: Interacts with RIT1 and RIT2. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q12967-6; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-12005546, EBI-3867333;
CC       Q12967-6; P49639: HOXA1; NbExp=3; IntAct=EBI-12005546, EBI-740785;
CC       Q12967; P01112: HRAS; NbExp=3; IntAct=EBI-365861, EBI-350145;
CC       Q12967-6; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-12005546, EBI-10171774;
CC       Q12967; P61224: RAP1B; NbExp=2; IntAct=EBI-365861, EBI-358143;
CC       Q12967-6; P61224: RAP1B; NbExp=3; IntAct=EBI-12005546, EBI-358143;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q03385}. Nucleus
CC       {ECO:0000250|UniProtKB:Q03385}. Note=Localizes mainly in the peripheral
CC       region of the cytoplasmic membrane in oocytes and in preimplantation
CC       embryos until the 8-cell stage. Between the late 1-cell and the early
CC       2-cell stages, nuclear localization becomes stronger. After the 4-cell
CC       stage, not detected in the nucleus. {ECO:0000250|UniProtKB:Q03385}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q12967-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12967-2; Sequence=VSP_035301;
CC       Name=3;
CC         IsoId=Q12967-3; Sequence=VSP_043659;
CC       Name=4;
CC         IsoId=Q12967-4; Sequence=VSP_055215, VSP_055217;
CC       Name=5;
CC         IsoId=Q12967-5; Sequence=VSP_055216;
CC       Name=6;
CC         IsoId=Q12967-6; Sequence=VSP_055217;
CC   -!- DOMAIN: The Ras-associating domain interacts with Ras.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF295773; AAG02122.1; -; mRNA.
DR   EMBL; AK127524; BAC87018.1; -; mRNA.
DR   EMBL; AK301470; BAH13489.1; -; mRNA.
DR   EMBL; AF295775; AAG10221.1; -; Genomic_DNA.
DR   EMBL; AF295778; AAG10221.1; JOINED; Genomic_DNA.
DR   EMBL; AF295780; AAG10225.1; -; Genomic_DNA.
DR   EMBL; AF027169; AAQ13414.1; -; mRNA.
DR   EMBL; AL162417; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW88040.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW88042.1; -; Genomic_DNA.
DR   EMBL; BC059362; AAH59362.1; -; mRNA.
DR   EMBL; AB037729; BAA92546.1; -; mRNA.
DR   EMBL; U14417; AAA52360.1; -; mRNA.
DR   CCDS; CCDS43897.1; -. [Q12967-3]
DR   CCDS; CCDS65172.1; -. [Q12967-6]
DR   CCDS; CCDS65173.1; -. [Q12967-5]
DR   CCDS; CCDS65174.1; -. [Q12967-4]
DR   CCDS; CCDS6959.1; -. [Q12967-1]
DR   PIR; I38853; I38853.
DR   RefSeq; NP_001035827.1; NM_001042368.2. [Q12967-3]
DR   RefSeq; NP_001258703.1; NM_001271774.1. [Q12967-4]
DR   RefSeq; NP_001258704.1; NM_001271775.1. [Q12967-5]
DR   RefSeq; NP_001258705.1; NM_001271776.1. [Q12967-6]
DR   RefSeq; NP_006257.1; NM_006266.3. [Q12967-1]
DR   PDB; 1RAX; NMR; -; A=775-886.
DR   PDB; 2B3A; NMR; -; A=798-884.
DR   PDB; 2RGF; NMR; -; A=788-884.
DR   PDB; 3KH0; X-ray; 2.10 A; A/B=793-914.
DR   PDBsum; 1RAX; -.
DR   PDBsum; 2B3A; -.
DR   PDBsum; 2RGF; -.
DR   PDBsum; 3KH0; -.
DR   SMR; Q12967; -.
DR   BioGrid; 111836; 24.
DR   DIP; DIP-31375N; -.
DR   IntAct; Q12967; 21.
DR   MINT; Q12967; -.
DR   STRING; 9606.ENSP00000361120; -.
DR   iPTMnet; Q12967; -.
DR   PhosphoSitePlus; Q12967; -.
DR   BioMuta; RALGDS; -.
DR   DMDM; 14549162; -.
DR   jPOST; Q12967; -.
DR   MassIVE; Q12967; -.
DR   MaxQB; Q12967; -.
DR   PaxDb; Q12967; -.
DR   PeptideAtlas; Q12967; -.
DR   PRIDE; Q12967; -.
DR   ProteomicsDB; 17741; -.
DR   ProteomicsDB; 17880; -.
DR   ProteomicsDB; 59058; -. [Q12967-1]
DR   ProteomicsDB; 59059; -. [Q12967-2]
DR   ProteomicsDB; 59060; -. [Q12967-3]
DR   ProteomicsDB; 67063; -.
DR   Antibodypedia; 31763; 118 antibodies.
DR   DNASU; 5900; -.
DR   Ensembl; ENST00000372047; ENSP00000361117; ENSG00000160271. [Q12967-6]
DR   Ensembl; ENST00000372050; ENSP00000361120; ENSG00000160271. [Q12967-1]
DR   Ensembl; ENST00000372062; ENSP00000361132; ENSG00000160271. [Q12967-4]
DR   Ensembl; ENST00000393157; ENSP00000376864; ENSG00000160271. [Q12967-5]
DR   Ensembl; ENST00000393160; ENSP00000376867; ENSG00000160271. [Q12967-3]
DR   GeneID; 5900; -.
DR   KEGG; hsa:5900; -.
DR   UCSC; uc004cco.5; human. [Q12967-1]
DR   CTD; 5900; -.
DR   DisGeNET; 5900; -.
DR   GeneCards; RALGDS; -.
DR   HGNC; HGNC:9842; RALGDS.
DR   HPA; ENSG00000160271; Low tissue specificity.
DR   MIM; 601619; gene.
DR   neXtProt; NX_Q12967; -.
DR   OpenTargets; ENSG00000160271; -.
DR   PharmGKB; PA34200; -.
DR   eggNOG; KOG3629; Eukaryota.
DR   eggNOG; ENOG410ZUT5; LUCA.
DR   GeneTree; ENSGT00940000153181; -.
DR   HOGENOM; CLU_010252_0_1_1; -.
DR   InParanoid; Q12967; -.
DR   KO; K08732; -.
DR   OMA; STRTHKR; -.
DR   PhylomeDB; Q12967; -.
DR   TreeFam; TF315204; -.
DR   Reactome; R-HSA-171007; p38MAPK events.
DR   SIGNOR; Q12967; -.
DR   ChiTaRS; RALGDS; human.
DR   EvolutionaryTrace; Q12967; -.
DR   GeneWiki; RALGDS; -.
DR   GenomeRNAi; 5900; -.
DR   Pharos; Q12967; Tbio.
DR   PRO; PR:Q12967; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q12967; protein.
DR   Bgee; ENSG00000160271; Expressed in adenohypophysis and 230 other tissues.
DR   ExpressionAtlas; Q12967; baseline and differential.
DR   Genevisible; Q12967; HS.
DR   GO; GO:0005903; C:brush border; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030695; F:GTPase regulator activity; IDA:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007265; P:Ras protein signal transduction; TAS:Reactome.
DR   CDD; cd00155; RasGEF; 1.
DR   CDD; cd06224; REM; 1.
DR   Gene3D; 1.10.840.10; -; 1.
DR   InterPro; IPR000159; RA_dom.
DR   InterPro; IPR015758; RalGDS.
DR   InterPro; IPR008937; Ras-like_GEF.
DR   InterPro; IPR000651; Ras-like_Gua-exchang_fac_N.
DR   InterPro; IPR019804; Ras_G-nucl-exch_fac_CS.
DR   InterPro; IPR023578; Ras_GEF_dom_sf.
DR   InterPro; IPR001895; RASGEF_cat_dom.
DR   InterPro; IPR036964; RASGEF_cat_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR23113; PTHR23113; 1.
DR   PANTHER; PTHR23113:SF35; PTHR23113:SF35; 1.
DR   Pfam; PF00788; RA; 1.
DR   Pfam; PF00617; RasGEF; 1.
DR   Pfam; PF00618; RasGEF_N; 1.
DR   SMART; SM00314; RA; 1.
DR   SMART; SM00147; RasGEF; 1.
DR   SMART; SM00229; RasGEFN; 1.
DR   SUPFAM; SSF48366; SSF48366; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50200; RA; 1.
DR   PROSITE; PS00720; RASGEF; 1.
DR   PROSITE; PS50009; RASGEF_CAT; 1.
DR   PROSITE; PS50212; RASGEF_NTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm;
KW   Guanine-nucleotide releasing factor; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..914
FT                   /note="Ral guanine nucleotide dissociation stimulator"
FT                   /id="PRO_0000068877"
FT   DOMAIN          112..249
FT                   /note="N-terminal Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00135"
FT   DOMAIN          386..648
FT                   /note="Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00168"
FT   DOMAIN          798..885
FT                   /note="Ras-associating"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00166"
FT   COMPBIAS        714..717
FT                   /note="Poly-Ser"
FT   COMPBIAS        753..765
FT                   /note="Poly-Ser"
FT   COMPBIAS        839..844
FT                   /note="Poly-Glu"
FT   VAR_SEQ         1..61
FT                   /note="MVQRMWAEAAGPAGGAEPLFPGSRRSRSVWDAVRLEVGVPDSCPVVLHSFTQ
FT                   LDPDLPRPE -> MMVDCQ (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_043659"
FT   VAR_SEQ         1..61
FT                   /note="MVQRMWAEAAGPAGGAEPLFPGSRRSRSVWDAVRLEVGVPDSCPVVLHSFTQ
FT                   LDPDLPRPE -> MCLWGHSTAPAHTLSSPPLLFCSLPCALHLQPGTGHPPGQVPRK
FT                   (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055215"
FT   VAR_SEQ         1..60
FT                   /note="MVQRMWAEAAGPAGGAEPLFPGSRRSRSVWDAVRLEVGVPDSCPVVLHSFTQ
FT                   LDPDLPRP -> MAREAGQVCARPAVPRGRKGSVFFACVSVVTARRRAVARRAALQSPT
FT                   PWLAPLPAPATT (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055216"
FT   VAR_SEQ         163..174
FT                   /note="Missing (in isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_055217"
FT   VAR_SEQ         738..912
FT                   /note="FWESASQSSPETSGISSASSSTSSSSASTTPVAATRTHKRSVSGLCNSSSAL
FT                   PLYNQQVGDCCIIRVSLDVDNGNMYKSILVTSQDKAPAVIRKAMDKHNLEEEEPEDYEL
FT                   LQILSDDRKLKIPENANVFYAMNSTANYDFVLKKRTFTKGVKVKHGASSTLPRMKQKGL
FT                   KIAKG -> VTACPSPQYPFPSPHSKSMHGARKPWILNTASRRFPIWQLAWGAPTGQWD
FT                   LLILPSPSVLGISLTVIPGDLRHQLSLQQHLVLLSLHHARGCHTHPQALCLRALQLQLR
FT                   AAALQPAGGRLLYHPRQPGRGQWQHVQEHPGKPAGVAWVPPSTGGKCTLNTVHHPCPPG
FT                   VYLVVGGEGQMSARYRNEEGSDQGQGWPEGRGGGKEQPCKAPRS (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:10718198"
FT                   /id="VSP_035301"
FT   VARIANT         496
FT                   /note="R -> L (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035822"
FT   CONFLICT        97
FT                   /note="L -> F (in Ref. 3; BAC87018)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        869
FT                   /note="A -> T (in Ref. 3; BAH13489)"
FT                   /evidence="ECO:0000305"
FT   STRAND          791..793
FT                   /evidence="ECO:0000244|PDB:2RGF"
FT   STRAND          795..797
FT                   /evidence="ECO:0000244|PDB:3KH0"
FT   STRAND          799..807
FT                   /evidence="ECO:0000244|PDB:3KH0"
FT   STRAND          809..820
FT                   /evidence="ECO:0000244|PDB:3KH0"
FT   HELIX           825..835
FT                   /evidence="ECO:0000244|PDB:3KH0"
FT   TURN            836..839
FT                   /evidence="ECO:0000244|PDB:2RGF"
FT   HELIX           843..845
FT                   /evidence="ECO:0000244|PDB:3KH0"
FT   STRAND          846..853
FT                   /evidence="ECO:0000244|PDB:3KH0"
FT   STRAND          856..859
FT                   /evidence="ECO:0000244|PDB:3KH0"
FT   STRAND          862..864
FT                   /evidence="ECO:0000244|PDB:2B3A"
FT   HELIX           866..869
FT                   /evidence="ECO:0000244|PDB:3KH0"
FT   STRAND          877..882
FT                   /evidence="ECO:0000244|PDB:3KH0"
FT   CONFLICT        Q12967-5:3
FT                   /note="R -> W (in Ref. 3; BAC87018)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   914 AA;  100607 MW;  EA5A5CF25AF3D523 CRC64;
     MVQRMWAEAA GPAGGAEPLF PGSRRSRSVW DAVRLEVGVP DSCPVVLHSF TQLDPDLPRP
     ESSTQEIGEE LINGVIYSIS LRKVQLHHGG NKGQRWLGYE NESALNLYET CKVRTVKAGT
     LEKLVEHLVP AFQGSDLSYV TIFLCTYRAF TTTQQVLDLL FKRYGRCDAL TASSRYGCIL
     PYSDEDGGPQ DQLKNAISSI LGTWLDQYSE DFCQPPDFPC LKQLVAYVQL NMPGSDLERR
     AHLLLAQLEH SEPIEAEPEA LSPVPALKPT PELELALTPA RAPSPVPAPA PEPEPAPTPA
     PGSELEVAPA PAPELQQAPE PAVGLESAPA PALELEPAPE QDPAPSQTLE LEPAPAPVPS
     LQPSWPSPVV AENGLSEEKP HLLVFPPDLV AEQFTLMDAE LFKKVVPYHC LGSIWSQRDK
     KGKEHLAPTI RATVTQFNSV ANCVITTCLG NRSTKAPDRA RVVEHWIEVA RECRILKNFS
     SLYAILSALQ SNSIHRLKKT WEDVSRDSFR IFQKLSEIFS DENNYSLSRE LLIKEGTSKF
     ATLEMNPKRA QKRPKETGII QGTVPYLGTF LTDLVMLDTA MKDYLYGRLI NFEKRRKEFE
     VIAQIKLLQS ACNNYSIAPD EQFGAWFRAV ERLSETESYN LSCELEPPSE SASNTLRTKK
     NTAIVKRWSD RQAPSTELST SGSSHSKSCD QLRCGPYLSS GDIADALSVH SAGSSSSDVE
     EINISFVPES PDGQEKKFWE SASQSSPETS GISSASSSTS SSSASTTPVA ATRTHKRSVS
     GLCNSSSALP LYNQQVGDCC IIRVSLDVDN GNMYKSILVT SQDKAPAVIR KAMDKHNLEE
     EEPEDYELLQ ILSDDRKLKI PENANVFYAM NSTANYDFVL KKRTFTKGVK VKHGASSTLP
     RMKQKGLKIA KGIF
//
ID   Q8N4Y1_HUMAN            Unreviewed;       411 AA.
AC   Q8N4Y1;
DT   01-OCT-2002, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2002, sequence version 1.
DT   11-DEC-2019, entry version 111.
DE   SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:AAH33198.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH33198.1};
RN   [1] {ECO:0000313|EMBL:AAH33198.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Primary B-Cells {ECO:0000313|EMBL:AAH33198.1};
RA   Strausberg R.;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC033198; AAH33198.1; -; mRNA.
DR   RefSeq; NP_001035827.1; NM_001042368.2.
DR   RefSeq; NP_001258703.1; NM_001271774.1.
DR   RefSeq; NP_001258704.1; NM_001271775.1.
DR   RefSeq; NP_001258705.1; NM_001271776.1.
DR   RefSeq; NP_006257.1; NM_006266.3.
DR   PeptideAtlas; Q8N4Y1; -.
DR   PRIDE; Q8N4Y1; -.
DR   DNASU; 5900; -.
DR   GeneID; 5900; -.
DR   KEGG; hsa:5900; -.
DR   CTD; 5900; -.
DR   PharmGKB; PA34200; -.
DR   eggNOG; KOG3629; Eukaryota.
DR   eggNOG; ENOG410ZUT5; LUCA.
DR   KO; K08732; -.
DR   OrthoDB; 940219at2759; -.
DR   GenomeRNAi; 5900; -.
DR   Genevisible; Q8N4Y1; HS.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   Gene3D; 1.10.840.10; -; 1.
DR   InterPro; IPR000159; RA_dom.
DR   InterPro; IPR015758; RalGDS.
DR   InterPro; IPR008937; Ras-like_GEF.
DR   InterPro; IPR019804; Ras_G-nucl-exch_fac_CS.
DR   InterPro; IPR023578; Ras_GEF_dom_sf.
DR   InterPro; IPR001895; RASGEF_cat_dom.
DR   InterPro; IPR036964; RASGEF_cat_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR23113; PTHR23113; 1.
DR   PANTHER; PTHR23113:SF35; PTHR23113:SF35; 1.
DR   Pfam; PF00788; RA; 1.
DR   Pfam; PF00617; RasGEF; 1.
DR   SMART; SM00314; RA; 1.
DR   SMART; SM00147; RasGEF; 1.
DR   SUPFAM; SSF48366; SSF48366; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50200; RA; 1.
DR   PROSITE; PS00720; RASGEF; 1.
DR   PROSITE; PS50009; RASGEF_CAT; 1.
PE   2: Evidence at transcript level;
KW   Guanine-nucleotide releasing factor {ECO:0000256|PROSITE-ProRule:PRU00168,
KW   ECO:0000256|SAAS:SAAS01081641}.
FT   DOMAIN          1..145
FT                   /note="Ras-GEF"
FT                   /evidence="ECO:0000259|PROSITE:PS50009"
FT   DOMAIN          295..382
FT                   /note="Ras-associating"
FT                   /evidence="ECO:0000259|PROSITE:PS50200"
FT   REGION          163..186
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          225..273
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        234..273
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:AAH33198.1"
SQ   SEQUENCE   411 AA;  45526 MW;  114CF1F26F923B79 CRC64;
     VSRDSFRIFQ KLSEIFSDEN NYSLSRELLI KEGTSKFATL EMNPKRAQKR PKETGIIQGT
     VPYLGTFLTD LVMLDTAMKD YLYGRLINFE KRRKEFEVIA QIKLLQSACN NYSIAPDEQF
     GAWFRAVERL SETESYNLSC ELEPPSESAS NTLRTKKNTA IVKRWSDRQA PSTELSTSGS
     SHSKSCDQLR CGPYLSSGDI ADALSVHSAG SSSSDVEEIN ISFVPESPDG QEKKFWESAS
     QSSPETSGIS SASSSTSSSS ASTTPVAATR THKRSVSGLC NSSSALPLYN QQVGDCCIIR
     VSLDVDNGNM YKSILVTSQD KAPAVIRKAM DKHNLEEEEP EDYELLQILS DDRKLKIPEN
     ANVFYAMNST ANYDFVLKKR TFTKGVKVKH GASSTLPRMK QKGLKIAKGI F
//
ID   S10A7_HUMAN             Reviewed;         101 AA.
AC   P31151; Q5SY67; Q6FGE3; Q9H1E2;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   26-FEB-2008, sequence version 4.
DT   22-APR-2020, entry version 197.
DE   RecName: Full=Protein S100-A7;
DE   AltName: Full=Psoriasin;
DE   AltName: Full=S100 calcium-binding protein A7;
GN   Name=S100A7; Synonyms=PSOR1, S100A7C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-28.
RC   TISSUE=Keratinocyte;
RX   PubMed=1940442; DOI=10.1111/1523-1747.ep12484041;
RA   Madsen P., Rasmussen H.H., Leffers H., Honore B., Dejgaard K., Olsen E.,
RA   Kiil J., Walbum E., Andersen A.H., Basse B., Lauridsen J.B., Ratz G.P.,
RA   Celis A., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning, occurrence, and expression of a novel partially
RT   secreted protein 'psoriasin' that is highly up-regulated in psoriatic
RT   skin.";
RL   J. Invest. Dermatol. 97:701-712(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-28.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-28.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-89, AND VARIANT ASP-28.
RA   Glaeser R., Harder J., Christophers E., Schroeder J.M.;
RT   "Genomic organization of human psoriasin (S100A7) gene.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 2-101, MASS SPECTROMETRY, AND ACETYLATION AT SER-2.
RC   TISSUE=Psoriatic skin;
RX   PubMed=8526920; DOI=10.1006/bbrc.1995.2772;
RA   Burgisser D.M., Siegenthaler G., Kuster T., Hellman U., Hunziker P.,
RA   Birchler N., Heizmann C.W.;
RT   "Amino acid sequence analysis of human S100A7 (psoriasin) by tandem mass
RT   spectrometry.";
RL   Biochem. Biophys. Res. Commun. 217:257-263(1995).
RN   [7]
RP   PROTEIN SEQUENCE OF 9-19; 38-48; 50-61; 69-87 AND 89-101.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [8]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=8618345; DOI=10.1016/s0022-5347(01)66118-4;
RA   Celis J.E., Rasmussen H.H., Vorum H., Madsen P., Honore B., Wolf H.,
RA   Orntoft T.F.;
RT   "Bladder squamous cell carcinomas express psoriasin and externalize it to
RT   the urine.";
RL   J. Urol. 155:2105-2112(1996).
RN   [9]
RP   INTERACTION WITH RANBP9.
RX   PubMed=12421467; DOI=10.1186/1471-2407-2-28;
RA   Emberley E.D., Gietz R.D., Campbell J.D., Hayglass K.T., Murphy L.C.,
RA   Watson P.H.;
RT   "RanBPM interacts with psoriasin in vitro and their expression correlates
RT   with specific clinical features in vivo in breast cancer.";
RL   BMC Cancer 2:28-28(2002).
RN   [10]
RP   GENOMIC ORGANIZATION.
RX   PubMed=12664160; DOI=10.1007/s00239-002-2410-5;
RA   Kulski J.K., Lim C.P., Dunn D.S., Bellgard M.;
RT   "Genomic and phylogenetic analysis of the S100A7 (psoriasin) gene
RT   duplications within the region of the S100 gene cluster on human chromosome
RT   1q21.";
RL   J. Mol. Evol. 56:397-406(2003).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.05 ANGSTROMS).
RX   PubMed=9562557; DOI=10.1016/s0969-2126(98)00049-5;
RA   Brodersen D.E., Etzerodt M., Madsen P., Celis J.E., Thoegersen H.C.,
RA   Nyborg J., Kjeldgaard M.;
RT   "EF-hands at atomic resolution: the structure of human psoriasin (S100A7)
RT   solved by MAD phasing.";
RL   Structure 6:477-489(1998).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS).
RX   PubMed=10026247; DOI=10.1021/bi982483d;
RA   Brodersen D.E., Nyborg J., Kjeldgaard M.;
RT   "Zinc-binding site of an S100 protein revealed. Two crystal structures of
RT   Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free
RT   states.";
RL   Biochemistry 38:1695-1704(1999).
CC   -!- SUBUNIT: Interacts with RANBP9. {ECO:0000269|PubMed:12421467}.
CC   -!- INTERACTION:
CC       P31151; Q5SYC1: CLVS2; NbExp=3; IntAct=EBI-357520, EBI-12357161;
CC       P31151; Q96S59: RANBP9; NbExp=3; IntAct=EBI-357520, EBI-636085;
CC       P31151; Q5SY68: S100A7L2; NbExp=10; IntAct=EBI-357520, EBI-12006206;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8618345}. Secreted
CC       {ECO:0000269|PubMed:8618345}. Note=Secreted by a non-classical
CC       secretory pathway.
CC   -!- TISSUE SPECIFICITY: Fetal ear, skin, and tongue and human cell lines.
CC       Highly up-regulated in psoriatic epidermis. Also highly expressed in
CC       the urine of bladder squamous cell carcinoma (SCC) bearing patients.
CC       {ECO:0000269|PubMed:8618345}.
CC   -!- MASS SPECTROMETRY: Mass=11365; Mass_error=0.7; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:8526920};
CC   -!- SIMILARITY: Belongs to the S-100 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/S100A7ID42194ch1q21.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M86757; AAA60210.1; -; mRNA.
DR   EMBL; CR542164; CAG46961.1; -; mRNA.
DR   EMBL; AL591704; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034687; AAH34687.1; -; mRNA.
DR   EMBL; AJ012825; CAC20409.1; -; Genomic_DNA.
DR   EMBL; BR000043; FAA00017.1; -; Genomic_DNA.
DR   CCDS; CCDS1039.1; -.
DR   PIR; A54327; A54327.
DR   RefSeq; NP_002954.2; NM_002963.3.
DR   PDB; 1PSR; X-ray; 1.05 A; A/B=2-101.
DR   PDB; 2PSR; X-ray; 2.05 A; A=2-101.
DR   PDB; 2WND; X-ray; 1.60 A; A=2-97.
DR   PDB; 2WOR; X-ray; 1.70 A; A=2-101.
DR   PDB; 2WOS; X-ray; 1.70 A; A=2-101.
DR   PDB; 3PSR; X-ray; 2.50 A; A/B=2-101.
DR   PDB; 4AQJ; X-ray; 1.60 A; A=1-101.
DR   PDBsum; 1PSR; -.
DR   PDBsum; 2PSR; -.
DR   PDBsum; 2WND; -.
DR   PDBsum; 2WOR; -.
DR   PDBsum; 2WOS; -.
DR   PDBsum; 3PSR; -.
DR   PDBsum; 4AQJ; -.
DR   SMR; P31151; -.
DR   BioGrid; 112186; 64.
DR   IntAct; P31151; 45.
DR   STRING; 9606.ENSP00000357712; -.
DR   DrugBank; DB04474; 1-Anilino-8-Naphthalene Sulfonate.
DR   DrugBank; DB09213; Dexibuprofen.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB01593; Zinc.
DR   DrugBank; DB14487; Zinc acetate.
DR   DrugBank; DB14533; Zinc chloride.
DR   iPTMnet; P31151; -.
DR   PhosphoSitePlus; P31151; -.
DR   BioMuta; S100A7; -.
DR   DMDM; 172046820; -.
DR   UCD-2DPAGE; P31151; -.
DR   EPD; P31151; -.
DR   jPOST; P31151; -.
DR   MassIVE; P31151; -.
DR   MaxQB; P31151; -.
DR   PaxDb; P31151; -.
DR   PeptideAtlas; P31151; -.
DR   PRIDE; P31151; -.
DR   ProteomicsDB; 54761; -.
DR   TopDownProteomics; P31151; -.
DR   Antibodypedia; 1683; 526 antibodies.
DR   DNASU; 6278; -.
DR   Ensembl; ENST00000368722; ENSP00000357711; ENSG00000143556.
DR   Ensembl; ENST00000368723; ENSP00000357712; ENSG00000143556.
DR   GeneID; 6278; -.
DR   KEGG; hsa:6278; -.
DR   UCSC; uc001fbv.2; human.
DR   CTD; 6278; -.
DR   DisGeNET; 6278; -.
DR   GeneCards; S100A7; -.
DR   HGNC; HGNC:10497; S100A7.
DR   HPA; ENSG00000143556; Tissue enhanced (esophagus, lymphoid tissue, tongue).
DR   MIM; 600353; gene.
DR   neXtProt; NX_P31151; -.
DR   OpenTargets; ENSG00000143556; -.
DR   PharmGKB; PA34909; -.
DR   eggNOG; ENOG410JEQ8; Eukaryota.
DR   eggNOG; ENOG41114XT; LUCA.
DR   GeneTree; ENSGT00940000163488; -.
DR   HOGENOM; CLU_138624_5_0_1; -.
DR   InParanoid; P31151; -.
DR   KO; K21126; -.
DR   OMA; FHNDTRH; -.
DR   OrthoDB; 1486203at2759; -.
DR   PhylomeDB; P31151; -.
DR   TreeFam; TF341148; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-6799990; Metal sequestration by antimicrobial proteins.
DR   EvolutionaryTrace; P31151; -.
DR   GeneWiki; S100A7; -.
DR   GenomeRNAi; 6278; -.
DR   Pharos; P31151; Tbio.
DR   PRO; PR:P31151; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P31151; protein.
DR   Bgee; ENSG00000143556; Expressed in ectocervix and 75 other tissues.
DR   Genevisible; P31151; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0050786; F:RAGE receptor binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; NAS:UniProtKB.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IMP:UniProtKB.
DR   GO; GO:0019730; P:antimicrobial humoral response; TAS:Reactome.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IMP:UniProtKB.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0045087; P:innate immune response; NAS:UniProtKB.
DR   GO; GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0071624; P:positive regulation of granulocyte chemotaxis; IDA:UniProtKB.
DR   GO; GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:UniProtKB.
DR   GO; GO:0010820; P:positive regulation of T cell chemotaxis; IDA:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:UniProtKB.
DR   GO; GO:0000302; P:response to reactive oxygen species; IDA:UniProtKB.
DR   GO; GO:0051238; P:sequestering of metal ion; IDA:UniProtKB.
DR   CDD; cd00213; S-100; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR034325; S-100_dom.
DR   InterPro; IPR001751; S100/CaBP-9k_CS.
DR   InterPro; IPR013787; S100_Ca-bd_sub.
DR   InterPro; IPR028477; S100A7.
DR   PANTHER; PTHR11639:SF128; PTHR11639:SF128; 1.
DR   Pfam; PF01023; S_100; 1.
DR   SMART; SM01394; S_100; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
DR   PROSITE; PS00303; S100_CABP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Calcium; Cytoplasm; Direct protein sequencing;
KW   Disulfide bond; Metal-binding; Polymorphism; Reference proteome; Repeat;
KW   Secreted; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:8526920"
FT   CHAIN           2..101
FT                   /note="Protein S100-A7"
FT                   /id="PRO_0000143990"
FT   DOMAIN          13..48
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          50..85
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   CA_BIND         63..74
FT                   /note="2; high affinity"
FT   METAL           18
FT                   /note="Zinc"
FT   METAL           25
FT                   /note="Zinc"
FT   METAL           87
FT                   /note="Zinc"
FT   METAL           91
FT                   /note="Zinc"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:8526920"
FT   DISULFID        47..96
FT   VARIANT         28
FT                   /note="E -> D (in dbSNP:rs3014837)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:1940442, ECO:0000269|Ref.2,
FT                   ECO:0000269|Ref.5"
FT                   /id="VAR_039118"
FT   HELIX           5..19
FT                   /evidence="ECO:0000244|PDB:1PSR"
FT   HELIX           29..39
FT                   /evidence="ECO:0000244|PDB:1PSR"
FT   HELIX           41..49
FT                   /evidence="ECO:0000244|PDB:1PSR"
FT   HELIX           54..56
FT                   /evidence="ECO:0000244|PDB:1PSR"
FT   HELIX           58..62
FT                   /evidence="ECO:0000244|PDB:1PSR"
FT   STRAND          67..70
FT                   /evidence="ECO:0000244|PDB:2WND"
FT   HELIX           72..89
FT                   /evidence="ECO:0000244|PDB:1PSR"
FT   TURN            90..92
FT                   /evidence="ECO:0000244|PDB:1PSR"
SQ   SEQUENCE   101 AA;  11471 MW;  02C4CE39BF140971 CRC64;
     MSNTQAERSI IGMIDMFHKY TRRDDKIEKP SLLTMMKENF PNFLSACDKK GTNYLADVFE
     KKDKNEDKKI DFSEFLSLLG DIATDYHKQS HGAAPCSGGS Q
//
ID   SEPT5_HUMAN             Reviewed;         369 AA.
AC   Q99719; O15251; Q96MY5;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   22-APR-2020, entry version 180.
DE   RecName: Full=Septin-5;
DE   AltName: Full=Cell division control-related protein 1;
DE            Short=CDCrel-1;
DE   AltName: Full=Peanut-like protein 1;
GN   Name=SEPTIN5 {ECO:0000312|HGNC:HGNC:9164}; Synonyms=PNUTL1, SEPT5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9022087; DOI=10.1172/jci119188;
RA   Zieger B., Hashimoto Y., Ware J.;
RT   "Alternative expression of platelet glycoprotein Ib(beta) mRNA from an
RT   adjacent 5' gene with an imperfect polyadenylation signal sequence.";
RL   J. Clin. Invest. 99:520-525(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=9385360; DOI=10.1007/s004390050576;
RA   McKie J., Sutherland H., Harvey E., Kim U.J., Scambler P.J.;
RT   "A human gene similar to Drosophila melanogaster peanut maps to the
RT   DiGeorge syndrome region of 22q11.";
RL   Hum. Genet. 101:6-12(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=9611266; DOI=10.1016/s0378-1119(98)00146-2;
RA   Yagi M., Zieger B., Roth G.J., Ware J.;
RT   "Structure and expression of the human septin gene HCDCREL-1.";
RL   Gene 212:229-236(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 23-36; 42-71; 82-90; 182-190; 297-308 AND 325-343, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   INTERACTION WITH SEPTIN8, AND TISSUE SPECIFICITY.
RX   PubMed=12023038; DOI=10.1016/s0014-5793(02)02749-7;
RA   Blaeser S., Jersch K., Hainmann I., Wunderle D., Zgaga-Griesz A., Busse A.,
RA   Zieger B.;
RT   "Human septin-septin interaction: CDCrel-1 partners with KIAA0202.";
RL   FEBS Lett. 519:169-172(2002).
RN   [11]
RP   IDENTIFICATION IN A COMPLEX WITH STX4, AND PHOSPHORYLATION.
RX   PubMed=11880646; DOI=10.1073/pnas.052715199;
RA   Dent J., Kato K., Peng X.-R., Martinez C., Cattaneo M., Poujol C.,
RA   Nurden P., Nurden A., Trimble W.S., Ware J.;
RT   "A prototypic platelet septin and its participation in secretion.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:3064-3069(2002).
RN   [12]
RP   POSSIBLE INVOLVEMENT IN PRKN.
RX   PubMed=14530399; DOI=10.1073/pnas.2132992100;
RA   Dong Z., Ferger B., Paterna J.-C., Vogel D., Furler S., Osinde M.,
RA   Feldon J., Bueeler H.;
RT   "Dopamine-dependent neurodegeneration in rats induced by viral vector-
RT   mediated overexpression of the parkin target protein, CDCrel-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12438-12443(2003).
RN   [13]
RP   TISSUE SPECIFICITY.
RX   PubMed=15915442; DOI=10.1002/path.1789;
RA   Hall P.A., Jung K., Hillan K.J., Russell S.E.H.;
RT   "Expression profiling the human septin gene family.";
RL   J. Pathol. 206:269-278(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225 AND SER-327, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225 AND SER-327, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Filament-forming cytoskeletal GTPase (By similarity). May
CC       play a role in cytokinesis (Potential). May play a role in platelet
CC       secretion (By similarity). {ECO:0000250, ECO:0000305}.
CC   -!- SUBUNIT: Septins polymerize into heterooligomeric protein complexes
CC       that form filaments, and can associate with cellular membranes, actin
CC       filaments and microtubules. GTPase activity is required for filament
CC       formation (By similarity). Interacts with SEPTIN2 and SEPTIN5. In
CC       platelets, associated with a complex containing STX4. Interacts with
CC       PRKN. This interaction leads to SEPTIN5 ubiquitination and degradation
CC       (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q99719; Q99719; NbExp=3; IntAct=EBI-373345, EBI-373345;
CC       Q99719; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-373345, EBI-742054;
CC       Q99719; P43356: MAGEA2B; NbExp=4; IntAct=EBI-373345, EBI-5650739;
CC       Q99719; Q8WYJ6: SEPTIN1; NbExp=13; IntAct=EBI-373345, EBI-693002;
CC       Q99719; Q9P0V9: SEPTIN10; NbExp=6; IntAct=EBI-373345, EBI-3943788;
CC       Q99719; Q9NVA2: SEPTIN11; NbExp=10; IntAct=EBI-373345, EBI-957999;
CC       Q99719; Q8IYM1: SEPTIN12; NbExp=4; IntAct=EBI-373345, EBI-2585067;
CC       Q99719; Q15019: SEPTIN2; NbExp=4; IntAct=EBI-373345, EBI-741220;
CC       Q99719; Q15019-3: SEPTIN2; NbExp=4; IntAct=EBI-373345, EBI-11525407;
CC       Q99719; Q14141: SEPTIN6; NbExp=6; IntAct=EBI-373345, EBI-745901;
CC       Q99719; Q92599: SEPTIN8; NbExp=6; IntAct=EBI-373345, EBI-958021;
CC       Q99719; Q9NZD8: SPG21; NbExp=3; IntAct=EBI-373345, EBI-742688;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000250}. Note=In platelets, found in areas surrounding alpha-
CC       granules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99719-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99719-2; Sequence=VSP_042689, VSP_042690;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in the CNS, as well as in
CC       heart and platelets (at protein level). {ECO:0000269|PubMed:12023038,
CC       ECO:0000269|PubMed:15915442}.
CC   -!- PTM: In platelets, phosphorylated in response to thrombin, phorbol-12-
CC       myristate-13-acetate and collagen. {ECO:0000269|PubMed:11880646}.
CC   -!- MISCELLANEOUS: In a heterologous system, SEPTIN5 overexpression has
CC       been shown to exert dopamine-dependent neurotoxicity. As wild-type
CC       PRKN, but not familial-linked PRKN mutants, ubiquitinates mouse SEPTIN5
CC       and promotes its degradation, it has been suggested that a deficiency
CC       in SEPTIN5 degradation may contribute to the development of early onset
CC       Parkinson disease 2 (PARK2).
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like
CC       GTPase superfamily. Septin GTPase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01056}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/hCDCRel-1ID220.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U74628; AAB93438.1; -; mRNA.
DR   EMBL; Y11593; CAA72332.1; -; mRNA.
DR   EMBL; AF006988; AAC39779.1; -; Genomic_DNA.
DR   EMBL; CR456545; CAG30431.1; -; mRNA.
DR   EMBL; AK056273; BAB71133.1; -; mRNA.
DR   EMBL; AC000093; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471176; EAX03032.1; -; Genomic_DNA.
DR   EMBL; BC025261; AAH25261.1; -; mRNA.
DR   CCDS; CCDS13764.1; -. [Q99719-1]
DR   CCDS; CCDS56224.1; -. [Q99719-2]
DR   RefSeq; NP_001009939.1; NM_001009939.2. [Q99719-2]
DR   RefSeq; NP_002679.2; NM_002688.5. [Q99719-1]
DR   SMR; Q99719; -.
DR   BioGrid; 111414; 29.
DR   DIP; DIP-31201N; -.
DR   IntAct; Q99719; 25.
DR   MINT; Q99719; -.
DR   STRING; 9606.ENSP00000391311; -.
DR   iPTMnet; Q99719; -.
DR   PhosphoSitePlus; Q99719; -.
DR   SwissPalm; Q99719; -.
DR   BioMuta; SEPT5; -.
DR   DMDM; 6685760; -.
DR   UCD-2DPAGE; Q99719; -.
DR   EPD; Q99719; -.
DR   jPOST; Q99719; -.
DR   MassIVE; Q99719; -.
DR   PaxDb; Q99719; -.
DR   PeptideAtlas; Q99719; -.
DR   PRIDE; Q99719; -.
DR   ProteomicsDB; 78433; -. [Q99719-1]
DR   ProteomicsDB; 78434; -. [Q99719-2]
DR   Antibodypedia; 4242; 223 antibodies.
DR   DNASU; 5413; -.
DR   Ensembl; ENST00000438754; ENSP00000394541; ENSG00000184702. [Q99719-2]
DR   Ensembl; ENST00000455784; ENSP00000391311; ENSG00000184702. [Q99719-1]
DR   GeneID; 5413; -.
DR   KEGG; hsa:5413; -.
DR   UCSC; uc002zpw.2; human. [Q99719-1]
DR   CTD; 5413; -.
DR   DisGeNET; 5413; -.
DR   GeneCards; SEPTIN5; -.
DR   HGNC; HGNC:9164; SEPTIN5.
DR   HPA; ENSG00000184702; Tissue enhanced (brain, parathyroid gland).
DR   MIM; 602724; gene.
DR   neXtProt; NX_Q99719; -.
DR   OpenTargets; ENSG00000184702; -.
DR   PharmGKB; PA33486; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00940000159913; -.
DR   HOGENOM; CLU_017718_0_0_1; -.
DR   InParanoid; Q99719; -.
DR   KO; K04557; -.
DR   OrthoDB; 845354at2759; -.
DR   PhylomeDB; Q99719; -.
DR   TreeFam; TF101079; -.
DR   ChiTaRS; SEPT5; human.
DR   GeneWiki; SEPT5; -.
DR   GenomeRNAi; 5413; -.
DR   Pharos; Q99719; Tbio.
DR   PRO; PR:Q99719; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q99719; protein.
DR   Bgee; ENSG00000184702; Expressed in right frontal lobe and 181 other tissues.
DR   ExpressionAtlas; Q99719; baseline and differential.
DR   Genevisible; Q99719; HS.
DR   GO; GO:0032153; C:cell division site; IBA:GO_Central.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031105; C:septin complex; ISS:UniProtKB.
DR   GO; GO:0005940; C:septin ring; IBA:GO_Central.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0060090; F:molecular adaptor activity; IBA:GO_Central.
DR   GO; GO:0005198; F:structural molecule activity; TAS:ProtInc.
DR   GO; GO:0030534; P:adult behavior; ISS:UniProtKB.
DR   GO; GO:0034613; P:cellular protein localization; IBA:GO_Central.
DR   GO; GO:0061640; P:cytoskeleton-dependent cytokinesis; IBA:GO_Central.
DR   GO; GO:0017157; P:regulation of exocytosis; IMP:UniProtKB.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0035176; P:social behavior; ISS:UniProtKB.
DR   GO; GO:0016080; P:synaptic vesicle targeting; TAS:UniProtKB.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030647; SEPT5.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF68; PTHR18884:SF68; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; GTP-binding; Methylation;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome.
FT   CHAIN           1..369
FT                   /note="Septin-5"
FT                   /id="PRO_0000173521"
FT   DOMAIN          41..314
FT                   /note="Septin-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   NP_BIND         51..58
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         190..198
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   REGION          51..58
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   REGION          108..111
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   REGION          189..192
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   COILED          338..369
FT                   /evidence="ECO:0000255"
FT   BINDING         85
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   BINDING         111
FT                   /note="GTP; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         248
FT                   /note="GTP; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         263
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         13
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2Q6"
FT   MOD_RES         168
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2Q6"
FT   MOD_RES         225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18088087,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         327
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         336
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2Q6"
FT   VAR_SEQ         1..18
FT                   /note="MSTGLRYKSKLATPEDKQ -> MDSLAAPQDRLVEQLLSPRTQAQRRLK
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042689"
FT   VAR_SEQ         272..369
FT                   /note="VENQAHCDFVKLRNMLIRTHMHDLKDVTCDVHYENYRAHCIQQMTSKLTQDS
FT                   RMESPIPILPLPTPDAETEKLIRMKDEELRRMQEMLQRMKQQMQDQ -> GALRLREAA
FT                   QHAHPHAYARPQGRDVRRALRELPRALHPADDQQTDPGQPHGEPHPDPAAAHPGRRD
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042690"
FT   CONFLICT        224
FT                   /note="D -> N (in Ref. 2; CAA72332)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   369 AA;  42777 MW;  47054765DEA10D33 CRC64;
     MSTGLRYKSK LATPEDKQDI DKQYVGFATL PNQVHRKSVK KGFDFTLMVA GESGLGKSTL
     VHSLFLTDLY KDRKLLSAEE RISQTVEILK HTVDIEEKGV KLKLTIVDTP GFGDAVNNTE
     CWKPITDYVD QQFEQYFRDE SGLNRKNIQD NRVHCCLYFI SPFGHGLRPV DVGFMKALHE
     KVNIVPLIAK ADCLVPSEIR KLKERIREEI DKFGIHVYQF PECDSDEDED FKQQDRELKE
     SAPFAVIGSN TVVEAKGQRV RGRLYPWGIV EVENQAHCDF VKLRNMLIRT HMHDLKDVTC
     DVHYENYRAH CIQQMTSKLT QDSRMESPIP ILPLPTPDAE TEKLIRMKDE ELRRMQEMLQ
     RMKQQMQDQ
//
ID   X5DNA9_HUMAN            Unreviewed;       369 AA.
AC   X5DNA9;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   22-APR-2020, entry version 53.
DE   SubName: Full=HCG2002594, isoform CRA_d {ECO:0000313|EMBL:EAX03030.1};
DE   SubName: Full=Septin 5 isoform A {ECO:0000313|EMBL:AHW56396.1};
DE   Flags: Fragment;
GN   Name=SEPT5 {ECO:0000313|EMBL:AHW56396.1};
GN   ORFNames=hCG_2002594 {ECO:0000313|EMBL:EAX03030.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHW56396.1};
RN   [1] {ECO:0000313|EMBL:EAX03030.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX03030.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AHW56396.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult whole brain {ECO:0000313|EMBL:AHW56396.1};
RX   PubMed=24722188;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L., Broly M.,
RA   Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S., Tasan M., Lemmens I.,
RA   Kuang X., Zhao N., Malhotra D., Michaelson J.J., Vacic V., Calderwood M.A.,
RA   Roth F.P., Tavernier J., Horvath S., Salehi-Ashtiani K., Korkin D.,
RA   Sebat J., Hill D.E., Hao T., Vidal M., Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from brain
RT   links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like
CC       GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KJ534756; AHW56396.1; -; mRNA.
DR   EMBL; CH471176; EAX03030.1; -; Genomic_DNA.
DR   RefSeq; NP_002679.2; NM_002688.5.
DR   Antibodypedia; 4242; 223 antibodies.
DR   GeneID; 5413; -.
DR   KEGG; hsa:5413; -.
DR   UCSC; uc002zpv.3; human.
DR   CTD; 5413; -.
DR   EuPathDB; HostDB:ENSG00000184702.17; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   HOGENOM; CLU_017718_0_0_1; -.
DR   KO; K04557; -.
DR   OrthoDB; 845354at2759; -.
DR   ChiTaRS; SEPT5; human.
DR   GenomeRNAi; 5413; -.
DR   Bgee; ENSG00000184702; Expressed in right frontal lobe and 181 other tissues.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0017157; P:regulation of exocytosis; IEA:InterPro.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030647; SEPT5.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF68; PTHR18884:SF68; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTP-binding {ECO:0000256|PIRSR:PIRSR006698-2,
KW   ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00312599};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR006698-2,
KW   ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00312599}.
FT   DOMAIN          41..314
FT                   /note="Septin-type G"
FT                   /evidence="ECO:0000259|PROSITE:PS51719"
FT   COILED          345..368
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   SITE            163
FT                   /note="Important for dimerization"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR006698-2"
FT   NON_TER         369
FT                   /evidence="ECO:0000313|EMBL:AHW56396.1"
SQ   SEQUENCE   369 AA;  42777 MW;  47054765DEA10D33 CRC64;
     MSTGLRYKSK LATPEDKQDI DKQYVGFATL PNQVHRKSVK KGFDFTLMVA GESGLGKSTL
     VHSLFLTDLY KDRKLLSAEE RISQTVEILK HTVDIEEKGV KLKLTIVDTP GFGDAVNNTE
     CWKPITDYVD QQFEQYFRDE SGLNRKNIQD NRVHCCLYFI SPFGHGLRPV DVGFMKALHE
     KVNIVPLIAK ADCLVPSEIR KLKERIREEI DKFGIHVYQF PECDSDEDED FKQQDRELKE
     SAPFAVIGSN TVVEAKGQRV RGRLYPWGIV EVENQAHCDF VKLRNMLIRT HMHDLKDVTC
     DVHYENYRAH CIQQMTSKLT QDSRMESPIP ILPLPTPDAE TEKLIRMKDE ELRRMQEMLQ
     RMKQQMQDQ
//
ID   B1AMS2_HUMAN            Unreviewed;       431 AA.
AC   B1AMS2;
DT   08-APR-2008, integrated into UniProtKB/TrEMBL.
DT   08-APR-2008, sequence version 1.
DT   22-APR-2020, entry version 110.
DE   SubName: Full=Septin 6, isoform CRA_b {ECO:0000313|EMBL:EAW89852.1};
DE   SubName: Full=Septin-6 {ECO:0000313|Ensembl:ENSP00000346397};
GN   Name=SEPTIN6 {ECO:0000313|Ensembl:ENSP00000346397};
GN   Synonyms=SEPT6 {ECO:0000313|EMBL:EAW89852.1};
GN   ORFNames=hCG_23191 {ECO:0000313|EMBL:EAW89852.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000346397, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW89852.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000346397, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3] {ECO:0000313|EMBL:EAW89852.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [5] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8] {ECO:0000313|Ensembl:ENSP00000346397}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like
CC       GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC004913; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355348; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471161; EAW89852.1; -; Genomic_DNA.
DR   RefSeq; XP_006724811.1; XM_006724748.2.
DR   ProteomicsDB; 3212; -.
DR   Antibodypedia; 465; 270 antibodies.
DR   Ensembl; ENST00000354416; ENSP00000346397; ENSG00000125354.
DR   GeneID; 23157; -.
DR   UCSC; uc065awu.1; human.
DR   CTD; 23157; -.
DR   EuPathDB; HostDB:ENSG00000125354.22; -.
DR   HGNC; HGNC:15848; SEPTIN6.
DR   OpenTargets; ENSG00000125354; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00940000158026; -.
DR   OrthoDB; 845354at2759; -.
DR   ChiTaRS; SEPT6; human.
DR   GenomeRNAi; 23157; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000125354; Expressed in lower esophagus and 226 other tissues.
DR   GO; GO:0031105; C:septin complex; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030644; SEPT6.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF55; PTHR18884:SF55; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTP-binding {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00312599};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00312599};
KW   Proteomics identification {ECO:0000213|EPD:B1AMS2,
KW   ECO:0000213|MaxQB:B1AMS2, ECO:0000213|PeptideAtlas:B1AMS2,
KW   ECO:0000213|ProteomicsDB:B1AMS2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          39..305
FT                   /note="Septin-type G"
FT                   /evidence="ECO:0000259|PROSITE:PS51719"
FT   REGION          406..431
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          321..341
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          343..399
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   431 AA;  49303 MW;  6A891C3002EB88E3 CRC64;
     MAATDIARQV GEGCRTVPLA GHVGFDSLPD QLVNKSVSQG FCFNILCVGE TGLGKSTLMD
     TLFNTKFEGE PATHTQPGVQ LQSNTYDLQE SNVRLKLTIV STVGFGDQIN KEDSYKPIVE
     FIDAQFEAYL QEELKIRRVL HTYHDSRIHV CLYFIAPTGH SLKSLDLVTM KKLDSKVNII
     PIIAKADAIS KSELTKFKIK ITSELVSNGV QIYQFPTDDE SVAEINGTMN AHLPFAVIGS
     TEELKIGNKM MRARQYPWGT VQVENEAHCD FVKLREMLIR VNMEDLREQT HTRHYELYRR
     CKLEEMGFKD TDPDSKPFSL QETYEAKRNE FLGELQKKEE EMRQMFVQRV KEKEAELKEA
     EKELHEKFDR LKKLHQDEKK KLEDKKKSLD DEVNAFKQRK TAAELLQSQG SQAGGSQTLK
     RDKEKKNLGF L
//
ID   SEPT6_HUMAN             Reviewed;         434 AA.
AC   Q14141; Q5JTK0; Q969W5; Q96A13; Q96GR1; Q96P86; Q96P87;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   22-APR-2020, entry version 184.
DE   RecName: Full=Septin-6;
GN   Name=SEPTIN6 {ECO:0000312|HGNC:HGNC:15848}; Synonyms=KIAA0128, SEP2, SEPT6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS I; II; IV AND V).
RX   PubMed=11809673;
RA   Ono R., Taki T., Taketani T., Kawaguchi H., Taniwaki M., Okamura T.,
RA   Kawa K., Hanada R., Kobayashi M., Hayashi Y.;
RT   "SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant
RT   acute myeloid leukemia with complex chromosomal abnormalities involving
RT   11q23 and Xq24.";
RL   Cancer Res. 62:333-337(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS II AND V).
RC   TISSUE=Muscle, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-8, AND ACETYLATION AT ALA-2.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-427 (ISOFORM I).
RC   TISSUE=Bone marrow;
RX   PubMed=8590280; DOI=10.1093/dnares/2.4.167;
RA   Nagase T., Seki N., Tanaka A., Ishikawa K., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. IV. The
RT   coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:167-174(1995).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=15915442; DOI=10.1002/path.1789;
RA   Hall P.A., Jung K., Hillan K.J., Russell S.E.H.;
RT   "Expression profiling the human septin gene family.";
RL   J. Pathol. 206:269-278(2005).
RN   [7]
RP   COORDINATED EXPRESSION WITH SEPTIN2 AND SEPTIN7.
RX   PubMed=16093351; DOI=10.1091/mbc.e05-03-0267;
RA   Kremer B.E., Haystead T., Macara I.G.;
RT   "Mammalian septins regulate microtubule stability through interaction with
RT   the microtubule-binding protein MAP4.";
RL   Mol. Biol. Cell 16:4648-4659(2005).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15774761; DOI=10.1126/science.1106823;
RA   Spiliotis E.T., Kinoshita M., Nelson W.J.;
RT   "A mitotic septin scaffold required for mammalian chromosome congression
RT   and segregation.";
RL   Science 307:1781-1785(2005).
RN   [9]
RP   INTERACTION WITH SEPTIN2 AND SEPTIN7.
RX   PubMed=16914550; DOI=10.1074/jbc.m605179200;
RA   Low C., Macara I.G.;
RT   "Structural analysis of septin 2, 6, and 7 complexes.";
RL   J. Biol. Chem. 281:30697-30706(2006).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH SOCS7.
RX   PubMed=17803907; DOI=10.1016/j.cell.2007.06.053;
RA   Kremer B.E., Adang L.A., Macara I.G.;
RT   "Septins regulate actin organization and cell-cycle arrest through nuclear
RT   accumulation of NCK mediated by SOCS7.";
RL   Cell 130:837-850(2007).
RN   [11]
RP   INTERACTION WITH SEPTIN12.
RX   PubMed=18047794; DOI=10.5483/bmbrep.2007.40.6.973;
RA   Ding X., Yu W., Liu M., Shen S., Chen F., Wan B., Yu L.;
RT   "SEPT12 interacts with SEPT6 and this interaction alters the filament
RT   structure of SEPT6 in Hela cells.";
RL   J. Biochem. Mol. Biol. 40:973-978(2007).
RN   [12]
RP   INTERACTION WITH HNRNPA1 AND HCV NS5B (MICROBIAL INFECTION), AND FUNCTION.
RX   PubMed=17229681; DOI=10.1128/jvi.01311-06;
RA   Kim C.S., Seol S.K., Song O.-K., Park J.H., Jang S.K.;
RT   "An RNA-binding protein, hnRNP A1, and a scaffold protein, septin 6,
RT   facilitate hepatitis C virus replication.";
RL   J. Virol. 81:3852-3865(2007).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   INTERACTION WITH SEPTIN9.
RX   PubMed=19145258; DOI=10.1371/journal.pone.0004196;
RA   Mostowy S., Nam Tham T., Danckaert A., Guadagnini S., Boisson-Dupuis S.,
RA   Pizarro-Cerda J., Cossart P.;
RT   "Septins regulate bacterial entry into host cells.";
RL   PLoS ONE 4:E4196-E4196(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-367, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-416 AND THR-418, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=25588830; DOI=10.1242/jcs.158998;
RA   Kuo Y.C., Shen Y.R., Chen H.I., Lin Y.H., Wang Y.Y., Chen Y.R., Wang C.Y.,
RA   Kuo P.L.;
RT   "SEPT12 orchestrates the formation of mammalian sperm annulus by organizing
RT   core octomeric complexes with other SEPT proteins.";
RL   J. Cell Sci. 128:923-934(2015).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (4.0 ANGSTROMS) OF 1-427 IN COMPLEX WITH GTP,
RP   ELECTRON MICROSCOPY OF SEPTIN COMPLEX, AND SUBUNIT.
RX   PubMed=17637674; DOI=10.1038/nature06052;
RA   Sirajuddin M., Farkasovsky M., Hauer F., Kuehlmann D., Macara I.G.,
RA   Weyand M., Stark H., Wittinghofer A.;
RT   "Structural insight into filament formation by mammalian septins.";
RL   Nature 449:311-315(2007).
CC   -!- FUNCTION: Filament-forming cytoskeletal GTPase. Required for normal
CC       organization of the actin cytoskeleton. Involved in cytokinesis. May
CC       play a role in HCV RNA replication. Forms a filamentous structure with
CC       SEPTIN12, SEPTIN6, SEPTIN2 and probably SEPTIN4 at the sperm annulus
CC       which is required for the structural integrity and motility of the
CC       sperm tail during postmeiotic differentiation (PubMed:25588830).
CC       {ECO:0000269|PubMed:17229681, ECO:0000269|PubMed:17803907,
CC       ECO:0000305|PubMed:25588830}.
CC   -!- SUBUNIT: Septins polymerize into heterooligomeric protein complexes
CC       that form filaments, and associate with cellular membranes, actin
CC       filaments and microtubules. GTPase activity is required for filament
CC       formation. Filaments are assembled from asymmetrical heterotrimers,
CC       composed of SEPTIN2, SEPTIN6 and SEPTIN7 that associate head-to-head to
CC       form a hexameric unit. Within the trimer, directly interacts with
CC       SEPTIN2 and SEPTIN7. Also interacts with SEPTIN9 and SEPTIN12.
CC       Interaction with SEPTIN12 alters filament structure. Component of a
CC       septin core octomeric complex consisting of SEPTIN12, SEPTIN7, SEPTIN6
CC       and SEPTIN2 or SEPTIN4 in the order 12-7-6-2-2-6-7-12 or 12-7-6-4-4-6-
CC       7-12 and located in the sperm annulus. Interacts with SOCS7. Interacts
CC       with HNRNPA1. {ECO:0000269|PubMed:16914550,
CC       ECO:0000269|PubMed:17229681, ECO:0000269|PubMed:17637674,
CC       ECO:0000269|PubMed:17803907, ECO:0000269|PubMed:18047794,
CC       ECO:0000269|PubMed:19145258, ECO:0000269|PubMed:25588830}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HCV NS5B.
CC       {ECO:0000269|PubMed:17229681}.
CC   -!- INTERACTION:
CC       Q14141; PRO_0000037577 [P27958]; Xeno; NbExp=4; IntAct=EBI-745901, EBI-6904388;
CC       Q14141; P09651: HNRNPA1; NbExp=3; IntAct=EBI-745901, EBI-352662;
CC       Q14141; Q8NDC4: MORN4; NbExp=6; IntAct=EBI-745901, EBI-10269566;
CC       Q14141; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-745901, EBI-742388;
CC       Q14141; A0A0S2Z5W9: SEPT9; NbExp=3; IntAct=EBI-745901, EBI-16437910;
CC       Q14141; Q8WYJ6: SEPTIN1; NbExp=9; IntAct=EBI-745901, EBI-693002;
CC       Q14141; Q8IYM1: SEPTIN12; NbExp=14; IntAct=EBI-745901, EBI-2585067;
CC       Q14141; Q15019: SEPTIN2; NbExp=11; IntAct=EBI-745901, EBI-741220;
CC       Q14141; Q9UH03: SEPTIN3; NbExp=3; IntAct=EBI-745901, EBI-727037;
CC       Q14141; Q99719: SEPTIN5; NbExp=6; IntAct=EBI-745901, EBI-373345;
CC       Q14141; Q16181: SEPTIN7; NbExp=3; IntAct=EBI-745901, EBI-2009373;
CC       Q14141; Q9UHD8: SEPTIN9; NbExp=4; IntAct=EBI-745901, EBI-851542;
CC       Q14141; O14512-1: SOCS7; NbExp=2; IntAct=EBI-745901, EBI-1539617;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15774761}.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:15774761}.
CC       Chromosome, centromere, kinetochore {ECO:0000269|PubMed:15774761}.
CC       Cleavage furrow {ECO:0000269|PubMed:15774761}. Midbody
CC       {ECO:0000269|PubMed:15774761}. Cell projection, cilium, flagellum
CC       {ECO:0000269|PubMed:25588830}. Note=In metaphase cells, localized
CC       within the microtubule spindle. At the metaphase plate, in close
CC       apposition to the kinetochores of the congressed chromosomes. In cells
CC       undergoing cytokinesis, localized to the midbody, the ingressing
CC       cleavage furrow, and the central spindle. Found in the sperm annulus
CC       (PubMed:25588830). {ECO:0000269|PubMed:25588830}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=II;
CC         IsoId=Q14141-1; Sequence=Displayed;
CC       Name=I; Synonyms=III;
CC         IsoId=Q14141-2; Sequence=VSP_006053;
CC       Name=IV;
CC         IsoId=Q14141-3; Sequence=VSP_006051, VSP_006052;
CC       Name=V;
CC         IsoId=Q14141-4; Sequence=VSP_006054;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15915442}.
CC   -!- MISCELLANEOUS: Coordinated expression with SEPTIN2 and SEPTIN7.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like
CC       GTPase superfamily. Septin GTPase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01056}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SEPTIN6ID376.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF403058; AAK98547.1; -; mRNA.
DR   EMBL; AF403059; AAK98548.1; -; mRNA.
DR   EMBL; AF403060; AAK98549.1; -; mRNA.
DR   EMBL; AF403061; AAK98550.1; -; mRNA.
DR   EMBL; AF403062; AAK98551.1; -; mRNA.
DR   EMBL; AC004913; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355348; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009291; AAH09291.1; -; mRNA.
DR   EMBL; BC011922; AAH11922.3; -; mRNA.
DR   EMBL; BC036240; AAH36240.1; -; mRNA.
DR   EMBL; D50918; BAA09477.1; -; mRNA.
DR   CCDS; CCDS14583.1; -. [Q14141-4]
DR   CCDS; CCDS14584.1; -. [Q14141-1]
DR   CCDS; CCDS14585.1; -. [Q14141-2]
DR   RefSeq; NP_055944.2; NM_015129.5. [Q14141-1]
DR   RefSeq; NP_665798.1; NM_145799.3. [Q14141-2]
DR   RefSeq; NP_665799.1; NM_145800.3. [Q14141-2]
DR   RefSeq; NP_665801.1; NM_145802.3. [Q14141-4]
DR   RefSeq; XP_006724813.1; XM_006724750.2. [Q14141-2]
DR   PDB; 2QAG; X-ray; 4.00 A; B=1-427.
DR   PDBsum; 2QAG; -.
DR   SMR; Q14141; -.
DR   BioGrid; 116770; 53.
DR   DIP; DIP-38218N; -.
DR   IntAct; Q14141; 36.
DR   MINT; Q14141; -.
DR   STRING; 9606.ENSP00000341524; -.
DR   iPTMnet; Q14141; -.
DR   MetOSite; Q14141; -.
DR   PhosphoSitePlus; Q14141; -.
DR   SwissPalm; Q14141; -.
DR   BioMuta; SEPT6; -.
DR   DMDM; 20178343; -.
DR   OGP; Q14141; -.
DR   EPD; Q14141; -.
DR   jPOST; Q14141; -.
DR   MassIVE; Q14141; -.
DR   MaxQB; Q14141; -.
DR   PaxDb; Q14141; -.
DR   PeptideAtlas; Q14141; -.
DR   PRIDE; Q14141; -.
DR   ProteomicsDB; 59843; -. [Q14141-1]
DR   ProteomicsDB; 59844; -. [Q14141-2]
DR   ProteomicsDB; 59845; -. [Q14141-3]
DR   ProteomicsDB; 59846; -. [Q14141-4]
DR   Antibodypedia; 465; 270 antibodies.
DR   DNASU; 23157; -.
DR   Ensembl; ENST00000343984; ENSP00000341524; ENSG00000125354. [Q14141-1]
DR   Ensembl; ENST00000354228; ENSP00000346169; ENSG00000125354. [Q14141-4]
DR   Ensembl; ENST00000360156; ENSP00000353278; ENSG00000125354. [Q14141-2]
DR   Ensembl; ENST00000394610; ENSP00000378108; ENSG00000125354. [Q14141-2]
DR   Ensembl; ENST00000460411; ENSP00000435818; ENSG00000125354. [Q14141-3]
DR   Ensembl; ENST00000489216; ENSP00000418715; ENSG00000125354. [Q14141-2]
DR   GeneID; 23157; -.
DR   KEGG; hsa:23157; -.
DR   UCSC; uc004erv.4; human. [Q14141-1]
DR   CTD; 23157; -.
DR   DisGeNET; 23157; -.
DR   GeneCards; SEPTIN6; -.
DR   HGNC; HGNC:15848; SEPTIN6.
DR   HPA; ENSG00000125354; Tissue enhanced (lymphoid).
DR   MIM; 300683; gene.
DR   neXtProt; NX_Q14141; -.
DR   OpenTargets; ENSG00000125354; -.
DR   PharmGKB; PA134941944; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00940000158026; -.
DR   HOGENOM; CLU_017718_8_1_1; -.
DR   InParanoid; Q14141; -.
DR   KO; K16939; -.
DR   OMA; SFQQTCE; -.
DR   OrthoDB; 845354at2759; -.
DR   PhylomeDB; Q14141; -.
DR   TreeFam; TF101080; -.
DR   SIGNOR; Q14141; -.
DR   ChiTaRS; SEPT6; human.
DR   EvolutionaryTrace; Q14141; -.
DR   GeneWiki; SEPT6; -.
DR   GenomeRNAi; 23157; -.
DR   Pharos; Q14141; Tbio.
DR   PRO; PR:Q14141; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q14141; protein.
DR   Bgee; ENSG00000125354; Expressed in lower esophagus and 226 other tissues.
DR   ExpressionAtlas; Q14141; baseline and differential.
DR   Genevisible; Q14141; HS.
DR   GO; GO:0043679; C:axon terminus; IEA:Ensembl.
DR   GO; GO:0032153; C:cell division site; IBA:GO_Central.
DR   GO; GO:0032154; C:cleavage furrow; IEA:UniProtKB-SubCell.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IBA:GO_Central.
DR   GO; GO:0030496; C:midbody; IEA:UniProtKB-SubCell.
DR   GO; GO:0032173; C:septin collar; IEA:Ensembl.
DR   GO; GO:0031105; C:septin complex; IDA:UniProtKB.
DR   GO; GO:0005940; C:septin ring; IBA:GO_Central.
DR   GO; GO:0097227; C:sperm annulus; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; TAS:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0060090; F:molecular adaptor activity; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0034613; P:cellular protein localization; IBA:GO_Central.
DR   GO; GO:0060271; P:cilium assembly; IBA:GO_Central.
DR   GO; GO:0061640; P:cytoskeleton-dependent cytokinesis; IBA:GO_Central.
DR   GO; GO:0000281; P:mitotic cytokinesis; TAS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030644; SEPT6.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF55; PTHR18884:SF55; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell cycle; Cell division;
KW   Cell projection; Centromere; Chromosome; Cilium; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Differentiation; Direct protein sequencing; Flagellum;
KW   GTP-binding; Host-virus interaction; Kinetochore; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Spermatogenesis.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000269|PubMed:12665801"
FT   CHAIN           2..434
FT                   /note="Septin-6"
FT                   /id="PRO_0000173525"
FT   DOMAIN          39..305
FT                   /note="Septin-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   NP_BIND         49..56
FT                   /note="GTP"
FT                   /evidence="ECO:0000269|PubMed:17637674"
FT   NP_BIND         185..193
FT                   /note="GTP"
FT                   /evidence="ECO:0000269|PubMed:17637674"
FT   REGION          49..56
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   REGION          101..104
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   REGION          184..187
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   COILED          321..409
FT                   /evidence="ECO:0000255"
FT   BINDING         104
FT                   /note="GTP; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         239
FT                   /note="GTP; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         254
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000269|PubMed:12665801"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         367
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         416
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         418
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         263..267
FT                   /note="VENEA -> AAREV (in isoform IV)"
FT                   /evidence="ECO:0000303|PubMed:11809673"
FT                   /id="VSP_006051"
FT   VAR_SEQ         268..434
FT                   /note="Missing (in isoform IV)"
FT                   /evidence="ECO:0000303|PubMed:11809673"
FT                   /id="VSP_006052"
FT   VAR_SEQ         428..434
FT                   /note="Missing (in isoform I)"
FT                   /evidence="ECO:0000303|PubMed:11809673,
FT                   ECO:0000303|PubMed:8590280"
FT                   /id="VSP_006053"
FT   VAR_SEQ         428..434
FT                   /note="NPWLCTE -> FF (in isoform V)"
FT                   /evidence="ECO:0000303|PubMed:11809673,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_006054"
FT   CONFLICT        406
FT                   /note="L -> P (in Ref. 3; AAH09291)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   434 AA;  49717 MW;  E684AE6A93B32362 CRC64;
     MAATDIARQV GEGCRTVPLA GHVGFDSLPD QLVNKSVSQG FCFNILCVGE TGLGKSTLMD
     TLFNTKFEGE PATHTQPGVQ LQSNTYDLQE SNVRLKLTIV STVGFGDQIN KEDSYKPIVE
     FIDAQFEAYL QEELKIRRVL HTYHDSRIHV CLYFIAPTGH SLKSLDLVTM KKLDSKVNII
     PIIAKADAIS KSELTKFKIK ITSELVSNGV QIYQFPTDDE SVAEINGTMN AHLPFAVIGS
     TEELKIGNKM MRARQYPWGT VQVENEAHCD FVKLREMLIR VNMEDLREQT HTRHYELYRR
     CKLEEMGFKD TDPDSKPFSL QETYEAKRNE FLGELQKKEE EMRQMFVQRV KEKEAELKEA
     EKELHEKFDR LKKLHQDEKK KLEDKKKSLD DEVNAFKQRK TAAELLQSQG SQAGGSQTLK
     RDKEKKNNPW LCTE
//
ID   Q541S4_HUMAN            Unreviewed;       427 AA.
AC   Q541S4;
DT   05-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   05-FEB-2008, sequence version 1.
DT   22-APR-2020, entry version 117.
DE   SubName: Full=Septin 6 {ECO:0000313|EMBL:AAK61492.1};
DE   SubName: Full=Septin 6, isoform CRA_d {ECO:0000313|EMBL:EAW89854.1};
DE   SubName: Full=cDNA FLJ58747, highly similar to Septin-6 {ECO:0000313|EMBL:BAG61293.1};
GN   Name=SEPT6 {ECO:0000313|EMBL:EAW89854.1};
GN   ORFNames=hCG_23191 {ECO:0000313|EMBL:EAW89854.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAK61492.1};
RN   [1] {ECO:0000313|EMBL:AAF97496.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Yu L.;
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:EAW89854.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [3] {ECO:0000313|EMBL:AAK61492.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Peng J., Yu L.;
RT   "Molecular cloning and characterization of human septins which are
RT   expressed in liver.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW89854.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAG61293.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like
CC       GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY005981; AAF97496.1; -; mRNA.
DR   EMBL; AY034177; AAK61492.1; -; mRNA.
DR   EMBL; AK299273; BAG61293.1; -; mRNA.
DR   EMBL; CH471161; EAW89854.1; -; Genomic_DNA.
DR   EMBL; CH471161; EAW89856.1; -; Genomic_DNA.
DR   RefSeq; NP_665798.1; NM_145799.3.
DR   RefSeq; NP_665799.1; NM_145800.3.
DR   RefSeq; XP_006724813.1; XM_006724750.2.
DR   Antibodypedia; 465; 270 antibodies.
DR   DNASU; 23157; -.
DR   GeneID; 23157; -.
DR   UCSC; uc004ers.4; human.
DR   CTD; 23157; -.
DR   EuPathDB; HostDB:ENSG00000125354.22; -.
DR   PharmGKB; PA134941944; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   HOGENOM; CLU_017718_8_1_1; -.
DR   OrthoDB; 845354at2759; -.
DR   ChiTaRS; SEPT6; human.
DR   GenomeRNAi; 23157; -.
DR   Bgee; ENSG00000125354; Expressed in lower esophagus and 226 other tissues.
DR   GO; GO:0031105; C:septin complex; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030644; SEPT6.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF55; PTHR18884:SF55; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTP-binding {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00312599};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00312599}.
FT   DOMAIN          39..305
FT                   /note="Septin-type G"
FT                   /evidence="ECO:0000259|PROSITE:PS51719"
FT   REGION          405..427
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          321..341
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          343..399
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   427 AA;  48873 MW;  62EB88E308386ADE CRC64;
     MAATDIARQV GEGCRTVPLA GHVGFDSLPD QLVNKSVSQG FCFNILCVGE TGLGKSTLMD
     TLFNTKFEGE PATHTQPGVQ LQSNTYDLQE SNVRLKLTIV STVGFGDQIN KEDSYKPIVE
     FIDAQFEAYL QEELKIRRVL HTYHDSRIHV CLYFIAPTGH SLKSLDLVTM KKLDSKVNII
     PIIAKADAIS KSELTKFKIK ITSELVSNGV QIYQFPTDDE SVAEINGTMN AHLPFAVIGS
     TEELKIGNKM MRARQYPWGT VQVENEAHCD FVKLREMLIR VNMEDLREQT HTRHYELYRR
     CKLEEMGFKD TDPDSKPFSL QETYEAKRNE FLGELQKKEE EMRQMFVQRV KEKEAELKEA
     EKELHEKFDR LKKLHQDEKK KLEDKKKSLD DEVNAFKQRK TAAELLQSQG SQAGGSQTLK
     RDKEKKN
//
ID   Q548C9_HUMAN            Unreviewed;       429 AA.
AC   Q548C9;
DT   05-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   05-FEB-2008, sequence version 1.
DT   22-APR-2020, entry version 109.
DE   SubName: Full=Septin 6 {ECO:0000313|EMBL:AAN76547.1};
DE   SubName: Full=Septin 6, isoform CRA_e {ECO:0000313|EMBL:EAW89855.1};
DE   SubName: Full=cDNA FLJ77872, highly similar to Homo sapiens SEPTIN6 type V (SEPTIN6) mRNA {ECO:0000313|EMBL:BAF83666.1};
GN   Name=SEPT6 {ECO:0000313|EMBL:EAW89855.1};
GN   ORFNames=hCG_23191 {ECO:0000313|EMBL:EAW89855.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAN76547.1};
RN   [1] {ECO:0000313|EMBL:EAW89855.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAN76547.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mao Y., Xie Y., Wu Q.;
RT   "Cloning and characterization of a novel human septin 6.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW89855.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAF83666.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like
CC       GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF397023; AAN76547.1; -; mRNA.
DR   EMBL; AK290977; BAF83666.1; -; mRNA.
DR   EMBL; CH471161; EAW89855.1; -; Genomic_DNA.
DR   RefSeq; NP_665801.1; NM_145802.3.
DR   Antibodypedia; 465; 270 antibodies.
DR   DNASU; 23157; -.
DR   GeneID; 23157; -.
DR   UCSC; uc004ert.4; human.
DR   CTD; 23157; -.
DR   EuPathDB; HostDB:ENSG00000125354.22; -.
DR   PharmGKB; PA134941944; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   OrthoDB; 845354at2759; -.
DR   ChiTaRS; SEPT6; human.
DR   GenomeRNAi; 23157; -.
DR   Bgee; ENSG00000125354; Expressed in lower esophagus and 226 other tissues.
DR   GO; GO:0031105; C:septin complex; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030644; SEPT6.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF55; PTHR18884:SF55; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTP-binding {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00312599};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00312599}.
FT   DOMAIN          39..305
FT                   /note="Septin-type G"
FT                   /evidence="ECO:0000259|PROSITE:PS51719"
FT   REGION          405..429
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          321..341
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          343..399
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   429 AA;  49167 MW;  3D8EE2EB88E30838 CRC64;
     MAATDIARQV GEGCRTVPLA GHVGFDSLPD QLVNKSVSQG FCFNILCVGE TGLGKSTLMD
     TLFNTKFEGE PATHTQPGVQ LQSNTYDLQE SNVRLKLTIV STVGFGDQIN KEDSYKPIVE
     FIDAQFEAYL QEELKIRRVL HTYHDSRIHV CLYFIAPTGH SLKSLDLVTM KKLDSKVNII
     PIIAKADAIS KSELTKFKIK ITSELVSNGV QIYQFPTDDE SVAEINGTMN AHLPFAVIGS
     TEELKIGNKM MRARQYPWGT VQVENEAHCD FVKLREMLIR VNMEDLREQT HTRHYELYRR
     CKLEEMGFKD TDPDSKPFSL QETYEAKRNE FLGELQKKEE EMRQMFVQRV KEKEAELKEA
     EKELHEKFDR LKKLHQDEKK KLEDKKKSLD DEVNAFKQRK TAAELLQSQG SQAGGSQTLK
     RDKEKKNFF
//
ID   A0A0S2Z5A5_HUMAN        Unreviewed;       568 AA.
AC   A0A0S2Z5A5;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 24.
DE   SubName: Full=Septin 9 isoform 1 {ECO:0000313|EMBL:ALQ33997.1};
DE   Flags: Fragment;
GN   Name=SEPT9 {ECO:0000313|EMBL:ALQ33997.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33997.1};
RN   [1] {ECO:0000313|EMBL:ALQ33997.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like
CC       GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178539; ALQ33997.1; -; mRNA.
DR   RefSeq; NP_006631.2; NM_006640.4.
DR   SMR; A0A0S2Z5A5; -.
DR   PRIDE; A0A0S2Z5A5; -.
DR   Antibodypedia; 32488; 203 antibodies.
DR   GeneID; 10801; -.
DR   CTD; 10801; -.
DR   ChiTaRS; SEPT9; human.
DR   GenomeRNAi; 10801; -.
DR   ExpressionAtlas; A0A0S2Z5A5; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030645; SEPT9.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF47; PTHR18884:SF47; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   2: Evidence at transcript level;
KW   GTP-binding {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00312599};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00312599}.
FT   DOMAIN          277..549
FT                   /note="Septin-type G"
FT                   /evidence="ECO:0000259|PROSITE:PS51719"
FT   REGION          44..90
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          116..250
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        57..71
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        137..151
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        185..206
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         568
FT                   /evidence="ECO:0000313|EMBL:ALQ33997.1"
SQ   SEQUENCE   568 AA;  63666 MW;  47A03DD79B5D6147 CRC64;
     MERDRISALK RSFEVEEVET PNSTPPRRVQ TPLLRATVAS STQKFQDLGV KNSEPSARHV
     DSLSQRSPKA SLRRVELSGP KAAEPVSRRT ELSIDISSKQ VENAGAIGPS RFGLKRAEVL
     GHKTPEPAPR RTEITIVKPQ ESAHRRMEPP ASKVPEVPTA PATDAAPKRV EIQMPKPAEA
     PTAPSPAQTL ENSEPAPVSQ LQSRLEPKPQ PPVAEATPRS QEATEAAPSC VGDMADTPRD
     AGLKQAPASR NEKAPVDFGY VGIDSILEQM RRKAMKQGFE FNIMVVGQSG LGKSTLINTL
     FKSKISRKSV QPTSEERIPK TIEIKSITHD IEEKGVRMKL TVIDTPGFGD HINNENCWQP
     IMKFINDQYE KYLQEEVNIN RKKRIPDTRV HCCLYFIPAT GHSLRPLDIE FMKRLSKVVN
     IVPVIAKADT LTLEERVHFK QRITADLLSN GIDVYPQKEF DEDSEDRLVN EKFREMIPFA
     VVGSDHEYQV NGKRILGRKT KWGTIEVENT THCEFAYLRD LLIRTHMQNI KDITSSIHFE
     AYRVKRLNEG SSAMANGMEE KEPEAPEM
//
ID   SEPT9_HUMAN             Reviewed;         586 AA.
AC   Q9UHD8; A8K2V3; B3KPM0; B4DTL9; B4E0N2; B4E274; B7Z654; Q96QF3; Q96QF4;
AC   Q96QF5; Q9HA04; Q9UG40; Q9Y5W4;
DT   21-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2006, sequence version 2.
DT   22-APR-2020, entry version 187.
DE   RecName: Full=Septin-9;
DE   AltName: Full=MLL septin-like fusion protein MSF-A;
DE            Short=MLL septin-like fusion protein;
DE   AltName: Full=Ovarian/Breast septin;
DE            Short=Ov/Br septin;
DE   AltName: Full=Septin D1;
GN   Name=SEPTIN9 {ECO:0000312|HGNC:HGNC:7323}; Synonyms=KIAA0991, MSF, SEPT9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANT VAL-576, TISSUE
RP   SPECIFICITY, DISEASE, AND CHROMOSOMAL TRANSLOCATION.
RX   PubMed=10339604; DOI=10.1073/pnas.96.11.6428;
RA   Osaka M., Rowley J.D., Zeleznik-Le N.J.;
RT   "MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-
RT   related acute myeloid leukemia with a t(11;17)(q23;q25).";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6428-6433(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 5), AND VARIANTS CYS-76;
RP   LEU-145 AND VAL-576.
RX   PubMed=10987277;
RA   Russell S.E.H., McIlhatton M.A., Burrows J.F., Donaghy P.G., Chanduloy S.,
RA   Petty E.M., Kalikin L.M., Church S.W., McIlroy S., Harkin D.P.,
RA   Keilty G.W., Cranston A.N., Weissenbach J., Hickey I., Johnston P.G.;
RT   "Isolation and mapping of a human septin gene to a region on chromosome
RT   17q, commonly deleted in sporadic epithelial ovarian tumors.";
RL   Cancer Res. 60:4729-4734(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), VARIANT VAL-576, TISSUE
RP   SPECIFICITY, AND ALTERNATIVE SPLICING.
RX   PubMed=10673329; DOI=10.1006/geno.1999.6077;
RA   Kalikin L.M., Sims H.L., Petty E.M.;
RT   "Genomic and expression analyses of alternatively spliced transcripts of
RT   the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in
RT   breast and ovarian tumors.";
RL   Genomics 63:165-172(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT VAL-576.
RA   Zhang W., He L., Wan T., Yuan Z., Zhu X., Cao X.;
RT   "Novel human cell division control protein septin D1.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3; 4; 5; 7; 8 AND 9), AND
RP   VARIANTS LEU-145 AND VAL-576.
RC   TISSUE=Fetal brain, Mammary gland, Placenta, Teratocarcinoma, Thymus,
RC   Tongue, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT VAL-576.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-576.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   VAL-576.
RC   TISSUE=Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 26-586, AND VARIANT VAL-576.
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 353-586, AND VARIANT VAL-576.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [11]
RP   TISSUE SPECIFICITY, AND ALTERNATIVE SPLICING.
RX   PubMed=11593400; DOI=10.1038/sj.onc.1204752;
RA   McIlhatton M.A., Burrows J.F., Donaghy P.G., Chanduloy S., Johnston P.G.,
RA   Russell S.E.;
RT   "Genomic organization, complex splicing pattern and expression of a human
RT   septin gene on chromosome 17q25.3.";
RL   Oncogene 20:5930-5939(2001).
RN   [12]
RP   INTERACTION WITH SEPTIN7 AND SEPTIN11.
RX   PubMed=15485874; DOI=10.1074/jbc.m406153200;
RA   Nagata K., Asano T., Nozawa Y., Inagaki M.;
RT   "Biochemical and cell biological analyses of a mammalian septin complex,
RT   Sept7/9b/11.";
RL   J. Biol. Chem. 279:55895-55904(2004).
RN   [13]
RP   TISSUE SPECIFICITY.
RX   PubMed=15915442; DOI=10.1002/path.1789;
RA   Hall P.A., Jung K., Hillan K.J., Russell S.E.H.;
RT   "Expression profiling the human septin gene family.";
RL   J. Pathol. 206:269-278(2005).
RN   [14]
RP   INTERACTION WITH ARHGEF18.
RX   PubMed=15558029; DOI=10.1038/sj.onc.1208101;
RA   Nagata K., Inagaki M.;
RT   "Cytoskeletal modification of Rho guanine nucleotide exchange factor
RT   activity: identification of a Rho guanine nucleotide exchange factor as a
RT   binding partner for Sept9b, a mammalian septin.";
RL   Oncogene 24:65-76(2005).
RN   [15]
RP   INTERACTION WITH RTKN.
RX   PubMed=16007136; DOI=10.1038/sj.onc.1208862;
RA   Ito H., Iwamoto I., Morishita R., Nozawa Y., Narumiya S., Asano T.,
RA   Nagata K.;
RT   "Possible role of Rho/Rhotekin signaling in mammalian septin
RT   organization.";
RL   Oncogene 24:7064-7072(2005).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30 AND THR-42, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [18]
RP   SUBCELLULAR LOCATION, INTERACTION WITH SEPTIN4, AND VARIANTS HNA TRP-106
RP   AND PHE-111.
RX   PubMed=17546647; DOI=10.1002/humu.20554;
RA   Sudo K., Ito H., Iwamoto I., Morishita R., Asano T., Nagata K.;
RT   "SEPT9 sequence alternations causing hereditary neuralgic amyotrophy are
RT   associated with altered interactions with SEPT4/SEPT11 and resistance to
RT   Rho/Rhotekin-signaling.";
RL   Hum. Mutat. 28:1005-1013(2007).
RN   [19]
RP   INTERACTION WITH SEPTIN14, AND SUBCELLULAR LOCATION.
RX   PubMed=17922164; DOI=10.1007/s00335-007-9065-x;
RA   Peterson E.A., Kalikin L.M., Steels J.D., Estey M.P., Trimble W.S.,
RA   Petty E.M.;
RT   "Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-
RT   specific septin.";
RL   Mamm. Genome 18:796-807(2007).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; THR-38 AND THR-42, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [23]
RP   INTERACTION WITH SEPTIN2; SEPTIN6; SEPTIN7 AND SEPTIN11, AND ASSOCIATION
RP   WITH ACTIN FILAMENTS AND MICROTUBULES.
RX   PubMed=19145258; DOI=10.1371/journal.pone.0004196;
RA   Mostowy S., Nam Tham T., Danckaert A., Guadagnini S., Boisson-Dupuis S.,
RA   Pizarro-Cerda J., Cossart P.;
RT   "Septins regulate bacterial entry into host cells.";
RL   PLoS ONE 4:E4196-E4196(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30 AND TYR-278, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; SER-82; SER-85; SER-96
RP   AND THR-142, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; SER-85 AND SER-327, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, ACETYLATION [LARGE SCALE
RP   ANALYSIS] AT MET-1 (ISOFORM 3), AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22; SER-30; THR-42; THR-49;
RP   SER-85; SER-89; THR-142 AND SER-332, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [32]
RP   VARIANTS HNA TRP-106 AND PHE-111.
RX   PubMed=16186812; DOI=10.1038/ng1649;
RA   Kuhlenbaeumer G., Hannibal M.C., Nelis E., Schirmacher A., Verpoorten N.,
RA   Meuleman J., Watts G.D.J., De Vriendt E., Young P., Stoegbauer F.,
RA   Halfter H., Irobi J., Goossens D., Del-Favero J., Betz B.G., Hor H.,
RA   Kurlemann G., Bird T.D., Airaksinen E., Mononen T., Serradell A.P.,
RA   Prats J.M., Van Broeckhoven C., De Jonghe P., Timmerman V.,
RA   Ringelstein E.B., Chance P.F.;
RT   "Mutations in SEPT9 cause hereditary neuralgic amyotrophy.";
RL   Nat. Genet. 37:1044-1046(2005).
RN   [33]
RP   VARIANT HNA TRP-106.
RX   PubMed=18492087; DOI=10.1111/j.1399-0004.2008.01022.x;
RA   Laccone F., Hannibal M.C., Neesen J., Grisold W., Chance P.F., Rehder H.;
RT   "Dysmorphic syndrome of hereditary neuralgic amyotrophy associated with a
RT   SEPT9 gene mutation -- a family study.";
RL   Clin. Genet. 74:279-283(2008).
RN   [34]
RP   VARIANTS HNA TRP-106 AND PHE-111, AND VARIANT LEU-145.
RX   PubMed=19451530; DOI=10.1212/wnl.0b013e3181a609e3;
RA   Hannibal M.C., Ruzzo E.K., Miller L.R., Betz B., Buchan J.G., Knutzen D.M.,
RA   Barnett K., Landsverk M.L., Brice A., LeGuern E., Bedford H.M.,
RA   Worrall B.B., Lovitt S., Appel S.H., Andermann E., Bird T.D., Chance P.F.;
RT   "SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary
RT   neuralgic amyotrophy.";
RL   Neurology 72:1755-1759(2009).
CC   -!- FUNCTION: Filament-forming cytoskeletal GTPase (By similarity). May
CC       play a role in cytokinesis (Potential). May play a role in the
CC       internalization of 2 intracellular microbial pathogens, Listeria
CC       monocytogenes and Shigella flexneri. {ECO:0000250, ECO:0000305}.
CC   -!- SUBUNIT: Septins polymerize into heterooligomeric protein complexes
CC       that form filaments, and associate with cellular membranes, actin
CC       filaments, and microtubules. GTPase activity is required for filament
CC       formation. Interacts with SEPTIN2, SEPTIN6, SEPTIN7, SEPTIN11 and
CC       SEPTIN14. Interacts with RTKN and ARHGEF18. In a mesenchymal cell line,
CC       Rho/RTKN signals cause disruption of wild-type septin filaments, but
CC       not of those containing isoform 2 variants HNA Trp-106 and Phe-111. In
CC       a mesenchymal cell line, isoform 2 variants HNA Trp-106 and Phe-111,
CC       but not wild type, form filaments with SEPTIN4.
CC       {ECO:0000269|PubMed:15485874, ECO:0000269|PubMed:15558029,
CC       ECO:0000269|PubMed:16007136, ECO:0000269|PubMed:17546647,
CC       ECO:0000269|PubMed:17922164, ECO:0000269|PubMed:19145258}.
CC   -!- INTERACTION:
CC       Q9UHD8-1; Q16665: HIF1A; NbExp=4; IntAct=EBI-851558, EBI-447269;
CC       Q9UHD8-2; O75031: HSF2BP; NbExp=3; IntAct=EBI-851564, EBI-7116203;
CC       Q9UHD8-1; Q6ZU15: SEPTIN14; NbExp=3; IntAct=EBI-851558, EBI-2009297;
CC       Q9UHD8-3; Q6ZU15: SEPTIN14; NbExp=3; IntAct=EBI-851569, EBI-2009297;
CC       Q9UHD8; Q14141: SEPTIN6; NbExp=4; IntAct=EBI-851542, EBI-745901;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:17546647, ECO:0000269|PubMed:17922164}. Note=In an
CC       epithelial cell line, concentrates at cell-cell contact areas. After
CC       TGF-beta1 treatment and induction of epithelial to mesenchymal
CC       transition, colocalizes partly with actin stress fibers. During
CC       bacterial infection, displays a collar shape structure next to actin at
CC       the pole of invading bacteria.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=There are potentially 18 isoforms.;
CC       Name=1; Synonyms=Epsilon, MSF-A;
CC         IsoId=Q9UHD8-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha;
CC         IsoId=Q9UHD8-2; Sequence=VSP_012337;
CC       Name=3; Synonyms=Beta, MSF-B;
CC         IsoId=Q9UHD8-3; Sequence=VSP_012336;
CC       Name=4; Synonyms=Delta;
CC         IsoId=Q9UHD8-4; Sequence=VSP_012335;
CC       Name=5; Synonyms=Gamma;
CC         IsoId=Q9UHD8-5; Sequence=VSP_012338;
CC       Name=7;
CC         IsoId=Q9UHD8-7; Sequence=VSP_038317;
CC       Name=8;
CC         IsoId=Q9UHD8-8; Sequence=VSP_038316, VSP_038318;
CC       Name=9;
CC         IsoId=Q9UHD8-9; Sequence=VSP_038315, VSP_038319;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Isoforms are differentially
CC       expressed in testes, kidney, liver heart, spleen, brain, peripheral
CC       blood leukocytes, skeletal muscle and kidney. Specific isoforms appear
CC       to demonstrate tissue specificity. Isoform 5 is the most highly
CC       expressed in fetal tissue. Isoform 1 is detected in all tissues except
CC       the brain and thymus, while isoform 2, isoform 3, and isoform 4 are
CC       detected at low levels in approximately half of the fetal tissues.
CC       {ECO:0000269|PubMed:10339604, ECO:0000269|PubMed:10673329,
CC       ECO:0000269|PubMed:11593400, ECO:0000269|PubMed:15915442}.
CC   -!- DISEASE: Note=A chromosomal aberration involving SEPTIN9/MSF is found
CC       in therapy-related acute myeloid leukemia (t-AML). Translocation
CC       t(11;17)(q23;q25) with KMT2A/MLL1. {ECO:0000269|PubMed:10339604}.
CC   -!- DISEASE: Hereditary neuralgic amyotrophy (HNA) [MIM:162100]: Autosomal
CC       dominant form of recurrent focal neuropathy characterized clinically by
CC       acute, recurrent episodes of brachial plexus neuropathy with muscle
CC       weakness and atrophy preceded by severe pain in the affected arm. HNA
CC       is triggered by environmental factors such as infection or parturition.
CC       {ECO:0000269|PubMed:16186812, ECO:0000269|PubMed:17546647,
CC       ECO:0000269|PubMed:18492087, ECO:0000269|PubMed:19451530}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like
CC       GTPase superfamily. Septin GTPase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01056}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14057.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MSFID208.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF123052; AAD39749.1; -; mRNA.
DR   EMBL; AJ312319; CAC42221.1; -; mRNA.
DR   EMBL; AJ312320; CAC42222.1; -; mRNA.
DR   EMBL; AJ312321; CAC42223.1; -; mRNA.
DR   EMBL; AJ312322; CAC42224.1; -; mRNA.
DR   EMBL; AF189712; AAF23373.1; -; mRNA.
DR   EMBL; AF189713; AAF23374.1; -; mRNA.
DR   EMBL; AF142408; AAG27919.1; -; mRNA.
DR   EMBL; AK022493; BAB14057.1; ALT_SEQ; mRNA.
DR   EMBL; AK290368; BAF83057.1; -; mRNA.
DR   EMBL; AK056495; BAG51732.1; -; mRNA.
DR   EMBL; AK300270; BAG62031.1; -; mRNA.
DR   EMBL; AK303449; BAG64494.1; -; mRNA.
DR   EMBL; AK304143; BAG65036.1; -; mRNA.
DR   EMBL; AK299828; BAH13140.1; -; mRNA.
DR   EMBL; AK316473; BAH14844.1; -; mRNA.
DR   EMBL; BT007215; AAP35879.1; -; mRNA.
DR   EMBL; CH471099; EAW89462.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89463.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89468.1; -; Genomic_DNA.
DR   EMBL; BC021192; AAH21192.1; -; mRNA.
DR   EMBL; BC054004; AAH54004.1; -; mRNA.
DR   EMBL; AB023208; BAA76835.2; -; mRNA.
DR   EMBL; AL080131; CAB45728.1; -; mRNA.
DR   CCDS; CCDS45790.1; -. [Q9UHD8-1]
DR   CCDS; CCDS45791.1; -. [Q9UHD8-2]
DR   CCDS; CCDS45792.1; -. [Q9UHD8-5]
DR   CCDS; CCDS45793.1; -. [Q9UHD8-3]
DR   CCDS; CCDS45794.1; -. [Q9UHD8-8]
DR   CCDS; CCDS45795.1; -. [Q9UHD8-4]
DR   CCDS; CCDS74166.1; -. [Q9UHD8-9]
DR   CCDS; CCDS77122.1; -. [Q9UHD8-7]
DR   PIR; T12519; T12519.
DR   RefSeq; NP_001106963.1; NM_001113491.1. [Q9UHD8-1]
DR   RefSeq; NP_001106964.1; NM_001113492.1. [Q9UHD8-3]
DR   RefSeq; NP_001106965.1; NM_001113493.1. [Q9UHD8-5]
DR   RefSeq; NP_001106966.1; NM_001113494.1. [Q9UHD8-3]
DR   RefSeq; NP_001106967.1; NM_001113495.1. [Q9UHD8-8]
DR   RefSeq; NP_001106968.1; NM_001113496.1. [Q9UHD8-4]
DR   RefSeq; NP_001280624.1; NM_001293695.1. [Q9UHD8-7]
DR   RefSeq; NP_001280625.1; NM_001293696.1. [Q9UHD8-9]
DR   RefSeq; NP_001280626.1; NM_001293697.1. [Q9UHD8-4]
DR   RefSeq; NP_001280627.1; NM_001293698.1. [Q9UHD8-4]
DR   RefSeq; NP_006631.2; NM_006640.4. [Q9UHD8-2]
DR   RefSeq; XP_005257019.1; XM_005256962.1.
DR   RefSeq; XP_006721706.1; XM_006721643.2.
DR   RefSeq; XP_006721707.1; XM_006721644.1.
DR   RefSeq; XP_011522509.1; XM_011524207.1.
DR   RefSeq; XP_011522510.1; XM_011524208.2.
DR   RefSeq; XP_016879520.1; XM_017024031.1.
DR   RefSeq; XP_016879521.1; XM_017024032.1.
DR   PDB; 4YQF; X-ray; 2.73 A; A/B=296-565.
DR   PDB; 5CYO; X-ray; 2.04 A; A/B=295-568.
DR   PDB; 5CYP; X-ray; 2.89 A; A/B/C/D=293-566.
DR   PDBsum; 4YQF; -.
DR   PDBsum; 5CYO; -.
DR   PDBsum; 5CYP; -.
DR   SMR; Q9UHD8; -.
DR   BioGrid; 116015; 92.
DR   CORUM; Q9UHD8; -.
DR   DIP; DIP-36697N; -.
DR   IntAct; Q9UHD8; 47.
DR   MINT; Q9UHD8; -.
DR   STRING; 9606.ENSP00000391249; -.
DR   ChEMBL; CHEMBL4105891; -.
DR   CarbonylDB; Q9UHD8; -.
DR   iPTMnet; Q9UHD8; -.
DR   MetOSite; Q9UHD8; -.
DR   PhosphoSitePlus; Q9UHD8; -.
DR   SwissPalm; Q9UHD8; -.
DR   BioMuta; SEPT9; -.
DR   DMDM; 93141311; -.
DR   EPD; Q9UHD8; -.
DR   jPOST; Q9UHD8; -.
DR   MassIVE; Q9UHD8; -.
DR   PaxDb; Q9UHD8; -.
DR   PeptideAtlas; Q9UHD8; -.
DR   PRIDE; Q9UHD8; -.
DR   ProteomicsDB; 84325; -. [Q9UHD8-1]
DR   ProteomicsDB; 84326; -. [Q9UHD8-2]
DR   ProteomicsDB; 84327; -. [Q9UHD8-3]
DR   ProteomicsDB; 84328; -. [Q9UHD8-4]
DR   ProteomicsDB; 84329; -. [Q9UHD8-5]
DR   ProteomicsDB; 84330; -. [Q9UHD8-7]
DR   ProteomicsDB; 84331; -. [Q9UHD8-8]
DR   ProteomicsDB; 84332; -. [Q9UHD8-9]
DR   Antibodypedia; 32488; 203 antibodies.
DR   DNASU; 10801; -.
DR   Ensembl; ENST00000329047; ENSP00000329161; ENSG00000184640. [Q9UHD8-2]
DR   Ensembl; ENST00000423034; ENSP00000405877; ENSG00000184640. [Q9UHD8-5]
DR   Ensembl; ENST00000427177; ENSP00000391249; ENSG00000184640. [Q9UHD8-1]
DR   Ensembl; ENST00000427180; ENSP00000415624; ENSG00000184640. [Q9UHD8-8]
DR   Ensembl; ENST00000427674; ENSP00000403194; ENSG00000184640. [Q9UHD8-3]
DR   Ensembl; ENST00000431235; ENSP00000406987; ENSG00000184640. [Q9UHD8-3]
DR   Ensembl; ENST00000449803; ENSP00000400181; ENSG00000184640. [Q9UHD8-3]
DR   Ensembl; ENST00000541152; ENSP00000438089; ENSG00000184640. [Q9UHD8-4]
DR   Ensembl; ENST00000585930; ENSP00000468120; ENSG00000184640. [Q9UHD8-9]
DR   Ensembl; ENST00000588690; ENSP00000468668; ENSG00000184640. [Q9UHD8-3]
DR   Ensembl; ENST00000590294; ENSP00000465464; ENSG00000184640. [Q9UHD8-2]
DR   Ensembl; ENST00000591088; ENSP00000466247; ENSG00000184640. [Q9UHD8-4]
DR   Ensembl; ENST00000591198; ENSP00000468406; ENSG00000184640. [Q9UHD8-7]
DR   Ensembl; ENST00000592951; ENSP00000466648; ENSG00000184640. [Q9UHD8-4]
DR   GeneID; 10801; -.
DR   KEGG; hsa:10801; -.
DR   UCSC; uc002jts.5; human. [Q9UHD8-1]
DR   CTD; 10801; -.
DR   DisGeNET; 10801; -.
DR   GeneCards; SEPTIN9; -.
DR   GeneReviews; SEPT9; -.
DR   HGNC; HGNC:7323; SEPTIN9.
DR   HPA; ENSG00000184640; Low tissue specificity.
DR   MalaCards; SEPTIN9; -.
DR   MIM; 162100; phenotype.
DR   MIM; 604061; gene.
DR   neXtProt; NX_Q9UHD8; -.
DR   OpenTargets; ENSG00000184640; -.
DR   Orphanet; 2901; Neuralgic amyotrophy.
DR   PharmGKB; PA31132; -.
DR   eggNOG; KOG1547; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00940000157195; -.
DR   HOGENOM; CLU_017718_5_0_1; -.
DR   InParanoid; Q9UHD8; -.
DR   KO; K16938; -.
DR   OMA; GECHRLP; -.
DR   OrthoDB; 845354at2759; -.
DR   PhylomeDB; Q9UHD8; -.
DR   TreeFam; TF101078; -.
DR   SIGNOR; Q9UHD8; -.
DR   ChiTaRS; SEPT9; human.
DR   GeneWiki; SEPT9; -.
DR   GenomeRNAi; 10801; -.
DR   Pharos; Q9UHD8; Tbio.
DR   PRO; PR:Q9UHD8; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9UHD8; protein.
DR   Bgee; ENSG00000184640; Expressed in parotid gland and 230 other tissues.
DR   ExpressionAtlas; Q9UHD8; baseline and differential.
DR   Genevisible; Q9UHD8; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005930; C:axoneme; IDA:GO_Central.
DR   GO; GO:0032153; C:cell division site; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IBA:GO_Central.
DR   GO; GO:0097730; C:non-motile cilium; IDA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031105; C:septin complex; IDA:UniProtKB.
DR   GO; GO:0005940; C:septin ring; IBA:GO_Central.
DR   GO; GO:0001725; C:stress fiber; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0060090; F:molecular adaptor activity; IBA:GO_Central.
DR   GO; GO:0034613; P:cellular protein localization; IBA:GO_Central.
DR   GO; GO:0061640; P:cytoskeleton-dependent cytokinesis; IBA:GO_Central.
DR   GO; GO:1902857; P:positive regulation of non-motile cilium assembly; IMP:GO_Central.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030645; SEPT9.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF47; PTHR18884:SF47; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell cycle; Cell division;
KW   Chromosomal rearrangement; Cytoplasm; Cytoskeleton; Disease mutation;
KW   GTP-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..586
FT                   /note="Septin-9"
FT                   /id="PRO_0000173535"
FT   DOMAIN          295..567
FT                   /note="Septin-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   NP_BIND         305..312
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         445..453
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   REGION          305..312
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   REGION          362..365
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   REGION          444..447
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01056"
FT   BINDING         339
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   BINDING         365
FT                   /note="GTP; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         501
FT                   /note="GTP; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         516
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         38
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         42
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163"
FT   MOD_RES         49
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         62
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80UG5"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         85
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         89
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         96
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         142
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         278
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         327
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..251
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10987277,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_012335"
FT   VAR_SEQ         1..224
FT                   /note="Missing (in isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038315"
FT   VAR_SEQ         1..164
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10673329,
FT                   ECO:0000303|PubMed:10987277, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012336"
FT   VAR_SEQ         1..112
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038316"
FT   VAR_SEQ         1..25
FT                   /note="MKKSYSGGTRTSSGRLRRLGDSSGP -> MERDRIS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10339604,
FT                   ECO:0000303|PubMed:10987277, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|Ref.4, ECO:0000303|Ref.6"
FT                   /id="VSP_012337"
FT   VAR_SEQ         1..25
FT                   /note="MKKSYSGGTRTSSGRLRRLGDSSGP -> MSDPAVNAQLDGIISDFE (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10987277,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_012338"
FT   VAR_SEQ         7..25
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038317"
FT   VAR_SEQ         113..240
FT                   /note="DISSKQVENAGAIGPSRFGLKRAEVLGHKTPEPAPRRTEITIVKPQESAHRR
FT                   MEPPASKVPEVPTAPATDAAPKRVEIQMPKPAEAPTAPSPAQTLENSEPAPVSQLQSRL
FT                   EPKPQPPVAEATPRSQE -> MGSSFWEGLQVAVGLPQGCWPQGLDSGEPAEGGQLEAA
FT                   PVCIVTRQSKETAGPTLGRGGWRQGSLRRGKGTSCRCRQLSPGHGPGRLTGCGECHRLP
FT                   CRGLVSGFTGLRGQEEDDLAFCLATIGSDRQ (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038318"
FT   VAR_SEQ         225..240
FT                   /note="PKPQPPVAEATPRSQE -> MAGAGCTGTWSWLWGT (in isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038319"
FT   VARIANT         76
FT                   /note="R -> C (in dbSNP:rs202079794)"
FT                   /evidence="ECO:0000269|PubMed:10987277"
FT                   /id="VAR_020667"
FT   VARIANT         106
FT                   /note="R -> W (in HNA; dbSNP:rs80338761)"
FT                   /evidence="ECO:0000269|PubMed:16186812,
FT                   ECO:0000269|PubMed:17546647, ECO:0000269|PubMed:18492087,
FT                   ECO:0000269|PubMed:19451530"
FT                   /id="VAR_033101"
FT   VARIANT         111
FT                   /note="S -> F (in HNA; dbSNP:rs80338762)"
FT                   /evidence="ECO:0000269|PubMed:16186812,
FT                   ECO:0000269|PubMed:17546647, ECO:0000269|PubMed:19451530"
FT                   /id="VAR_033102"
FT   VARIANT         145
FT                   /note="P -> L (in dbSNP:rs34587622)"
FT                   /evidence="ECO:0000269|PubMed:10987277,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:19451530"
FT                   /id="VAR_020668"
FT   VARIANT         576
FT                   /note="M -> V (in dbSNP:rs2627223)"
FT                   /evidence="ECO:0000269|PubMed:10231032,
FT                   ECO:0000269|PubMed:10339604, ECO:0000269|PubMed:10673329,
FT                   ECO:0000269|PubMed:10987277, ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005,
FT                   ECO:0000269|Ref.4, ECO:0000269|Ref.6, ECO:0000269|Ref.7"
FT                   /id="VAR_020669"
FT   CONFLICT        251
FT                   /note="D -> G (in Ref. 5; BAG64494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        487
FT                   /note="V -> E (in Ref. 5; BAB14057)"
FT                   /evidence="ECO:0000305"
FT   STRAND          297..305
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   HELIX           311..322
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          343..351
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          354..362
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          369..371
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   TURN            373..376
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   HELIX           377..395
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          410..415
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          419..421
FT                   /evidence="ECO:0000244|PDB:5CYP"
FT   HELIX           424..434
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          437..443
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   HELIX           446..448
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   HELIX           451..467
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          472..474
FT                   /evidence="ECO:0000244|PDB:4YQF"
FT   HELIX           476..478
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   HELIX           482..494
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          496..498
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          503..508
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          511..517
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   STRAND          522..524
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   TURN            528..530
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   HELIX           533..539
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   HELIX           542..554
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   HELIX           556..567
FT                   /evidence="ECO:0000244|PDB:5CYO"
FT   MOD_RES         Q9UHD8-3:1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
SQ   SEQUENCE   586 AA;  65401 MW;  D4404578328CFCFE CRC64;
     MKKSYSGGTR TSSGRLRRLG DSSGPALKRS FEVEEVETPN STPPRRVQTP LLRATVASST
     QKFQDLGVKN SEPSARHVDS LSQRSPKASL RRVELSGPKA AEPVSRRTEL SIDISSKQVE
     NAGAIGPSRF GLKRAEVLGH KTPEPAPRRT EITIVKPQES AHRRMEPPAS KVPEVPTAPA
     TDAAPKRVEI QMPKPAEAPT APSPAQTLEN SEPAPVSQLQ SRLEPKPQPP VAEATPRSQE
     ATEAAPSCVG DMADTPRDAG LKQAPASRNE KAPVDFGYVG IDSILEQMRR KAMKQGFEFN
     IMVVGQSGLG KSTLINTLFK SKISRKSVQP TSEERIPKTI EIKSITHDIE EKGVRMKLTV
     IDTPGFGDHI NNENCWQPIM KFINDQYEKY LQEEVNINRK KRIPDTRVHC CLYFIPATGH
     SLRPLDIEFM KRLSKVVNIV PVIAKADTLT LEERVHFKQR ITADLLSNGI DVYPQKEFDE
     DSEDRLVNEK FREMIPFAVV GSDHEYQVNG KRILGRKTKW GTIEVENTTH CEFAYLRDLL
     IRTHMQNIKD ITSSIHFEAY RVKRLNEGSS AMANGMEEKE PEAPEM
//
ID   SHOT1_HUMAN             Reviewed;         631 AA.
AC   A0MZ66; A8MYU7; B3KRD3; B3KRH2; B3KTE0; B3KTJ7; B3KTJ8; B4E3U1; B7Z7Z9;
AC   Q68DG1; Q6PIM5; Q9HCH4; Q9NUV0;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 4.
DT   22-APR-2020, entry version 120.
DE   RecName: Full=Shootin-1 {ECO:0000312|HGNC:HGNC:29319};
DE   AltName: Full=Shootin1 {ECO:0000250|UniProtKB:A0MZ67};
GN   Name=SHTN1 {ECO:0000312|HGNC:HGNC:29319}; Synonyms=KIAA1598;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=17030985; DOI=10.1083/jcb.200604160;
RA   Toriyama M., Shimada T., Kim K.B., Mitsuba M., Nomura E., Katsuta K.,
RA   Sakumura Y., Roepstorff P., Inagaki N.;
RT   "Shootin1: a protein involved in the organization of an asymmetric signal
RT   for neuronal polarization.";
RL   J. Cell Biol. 175:147-157(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 5; 6; 7 AND 8), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 349-631 (ISOFORM 1).
RC   TISSUE=Brain, Placenta, Testis, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 388-631 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 11-631 (ISOFORM 2).
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [8]
RP   PROTEIN SEQUENCE OF 9-17; 160-169; 187-197 AND 467-479, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-506; SER-515; SER-532 AND
RP   THR-537, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-506, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249; THR-496; SER-506;
RP   SER-532 AND THR-537, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-506, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-249; SER-375; SER-473;
RP   THR-487; SER-494; SER-506; SER-532; SER-534 AND THR-537, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375; SER-494 AND SER-506, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Involved in the generation of internal asymmetric signals
CC       required for neuronal polarization and neurite outgrowth. Mediates
CC       netrin-1-induced F-actin-substrate coupling or 'clutch engagement'
CC       within the axon growth cone through activation of CDC42, RAC1 and PAK1-
CC       dependent signaling pathway, thereby converting the F-actin retrograde
CC       flow into traction forces, concomitantly with filopodium extension and
CC       axon outgrowth. Plays a role in cytoskeletal organization by regulating
CC       the subcellular localization of phosphoinositide 3-kinase (PI3K)
CC       activity at the axonal growth cone. Plays also a role in regenerative
CC       neurite outgrowth. In the developing cortex, cooperates with KIF20B to
CC       promote both the transition from the multipolar to the bipolar stage
CC       and the radial migration of cortical neurons from the ventricular zone
CC       toward the superficial layer of the neocortex. Involved in the
CC       accumulation of phosphatidylinositol 3,4,5-trisphosphate (PIP3) in the
CC       growth cone of primary hippocampal neurons.
CC       {ECO:0000250|UniProtKB:A0MZ67, ECO:0000250|UniProtKB:Q8K2Q9}.
CC   -!- SUBUNIT: Interacts with L1CAM; this interaction occurs in axonal growth
CC       cones. Interacts with actin filament retrograde flow; this interaction
CC       is enhanced in a netrin-1- and PAK1-dependent manner and promotes F-
CC       actin-substrate coupling and concomitant formation of traction forces
CC       at axonal growth cones. Interacts with RUFY3. Interacts with PFN2.
CC       Interacts (via N-terminus) with KIF20B; this interaction is direct and
CC       promotes the association of SHTN1 to microtubules in primary neurons.
CC       Associates with microtubule. {ECO:0000250|UniProtKB:A0MZ67,
CC       ECO:0000250|UniProtKB:Q8K2Q9}.
CC   -!- INTERACTION:
CC       A0MZ66-4; A0MZ66-4; NbExp=3; IntAct=EBI-12097232, EBI-12097232;
CC       A0MZ66-7; O75936: BBOX1; NbExp=3; IntAct=EBI-10171490, EBI-715662;
CC       A0MZ66; P62508: ESRRG; NbExp=3; IntAct=EBI-308778, EBI-2834260;
CC       A0MZ66-4; P62508-3: ESRRG; NbExp=3; IntAct=EBI-12097232, EBI-12001340;
CC       A0MZ66-4; Q9Y2D4: EXOC6B; NbExp=3; IntAct=EBI-12097232, EBI-2690026;
CC       A0MZ66; P05413: FABP3; NbExp=3; IntAct=EBI-308778, EBI-704216;
CC       A0MZ66-4; P05413: FABP3; NbExp=3; IntAct=EBI-12097232, EBI-704216;
CC       A0MZ66; Q6PJR7: IGL@; NbExp=3; IntAct=EBI-308778, EBI-10254102;
CC       A0MZ66; Q9Y5B8: NME7; NbExp=3; IntAct=EBI-308778, EBI-744782;
CC       A0MZ66-4; Q9Y5B8: NME7; NbExp=3; IntAct=EBI-12097232, EBI-744782;
CC       A0MZ66-7; Q12800: TFCP2; NbExp=3; IntAct=EBI-10171490, EBI-717422;
CC       A0MZ66-4; Q15025: TNIP1; NbExp=3; IntAct=EBI-12097232, EBI-357849;
CC       A0MZ66-4; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-12097232, EBI-11952721;
CC       A0MZ66-4; Q9NP64: ZCCHC17; NbExp=3; IntAct=EBI-12097232, EBI-746345;
CC   -!- SUBCELLULAR LOCATION: Perikaryon {ECO:0000250|UniProtKB:Q8K2Q9}. Cell
CC       projection, axon {ECO:0000250|UniProtKB:Q8K2Q9}. Cell projection,
CC       growth cone {ECO:0000250|UniProtKB:Q8K2Q9}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q8K2Q9}. Cell projection, filopodium
CC       {ECO:0000250|UniProtKB:A0MZ67}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:A0MZ67}. Note=Localizes in multiple growth cones
CC       at neurite tips before the neuronal symmetry-breaking step. Accumulates
CC       in growth cones of a single nascent axon in a neurite length-dependent
CC       manner during the neuronal symmetry-breaking step; when absent from the
CC       nascent axon's siblings, probably due to competitive transport,
CC       prevents the formation of surplus axons. Transported anterogradely from
CC       the soma to the axon growth cone in an actin and myosin-dependent
CC       manner and passively diffuses back to the cell bodies. Colocalized with
CC       L1CAM in close apposition with actin filaments in filopodia and
CC       lamellipodia of axonal growth cones in hippocampal neurons. Exhibits
CC       retrograde movements in filopodia and lamellopodia of axonal growth
CC       cones. Colocalized with KIF20B along microtubules to the tip of the
CC       growing cone in primary hippocampal neurons. Recruted to the growth
CC       cone of developing axon in a KIF20B- and microtubule-dependent manner.
CC       {ECO:0000250|UniProtKB:A0MZ67, ECO:0000250|UniProtKB:Q8K2Q9}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1;
CC         IsoId=A0MZ66-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A0MZ66-2; Sequence=VSP_027050, VSP_027051;
CC       Name=3;
CC         IsoId=A0MZ66-3; Sequence=VSP_027053;
CC       Name=4;
CC         IsoId=A0MZ66-4; Sequence=VSP_027052;
CC       Name=5;
CC         IsoId=A0MZ66-5; Sequence=VSP_036498;
CC       Name=6;
CC         IsoId=A0MZ66-6; Sequence=VSP_036499;
CC       Name=7;
CC         IsoId=A0MZ66-7; Sequence=VSP_036497;
CC       Name=8;
CC         IsoId=A0MZ66-8; Sequence=VSP_036498, VSP_027052;
CC   -!- DOMAIN: The N-terminus region is necessary for interaction with actin
CC       retrograde filament flow and accumulation in neuronal growth cones.
CC       {ECO:0000250|UniProtKB:A0MZ67}.
CC   -!- PTM: Phosphorylated on Ser-101 and Ser-249 by PAK1 through a CDC42- and
CC       RAC1-dependent signaling pathway, which enhances its association with
CC       F-actin retrograde flow in filopodia and lamellipodia of axonal growth
CC       cones. Phosphorylation on Ser-101 and Ser-249 is increased by netrin-1.
CC       {ECO:0000250|UniProtKB:A0MZ67}.
CC   -!- SIMILARITY: Belongs to the shootin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH22348.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA92019.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG53052.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG53110.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF055487; ABK56022.1; -; mRNA.
DR   EMBL; AK001984; BAA92019.1; ALT_INIT; mRNA.
DR   EMBL; AK091381; BAG52345.1; -; mRNA.
DR   EMBL; AK091578; BAG52384.1; -; mRNA.
DR   EMBL; AK095419; BAG53052.1; ALT_INIT; mRNA.
DR   EMBL; AK095703; BAG53109.1; -; mRNA.
DR   EMBL; AK095709; BAG53110.1; ALT_INIT; mRNA.
DR   EMBL; AK302705; BAH13785.1; -; mRNA.
DR   EMBL; AK304865; BAG65603.1; -; mRNA.
DR   EMBL; CR749417; CAH18259.1; -; mRNA.
DR   EMBL; AC012308; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL731557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49434.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49438.1; -; Genomic_DNA.
DR   EMBL; BC022348; AAH22348.1; ALT_INIT; mRNA.
DR   EMBL; BC032303; AAH32303.1; -; mRNA.
DR   EMBL; AB046818; BAB13424.1; -; mRNA.
DR   CCDS; CCDS31293.1; -. [A0MZ66-2]
DR   CCDS; CCDS44482.1; -. [A0MZ66-1]
DR   CCDS; CCDS58097.1; -. [A0MZ66-8]
DR   CCDS; CCDS73207.1; -. [A0MZ66-5]
DR   CCDS; CCDS73208.1; -. [A0MZ66-4]
DR   RefSeq; NP_001120683.1; NM_001127211.2. [A0MZ66-1]
DR   RefSeq; NP_001245227.1; NM_001258298.1. [A0MZ66-5]
DR   RefSeq; NP_001245228.1; NM_001258299.1. [A0MZ66-4]
DR   RefSeq; NP_001245229.1; NM_001258300.1. [A0MZ66-8]
DR   RefSeq; NP_060800.2; NM_018330.6. [A0MZ66-2]
DR   RefSeq; XP_016871951.1; XM_017016462.1.
DR   SMR; A0MZ66; -.
DR   BioGrid; 121723; 45.
DR   IntAct; A0MZ66; 26.
DR   MINT; A0MZ66; -.
DR   STRING; 9606.ENSP00000347532; -.
DR   iPTMnet; A0MZ66; -.
DR   PhosphoSitePlus; A0MZ66; -.
DR   BioMuta; SHTN1; -.
DR   EPD; A0MZ66; -.
DR   jPOST; A0MZ66; -.
DR   MassIVE; A0MZ66; -.
DR   MaxQB; A0MZ66; -.
DR   PaxDb; A0MZ66; -.
DR   PRIDE; A0MZ66; -.
DR   ProteomicsDB; 45; -. [A0MZ66-1]
DR   ProteomicsDB; 46; -. [A0MZ66-2]
DR   ProteomicsDB; 47; -. [A0MZ66-3]
DR   ProteomicsDB; 48; -. [A0MZ66-4]
DR   ProteomicsDB; 49; -. [A0MZ66-5]
DR   ProteomicsDB; 50; -. [A0MZ66-6]
DR   ProteomicsDB; 51; -. [A0MZ66-7]
DR   ProteomicsDB; 6909; -.
DR   Antibodypedia; 46270; 36 antibodies.
DR   Ensembl; ENST00000260777; ENSP00000260777; ENSG00000187164. [A0MZ66-5]
DR   Ensembl; ENST00000355371; ENSP00000347532; ENSG00000187164. [A0MZ66-1]
DR   Ensembl; ENST00000392901; ENSP00000376635; ENSG00000187164. [A0MZ66-8]
DR   Ensembl; ENST00000392903; ENSP00000376636; ENSG00000187164. [A0MZ66-4]
DR   Ensembl; ENST00000615301; ENSP00000480109; ENSG00000187164. [A0MZ66-2]
DR   GeneID; 57698; -.
DR   KEGG; hsa:57698; -.
DR   UCSC; uc001lcz.6; human. [A0MZ66-1]
DR   CTD; 57698; -.
DR   DisGeNET; 57698; -.
DR   GeneCards; SHTN1; -.
DR   HGNC; HGNC:29319; SHTN1.
DR   HPA; ENSG00000187164; Tissue enhanced (brain).
DR   MIM; 611171; gene.
DR   neXtProt; NX_A0MZ66; -.
DR   OpenTargets; ENSG00000187164; -.
DR   PharmGKB; PA134973737; -.
DR   eggNOG; ENOG410IFIH; Eukaryota.
DR   eggNOG; ENOG4111HDU; LUCA.
DR   GeneTree; ENSGT00510000048167; -.
DR   HOGENOM; CLU_027649_1_1_1; -.
DR   InParanoid; A0MZ66; -.
DR   OMA; KCNRVSV; -.
DR   OrthoDB; 744654at2759; -.
DR   PhylomeDB; A0MZ66; -.
DR   TreeFam; TF326250; -.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   ChiTaRS; SHTN1; human.
DR   GenomeRNAi; 57698; -.
DR   Pharos; A0MZ66; Tdark.
DR   PRO; PR:A0MZ66; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; A0MZ66; protein.
DR   Bgee; ENSG00000187164; Expressed in substantia nigra and 217 other tissues.
DR   Genevisible; A0MZ66; HS.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0044295; C:axonal growth cone; ISS:UniProtKB.
DR   GO; GO:0031252; C:cell leading edge; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0030175; C:filopodium; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:Ensembl.
DR   GO; GO:0005875; C:microtubule associated complex; ISS:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0019894; F:kinesin binding; IEA:Ensembl.
DR   GO; GO:0061573; P:actin filament bundle retrograde transport; ISS:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0032488; P:Cdc42 protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0060327; P:cytoplasmic actin-based contraction involved in cell motility; ISS:UniProtKB.
DR   GO; GO:0061163; P:endoplasmic reticulum polarization; ISS:UniProtKB.
DR   GO; GO:0038007; P:netrin-activated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB.
DR   GO; GO:0045773; P:positive regulation of axon extension; ISS:UniProtKB.
DR   GO; GO:2001224; P:positive regulation of neuron migration; IDA:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISS:UniProtKB.
DR   GO; GO:2000114; P:regulation of establishment of cell polarity; ISS:UniProtKB.
DR   GO; GO:0006930; P:substrate-dependent cell migration, cell extension; ISS:UniProtKB.
DR   InterPro; IPR024849; Shootin-1.
DR   PANTHER; PTHR46606; PTHR46606; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell projection; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Direct protein sequencing;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..631
FT                   /note="Shootin-1"
FT                   /id="PRO_0000295740"
FT   COILED          7..353
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        353..369
FT                   /note="Pro-rich"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2Q9"
FT   MOD_RES         3
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2Q9"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         101
FT                   /note="Phosphoserine; by PAK1"
FT                   /evidence="ECO:0000250|UniProtKB:A0MZ67"
FT   MOD_RES         249
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         375
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         473
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         487
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         494
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         496
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         506
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         515
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         532
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         534
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         537
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..412
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036497"
FT   VAR_SEQ         1..60
FT                   /note="Missing (in isoform 5 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036498"
FT   VAR_SEQ         1..37
FT                   /note="MNSSDEEKQLQLITSLKEQAIGEYEDLRAENQKTKEK -> MPRILKQ (in
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036499"
FT   VAR_SEQ         454..456
FT                   /note="GTL -> ASQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10997877,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:17030985"
FT                   /id="VSP_027050"
FT   VAR_SEQ         457..631
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10997877,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:17030985"
FT                   /id="VSP_027051"
FT   VAR_SEQ         559..631
FT                   /note="Missing (in isoform 4 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_027052"
FT   VAR_SEQ         623..631
FT                   /note="VRETDSSNC -> FFPFHFGFEGVLPLAGVTLSTKARDPK (in isoform
FT                   3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_027053"
FT   CONFLICT        399
FT                   /note="T -> A (in Ref. 4; AC023283)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        417
FT                   /note="I -> V (in Ref. 2; BAG52345)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   631 AA;  71640 MW;  826B88F18151228D CRC64;
     MNSSDEEKQL QLITSLKEQA IGEYEDLRAE NQKTKEKCDK IRQERDEAVK KLEEFQKISH
     MVIEEVNFMQ NHLEIEKTCR ESAEALATKL NKENKTLKRI SMLYMAKLGP DVITEEINID
     DEDSTTDTDG AAETCVSVQC QKQIKELRDQ IVSVQEEKKI LAIELENLKS KLVEVIEEVN
     KVKQEKTVLN SEVLEQRKVL EKCNRVSMLA VEEYEEMQVN LELEKDLRKK AESFAQEMFI
     EQNKLKRQSH LLLQSSIPDQ QLLKALDENA KLTQQLEEER IQHQQKVKEL EEQLENETLH
     KEIHNLKQQL ELLEEDKKEL ELKYQNSEEK ARNLKHSVDE LQKRVNQSEN SVPPPPPPPP
     PLPPPPPNPI RSLMSMIRKR SHPSGSGAKK EKATQPETTE EVTDLKRQAV EEMMDRIKKG
     VHLRPVNQTA RPKTKPESSK GCESAVDELK GILGTLNKST SSRSLKSLDP ENSETELERI
     LRRRKVTAEA DSSSPTGILA TSESKSMPVL GSVSSVTKTA LNKKTLEAEF NSPSPPTPEP
     GEGPRKLEGC TSSKVTFQPP SSIGCRKKYI DGEKQAEPVV VLDPVSTHEP QTKDQVAEKD
     PTQHKEDEGE IQPENKEDSI ENVRETDSSN C
//
ID   SNX29_HUMAN             Reviewed;         813 AA.
AC   Q8TEQ0; B5MDW2; Q8N2X2; Q9HA26;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 3.
DT   22-APR-2020, entry version 123.
DE   RecName: Full=Sorting nexin-29;
DE   AltName: Full=RUN domain-containing protein 2A;
GN   Name=SNX29; Synonyms=RUNDC2A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-375 (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 441-813 (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 512-813 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268 AND SER-330, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TEQ0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TEQ0-2; Sequence=VSP_027281;
CC   -!- SIMILARITY: Belongs to the sorting nexin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14033.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC007216; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC007598; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC007601; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010333; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092365; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131391; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK022425; BAB14033.1; ALT_SEQ; mRNA.
DR   EMBL; AK074072; BAB84898.1; -; mRNA.
DR   EMBL; BC029857; AAH29857.1; -; mRNA.
DR   CCDS; CCDS10553.2; -. [Q8TEQ0-1]
DR   RefSeq; NP_115543.3; NM_032167.4. [Q8TEQ0-1]
DR   SMR; Q8TEQ0; -.
DR   BioGrid; 124903; 13.
DR   IntAct; Q8TEQ0; 10.
DR   STRING; 9606.ENSP00000456480; -.
DR   iPTMnet; Q8TEQ0; -.
DR   PhosphoSitePlus; Q8TEQ0; -.
DR   BioMuta; SNX29; -.
DR   DMDM; 353526314; -.
DR   EPD; Q8TEQ0; -.
DR   jPOST; Q8TEQ0; -.
DR   MassIVE; Q8TEQ0; -.
DR   MaxQB; Q8TEQ0; -.
DR   PaxDb; Q8TEQ0; -.
DR   PeptideAtlas; Q8TEQ0; -.
DR   PRIDE; Q8TEQ0; -.
DR   ProteomicsDB; 74476; -. [Q8TEQ0-1]
DR   ProteomicsDB; 74477; -. [Q8TEQ0-2]
DR   Antibodypedia; 2225; 121 antibodies.
DR   DNASU; 92017; -.
DR   Ensembl; ENST00000566228; ENSP00000456480; ENSG00000048471. [Q8TEQ0-1]
DR   GeneID; 92017; -.
DR   KEGG; hsa:92017; -.
DR   UCSC; uc002dby.6; human. [Q8TEQ0-1]
DR   CTD; 92017; -.
DR   DisGeNET; 92017; -.
DR   GeneCards; SNX29; -.
DR   HGNC; HGNC:30542; SNX29.
DR   HPA; ENSG00000048471; Low tissue specificity.
DR   neXtProt; NX_Q8TEQ0; -.
DR   OpenTargets; ENSG00000048471; -.
DR   PharmGKB; PA162404312; -.
DR   eggNOG; KOG4381; Eukaryota.
DR   eggNOG; ENOG410XRAX; LUCA.
DR   GeneTree; ENSGT00730000110975; -.
DR   HOGENOM; CLU_020563_1_0_1; -.
DR   InParanoid; Q8TEQ0; -.
DR   KO; K17935; -.
DR   OMA; HEQERFS; -.
DR   OrthoDB; 543799at2759; -.
DR   ChiTaRS; SNX29; human.
DR   GenomeRNAi; 92017; -.
DR   Pharos; Q8TEQ0; Tdark.
DR   PRO; PR:Q8TEQ0; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q8TEQ0; protein.
DR   Bgee; ENSG00000048471; Expressed in metanephros and 192 other tissues.
DR   ExpressionAtlas; Q8TEQ0; baseline and differential.
DR   Genevisible; Q8TEQ0; HS.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   CDD; cd07277; PX_RUN; 1.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   InterPro; IPR001683; Phox.
DR   InterPro; IPR036871; PX_dom_sf.
DR   InterPro; IPR004012; Run_dom.
DR   InterPro; IPR037213; Run_dom_sf.
DR   InterPro; IPR037916; SNX29_PX.
DR   Pfam; PF00787; PX; 1.
DR   Pfam; PF02759; RUN; 1.
DR   SMART; SM00312; PX; 1.
DR   SMART; SM00593; RUN; 1.
DR   SUPFAM; SSF140741; SSF140741; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS50195; PX; 1.
DR   PROSITE; PS50826; RUN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Phosphoprotein; Reference proteome.
FT   CHAIN           1..813
FT                   /note="Sorting nexin-29"
FT                   /id="PRO_0000297565"
FT   DOMAIN          36..180
FT                   /note="RUN"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00178"
FT   DOMAIN          656..779
FT                   /note="PX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00147"
FT   COILED          466..545
FT                   /evidence="ECO:0000255"
FT   MOD_RES         268
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3S3"
FT   MOD_RES         292
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3S3"
FT   MOD_RES         330
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         344
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3S3"
FT   MOD_RES         445
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3S3"
FT   MOD_RES         450
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3S3"
FT   MOD_RES         639
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3S3"
FT   MOD_RES         641
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3S3"
FT   MOD_RES         642
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3S3"
FT   MOD_RES         646
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3S3"
FT   VAR_SEQ         775..813
FT                   /note="ITPPGEPVNSRPKAASRFPKLSRGQPRETRNVEPQSGDL -> WISLFGNGR
FT                   DSSREEFSSS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_027281"
FT   CONFLICT        183
FT                   /note="N -> D (in Ref. 2; BAB14033)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        344
FT                   /note="S -> G (in Ref. 2; BAB14033)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   813 AA;  91254 MW;  A1868A682CCFBE0C CRC64;
     MSGSQNNDKR QFLLERLLDA VKQCQIRFGG RKEIASDSDS RVTCLCAQFE AVLQHGLKRS
     RGLALTAAAI KQAAGFASKT ETEPVFWYYV KEVLNKHELQ RFYSLRHIAS DVGRGRAWLR
     CALNEHSLER YLHMLLADRC RLSTFYEDWS FVMDEERSSM LPTMAAGLNS ILFAINIDNK
     DLNGQSKFAP TVSDLLKEST QNVTSLLKES TQGVSSLFRE ITASSAVSIL IKPEQETDPL
     PVVSRNVSAD AKCKKERKKK KKVTNIISFD DEEDEQNSGD VFKKTPGAGE SSEDNSDRSS
     VNIMSAFESP FGPNSNGSQS SNSWKIDSLS LNGEFGYQKL DVKSIDDEDV DENEDDVYGN
     SSGRKHRGHS ESPEKPLEGN TCLSQMHSWA PLKVLHNDSD ILFPVSGVGS YSPADAPLGS
     LENGTGPEDH VLPDPGLRYS VEASSPGHGS PLSSLLPSAS VPESMTISEL RQATVAMMNR
     KDELEEENRS LRNLLDGEME HSAALRQEVD TLKRKVAEQE ERQGMKVQAL ARENEVLKVQ
     LKKYVGAVQM LKREGQTAEV PNLWSVDGEV TVAEQKPGEI AEELASSYER KLIEVAEMHG
     ELIEFNERLH RALVAKEALV SQMRQELIDL RGPVPGDLSQ TSEDQSLSDF EISNRALINV
     WIPSVFLRGK AANAFHVYQV YIRIKDDEWN IYRRYTEFRS LHHKLQNKYP QVRAYNFPPK
     KAIGNKDAKF VEERRKQLQN YLRSVMNKVI QMVPEFAASP KKETLIQLMP FFVDITPPGE
     PVNSRPKAAS RFPKLSRGQP RETRNVEPQS GDL
//
ID   A0A024QYY9_HUMAN        Unreviewed;      1068 AA.
AC   A0A024QYY9;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 49.
DE   SubName: Full=Spectrin domain with coiled-coils 1, isoform CRA_a {ECO:0000313|EMBL:EAW50917.1};
GN   Name=SPECC1 {ECO:0000313|EMBL:EAW50917.1};
GN   ORFNames=hCG_28279 {ECO:0000313|EMBL:EAW50917.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW50917.1};
RN   [1] {ECO:0000313|EMBL:EAW50917.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW50917.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471212; EAW50914.1; -; Genomic_DNA.
DR   EMBL; CH471212; EAW50917.1; -; Genomic_DNA.
DR   RefSeq; NP_001028725.1; NM_001033553.2.
DR   RefSeq; NP_001230368.1; NM_001243439.1.
DR   Antibodypedia; 13788; 224 antibodies.
DR   GeneID; 92521; -.
DR   KEGG; hsa:92521; -.
DR   CTD; 92521; -.
DR   EuPathDB; HostDB:ENSG00000128487.16; -.
DR   eggNOG; KOG4678; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   HOGENOM; CLU_009328_2_0_1; -.
DR   KO; K23028; -.
DR   OMA; KEVCDRQ; -.
DR   ChiTaRS; SPECC1; human.
DR   GenomeRNAi; 92521; -.
DR   Bgee; ENSG00000128487; Expressed in corpus callosum and 152 other tissues.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   Pfam; PF00307; CH; 1.
DR   SMART; SM00033; CH; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS50021; CH; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          962..1067
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000259|PROSITE:PS50021"
FT   REGION          1..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          261..367
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          777..796
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          859..885
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          898..922
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          226..260
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          481..529
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          584..611
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          651..678
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          686..727
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          746..773
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        30..45
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        81..101
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        126..149
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        150..166
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        173..202
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        263..297
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        307..324
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        338..367
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        863..879
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        899..913
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1068 AA;  118585 MW;  E6FB6987C835A1CA CRC64;
     MRSAAKPWNP AIRAGGHGPD RVRPLPAASS GMKSSKSSTS LAFESRLSRL KRASSEDTLN
     KPGSTAASGV VRLKKTATAG AISELTESRL RSGTGAFTTT KRTGIPAPRE FSVTVSRERS
     VPRGPSNPRK SVSSPTSSNT PTPTKHLRTP STKPKQENEG GEKAALESQV RELLAEAKAK
     DSEINRLRSE LKKYKEKRTL NAEGTDALGP NVDGTSVSPG DTEPMIRALE EKNKNFQKEL
     SDLEEENRVL KEKLIYLEHS PNSEGAASHT GDSSCPTSIT QESSFGSPTG NQMSSDIDEY
     KKNIHGNALR TSGSSSSDVT KASLSPDASD FEHITAETPS RPLSSTSNPF KSSKCSTAGS
     SPNSVSELSL ASLTEKIQKM EENHHSTAEE LQATLQELSD QQQMVQELTA ENEKLVDEKT
     ILETSFHQHR ERAEQLSQEN EKLMNLLQER VKNEEPTTQE GKIIELEQKC TGILEQGRFE
     REKLLNIQQQ LTCSLRKVEE ENQGALEMIK RLKEENEKLN EFLELERHNN NMMAKTLEEC
     RVTLEGLKME NGSLKSHLQG EKQKATEASA VEQTAESCEV QEMLKVARAE KDLLELSCNE
     LRQELLKANG EIKHVSSLLA KVEKDYSYLK EICDHQAEQL SRTSLKLQEK ASESDAEIKD
     MKETIFELED QVEQHRAVKL HNNQLISELE SSVIKLEEQK SDLERQLKTL TKQMKEETEE
     WRRFQADLQT AVVVANDIKC EAQQELRTVK RKLLEEEEKN ARLQKELGDV QGHGRVVTSR
     AAPPPVDEEP ESSEVDAAGR WPGVCVSRTS PTPPESATTV KSLIKSFDLG RPGGAGQNIS
     VHKTPRSPLS GIPVRTAPAA AVSPMQRHST YSSVRPASRG VTQRLDLPDL PLSDILKGRT
     ETLKPDPHLR KSPSLESLSR PPSLGFGDTR LLSASTRAWK PQSKLSVERK DPLAALAREY
     GGSKRNALLK WCQKKTQGYA NIDITNFSSS WSDGLAFCAL LHTYLPAHIP YQELNSQEKK
     RNLLLAFEAA ESVGIKPSLE LSEMLYTDRP DWQSVMQYVA QIYKYFET
//
ID   B4DW07_HUMAN            Unreviewed;       408 AA.
AC   B4DW07;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   11-DEC-2019, entry version 51.
DE   SubName: Full=cDNA FLJ50032, highly similar to Homo sapiens spectrin domain with coiled-coils 1 (SPECC1), transcript variant, mRNA {ECO:0000313|EMBL:BAG62869.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG62869.1};
RN   [1] {ECO:0000313|EMBL:BAG62869.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Stomach {ECO:0000313|EMBL:BAG62869.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK301318; BAG62869.1; -; mRNA.
DR   RefSeq; NP_001028725.1; NM_001033553.2.
DR   RefSeq; NP_001028727.1; NM_001033555.2.
DR   RefSeq; NP_001230368.1; NM_001243439.1.
DR   PeptideAtlas; B4DW07; -.
DR   PRIDE; B4DW07; -.
DR   GeneID; 92521; -.
DR   KEGG; hsa:92521; -.
DR   CTD; 92521; -.
DR   eggNOG; KOG4678; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   KO; K23028; -.
DR   GenomeRNAi; 92521; -.
DR   Genevisible; B4DW07; HS.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   Pfam; PF00307; CH; 1.
DR   SMART; SM00033; CH; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS50021; CH; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          302..407
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000259|PROSITE:PS50021"
FT   REGION          117..136
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          203..225
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          238..262
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          26..67
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          86..113
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        203..219
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        239..253
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   408 AA;  45731 MW;  47B8B76A19A7329F CRC64;
     MKETIFELED QVEQHRAVKL HNNQLISELE SSVIKLEEQK SDLERQLKTL TKQMKEETEE
     WRRFQADLQT AVVVANDIKC EAQQELRTVK RKLLEEEEKN ARLQKELGDV QGHGRVVTSR
     AAPPPVDEEP ESSEVDAAGR WPGVCVSRTS PTPPESATTV KSLIKSFDLG RPGGAGQNIS
     VHKTPRSPLS GIPVRTAPAA AVSPMQRHST YSSVRPASRG VTQRLDLPDL PLSDILKGRT
     ETLKPDPHLR KSPSLESLSR PPSLGFGDTR LLSASTRAWK PQNKLSVERK DPLAALAREY
     GGSKRNALLK WCQKKTQGYA NIDITNFSSS WSDGLAFCAL LHTYLPAHIP YQELNSQEKK
     RNLLLAFEAA ESVGIKPSLE LSEMLYTDRP DWQSVMQYVA QIYKYFET
//
ID   B4E2A4_HUMAN            Unreviewed;       987 AA.
AC   B4E2A4;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   11-DEC-2019, entry version 51.
DE   SubName: Full=cDNA FLJ53275, highly similar to Homo sapiens spectrin domain with coiled-coils 1 (SPECC1), transcript variant, mRNA {ECO:0000313|EMBL:BAG65066.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65066.1};
RN   [1] {ECO:0000313|EMBL:BAG65066.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG65066.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK304186; BAG65066.1; -; mRNA.
DR   RefSeq; NP_001028725.1; NM_001033553.2.
DR   RefSeq; NP_001028726.1; NM_001033554.2.
DR   RefSeq; NP_001028727.1; NM_001033555.2.
DR   RefSeq; NP_001230367.1; NM_001243438.1.
DR   RefSeq; NP_001230368.1; NM_001243439.1.
DR   RefSeq; NP_690868.3; NM_152904.4.
DR   PeptideAtlas; B4E2A4; -.
DR   PRIDE; B4E2A4; -.
DR   GeneID; 92521; -.
DR   KEGG; hsa:92521; -.
DR   CTD; 92521; -.
DR   eggNOG; KOG4678; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   KO; K23028; -.
DR   GenomeRNAi; 92521; -.
DR   Genevisible; B4E2A4; HS.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   Pfam; PF00307; CH; 1.
DR   SMART; SM00033; CH; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS50021; CH; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          881..986
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000259|PROSITE:PS50021"
FT   REGION          1..138
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          179..214
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          226..286
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          696..715
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          778..804
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          817..841
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          145..179
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          400..448
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          503..530
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          570..597
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          605..646
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          665..692
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        45..68
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        69..85
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        92..121
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        182..214
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        226..243
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        257..286
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        782..798
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        818..832
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   987 AA;  110293 MW;  9039F4C840B6B338 CRC64;
     MGNHSGRPED PEPGAFTTTK RTGIPAPREF SVTVSRERSV PRGPSNPRKS VSSPTSSNTP
     TPTKHLRTPS TKPKQENEGG EKAALESQVR ELLAEAKAKD SEINRLRSEL KKYKEKRTLN
     AEGTDALGPN VDGTSVSPGD TEPMIRALEE KNKNFQKELS DLEEENRVLK EKLIYLEHSP
     NSEGAASHTG DSRCPTSITQ ESSFGSPTGN QLSSDIDEYK KNIHGNALRT SGSSSSDVTK
     ASLSPDASDF EHITAETPSR PLSSTSNPFK SSKCSTAGSS PNSVSELSLA SLTEKIQKME
     ENHHSTAEEL QATLQELSDQ QQMVQELTAE NEKLVDEKTI LETSFHQHRE RAEQLSQENE
     KLMNLLQERV KNEEPTTQEG KIIELEQKCT GILEQGRFER EKLLNIQQQL TCSLRKVEEE
     NQGALEMIKR LKEENEKLNE FLELERHNNN MMAKTLEECR VTLEGLKMEN GSLKSHLQGE
     KQKATEASAV EQTAESCEVQ EMLKVARAEK DLLELSCNEL RQELLKANGE IKHVSSLLAK
     VEKDYSYLKE ICDHQAEQLS RTSLKLQEKA SESDAEIKDM KETIFELEDQ VEQHRAVKLH
     NNQLISELES SVIKLEEQKS DLERQLKTLT KQMKEETEEW RRFQADLQTA VVVANDIKCE
     AQQELRTVKR KLLEEEEKNA RLQKELGDVQ GHGRVVTSRA APPPVDEEPE SSEVDAAGRW
     PGVCVSRTSP TPPESATTVK SLIKSFDLGR PGGAGQNISV HKTPRSPLSG IPVRTAPAAA
     VSPMQRHSTY SSVRPASRGV TQRLDLPDLP LSDILKGRTE TLKPDPHLRK SPSLESLSRP
     PSLGFGDTRL LSASTRAWKP QSKLSVERKD PLAALAREYG GSKRNALLKW CQKKTQGYAN
     IDITNFSSSW SDGLAFCALL HTYLPAHIPY QELNSQEKKR NLLLAFEAAE SVGIKPSLEL
     SEMLYTDRPD WQSVMQYVAQ IYKYFET
//
ID   CYTSB_HUMAN             Reviewed;        1068 AA.
AC   Q5M775; B4DHH0; B7WNS8; Q5IBP1; Q5IBP2; Q5IBP3; Q5IBP4; Q5M772; Q5M773;
AC   Q5M774; Q86XT8; Q8N4U4; Q8WU84; Q9HCQ3;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 1.
DT   22-APR-2020, entry version 131.
DE   RecName: Full=Cytospin-B;
DE   AltName: Full=Nuclear structure protein 5;
DE            Short=NSP5;
DE   AltName: Full=Sperm antigen HCMOGT-1;
DE   AltName: Full=Sperm antigen with calponin homology and coiled-coil domains 1;
GN   Name=SPECC1; Synonyms=CYTSB, NSP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS ARG-274 AND LEU-293.
RC   TISSUE=Testis;
RA   Komori S.;
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), VARIANT LEU-293,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=15602574; DOI=10.1038/sj.onc.1207988;
RA   Sang N., Fath D.M., Giordano A.;
RT   "A gene highly expressed in tumor cells encodes novel structure proteins.";
RL   Oncogene 23:9438-9446(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT LEU-293.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 313-1068 (ISOFORMS 2/3), AND VARIANT
RP   LEU-293.
RC   TISSUE=Brain, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH PDGFRB.
RX   PubMed=15087372; DOI=10.1158/0008-5472.can-03-4026;
RA   Morerio C., Acquila M., Rosanda C., Rapella A., Dufour C., Locatelli F.,
RA   Maserati E., Pasquali F., Panarello C.;
RT   "HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic
RT   leukemia with t(5;17)(q33;p11.2).";
RL   Cancer Res. 64:2649-2651(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-134; SER-138;
RP   THR-142; SER-218; SER-847; SER-863 AND SER-912, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218; SER-241; SER-425;
RP   SER-847 AND SER-912, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55; THR-78; SER-112; SER-131;
RP   SER-134; SER-218; SER-241; SER-425; SER-847; SER-863 AND SER-914, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   MYRISTOYLATION AT GLY-2 (ISOFORMS 3; 4 AND 5), CLEAVAGE OF INITIATOR
RP   METHIONINE (ISOFORMS 3; 4 AND 5), AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25807930; DOI=10.1002/anie.201500342;
RA   Broncel M., Serwa R.A., Ciepla P., Krause E., Dallman M.J., Magee A.I.,
RA   Tate E.W.;
RT   "Multifunctional reagents for quantitative proteome-wide analysis of
RT   protein modification in human cells and dynamic profiling of protein
RT   lipidation during vertebrate development.";
RL   Angew. Chem. Int. Ed. 54:5948-5951(2015).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15602574}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=NSP5beta3beta;
CC         IsoId=Q5M775-1; Sequence=Displayed;
CC       Name=2; Synonyms=NSP5beta3alpha;
CC         IsoId=Q5M775-2; Sequence=VSP_021164, VSP_021165;
CC       Name=3; Synonyms=NSP5alpha3alpha;
CC         IsoId=Q5M775-3; Sequence=VSP_021162, VSP_021164, VSP_021165;
CC       Name=4; Synonyms=NSP5alpha3beta;
CC         IsoId=Q5M775-4; Sequence=VSP_021162;
CC       Name=5;
CC         IsoId=Q5M775-5; Sequence=VSP_021162, VSP_021163;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis. Barely detectable in
CC       other tissues. Also highly expressed in some cancer cell lines.
CC       {ECO:0000269|PubMed:15602574}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CYTSB may be a cause
CC       of juvenile myelomonocytic leukemia. Translocation t(5;17)(q33;p11.2)
CC       with PDGFRB. {ECO:0000269|PubMed:15087372}.
CC   -!- SIMILARITY: Belongs to the cytospin-A family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH33618.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB16440.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HCMOGT1ID174.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB041533; BAB16440.1; ALT_FRAME; mRNA.
DR   EMBL; AY816326; AAW29999.1; -; mRNA.
DR   EMBL; AY816327; AAW30000.1; -; mRNA.
DR   EMBL; AY816328; AAW30001.1; -; mRNA.
DR   EMBL; AY816329; AAW30002.1; -; mRNA.
DR   EMBL; BK005598; DAA05629.1; -; Genomic_DNA.
DR   EMBL; BK005598; DAA05630.1; -; Genomic_DNA.
DR   EMBL; BK005598; DAA05631.1; -; Genomic_DNA.
DR   EMBL; BK005598; DAA05632.1; -; Genomic_DNA.
DR   EMBL; AK295093; BAG58132.1; -; mRNA.
DR   EMBL; AC005730; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021123; AAH21123.2; -; mRNA.
DR   EMBL; BC033618; AAH33618.1; ALT_INIT; mRNA.
DR   EMBL; BC050058; AAH50058.1; -; mRNA.
DR   CCDS; CCDS32590.1; -. [Q5M775-1]
DR   CCDS; CCDS42280.1; -. [Q5M775-2]
DR   CCDS; CCDS42281.1; -. [Q5M775-4]
DR   CCDS; CCDS45628.1; -. [Q5M775-3]
DR   CCDS; CCDS58531.1; -. [Q5M775-5]
DR   RefSeq; NP_001028725.1; NM_001033553.2. [Q5M775-1]
DR   RefSeq; NP_001028726.1; NM_001033554.2. [Q5M775-3]
DR   RefSeq; NP_001028727.1; NM_001033555.2. [Q5M775-4]
DR   RefSeq; NP_001230367.1; NM_001243438.1. [Q5M775-5]
DR   RefSeq; NP_001230368.1; NM_001243439.1. [Q5M775-1]
DR   RefSeq; NP_690868.3; NM_152904.4. [Q5M775-2]
DR   RefSeq; XP_016880814.1; XM_017025325.1. [Q5M775-2]
DR   SMR; Q5M775; -.
DR   BioGrid; 124953; 72.
DR   IntAct; Q5M775; 55.
DR   STRING; 9606.ENSP00000261503; -.
DR   iPTMnet; Q5M775; -.
DR   PhosphoSitePlus; Q5M775; -.
DR   BioMuta; SPECC1; -.
DR   DMDM; 74722683; -.
DR   EPD; Q5M775; -.
DR   jPOST; Q5M775; -.
DR   MassIVE; Q5M775; -.
DR   MaxQB; Q5M775; -.
DR   PaxDb; Q5M775; -.
DR   PeptideAtlas; Q5M775; -.
DR   PRIDE; Q5M775; -.
DR   ProteomicsDB; 63559; -. [Q5M775-1]
DR   ProteomicsDB; 63560; -. [Q5M775-2]
DR   ProteomicsDB; 63561; -. [Q5M775-3]
DR   ProteomicsDB; 63562; -. [Q5M775-4]
DR   ProteomicsDB; 63563; -. [Q5M775-5]
DR   Antibodypedia; 13788; 224 antibodies.
DR   Ensembl; ENST00000261503; ENSP00000261503; ENSG00000128487. [Q5M775-1]
DR   Ensembl; ENST00000395522; ENSP00000378893; ENSG00000128487. [Q5M775-5]
DR   Ensembl; ENST00000395525; ENSP00000378896; ENSG00000128487. [Q5M775-3]
DR   Ensembl; ENST00000395527; ENSP00000378898; ENSG00000128487. [Q5M775-1]
DR   Ensembl; ENST00000395529; ENSP00000378900; ENSG00000128487. [Q5M775-2]
DR   Ensembl; ENST00000395530; ENSP00000378901; ENSG00000128487. [Q5M775-4]
DR   GeneID; 92521; -.
DR   KEGG; hsa:92521; -.
DR   UCSC; uc002gwq.4; human. [Q5M775-1]
DR   CTD; 92521; -.
DR   DisGeNET; 92521; -.
DR   GeneCards; SPECC1; -.
DR   HGNC; HGNC:30615; SPECC1.
DR   HPA; ENSG00000128487; Tissue enhanced (brain).
DR   MIM; 608793; gene.
DR   neXtProt; NX_Q5M775; -.
DR   OpenTargets; ENSG00000128487; -.
DR   PharmGKB; PA164718712; -.
DR   eggNOG; KOG4678; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00940000153592; -.
DR   HOGENOM; CLU_009328_2_0_1; -.
DR   InParanoid; Q5M775; -.
DR   KO; K23028; -.
DR   OMA; KEVCDRQ; -.
DR   PhylomeDB; Q5M775; -.
DR   TreeFam; TF316716; -.
DR   ChiTaRS; SPECC1; human.
DR   GeneWiki; SPECC1; -.
DR   GenomeRNAi; 92521; -.
DR   Pharos; Q5M775; Tbio.
DR   PRO; PR:Q5M775; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q5M775; protein.
DR   Bgee; ENSG00000128487; Expressed in corpus callosum and 152 other tissues.
DR   ExpressionAtlas; Q5M775; baseline and differential.
DR   Genevisible; Q5M775; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0031941; C:filamentous actin; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005815; C:microtubule organizing center; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   Pfam; PF00307; CH; 1.
DR   SMART; SM00033; CH; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS50021; CH; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Coiled coil; Lipoprotein;
KW   Membrane; Myristate; Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome.
FT   CHAIN           1..1068
FT                   /note="Cytospin-B"
FT                   /id="PRO_0000254033"
FT   DOMAIN          962..1067
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   COILED          579..773
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        260..372
FT                   /note="Ser-rich"
FT   MOD_RES         38
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SXY1"
FT   MOD_RES         55
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         78
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         131
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         134
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SXY1"
FT   MOD_RES         138
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         142
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         218
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         241
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         361
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SXY1"
FT   MOD_RES         366
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SXY1"
FT   MOD_RES         369
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SXY1"
FT   MOD_RES         425
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         847
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         863
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         912
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         914
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..94
FT                   /note="MRSAAKPWNPAIRAGGHGPDRVRPLPAASSGMKSSKSSTSLAFESRLSRLKR
FT                   ASSEDTLNKPGSTAASGVVRLKKTATAGAISELTESRLRSGT -> MGNHSGRPEDPEP
FT                   (in isoform 3, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:15602574"
FT                   /id="VSP_021162"
FT   VAR_SEQ         785..1068
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_021163"
FT   VAR_SEQ         785..790
FT                   /note="PVDEEP -> SLGSVS (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15602574, ECO:0000303|Ref.1"
FT                   /id="VSP_021164"
FT   VAR_SEQ         791..1068
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15602574, ECO:0000303|Ref.1"
FT                   /id="VSP_021165"
FT   VARIANT         274
FT                   /note="S -> R (in dbSNP:rs9908032)"
FT                   /evidence="ECO:0000269|Ref.1"
FT                   /id="VAR_053055"
FT   VARIANT         293
FT                   /note="M -> L (in dbSNP:rs2703806)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:15602574,
FT                   ECO:0000269|Ref.1"
FT                   /id="VAR_028800"
FT   VARIANT         769
FT                   /note="D -> N (in dbSNP:rs35835131)"
FT                   /id="VAR_053056"
FT   CONFLICT        164..170
FT                   /note="AALESQV -> VRLSPKF (in Ref. 1; BAB16440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        179
FT                   /note="A -> S (in Ref. 1; BAB16440 and 2; AAW30001)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        330
FT                   /note="D -> N (in Ref. 5; AAH50058)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        359
FT                   /note="G -> R (in Ref. 5; AAH50058)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        364
FT                   /note="S -> I (in Ref. 5; AAH33618)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        382
FT                   /note="E -> G (in Ref. 2; AAW29999/AAW30000/AAW30002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        434..435
FT                   /note="EQ -> DE (in Ref. 5; AAH50058)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        831
FT                   /note="R -> G (in Ref. 2; AAW30000/AAW30002)"
FT                   /evidence="ECO:0000305"
FT   INIT_MET        Q5M775-3:1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:25807930"
FT   LIPID           Q5M775-3:2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:25807930"
FT   INIT_MET        Q5M775-4:1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:25807930"
FT   LIPID           Q5M775-4:2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:25807930"
FT   INIT_MET        Q5M775-5:1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:25807930"
FT   LIPID           Q5M775-5:2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:25807930"
SQ   SEQUENCE   1068 AA;  118585 MW;  E6FB6987C835A1CA CRC64;
     MRSAAKPWNP AIRAGGHGPD RVRPLPAASS GMKSSKSSTS LAFESRLSRL KRASSEDTLN
     KPGSTAASGV VRLKKTATAG AISELTESRL RSGTGAFTTT KRTGIPAPRE FSVTVSRERS
     VPRGPSNPRK SVSSPTSSNT PTPTKHLRTP STKPKQENEG GEKAALESQV RELLAEAKAK
     DSEINRLRSE LKKYKEKRTL NAEGTDALGP NVDGTSVSPG DTEPMIRALE EKNKNFQKEL
     SDLEEENRVL KEKLIYLEHS PNSEGAASHT GDSSCPTSIT QESSFGSPTG NQMSSDIDEY
     KKNIHGNALR TSGSSSSDVT KASLSPDASD FEHITAETPS RPLSSTSNPF KSSKCSTAGS
     SPNSVSELSL ASLTEKIQKM EENHHSTAEE LQATLQELSD QQQMVQELTA ENEKLVDEKT
     ILETSFHQHR ERAEQLSQEN EKLMNLLQER VKNEEPTTQE GKIIELEQKC TGILEQGRFE
     REKLLNIQQQ LTCSLRKVEE ENQGALEMIK RLKEENEKLN EFLELERHNN NMMAKTLEEC
     RVTLEGLKME NGSLKSHLQG EKQKATEASA VEQTAESCEV QEMLKVARAE KDLLELSCNE
     LRQELLKANG EIKHVSSLLA KVEKDYSYLK EICDHQAEQL SRTSLKLQEK ASESDAEIKD
     MKETIFELED QVEQHRAVKL HNNQLISELE SSVIKLEEQK SDLERQLKTL TKQMKEETEE
     WRRFQADLQT AVVVANDIKC EAQQELRTVK RKLLEEEEKN ARLQKELGDV QGHGRVVTSR
     AAPPPVDEEP ESSEVDAAGR WPGVCVSRTS PTPPESATTV KSLIKSFDLG RPGGAGQNIS
     VHKTPRSPLS GIPVRTAPAA AVSPMQRHST YSSVRPASRG VTQRLDLPDL PLSDILKGRT
     ETLKPDPHLR KSPSLESLSR PPSLGFGDTR LLSASTRAWK PQSKLSVERK DPLAALAREY
     GGSKRNALLK WCQKKTQGYA NIDITNFSSS WSDGLAFCAL LHTYLPAHIP YQELNSQEKK
     RNLLLAFEAA ESVGIKPSLE LSEMLYTDRP DWQSVMQYVA QIYKYFET
//
ID   SRGP3_HUMAN             Reviewed;        1099 AA.
AC   O43295; Q8IX13; Q8IZV8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 3.
DT   22-APR-2020, entry version 181.
DE   RecName: Full=SLIT-ROBO Rho GTPase-activating protein 3;
DE            Short=srGAP3;
DE   AltName: Full=Mental disorder-associated GAP;
DE   AltName: Full=Rho GTPase-activating protein 14;
DE   AltName: Full=WAVE-associated Rac GTPase-activating protein;
DE            Short=WRP;
GN   Name=SRGAP3; Synonyms=ARHGAP14, KIAA0411, KIAA1156, MEGAP, SRGAP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY, AND
RP   INTERACTION WITH WASF1.
RX   PubMed=12447388; DOI=10.1038/ncb886;
RA   Soderling S.H., Binns K.L., Wayman G.A., Davee S.M., Ong S.H., Pawson T.,
RA   Scott J.D.;
RT   "The WRP component of the WAVE-1 complex attenuates Rac-mediated
RT   signalling.";
RL   Nat. Cell Biol. 4:970-975(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORMS 2
RP   AND 3), FUNCTION, TISSUE SPECIFICITY, AND CHROMOSOMAL TRANSLOCATION.
RX   PubMed=12195014; DOI=10.1073/pnas.162241099;
RA   Endris V., Wogatzky B., Leimer U., Bartsch D., Zatyka M., Latif F.,
RA   Maher E.R., Tariverdian G., Kirsch S., Karch D., Rappold G.A.;
RT   "The novel Rho-GTPase activating gene MEGAP/ srGAP3 has a putative role in
RT   severe mental retardation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:11754-11759(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 15-1099 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9455477; DOI=10.1093/dnares/4.5.307;
RA   Ishikawa K., Nagase T., Nakajima D., Seki N., Ohira M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VIII. 78
RT   new cDNA clones from brain which code for large proteins in vitro.";
RL   DNA Res. 4:307-313(1997).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   INTERACTION WITH ROBO1.
RX   PubMed=11672528; DOI=10.1016/s0092-8674(01)00530-x;
RA   Wong K., Ren X.R., Huang Y.Z., Xie Y., Liu G., Saito H., Tang H., Wen L.,
RA   Brady-Kalnay S.M., Mei L., Wu J.Y., Xiong W.C., Rao Y.;
RT   "Signal transduction in neuronal migration: roles of GTPase activating
RT   proteins and the small GTPase Cdc42 in the Slit-Robo pathway.";
RL   Cell 107:209-221(2001).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-837, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-623.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: GTPase-activating protein for RAC1 and perhaps Cdc42, but not
CC       for RhoA small GTPase. May attenuate RAC1 signaling in neurons.
CC       {ECO:0000269|PubMed:12195014, ECO:0000269|PubMed:12447388}.
CC   -!- SUBUNIT: Homodimer (Probable). Forms a heterooligomer with SRGAP1 and
CC       SRGAP2 through its F-BAR domain. Interacts with WASF1. Probably
CC       interacts with ROBO1. Interacts with FASLG.
CC       {ECO:0000269|PubMed:11672528, ECO:0000269|PubMed:12447388,
CC       ECO:0000269|PubMed:19807924, ECO:0000305}.
CC   -!- INTERACTION:
CC       O43295; O08838: Amph; Xeno; NbExp=3; IntAct=EBI-368166, EBI-80080;
CC       O43295; P62993: GRB2; NbExp=2; IntAct=EBI-368166, EBI-401755;
CC       O43295; P42858: HTT; NbExp=4; IntAct=EBI-368166, EBI-466029;
CC       O43295; O35964: Sh3gl1; Xeno; NbExp=3; IntAct=EBI-368166, EBI-1149235;
CC       O43295; O35179: Sh3gl2; Xeno; NbExp=3; IntAct=EBI-368166, EBI-1149197;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=MEGAPa, srGAP3a;
CC         IsoId=O43295-1; Sequence=Displayed;
CC       Name=2; Synonyms=MEGAPb, srGAP3b;
CC         IsoId=O43295-2; Sequence=VSP_010581;
CC       Name=3; Synonyms=MEGAPc, srGAP3c;
CC         IsoId=O43295-3; Sequence=VSP_010582, VSP_010583;
CC   -!- TISSUE SPECIFICITY: Highly expressed in adult and fetal brain.
CC       Expressed at low levels in kidney. Isoform 3 is expressed in the kidney
CC       but is absent in the brain. {ECO:0000269|PubMed:12195014,
CC       ECO:0000269|PubMed:12447388}.
CC   -!- DOMAIN: The F-BAR domain mediates oligomerization, binds membranes, and
CC       induces plasma membrane protrusions.
CC   -!- DISEASE: Note=A chromosomal aberration involving SRGAP3 is found in a
CC       patient with severe idiopathic mental retardation (PubMed:12195014).
CC       Translocation t(X;3)(p11.2;p25) (PubMed:12195014).
CC       {ECO:0000269|PubMed:12195014}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF464189; AAN57784.1; -; mRNA.
DR   EMBL; AF427144; AAN07095.1; -; mRNA.
DR   EMBL; AB007871; BAA24841.2; -; mRNA.
DR   CCDS; CCDS2572.1; -. [O43295-1]
DR   CCDS; CCDS33689.1; -. [O43295-2]
DR   RefSeq; NP_001028289.1; NM_001033117.2. [O43295-2]
DR   RefSeq; NP_055665.1; NM_014850.3. [O43295-1]
DR   SMR; O43295; -.
DR   BioGrid; 115230; 23.
DR   IntAct; O43295; 36.
DR   MINT; O43295; -.
DR   STRING; 9606.ENSP00000373347; -.
DR   iPTMnet; O43295; -.
DR   PhosphoSitePlus; O43295; -.
DR   BioMuta; SRGAP3; -.
DR   EPD; O43295; -.
DR   jPOST; O43295; -.
DR   MassIVE; O43295; -.
DR   MaxQB; O43295; -.
DR   PaxDb; O43295; -.
DR   PeptideAtlas; O43295; -.
DR   PRIDE; O43295; -.
DR   ProteomicsDB; 48867; -. [O43295-1]
DR   ProteomicsDB; 48868; -. [O43295-2]
DR   ProteomicsDB; 48869; -. [O43295-3]
DR   Antibodypedia; 25344; 122 antibodies.
DR   DNASU; 9901; -.
DR   Ensembl; ENST00000360413; ENSP00000353587; ENSG00000196220. [O43295-2]
DR   Ensembl; ENST00000383836; ENSP00000373347; ENSG00000196220. [O43295-1]
DR   GeneID; 9901; -.
DR   KEGG; hsa:9901; -.
DR   UCSC; uc003brf.4; human. [O43295-1]
DR   CTD; 9901; -.
DR   DisGeNET; 9901; -.
DR   GeneCards; SRGAP3; -.
DR   HGNC; HGNC:19744; SRGAP3.
DR   HPA; ENSG00000196220; Tissue enhanced (brain).
DR   MalaCards; SRGAP3; -.
DR   MIM; 606525; gene.
DR   neXtProt; NX_O43295; -.
DR   OpenTargets; ENSG00000196220; -.
DR   Orphanet; 251615; Pilomyxoid astrocytoma.
DR   PharmGKB; PA134935463; -.
DR   eggNOG; KOG3565; Eukaryota.
DR   eggNOG; ENOG410XS44; LUCA.
DR   GeneTree; ENSGT00950000182824; -.
DR   HOGENOM; CLU_005715_0_0_1; -.
DR   InParanoid; O43295; -.
DR   KO; K07526; -.
DR   OMA; NHEAIFP; -.
DR   OrthoDB; 1245523at2759; -.
DR   PhylomeDB; O43295; -.
DR   TreeFam; TF315892; -.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-428543; Inactivation of CDC42 and RAC1.
DR   SIGNOR; O43295; -.
DR   ChiTaRS; SRGAP3; human.
DR   GeneWiki; SRGAP3; -.
DR   GenomeRNAi; 9901; -.
DR   Pharos; O43295; Tbio.
DR   PRO; PR:O43295; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; O43295; protein.
DR   Bgee; ENSG00000196220; Expressed in middle temporal gyrus and 170 other tissues.
DR   ExpressionAtlas; O43295; baseline and differential.
DR   Genevisible; O43295; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:Reactome.
DR   GO; GO:0048365; F:Rac GTPase binding; IBA:GO_Central.
DR   GO; GO:0030336; P:negative regulation of cell migration; IBA:GO_Central.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd11955; SH3_srGAP1-3; 1.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR035648; srGAP1/2/3_SH3.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   GTPase activation; Phosphoprotein; Polymorphism; Reference proteome;
KW   SH3 domain.
FT   CHAIN           1..1099
FT                   /note="SLIT-ROBO Rho GTPase-activating protein 3"
FT                   /id="PRO_0000056769"
FT   DOMAIN          19..314
FT                   /note="F-BAR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01077"
FT   DOMAIN          482..670
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   DOMAIN          744..803
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   COILED          352..392
FT                   /evidence="ECO:0000255"
FT   COILED          952..987
FT                   /evidence="ECO:0000255"
FT   MOD_RES         817
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q812A2"
FT   MOD_RES         820
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q812A2"
FT   MOD_RES         821
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q812A2"
FT   MOD_RES         837
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         858
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q812A2"
FT   MOD_RES         954
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q812A2"
FT   VAR_SEQ         480..513
FT                   /note="PPCLPPKPQKMRRPRPLSVYSHKLFNGSMEAFIK -> GRRNARTRNQ (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12447388,
FT                   ECO:0000303|PubMed:9455477"
FT                   /id="VSP_010581"
FT   VAR_SEQ         480..489
FT                   /note="PPCLPPKPQK -> IQDKLYRL (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_010582"
FT   VAR_SEQ         490..1099
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_010583"
FT   VARIANT         623
FT                   /note="L -> I (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035550"
FT   VARIANT         628
FT                   /note="I -> V (in dbSNP:rs2271207)"
FT                   /id="VAR_049159"
SQ   SEQUENCE   1099 AA;  124504 MW;  2D1BA2D338E1BF13 CRC64;
     MSSQTKFKKD KEIIAEYEAQ IKEIRTQLVE QFKCLEQQSE SRLQLLQDLQ EFFRRKAEIE
     LEYSRSLEKL AERFSSKIRS SREHQFKKDQ YLLSPVNCWY LVLHQTRRES RDHATLNDIF
     MNNVIVRLSQ ISEDVIRLFK KSKEIGLQMH EELLKVTNEL YTVMKTYHMY HAESISAESK
     LKEAEKQEEK QFNKSGDLSM NLLRHEDRPQ RRSSVKKIEK MKEKRQAKYS ENKLKCTKAR
     NDYLLNLAAT NAAISKYYIH DVSDLIDCCD LGFHASLART FRTYLSAEYN LETSRHEGLD
     VIENAVDNLD SRSDKHTVMD MCNQVFCPPL KFEFQPHMGD EVCQVSAQQP VQTELLMRYH
     QLQSRLATLK IENEEVRKTL DATMQTLQDM LTVEDFDVSD AFQHSRSTES VKSAASETYM
     SKINIAKRRA NQQETEMFYF TKFKEYVNGS NLITKLQAKH DLLKQTLGEG ERAECGTTRP
     PCLPPKPQKM RRPRPLSVYS HKLFNGSMEA FIKDSGQAIP LVVESCIRYI NLYGLQQQGI
     FRVPGSQVEV NDIKNSFERG EDPLVDDQNE RDINSVAGVL KLYFRGLENP LFPKERFQDL
     ISTIKLENPA ERVHQIQQIL VTLPRVVIVV MRYLFAFLNH LSQYSDENMM DPYNLAICFG
     PTLMHIPDGQ DPVSCQAHIN EVIKTIIIHH EAIFPSPREL EGPVYEKCMA GGEEYCDSPH
     SEPGAIDEVD HDNGTEPHTS DEEVEQIEAI AKFDYMGRSP RELSFKKGAS LLLYHRASED
     WWEGRHNGVD GLIPHQYIVV QDMDDAFSDS LSQKADSEAS SGPLLDDKAS SKNDLQSPTE
     HISDYGFGGV MGRVRLRSDG AAIPRRRSGG DTHSPPRGLG PSIDTPPRAA ACPSSPHKIP
     LTRGRIESPE KRRMATFGSA GSINYPDKKA LSEGHSMRST CGSTRHSSLG DHKSLEAEAL
     AEDIEKTMST ALHELRELER QNTVKQAPDV VLDTLEPLKN PPGPVSSEPA SPLHTIVIRD
     PDAAMRRSSS SSTEMMTTFK PALSARLAGA QLRPPPMRPV RPVVQHRSSS SSSSGVGSPA
     VTPTEKMFPN SSADKSGTM
//
ID   A0A024R4Q5_HUMAN        Unreviewed;       253 AA.
AC   A0A024R4Q5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 52.
DE   SubName: Full=TCF3 (E2A) fusion partner (In childhood Leukemia), isoform CRA_c {ECO:0000313|EMBL:EAW72188.1};
GN   Name=TFPT {ECO:0000313|EMBL:EAW72188.1};
GN   ORFNames=hCG_20946 {ECO:0000313|EMBL:EAW72188.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW72188.1};
RN   [1] {ECO:0000313|EMBL:EAW72188.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW72188.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [4] {ECO:0000213|PubMed:18220336}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.D., Yates J.R.;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471135; EAW72187.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW72188.1; -; Genomic_DNA.
DR   RefSeq; NP_037474.1; NM_013342.3.
DR   IntAct; A0A024R4Q5; 6.
DR   Antibodypedia; 32793; 147 antibodies.
DR   GeneID; 29844; -.
DR   KEGG; hsa:29844; -.
DR   CTD; 29844; -.
DR   eggNOG; ENOG410IY8E; Eukaryota.
DR   eggNOG; ENOG4111UBX; LUCA.
DR   KO; K11670; -.
DR   OMA; NEPPDKE; -.
DR   OrthoDB; 1308382at2759; -.
DR   ChiTaRS; TFPT; human.
DR   GenomeRNAi; 29844; -.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0006915; P:apoptotic process; IEA:InterPro.
DR   InterPro; IPR033555; TFPT.
DR   PANTHER; PTHR35084; PTHR35084; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   REGION          49..72
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          142..211
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          234..253
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          96..116
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        56..72
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        167..183
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   253 AA;  28278 MW;  C57CC8436F963F36 CRC64;
     MELEQREGTM AAVGFEEFSA PPGSELALPP LFGGHILESE LETEVEFVSG GLGGSGLRER
     DEEEEAARGR RRRQRELNRR KYQALGRRCR EIEQVNERVL NRLHQVQRIT RRLQQERRFL
     MRVLDSYGDD YRASQFTIVL EDEGSQGTDA PTPGNAENEP PEKETLSPPR RTPAPPEPGS
     PAPGEGPSGR KRRRVPRDGR RAGNALTPEL APVQIKVEED FGFEADEALD SSWVSRGPDK
     LLPYPTLASP ASD
//
ID   TFPT_HUMAN              Reviewed;         253 AA.
AC   P0C1Z6; G5E9B5;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2006, sequence version 1.
DT   22-APR-2020, entry version 124.
DE   RecName: Full=TCF3 fusion partner;
DE   AltName: Full=INO80 complex subunit F;
DE   AltName: Full=Protein FB1;
GN   Name=TFPT; Synonyms=INO80F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION WITH
RP   TCF3.
RC   TISSUE=Leukemia;
RX   PubMed=10086727; DOI=10.1038/sj.leu.2401338;
RA   Brambillasca F., Mosna G., Colombo M., Rivolta A., Caslini C., Minuzzo M.,
RA   Giudici G., Mizzi L., Biondi A., Privitera E.;
RT   "Identification of a novel molecular partner of the E2A gene in childhood
RT   leukemia.";
RL   Leukemia 13:369-375(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Retinoblastoma, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION IN INO80 COMPLEX, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16230350; DOI=10.1074/jbc.m509128200;
RA   Jin J., Cai Y., Yao T., Gottschalk A.J., Florens L., Swanson S.K.,
RA   Gutierrez J.L., Coleman M.K., Workman J.L., Mushegian A., Washburn M.P.,
RA   Conaway R.C., Conaway J.W.;
RT   "A mammalian chromatin remodeling complex with similarities to the yeast
RT   INO80 complex.";
RL   J. Biol. Chem. 280:41207-41212(2005).
RN   [6]
RP   POSSIBLE FUNCTION IN APOPTOSIS.
RX   PubMed=17041757; DOI=10.1007/s10495-006-0195-5;
RA   Franchini C., Fontana F., Minuzzo M., Babbio F., Privitera E.;
RT   "Apoptosis promoted by up-regulation of TFPT (TCF3 fusion partner) appears
RT   p53 independent, cell type restricted and cell density influenced.";
RL   Apoptosis 11:2217-2224(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180; SER-249 AND SER-252, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [9]
RP   IDENTIFICATION IN THE INO80 COMPLEX, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18922472; DOI=10.1016/j.molcel.2008.08.027;
RA   Yao T., Song L., Jin J., Cai Y., Takahashi H., Swanson S.K., Washburn M.P.,
RA   Florens L., Conaway R.C., Cohen R.E., Conaway J.W.;
RT   "Distinct modes of regulation of the Uch37 deubiquitinating enzyme in the
RT   proteasome and in the Ino80 chromatin-remodeling complex.";
RL   Mol. Cell 31:909-917(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180; SER-188; SER-249 AND
RP   SER-252, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180; THR-207; SER-249 AND
RP   SER-252, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION IN THE INO80 COMPLEX.
RX   PubMed=21303910; DOI=10.1074/jbc.m111.222505;
RA   Chen L., Cai Y., Jin J., Florens L., Swanson S.K., Washburn M.P.,
RA   Conaway J.W., Conaway R.C.;
RT   "Subunit organization of the human INO80 chromatin remodeling complex: An
RT   evolutionarily conserved core complex catalyzes ATP-dependent nucleosome
RT   remodeling.";
RL   J. Biol. Chem. 286:11283-11289(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249 AND SER-252, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167; SER-180; THR-207;
RP   SER-249 AND SER-252, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-172; SER-180 AND SER-252, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-216, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Appears to promote apoptosis in a p53/TP53-independent
CC       manner.
CC   -!- FUNCTION: Putative regulatory component of the chromatin remodeling
CC       INO80 complex which is involved in transcriptional regulation, DNA
CC       replication and probably DNA repair.
CC   -!- SUBUNIT: Interacts with NOL3; translocates NOL3 into the nucleus and
CC       negatively regulated TFPT-induced cell death (By similarity). Component
CC       of the chromatin remodeling INO80 complex; specifically part of a
CC       complex module associated with the N-terminus of INO80. {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q9JMG6, ECO:0000269|PubMed:16230350,
CC       ECO:0000269|PubMed:18922472, ECO:0000269|PubMed:21303910}.
CC   -!- INTERACTION:
CC       P0C1Z6; Q9UFG5: C19orf25; NbExp=3; IntAct=EBI-1245626, EBI-741214;
CC       P0C1Z6-2; Q504U0: C4orf46; NbExp=3; IntAct=EBI-10178002, EBI-6657981;
CC       P0C1Z6; Q2TAC2-2: CCDC57; NbExp=3; IntAct=EBI-1245626, EBI-10961624;
CC       P0C1Z6-2; Q96GN5: CDCA7L; NbExp=3; IntAct=EBI-10178002, EBI-5278764;
CC       P0C1Z6-2; Q05D60: DEUP1; NbExp=3; IntAct=EBI-10178002, EBI-748597;
CC       P0C1Z6-2; Q8WWB3: DYDC1; NbExp=3; IntAct=EBI-10178002, EBI-740680;
CC       P0C1Z6; Q96CJ1: EAF2; NbExp=4; IntAct=EBI-1245626, EBI-1245604;
CC       P0C1Z6-2; Q96C92-2: ENTR1; NbExp=3; IntAct=EBI-10178002, EBI-10178036;
CC       P0C1Z6-2; Q96CS2: HAUS1; NbExp=3; IntAct=EBI-10178002, EBI-2514791;
CC       P0C1Z6-2; P08727: KRT19; NbExp=3; IntAct=EBI-10178002, EBI-742756;
CC       P0C1Z6-2; P25791: LMO2; NbExp=3; IntAct=EBI-10178002, EBI-739696;
CC       P0C1Z6-2; P11309: PIM1; NbExp=3; IntAct=EBI-10178002, EBI-696621;
CC       P0C1Z6; Q13526: PIN1; NbExp=3; IntAct=EBI-1245626, EBI-714158;
CC       P0C1Z6; P20618: PSMB1; NbExp=3; IntAct=EBI-1245626, EBI-372273;
CC       P0C1Z6-2; Q15311: RALBP1; NbExp=5; IntAct=EBI-10178002, EBI-749285;
CC       P0C1Z6-2; Q96KN7: RPGRIP1; NbExp=3; IntAct=EBI-10178002, EBI-1050213;
CC       P0C1Z6-2; Q59EK9: RUNDC3A; NbExp=3; IntAct=EBI-10178002, EBI-747225;
CC       P0C1Z6; Q13188: STK3; NbExp=3; IntAct=EBI-1245626, EBI-992580;
CC       P0C1Z6-2; Q13188: STK3; NbExp=3; IntAct=EBI-10178002, EBI-992580;
CC       P0C1Z6-2; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-10178002, EBI-1105213;
CC       P0C1Z6; P09493-10: TPM1; NbExp=3; IntAct=EBI-1245626, EBI-12123928;
CC       P0C1Z6-2; P09493-5: TPM1; NbExp=3; IntAct=EBI-10178002, EBI-10196387;
CC       P0C1Z6; P07951-2: TPM2; NbExp=3; IntAct=EBI-1245626, EBI-10977815;
CC       P0C1Z6; P06753: TPM3; NbExp=7; IntAct=EBI-1245626, EBI-355607;
CC       P0C1Z6-2; P06753: TPM3; NbExp=3; IntAct=EBI-10178002, EBI-355607;
CC       P0C1Z6-2; Q5VU62: TPM3; NbExp=3; IntAct=EBI-10178002, EBI-10184033;
CC       P0C1Z6; Q9Y5K5: UCHL5; NbExp=3; IntAct=EBI-1245626, EBI-1051183;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18922472}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P0C1Z6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P0C1Z6-2; Sequence=VSP_058937;
CC   -!- DISEASE: Note=A chromosomal aberration involving TFPT is a cause of
CC       pre-B-cell acute lymphoblastic leukemia (B-ALL). Inversion
CC       inv(19)(p13;q13) with TCF3. {ECO:0000269|PubMed:10086727}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TFPTID495ch19q13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF052052; AAD45182.1; -; mRNA.
DR   EMBL; AC012314; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471135; EAW72186.1; -; Genomic_DNA.
DR   EMBL; BC001728; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC004281; AAH04281.1; -; mRNA.
DR   EMBL; BC007776; AAH07776.1; -; mRNA.
DR   CCDS; CCDS12878.1; -. [P0C1Z6-1]
DR   CCDS; CCDS82396.1; -. [P0C1Z6-2]
DR   RefSeq; NP_001308721.1; NM_001321792.1. [P0C1Z6-2]
DR   RefSeq; NP_037474.1; NM_013342.3. [P0C1Z6-1]
DR   BioGrid; 118931; 82.
DR   ComplexPortal; CPX-846; INO80 chromatin remodeling complex.
DR   IntAct; P0C1Z6; 44.
DR   STRING; 9606.ENSP00000375639; -.
DR   iPTMnet; P0C1Z6; -.
DR   PhosphoSitePlus; P0C1Z6; -.
DR   BioMuta; TFPT; -.
DR   DMDM; 126352246; -.
DR   EPD; P0C1Z6; -.
DR   jPOST; P0C1Z6; -.
DR   MassIVE; P0C1Z6; -.
DR   MaxQB; P0C1Z6; -.
DR   PaxDb; P0C1Z6; -.
DR   PeptideAtlas; P0C1Z6; -.
DR   PRIDE; P0C1Z6; -.
DR   ProteomicsDB; 33890; -.
DR   ProteomicsDB; 52299; -.
DR   Antibodypedia; 32793; 147 antibodies.
DR   DNASU; 29844; -.
DR   Ensembl; ENST00000391758; ENSP00000375638; ENSG00000105619. [P0C1Z6-2]
DR   Ensembl; ENST00000391759; ENSP00000375639; ENSG00000105619. [P0C1Z6-1]
DR   Ensembl; ENST00000611344; ENSP00000484338; ENSG00000276504. [P0C1Z6-2]
DR   Ensembl; ENST00000611514; ENSP00000481443; ENSG00000278161. [P0C1Z6-1]
DR   Ensembl; ENST00000611935; ENSP00000482185; ENSG00000276022. [P0C1Z6-1]
DR   Ensembl; ENST00000614788; ENSP00000482785; ENSG00000273833. [P0C1Z6-1]
DR   Ensembl; ENST00000615534; ENSP00000480353; ENSG00000274073. [P0C1Z6-1]
DR   Ensembl; ENST00000615620; ENSP00000483971; ENSG00000276263. [P0C1Z6-1]
DR   Ensembl; ENST00000616277; ENSP00000483417; ENSG00000276296. [P0C1Z6-1]
DR   Ensembl; ENST00000616798; ENSP00000480169; ENSG00000276504. [P0C1Z6-1]
DR   Ensembl; ENST00000617348; ENSP00000477775; ENSG00000275086. [P0C1Z6-1]
DR   Ensembl; ENST00000619581; ENSP00000484685; ENSG00000276323. [P0C1Z6-1]
DR   GeneID; 29844; -.
DR   KEGG; hsa:29844; -.
DR   UCSC; uc010yej.1; human. [P0C1Z6-1]
DR   UCSC; uc061cmq.1; human.
DR   CTD; 29844; -.
DR   DisGeNET; 29844; -.
DR   GeneCards; TFPT; -.
DR   HGNC; HGNC:13630; TFPT.
DR   HPA; ENSG00000105619; Tissue enhanced (brain).
DR   MIM; 609519; gene.
DR   neXtProt; NX_P0C1Z6; -.
DR   OpenTargets; ENSG00000105619; -.
DR   PharmGKB; PA37802; -.
DR   eggNOG; ENOG410IY8E; Eukaryota.
DR   eggNOG; ENOG4111UBX; LUCA.
DR   GeneTree; ENSGT00390000016605; -.
DR   InParanoid; P0C1Z6; -.
DR   KO; K11670; -.
DR   OMA; NEPPDKE; -.
DR   PhylomeDB; P0C1Z6; -.
DR   TreeFam; TF338152; -.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5696394; DNA Damage Recognition in GG-NER.
DR   ChiTaRS; TFPT; human.
DR   GeneWiki; TFPT; -.
DR   GenomeRNAi; 29844; -.
DR   Pharos; P0C1Z6; Tbio.
DR   PRO; PR:P0C1Z6; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P0C1Z6; protein.
DR   Bgee; ENSG00000105619; Expressed in amygdala and 193 other tissues.
DR   ExpressionAtlas; P0C1Z6; baseline and differential.
DR   Genevisible; P0C1Z6; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031011; C:Ino80 complex; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   InterPro; IPR033555; TFPT.
DR   PANTHER; PTHR35084; PTHR35084; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Chromosomal rearrangement; DNA damage;
KW   DNA recombination; DNA repair; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Proto-oncogene; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..253
FT                   /note="TCF3 fusion partner"
FT                   /id="PRO_0000254581"
FT   MOD_RES         167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         172
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         180
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         188
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         207
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         249
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         252
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   CROSSLNK        216
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..9
FT                   /note="Missing (in isoform 2)"
FT                   /id="VSP_058937"
SQ   SEQUENCE   253 AA;  28278 MW;  C57CC8436F963F36 CRC64;
     MELEQREGTM AAVGFEEFSA PPGSELALPP LFGGHILESE LETEVEFVSG GLGGSGLRER
     DEEEEAARGR RRRQRELNRR KYQALGRRCR EIEQVNERVL NRLHQVQRIT RRLQQERRFL
     MRVLDSYGDD YRASQFTIVL EDEGSQGTDA PTPGNAENEP PEKETLSPPR RTPAPPEPGS
     PAPGEGPSGR KRRRVPRDGR RAGNALTPEL APVQIKVEED FGFEADEALD SSWVSRGPDK
     LLPYPTLASP ASD
//
ID   A8K6Q8_HUMAN            Unreviewed;       760 AA.
AC   A8K6Q8;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   11-DEC-2019, entry version 70.
DE   SubName: Full=cDNA FLJ75881, highly similar to Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA {ECO:0000313|EMBL:BAF84412.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF84412.1};
RN   [1] {ECO:0000313|EMBL:BAF84412.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAF84412.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK291723; BAF84412.1; -; mRNA.
DR   RefSeq; NP_003225.2; NM_003234.3.
DR   IntAct; A8K6Q8; 1.
DR   PeptideAtlas; A8K6Q8; -.
DR   PRIDE; A8K6Q8; -.
DR   DNASU; 7037; -.
DR   GeneID; 7037; -.
DR   CTD; 7037; -.
DR   PharmGKB; PA36478; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   OrthoDB; 804230at2759; -.
DR   GenomeRNAi; 7037; -.
DR   Genevisible; A8K6Q8; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0004998; F:transferrin receptor activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IEA:InterPro.
DR   GO; GO:0033572; P:transferrin transport; IEA:InterPro.
DR   CDD; cd02128; PA_TfR; 1.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR039373; Peptidase_M28B.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   InterPro; IPR037324; TfR1/2_PA.
DR   PANTHER; PTHR10404; PTHR10404; 1.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Receptor {ECO:0000313|EMBL:BAF84412.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        66..88
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          228..345
FT                   /note="PA"
FT                   /evidence="ECO:0000259|Pfam:PF02225"
FT   DOMAIN          388..576
FT                   /note="Peptidase_M28"
FT                   /evidence="ECO:0000259|Pfam:PF04389"
FT   DOMAIN          637..749
FT                   /note="TFR_dimer"
FT                   /evidence="ECO:0000259|Pfam:PF04253"
SQ   SEQUENCE   760 AA;  84873 MW;  3DAEE97671E394D4 CRC64;
     MMDQARSAFS NLFGGEPLSY TRFSLARQVD GDNSHVEMKL AVDEEENADN NTKANVTKPK
     RCSGSICYGT IAVIVFFLIG FMIGYLGYCK GVEPKTECER LAGTESPVRE EPGEDFPAAR
     RLYWDDLKRK LSEKLDSTDF TSTIKLLNEN SYVPREAGSQ KDENLALYVE NQFREFKLSK
     VWRDQHFVKI QVKDSAQNSV IIVDKNGRLV YLVENPGGYV AYSKAATATG KLVHANFGTK
     KDFEDLYTPV NGSIVIVRAG KITFAEKVAN AESLNAIGVL IYMDQTKFPI VNAELSFFGH
     AHLGTGDPYT PGFPSFNHTQ FPPSRSSGLP NIPVQTISRA AAEKLFGNME GDCPSDWKTD
     STCRMVTSES KNVKLTVSNV LKEIKILNIF GVIKGFVEPD HYVVVGAQRD AWGPGAAKSG
     VGTALLLKLA QMFSDMVLKD GFQPSRSIIF ASWSAGDFGS VGATEWLEGY LSSLHLKAFT
     YINLDKAVLG TSNFKVSASP LLYTLIEKTM QNVKHPVTGQ FLYQDSNWAS KVEKLTLDNA
     AFPFLAYSGI PAVSFCFCED TDYPYLGTTM DTYKELIERI PELNKVARAA AEVAGQFVIK
     LTHDVELNLD YERYNSQLLS FVRDLNQYRA DIKEMGLSLQ WLYSARGDFF RATSRLTTDF
     GNAEKTDRFV MKKLNDRVMR VEYHFLSPYV SPKESPFRHV FWGSGSHTLP ALLENLKLRK
     QNNGAFNETL FRNQLALATW TIQGAANALS GDVWDIDNEF
//
ID   B7Z2I6_HUMAN            Unreviewed;       478 AA.
AC   B7Z2I6;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=cDNA FLJ57106, highly similar to Transferrin receptor protein 1 {ECO:0000313|EMBL:BAH11872.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11872.1};
RN   [1] {ECO:0000313|EMBL:BAH11872.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAH11872.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK294758; BAH11872.1; -; mRNA.
DR   RefSeq; NP_001300895.1; NM_001313966.1.
DR   SMR; B7Z2I6; -.
DR   PeptideAtlas; B7Z2I6; -.
DR   PRIDE; B7Z2I6; -.
DR   GeneID; 7037; -.
DR   CTD; 7037; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   GenomeRNAi; 7037; -.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0004998; F:transferrin receptor activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IEA:InterPro.
DR   GO; GO:0033572; P:transferrin transport; IEA:InterPro.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR039373; Peptidase_M28B.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   PANTHER; PTHR10404; PTHR10404; 1.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   2: Evidence at transcript level;
KW   Receptor {ECO:0000313|EMBL:BAH11872.1}.
FT   DOMAIN          106..294
FT                   /note="Peptidase_M28"
FT                   /evidence="ECO:0000259|Pfam:PF04389"
FT   DOMAIN          355..467
FT                   /note="TFR_dimer"
FT                   /evidence="ECO:0000259|Pfam:PF04253"
SQ   SEQUENCE   478 AA;  53484 MW;  D23C6217E3CC79EB CRC64;
     MDQTKFPIVN AELSFFGHAH LGTGDPYTPG FPSFNHTQFP PSRSSGLPNI PVQTISRAAA
     EKLFGNMEGD CPSDWKTDST CRMVTSESKN VKLTVSNVLK EIKILNIFGV IKGFVEPDHY
     VVVGAQRDAW GPGAAKSGVG TALLLKLAQM FSDMVLKDGF QPSRSIIFAS WSAGDFGSVG
     ATEWLEGYLS SLHLKAFTYI NLDKAVLGTS NFKVSASPLL YTLIEKTMQN VKHPFTGQFL
     YQDSNWASKV EKLTLDNAAF PFLAYSGIPA VSFCFCEDTD YPYLGTTMDT YKELIERIPE
     LNKVARAAAE VAGQFVIKLT HDVELNLDYE RYNSQLLSFV RDLNQYRADI KEMGLSLQWL
     YSARGDFFRA TSRLTTDFGN AEKTDRFVMK KLNDRVMRVE YHFLSPYVSP KESPFRHVFW
     GSGSHTLPAL LENLKLRKQN NGAFNETLFR NQLALATWTI QGAANALSGD VWDIDNEF
//
ID   G3V0E5_HUMAN            Unreviewed;       679 AA.
AC   G3V0E5;
DT   16-NOV-2011, integrated into UniProtKB/TrEMBL.
DT   16-NOV-2011, sequence version 1.
DT   22-APR-2020, entry version 89.
DE   SubName: Full=Transferrin receptor (P90, CD71), isoform CRA_c {ECO:0000313|EMBL:EAW53672.1};
DE   SubName: Full=Transferrin receptor protein 1 {ECO:0000313|Ensembl:ENSP00000390133};
GN   Name=TFRC {ECO:0000313|EMBL:EAW53672.1,
GN   ECO:0000313|Ensembl:ENSP00000390133};
GN   ORFNames=hCG_22086 {ECO:0000313|EMBL:EAW53672.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000390133, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW53672.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW53672.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000390133, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000390133}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC024937; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471191; EAW53672.1; -; Genomic_DNA.
DR   RefSeq; NP_001300894.1; NM_001313965.1.
DR   ProteomicsDB; 32173; -.
DR   Antibodypedia; 4559; 2881 antibodies.
DR   Ensembl; ENST00000420415; ENSP00000390133; ENSG00000072274.
DR   GeneID; 7037; -.
DR   UCSC; uc010hzy.4; human.
DR   CTD; 7037; -.
DR   EuPathDB; HostDB:ENSG00000072274.12; -.
DR   HGNC; HGNC:11763; TFRC.
DR   OpenTargets; ENSG00000072274; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   GeneTree; ENSGT00950000182766; -.
DR   HOGENOM; CLU_005688_5_0_1; -.
DR   ChiTaRS; TFRC; human.
DR   GenomeRNAi; 7037; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000072274; Expressed in liver and 242 other tissues.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0004998; F:transferrin receptor activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IEA:InterPro.
DR   GO; GO:0033572; P:transferrin transport; IEA:InterPro.
DR   CDD; cd02128; PA_TfR; 1.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR039373; Peptidase_M28B.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   InterPro; IPR037324; TfR1/2_PA.
DR   PANTHER; PTHR10404; PTHR10404; 1.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:G3V0E5,
KW   ECO:0000213|MaxQB:G3V0E5, ECO:0000213|PeptideAtlas:G3V0E5,
KW   ECO:0000213|ProteomicsDB:G3V0E5}; Receptor {ECO:0000313|EMBL:EAW53672.1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          147..264
FT                   /note="PA"
FT                   /evidence="ECO:0000259|Pfam:PF02225"
FT   DOMAIN          307..495
FT                   /note="Peptidase_M28"
FT                   /evidence="ECO:0000259|Pfam:PF04389"
FT   DOMAIN          556..668
FT                   /note="TFR_dimer"
FT                   /evidence="ECO:0000259|Pfam:PF04253"
SQ   SEQUENCE   679 AA;  75964 MW;  00830FDA9668C11B CRC64;
     MIGYLGYCKG VEPKTECERL AGTESPVREE PGEDFPAARR LYWDDLKRKL SEKLDSTDFT
     GTIKLLNENS YVPREAGSQK DENLALYVEN QFREFKLSKV WRDQHFVKIQ VKDSAQNSVI
     IVDKNGRLVY LVENPGGYVA YSKAATVTGK LVHANFGTKK DFEDLYTPVN GSIVIVRAGK
     ITFAEKVANA ESLNAIGVLI YMDQTKFPIV NAELSFFGHA HLGTGDPYTP GFPSFNHTQF
     PPSRSSGLPN IPVQTISRAA AEKLFGNMEG DCPSDWKTDS TCRMVTSESK NVKLTVSNVL
     KEIKILNIFG VIKGFVEPDH YVVVGAQRDA WGPGAAKSGV GTALLLKLAQ MFSDMVLKDG
     FQPSRSIIFA SWSAGDFGSV GATEWLEGYL SSLHLKAFTY INLDKAVLGT SNFKVSASPL
     LYTLIEKTMQ NVKHPVTGQF LYQDSNWASK VEKLTLDNAA FPFLAYSGIP AVSFCFCEDT
     DYPYLGTTMD TYKELIERIP ELNKVARAAA EVAGQFVIKL THDVELNLDY ERYNSQLLSF
     VRDLNQYRAD IKEMGLSLQW LYSARGDFFR ATSRLTTDFG NAEKTDRFVM KKLNDRVMRV
     EYHFLSPYVS PKESPFRHVF WGSGSHTLPA LLENLKLRKQ NNGAFNETLF RNQLALATWT
     IQGAANALSG DVWDIDNEF
//
ID   TFR1_HUMAN              Reviewed;         760 AA.
AC   P02786; D3DXB0; Q1HE24; Q59G55; Q9UCN0; Q9UCU5; Q9UDF9; Q9UK21;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 2.
DT   22-APR-2020, entry version 242.
DE   RecName: Full=Transferrin receptor protein 1;
DE            Short=TR;
DE            Short=TfR;
DE            Short=TfR1;
DE            Short=Trfr;
DE   AltName: Full=T9;
DE   AltName: Full=p90;
DE   AltName: CD_antigen=CD71;
DE   Contains:
DE     RecName: Full=Transferrin receptor protein 1, serum form;
DE              Short=sTfR;
GN   Name=TFRC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-142.
RX   PubMed=6090955; DOI=10.1038/311675b0;
RA   Schneider C., Owen M.J., Banville D., Williams J.G.;
RT   "Primary structure of human transferrin receptor deduced from the mRNA
RT   sequence.";
RL   Nature 311:675-678(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-142.
RX   PubMed=6094009; DOI=10.1016/0092-8674(84)90004-7;
RA   McClelland A., Kuhn L.C., Ruddle F.H.;
RT   "The human transferrin receptor gene: genomic organization, and the
RT   complete primary structure of the receptor deduced from a cDNA sequence.";
RL   Cell 39:267-274(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=9358047; DOI=10.1016/s0378-1119(97)00356-9;
RA   Evans P., Kemp J.;
RT   "Exon/intron structure of the human transferrin receptor gene.";
RL   Gene 199:123-131(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RA   Wheeler D.L.;
RT   "Molecular and evolutionary studies of the transferrin receptor.";
RL   Thesis (1999), University of Iowa, United States.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 101-119 (STFR).
RX   PubMed=2229063;
RA   Shih Y.J., Baynes R.D., Hudson B.G., Flowers C.H., Skikne B.S., Cook J.D.;
RT   "Serum transferrin receptor is a truncated form of tissue receptor.";
RL   J. Biol. Chem. 265:19077-19081(1990).
RN   [10]
RP   PROTEIN SEQUENCE OF 101-123 (STFR), AND CHARACTERIZATION.
RC   TISSUE=Erythroleukemia;
RX   PubMed=1871153; DOI=10.3181/00379727-197-43276;
RA   Baynes R.D., Shih Y.J., Hudson B.G., Cook J.D.;
RT   "Characterization of transferrin receptor released by K562 erythroleukemia
RT   cells.";
RL   Proc. Soc. Exp. Biol. Med. 197:416-423(1991).
RN   [11]
RP   PROTEIN SEQUENCE OF 288-302; 694-708 AND 721-730.
RC   TISSUE=Prostatic carcinoma;
RX   PubMed=7864799; DOI=10.1042/bj3060129;
RA   Coppolino M., Migliorini M., Argraves W.S., Dedhar S.;
RT   "Identification of a novel form of the alpha 3 integrin subunit: covalent
RT   association with transferrin receptor.";
RL   Biochem. J. 306:129-134(1995).
RN   [12]
RP   PROTEIN SEQUENCE OF 680-696.
RX   PubMed=1380674; DOI=10.1038/358764a0;
RA   Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J., Vignali D.A.A.,
RA   Strominger J.L.;
RT   "Predominant naturally processed peptides bound to HLA-DR1 are derived from
RT   MHC-related molecules and are heterogeneous in size.";
RL   Nature 358:764-768(1992).
RN   [13]
RP   FUNCTION.
RX   PubMed=3568132; DOI=10.1016/0092-8674(87)90295-9;
RA   Rothenberger S., Iacopetta B.J., Kuhn L.C.;
RT   "Endocytosis of the transferrin receptor requires the cytoplasmic domain
RT   but not its phosphorylation site.";
RL   Cell 49:423-431(1987).
RN   [14]
RP   PALMITOYLATION AT CYS-62 AND CYS-67.
RX   PubMed=3582362; DOI=10.1002/j.1460-2075.1987.tb04758.x;
RA   Jing S., Trowbridge I.S.;
RT   "Identification of the intermolecular disulfide bonds of the human
RT   transferrin receptor and its lipid-attachment site.";
RL   EMBO J. 6:327-331(1987).
RN   [15]
RP   MUTAGENESIS OF CYSTEINE RESIDUES INVOLVED IN INTERMOLECULAR BONDS.
RX   PubMed=2507316; DOI=10.1002/j.1460-2075.1989.tb08347.x;
RA   Alvarez E., Girones N., Davis R.J.;
RT   "Intermolecular disulfide bonds are not required for the expression of the
RT   dimeric state and functional activity of the transferrin receptor.";
RL   EMBO J. 8:2231-2240(1989).
RN   [16]
RP   MUTAGENESIS OF TYR-20.
RX   PubMed=2327986; DOI=10.1042/bj2670031;
RA   Alvarez E., Girones N., Davis R.J.;
RT   "A point mutation in the cytoplasmic domain of the transferrin receptor
RT   inhibits endocytosis.";
RL   Biochem. J. 267:31-35(1990).
RN   [17]
RP   INTERNALIZATION SEQUENCE, AND MUTAGENESIS OF TYR-20.
RX   PubMed=2298808; DOI=10.1083/jcb.110.2.283;
RA   Jing S., Spencer T., Miller K., Hopkins C., Trowbridge I.S.;
RT   "Role of the human transferrin receptor cytoplasmic domain in endocytosis:
RT   localization of a specific signal sequence for internalization.";
RL   J. Cell Biol. 110:283-294(1990).
RN   [18]
RP   GLYCOSYLATION AT THR-104.
RX   PubMed=1421756; DOI=10.1093/glycob/2.4.345;
RA   Do S.-I., Cummings R.D.;
RT   "Presence of O-linked oligosaccharide on a threonine residue in the human
RT   transferrin receptor.";
RL   Glycobiology 2:345-353(1992).
RN   [19]
RP   GLYCOSYLATION AT THR-104.
RX   PubMed=1421757; DOI=10.1093/glycob/2.4.355;
RA   Hayes G.R., Enns C.A., Lucas J.J.;
RT   "Identification of the O-linked glycosylation site of the human transferrin
RT   receptor.";
RL   Glycobiology 2:355-359(1992).
RN   [20]
RP   MUTAGENESIS OF 20-TYR--PHE-23; TYR-20; THR-21 AND PHE-23.
RX   PubMed=8408022;
RA   Collawn J.F., Lai A., Domingo D.L., Fitch M., Hatton S., Trowbridge I.S.;
RT   "YTRF is the conserved internalization signal of the transferrin receptor,
RT   and a second YTRF signal at position 31-34 enhances endocytosis.";
RL   J. Biol. Chem. 268:21686-21692(1993).
RN   [21]
RP   GLYCOSYLATION AT ASN-727, AND STRUCTURE OF CARBOHYDRATES ON ASN-727.
RX   PubMed=7780197; DOI=10.1093/glycob/5.2.227;
RA   Hayes G.R., Williams A., Costello C.E., Enns C.A., Lucas J.J.;
RT   "The critical glycosylation site of human transferrin receptor contains a
RT   high-mannose oligosaccharide.";
RL   Glycobiology 5:227-232(1995).
RN   [22]
RP   IDENTIFICATION OF LIGAND-BINDING DOMAIN.
RX   PubMed=8631371; DOI=10.1111/j.1432-1033.1996.0009u.x;
RA   Buchegger F., Trowbridge I.S., Liu L.F., White S., Collawn J.F.;
RT   "Functional analysis of human/chicken transferrin receptor chimeras
RT   indicates that the carboxy-terminal region is important for ligand
RT   binding.";
RL   Eur. J. Biochem. 235:9-17(1996).
RN   [23]
RP   MUTAGENESIS OF ARG-646; GLY-647 AND ASP-648.
RX   PubMed=10377239; DOI=10.1042/bj3410011;
RA   Dubljevic V., Sali A., Goding J.W.;
RT   "A conserved RGD (Arg-Gly-Asp) motif in the transferrin receptor is
RT   required for binding to transferrin.";
RL   Biochem. J. 341:11-14(1999).
RN   [24]
RP   MUTAGENESIS.
RX   PubMed=11800564; DOI=10.1006/jmbi.2001.5048;
RA   West A.P. Jr., Giannetti A.M., Herr A.B., Bennett M.J., Nangiana J.S.,
RA   Pierce J.R., Weiner L.P., Snow P.M., Bjorkman P.J.;
RT   "Mutational analysis of the transferrin receptor reveals overlapping HFE
RT   and transferrin binding sites.";
RL   J. Mol. Biol. 313:385-397(2001).
RN   [25]
RP   INTERACTION WITH SH3BP4.
RX   PubMed=16325581; DOI=10.1016/j.cell.2005.10.021;
RA   Tosoni D., Puri C., Confalonieri S., Salcini A.E., De Camilli P.,
RA   Tacchetti C., Di Fiore P.P.;
RT   "TTP specifically regulates the internalization of the transferrin
RT   receptor.";
RL   Cell 123:875-888(2005).
RN   [26]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [28]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [29]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH MACHUPO VIRUS PROTEIN
RP   GLYCOPROTEIN COMPLEX.
RX   PubMed=17287727; DOI=10.1038/nature05539;
RA   Radoshitzky S.R., Abraham J., Spiropoulou C.F., Kuhn J.H., Nguyen D.,
RA   Li W., Nagel J., Schmidt P.J., Nunberg J.H., Andrews N.C., Farzan M.,
RA   Choe H.;
RT   "Transferrin receptor 1 is a cellular receptor for New World haemorrhagic
RT   fever arenaviruses.";
RL   Nature 446:92-96(2007).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [31]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH GUANARITO VIRUS
RP   GLYCOPROTEIN COMPLEX, INTERACTION WITH JUNIN VIRUS GLYCOPROTEIN COMPLEX,
RP   AND INTERACTION WITH MACHUPO VIRUS GLYCOPROTEIN COMPLEX.
RX   PubMed=18268337; DOI=10.1073/pnas.0709254105;
RA   Radoshitzky S.R., Kuhn J.H., Spiropoulou C.F., Albarino C.G., Nguyen D.P.,
RA   Salazar-Bravo J., Dorfman T., Lee A.S., Wang E., Ross S.R., Choe H.,
RA   Farzan M.;
RT   "Receptor determinants of zoonotic transmission of New World hemorrhagic
RT   fever arenaviruses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:2664-2669(2008).
RN   [32]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251 AND ASN-727.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [33]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [40]
RP   ELECTRON MICROSCOPY, AND PHOSPHORYLATION AT SER-24.
RX   PubMed=9782058; DOI=10.1016/s0969-2126(98)00124-5;
RA   Fuchs H., Luecken W., Tauber R., Engel A.;
RT   "Structural model of phospholipid-reconstituted human transferrin receptor
RT   derived by electron microscopy.";
RL   Structure 6:1235-1243(1998).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 121-760, AND GLYCOSYLATION AT
RP   ASN-251; ASN-317 AND ASN-727.
RX   PubMed=10531064; DOI=10.1126/science.286.5440.779;
RA   Lawrence C.M., Ray S., Babyonyshev M., Galluser R., Borhani D.W.,
RA   Harrison S.C.;
RT   "Crystal structure of the ectodomain of human transferrin receptor.";
RL   Science 286:779-782(1999).
RN   [42]
RP   VARIANT SER-142.
RX   PubMed=11702220; DOI=10.1007/s004390100599;
RA   Douabin-Gicquel V., Soriano N., Ferran H., Wojcik F., Palierne E.,
RA   Tamim S., Jovelin T., McKie A.T., Le Gall J.-Y., David V., Mosser J.;
RT   "Identification of 96 single nucleotide polymorphisms in eight genes
RT   involved in iron metabolism: efficiency of bioinformatic extraction
RT   compared with a systematic sequencing approach.";
RL   Hum. Genet. 109:393-401(2001).
RN   [43]
RP   INVOLVEMENT IN IMD46, VARIANT IMD46 HIS-20, CHARACTERIZATION OF VARIANT
RP   IMD46 HIS-20, FUNCTION, AND INTERACTION WITH STEAP3.
RX   PubMed=26642240; DOI=10.1038/ng.3465;
RA   Jabara H.H., Boyden S.E., Chou J., Ramesh N., Massaad M.J., Benson H.,
RA   Bainter W., Fraulino D., Rahimov F., Sieff C., Liu Z.J., Alshemmari S.H.,
RA   Al-Ramadi B.K., Al-Dhekri H., Arnaout R., Abu-Shukair M., Vatsayan A.,
RA   Silver E., Ahuja S., Davies E.G., Sola-Visner M., Ohsumi T.K.,
RA   Andrews N.C., Notarangelo L.D., Fleming M.D., Al-Herz W., Kunkel L.M.,
RA   Geha R.S.;
RT   "A missense mutation in TFRC, encoding transferrin receptor 1, causes
RT   combined immunodeficiency.";
RL   Nat. Genet. 48:74-78(2016).
CC   -!- FUNCTION: Cellular uptake of iron occurs via receptor-mediated
CC       endocytosis of ligand-occupied transferrin receptor into specialized
CC       endosomes. Endosomal acidification leads to iron release. The
CC       apotransferrin-receptor complex is then recycled to the cell surface
CC       with a return to neutral pH and the concomitant loss of affinity of
CC       apotransferrin for its receptor. Transferrin receptor is necessary for
CC       development of erythrocytes and the nervous system (By similarity). A
CC       second ligand, the heditary hemochromatosis protein HFE, competes for
CC       binding with transferrin for an overlapping C-terminal binding site.
CC       Positively regulates T and B cell proliferation through iron uptake
CC       (PubMed:26642240). {ECO:0000250, ECO:0000269|PubMed:26642240,
CC       ECO:0000269|PubMed:3568132}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for new-world
CC       arenaviruses: Guanarito, Junin and Machupo virus.
CC       {ECO:0000269|PubMed:17287727, ECO:0000269|PubMed:18268337}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Binds one transferrin or HFE
CC       molecule per subunit. Binds the HLA class II histocompatibility
CC       antigen, DR1. Interacts with SH3BP3. Interacts with STEAP3; facilitates
CC       TFRC endocytosis in erythroid precursor cells (PubMed:26642240).
CC       {ECO:0000269|PubMed:16325581, ECO:0000269|PubMed:26642240}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Guanarito, Junin and
CC       Machupo arenavirus glycoprotein complex (PubMed:17287727,
CC       PubMed:18268337). {ECO:0000269|PubMed:17287727,
CC       ECO:0000269|PubMed:18268337}.
CC   -!- INTERACTION:
CC       P02786; P02786; NbExp=4; IntAct=EBI-355727, EBI-355727;
CC       P02786; P02768: ALB; NbExp=2; IntAct=EBI-355727, EBI-714423;
CC       P02786; Q13520: AQP6; NbExp=3; IntAct=EBI-355727, EBI-13059134;
CC       P02786; Q3SXY8: ARL13B; NbExp=3; IntAct=EBI-355727, EBI-11343438;
CC       P02786; P07307-3: ASGR2; NbExp=3; IntAct=EBI-355727, EBI-12808270;
CC       P02786; Q96HA4-2: C1orf159; NbExp=3; IntAct=EBI-355727, EBI-17586094;
CC       P02786; Q96BA8: CREB3L1; NbExp=3; IntAct=EBI-355727, EBI-6942903;
CC       P02786; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-355727, EBI-18304435;
CC       P02786; Q96KR6: FAM210B; NbExp=3; IntAct=EBI-355727, EBI-18938272;
CC       P02786; P02794: FTH1; NbExp=2; IntAct=EBI-355727, EBI-713259;
CC       P02786; Q8TDT2: GPR152; NbExp=3; IntAct=EBI-355727, EBI-13345167;
CC       P02786; Q30201: HFE; NbExp=3; IntAct=EBI-355727, EBI-1028850;
CC       P02786; Q30201-1: HFE; NbExp=3; IntAct=EBI-355727, EBI-15489346;
CC       P02786; P31937: HIBADH; NbExp=3; IntAct=EBI-355727, EBI-11427100;
CC       P02786; Q8TAF8: LHFPL5; NbExp=3; IntAct=EBI-355727, EBI-2820517;
CC       P02786; Q9GZY8-5: MFF; NbExp=3; IntAct=EBI-355727, EBI-11956541;
CC       P02786; O14880: MGST3; NbExp=3; IntAct=EBI-355727, EBI-724754;
CC       P02786; O75459: PAGE1; NbExp=3; IntAct=EBI-355727, EBI-2559100;
CC       P02786; A5K736: PVX_094255; Xeno; NbExp=12; IntAct=EBI-355727, EBI-20622076;
CC       P02786; Q86WH2: RASSF3; NbExp=3; IntAct=EBI-355727, EBI-2845202;
CC       P02786; Q8NC24: RELL2; NbExp=3; IntAct=EBI-355727, EBI-10269209;
CC       P02786; Q96TC7: RMDN3; NbExp=3; IntAct=EBI-355727, EBI-1056589;
CC       P02786; O43765: SGTA; NbExp=6; IntAct=EBI-355727, EBI-347996;
CC       P02786; Q9P0V3: SH3BP4; NbExp=6; IntAct=EBI-355727, EBI-1049513;
CC       P02786; Q14973: SLC10A1; NbExp=3; IntAct=EBI-355727, EBI-3923031;
CC       P02786; P54219-3: SLC18A1; NbExp=3; IntAct=EBI-355727, EBI-17595455;
CC       P02786; P02787: TF; NbExp=11; IntAct=EBI-355727, EBI-714319;
CC       P02786; O00258: WRB; NbExp=3; IntAct=EBI-355727, EBI-18908258;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17081065};
CC       Single-pass type II membrane protein {ECO:0000269|PubMed:17081065}.
CC       Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC       {ECO:0000269|PubMed:17081065}.
CC   -!- SUBCELLULAR LOCATION: [Transferrin receptor protein 1, serum form]:
CC       Secreted {ECO:0000269|PubMed:17081065}.
CC   -!- INDUCTION: Regulated by cellular iron levels through binding of the
CC       iron regulatory proteins, IRP1 and IRP2, to iron-responsive elements in
CC       the 3'-UTR. Up-regulated upon mitogenic stimulation.
CC   -!- PTM: N- and O-glycosylated, phosphorylated and palmitoylated. The serum
CC       form is only glycosylated. {ECO:0000269|PubMed:1421756,
CC       ECO:0000269|PubMed:1421757, ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19349973,
CC       ECO:0000269|PubMed:3582362}.
CC   -!- PTM: Proteolytically cleaved on Arg-100 to produce the soluble serum
CC       form (sTfR).
CC   -!- PTM: Palmitoylated on both Cys-62 and Cys-67. Cys-62 seems to be the
CC       major site of palmitoylation. {ECO:0000269|PubMed:3582362}.
CC   -!- DISEASE: Immunodeficiency 46 (IMD46) [MIM:616740]: An autosomal
CC       recessive primary immunodeficiency disorder characterized by early-
CC       onset chronic diarrhea, recurrent infections, hypo- or
CC       agammaglobulinemia, normal lymphocyte counts, intermittent neutropenia,
CC       and intermittent thrombocytopenia. {ECO:0000269|PubMed:26642240}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- MISCELLANEOUS: Serum transferrin receptor (sTfR) is used as a means of
CC       detecting erythropoietin (EPO) misuse by athletes and as a diagnostic
CC       test for anemia resulting from a number of conditions including
CC       rheumatoid arthritis, pregnancy, irritable bowel syndrome and in HIV
CC       patients.
CC   -!- MISCELLANEOUS: Canine and feline parvoviruses bind human and feline
CC       transferrin receptors and use these receptors to enter and infect
CC       cells.
CC   -!- SIMILARITY: Belongs to the peptidase M28 family. M28B subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92491.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TFRCID259ch3q29.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X01060; CAA25527.1; -; mRNA.
DR   EMBL; M11507; AAA61153.1; -; mRNA.
DR   EMBL; AF187320; AAF04564.1; -; Genomic_DNA.
DR   EMBL; AB209254; BAD92491.1; ALT_INIT; mRNA.
DR   EMBL; DQ496099; ABF47088.1; -; Genomic_DNA.
DR   EMBL; CH471191; EAW53670.1; -; Genomic_DNA.
DR   EMBL; CH471191; EAW53673.1; -; Genomic_DNA.
DR   EMBL; BC001188; AAH01188.1; -; mRNA.
DR   CCDS; CCDS3312.1; -.
DR   PIR; A93343; JXHU.
DR   RefSeq; NP_001121620.1; NM_001128148.2.
DR   RefSeq; NP_001300894.1; NM_001313965.1.
DR   RefSeq; NP_001300895.1; NM_001313966.1.
DR   RefSeq; NP_003225.2; NM_003234.3.
DR   PDB; 1CX8; X-ray; 3.20 A; A/B/C/D/E/F/G/H=122-760.
DR   PDB; 1DE4; X-ray; 2.80 A; C/F/I=121-760.
DR   PDB; 1SUV; EM; 7.50 A; A/B=122-760.
DR   PDB; 2NSU; EM; 27.00 A; A/B=122-760.
DR   PDB; 3KAS; X-ray; 2.40 A; A=121-760.
DR   PDB; 3S9L; X-ray; 3.22 A; A/B=120-760.
DR   PDB; 3S9M; X-ray; 3.32 A; A/B=120-760.
DR   PDB; 3S9N; X-ray; 3.25 A; A/B=120-760.
DR   PDB; 6D03; EM; 3.68 A; A/B=121-760.
DR   PDB; 6D04; EM; 3.74 A; A/B=121-760.
DR   PDB; 6D05; EM; 3.80 A; A/B=121-760.
DR   PDB; 6GSR; EM; 5.50 A; Ab/Aq=121-760.
DR   PDB; 6H5I; EM; 3.90 A; Ab/Aq=121-760.
DR   PDBsum; 1CX8; -.
DR   PDBsum; 1DE4; -.
DR   PDBsum; 1SUV; -.
DR   PDBsum; 2NSU; -.
DR   PDBsum; 3KAS; -.
DR   PDBsum; 3S9L; -.
DR   PDBsum; 3S9M; -.
DR   PDBsum; 3S9N; -.
DR   PDBsum; 6D03; -.
DR   PDBsum; 6D04; -.
DR   PDBsum; 6D05; -.
DR   PDBsum; 6GSR; -.
DR   PDBsum; 6H5I; -.
DR   SMR; P02786; -.
DR   BioGrid; 112895; 134.
DR   CORUM; P02786; -.
DR   DIP; DIP-2736N; -.
DR   ELM; P02786; -.
DR   IntAct; P02786; 117.
DR   MINT; P02786; -.
DR   STRING; 9606.ENSP00000353224; -.
DR   ChEMBL; CHEMBL3712860; -.
DR   DrugBank; DB13949; Ferric cation.
DR   DrugBank; DB14490; Ferrous ascorbate.
DR   DrugBank; DB14491; Ferrous fumarate.
DR   DrugBank; DB14488; Ferrous gluconate.
DR   DrugBank; DB14501; Ferrous glycine sulfate.
DR   DrugBank; DB14489; Ferrous succinate.
DR   DrugBank; DB06784; Gallium citrate Ga 67.
DR   DrugBank; DB05260; Gallium nitrate.
DR   DrugBank; DB01592; Iron.
DR   DrugBank; DB14520; Tetraferric tricitrate decahydrate.
DR   MEROPS; M28.972; -.
DR   TCDB; 9.B.229.1.1; the transferrin receptor, cd71, (tfr) family.
DR   GlyConnect; 607; -.
DR   iPTMnet; P02786; -.
DR   MetOSite; P02786; -.
DR   PhosphoSitePlus; P02786; -.
DR   SwissPalm; P02786; -.
DR   UniCarbKB; P02786; -.
DR   BioMuta; TFRC; -.
DR   DMDM; 108935939; -.
DR   CPTAC; non-CPTAC-2704; -.
DR   EPD; P02786; -.
DR   jPOST; P02786; -.
DR   MassIVE; P02786; -.
DR   MaxQB; P02786; -.
DR   PaxDb; P02786; -.
DR   PeptideAtlas; P02786; -.
DR   PRIDE; P02786; -.
DR   ProteomicsDB; 51595; -.
DR   ABCD; P02786; -.
DR   Antibodypedia; 4559; 2881 antibodies.
DR   DNASU; 7037; -.
DR   Ensembl; ENST00000360110; ENSP00000353224; ENSG00000072274.
DR   Ensembl; ENST00000392396; ENSP00000376197; ENSG00000072274.
DR   GeneID; 7037; -.
DR   KEGG; hsa:7037; -.
DR   UCSC; uc003fvz.5; human.
DR   CTD; 7037; -.
DR   DisGeNET; 7037; -.
DR   GeneCards; TFRC; -.
DR   HGNC; HGNC:11763; TFRC.
DR   HPA; ENSG00000072274; Tissue enhanced (placenta).
DR   MalaCards; TFRC; -.
DR   MIM; 190010; gene.
DR   MIM; 616740; phenotype.
DR   neXtProt; NX_P02786; -.
DR   OpenTargets; ENSG00000072274; -.
DR   Orphanet; 476113; Combined immunodeficiency due to TFRC deficiency.
DR   PharmGKB; PA36478; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   GeneTree; ENSGT00950000182766; -.
DR   InParanoid; P02786; -.
DR   KO; K06503; -.
DR   OMA; VEPKTEC; -.
DR   OrthoDB; 804230at2759; -.
DR   PhylomeDB; P02786; -.
DR   TreeFam; TF312981; -.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-917977; Transferrin endocytosis and recycling.
DR   SIGNOR; P02786; -.
DR   ChiTaRS; TFRC; human.
DR   EvolutionaryTrace; P02786; -.
DR   GeneWiki; TFRC; -.
DR   GenomeRNAi; 7037; -.
DR   Pharos; P02786; Tbio.
DR   PRO; PR:P02786; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P02786; protein.
DR   Bgee; ENSG00000072274; Expressed in liver and 242 other tissues.
DR   ExpressionAtlas; P02786; baseline and differential.
DR   Genevisible; P02786; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005905; C:clathrin-coated pit; IDA:UniProtKB.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; TAS:Reactome.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0005769; C:early endosome; IEA:Ensembl.
DR   GO; GO:0005768; C:endosome; IDA:MGI.
DR   GO; GO:0010008; C:endosome membrane; IDA:CAFA.
DR   GO; GO:0009897; C:external side of plasma membrane; IGI:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:1990712; C:HFE-transferrin receptor complex; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IGI:BHF-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:CAFA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:ARUK-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0004998; F:transferrin receptor activity; IDA:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IBA:GO_Central.
DR   GO; GO:0035690; P:cellular response to drug; IDA:MGI.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0006826; P:iron ion transport; IDA:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:ARUK-UCL.
DR   GO; GO:0030316; P:osteoclast differentiation; IEA:Ensembl.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IDA:UniProtKB.
DR   GO; GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:ARUK-UCL.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:ARUK-UCL.
DR   GO; GO:0045830; P:positive regulation of isotype switching; IDA:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:ARUK-UCL.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:ARUK-UCL.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; IMP:ARUK-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:ARUK-UCL.
DR   GO; GO:0031334; P:positive regulation of protein-containing complex assembly; IMP:ARUK-UCL.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IDA:UniProtKB.
DR   GO; GO:0033572; P:transferrin transport; IDA:UniProtKB.
DR   CDD; cd02128; PA_TfR; 1.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR039373; Peptidase_M28B.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   InterPro; IPR037324; TfR1/2_PA.
DR   PANTHER; PTHR10404; PTHR10404; 1.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Direct protein sequencing; Disease mutation;
KW   Disulfide bond; Endocytosis; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction; Lipoprotein;
KW   Membrane; Palmitate; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Secreted; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..760
FT                   /note="Transferrin receptor protein 1"
FT                   /id="PRO_0000174132"
FT   CHAIN           101..760
FT                   /note="Transferrin receptor protein 1, serum form"
FT                   /id="PRO_0000292265"
FT   TOPO_DOM        1..67
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        68..88
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        89..760
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          223..313
FT                   /note="PA"
FT   REGION          1..67
FT                   /note="Mediates interaction with SH3BP4"
FT                   /evidence="ECO:0000269|PubMed:16325581"
FT   REGION          569..760
FT                   /note="Ligand-binding"
FT   MOTIF           20..23
FT                   /note="Endocytosis signal"
FT   MOTIF           58..61
FT                   /note="Stop-transfer sequence"
FT   MOTIF           646..648
FT                   /note="Cell attachment site; required for binding to
FT                   transferrin"
FT   SITE            100..101
FT                   /note="Cleavage; by trypsin; to produce soluble form"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         19
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62351"
FT   MOD_RES         20
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         21
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         24
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:9782058"
FT   LIPID           62
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:3582362"
FT   LIPID           67
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:3582362"
FT   CARBOHYD        104
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:1421756,
FT                   ECO:0000269|PubMed:1421757"
FT                   /id="CAR_000072"
FT   CARBOHYD        251
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000244|PDB:1CX8,
FT                   ECO:0000269|PubMed:10531064, ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19349973"
FT   CARBOHYD        317
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000244|PDB:1CX8,
FT                   ECO:0000269|PubMed:10531064"
FT   CARBOHYD        727
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000244|PDB:1CX8,
FT                   ECO:0000269|PubMed:10531064, ECO:0000269|PubMed:19159218,
FT                   ECO:0000269|PubMed:7780197"
FT                   /id="CAR_000173"
FT   DISULFID        89
FT                   /note="Interchain"
FT   DISULFID        98
FT                   /note="Interchain"
FT   VARIANT         20
FT                   /note="Y -> H (in IMD46; increases protein expression;
FT                   increases cell surface expression on T and B cells;
FT                   increases soluble form level; impairs receptor
FT                   internalization; impairs transferrin transport; impairs T
FT                   and B cell proliferation as well as B cell class-switching;
FT                   interacts with STEAP3; doesn't affect receptor
FT                   internalization in erythroid precursor cells;
FT                   dbSNP:rs863225436)"
FT                   /evidence="ECO:0000269|PubMed:26642240"
FT                   /id="VAR_076365"
FT   VARIANT         142
FT                   /note="G -> S (rare polymorphism; dbSNP:rs3817672)"
FT                   /evidence="ECO:0000269|PubMed:11702220,
FT                   ECO:0000269|PubMed:6090955, ECO:0000269|PubMed:6094009"
FT                   /id="VAR_012737"
FT   VARIANT         212
FT                   /note="L -> V (in dbSNP:rs41301381)"
FT                   /id="VAR_051806"
FT   VARIANT         420
FT                   /note="G -> S (in dbSNP:rs41295879)"
FT                   /id="VAR_051807"
FT   VARIANT         677
FT                   /note="R -> H (in dbSNP:rs41298067)"
FT                   /id="VAR_051808"
FT   MUTAGEN         9..12
FT                   /note="FSNL->YTRF: Only 80% as active as wild-type
FT                   receptor."
FT   MUTAGEN         20..34
FT                   /note="YTRFSLARQVDGDNS->PPGYSLARQVDYTRF: No influence on
FT                   endocytic uptake of the receptor."
FT   MUTAGEN         20..23
FT                   /note="YTRF->PPGY: Only 16% as active as wild-type
FT                   receptor."
FT                   /evidence="ECO:0000269|PubMed:8408022"
FT   MUTAGEN         20
FT                   /note="Y->C: Only 35% as active as wild-type receptor."
FT                   /evidence="ECO:0000269|PubMed:2298808,
FT                   ECO:0000269|PubMed:2327986, ECO:0000269|PubMed:8408022"
FT   MUTAGEN         20
FT                   /note="Y->G: Only 20% as active as wild-type receptor."
FT                   /evidence="ECO:0000269|PubMed:2298808,
FT                   ECO:0000269|PubMed:2327986, ECO:0000269|PubMed:8408022"
FT   MUTAGEN         21
FT                   /note="T->F: Only 88% as active as wild-type receptor."
FT                   /evidence="ECO:0000269|PubMed:8408022"
FT   MUTAGEN         21
FT                   /note="T->TA: Only 14% as active as wild-type receptor."
FT                   /evidence="ECO:0000269|PubMed:8408022"
FT   MUTAGEN         21
FT                   /note="T->TAA: Only 19% as active as wild-type receptor."
FT                   /evidence="ECO:0000269|PubMed:8408022"
FT   MUTAGEN         23
FT                   /note="F->Y: Only 48% as active as wild-type receptor."
FT                   /evidence="ECO:0000269|PubMed:8408022"
FT   MUTAGEN         31..34
FT                   /note="GDNS->YTRF: 2-fold increase of the endocytic uptake
FT                   of the receptor."
FT   MUTAGEN         47..50
FT                   /note="NADN->YTRF: 1.27-fold increase of the endocytic
FT                   uptake of the receptor."
FT   MUTAGEN         619
FT                   /note="L->A: 20-fold reduced affinity for transferrin
FT                   receptor. No binding to HFE."
FT   MUTAGEN         622
FT                   /note="V->A: No significant effect on binding to
FT                   transferrin nor HFE."
FT   MUTAGEN         623
FT                   /note="R->A: No significant effect on binding to
FT                   transferrin nor HFE."
FT   MUTAGEN         629
FT                   /note="R->A: >5-fold reduced affinity for transferrin. >10-
FT                   fold reduced affinity for HFE."
FT   MUTAGEN         640
FT                   /note="Q->A: No effect on binding to transferrin. >10-fold
FT                   reduced affinity for HFE."
FT   MUTAGEN         641
FT                   /note="W->A: No significant effect on binding to
FT                   transferrin nor HFE."
FT   MUTAGEN         643
FT                   /note="Y->A: 20-fold reduced affinity for transferrin. No
FT                   binding to HFE."
FT   MUTAGEN         644
FT                   /note="S->A: No significant effect on binding to
FT                   transferrin nor HFE."
FT   MUTAGEN         646
FT                   /note="R->A,H: No binding to transferrin."
FT                   /evidence="ECO:0000269|PubMed:10377239"
FT   MUTAGEN         646
FT                   /note="R->K: 5% binding to transferrin."
FT                   /evidence="ECO:0000269|PubMed:10377239"
FT   MUTAGEN         647
FT                   /note="G->A: Large effect on affinity for transferrin. 4-
FT                   fold reduced affinity for HFE."
FT                   /evidence="ECO:0000269|PubMed:10377239"
FT   MUTAGEN         648
FT                   /note="D->A: 16% binding to transferrin."
FT                   /evidence="ECO:0000269|PubMed:10377239"
FT   MUTAGEN         648
FT                   /note="D->E: 57% binding to transferrin."
FT                   /evidence="ECO:0000269|PubMed:10377239"
FT   MUTAGEN         650
FT                   /note="F->Q: >5-fold reduced affinity for transferrin. >10-
FT                   fold reduced affinity for HFE."
FT   CONFLICT        104
FT                   /note="T -> K (in Ref. 10; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        109
FT                   /note="R -> V (in Ref. 10; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        123
FT                   /note="Y -> T (in Ref. 10; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   HELIX           124..136
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           140..146
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            150..152
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           160..176
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          179..192
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          199..204
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            205..208
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          209..214
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          220..222
FT                   /evidence="ECO:0000244|PDB:3S9L"
FT   STRAND          226..230
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          232..234
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            236..238
FT                   /evidence="ECO:0000244|PDB:1CX8"
FT   HELIX           240..244
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          245..248
FT                   /evidence="ECO:0000244|PDB:1CX8"
FT   STRAND          253..259
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           264..272
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            273..275
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          277..282
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            285..287
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          303..306
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          308..310
FT                   /evidence="ECO:0000244|PDB:3S9L"
FT   STRAND          311..313
FT                   /evidence="ECO:0000244|PDB:1CX8"
FT   HELIX           317..319
FT                   /evidence="ECO:0000244|PDB:1DE4"
FT   STRAND          334..336
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           339..346
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          349..352
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           355..357
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          364..367
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          371..377
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          380..393
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          396..408
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          411..413
FT                   /evidence="ECO:0000244|PDB:3S9N"
FT   TURN            416..419
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           420..438
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          445..455
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           456..458
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           461..469
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            470..473
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           474..476
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          478..483
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          491..498
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           500..502
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           503..510
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            516..518
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          520..522
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           528..531
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           541..546
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          552..558
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            564..567
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           573..579
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           583..603
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          604..606
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           613..625
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           626..628
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            629..636
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           640..662
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           668..680
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           682..685
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          688..690
FT                   /evidence="ECO:0000244|PDB:3S9L"
FT   TURN            692..694
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            700..702
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   STRAND          705..708
FT                   /evidence="ECO:0000244|PDB:3S9M"
FT   HELIX           709..717
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   TURN            718..722
FT                   /evidence="ECO:0000244|PDB:3S9L"
FT   HELIX           728..749
FT                   /evidence="ECO:0000244|PDB:3KAS"
FT   HELIX           753..755
FT                   /evidence="ECO:0000244|PDB:1DE4"
SQ   SEQUENCE   760 AA;  84871 MW;  C886F14000D90154 CRC64;
     MMDQARSAFS NLFGGEPLSY TRFSLARQVD GDNSHVEMKL AVDEEENADN NTKANVTKPK
     RCSGSICYGT IAVIVFFLIG FMIGYLGYCK GVEPKTECER LAGTESPVRE EPGEDFPAAR
     RLYWDDLKRK LSEKLDSTDF TGTIKLLNEN SYVPREAGSQ KDENLALYVE NQFREFKLSK
     VWRDQHFVKI QVKDSAQNSV IIVDKNGRLV YLVENPGGYV AYSKAATVTG KLVHANFGTK
     KDFEDLYTPV NGSIVIVRAG KITFAEKVAN AESLNAIGVL IYMDQTKFPI VNAELSFFGH
     AHLGTGDPYT PGFPSFNHTQ FPPSRSSGLP NIPVQTISRA AAEKLFGNME GDCPSDWKTD
     STCRMVTSES KNVKLTVSNV LKEIKILNIF GVIKGFVEPD HYVVVGAQRD AWGPGAAKSG
     VGTALLLKLA QMFSDMVLKD GFQPSRSIIF ASWSAGDFGS VGATEWLEGY LSSLHLKAFT
     YINLDKAVLG TSNFKVSASP LLYTLIEKTM QNVKHPVTGQ FLYQDSNWAS KVEKLTLDNA
     AFPFLAYSGI PAVSFCFCED TDYPYLGTTM DTYKELIERI PELNKVARAA AEVAGQFVIK
     LTHDVELNLD YERYNSQLLS FVRDLNQYRA DIKEMGLSLQ WLYSARGDFF RATSRLTTDF
     GNAEKTDRFV MKKLNDRVMR VEYHFLSPYV SPKESPFRHV FWGSGSHTLP ALLENLKLRK
     QNNGAFNETL FRNQLALATW TIQGAANALS GDVWDIDNEF
//
ID   Q7Z3E0_HUMAN            Unreviewed;        13 AA.
AC   Q7Z3E0;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   11-DEC-2019, entry version 45.
DE   SubName: Full=Uncharacterized protein DKFZp686O0451 {ECO:0000313|EMBL:CAD97930.1};
GN   Name=DKFZp686O0451 {ECO:0000313|EMBL:CAD97930.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAD97930.1};
RN   [1] {ECO:0000313|EMBL:CAD97930.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Human endometrium carcinoma cell line {ECO:0000313|EMBL:CAD97930.1};
RA   Poustka A., Albert R., Moosmayer P., Schupp I., Wellenreuther R.,
RA   Mewes H.W., Weil B., Amid C., Osanger A., Fobo G., Han M., Wiemann S.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX537966; CAD97930.1; -; mRNA.
DR   RefSeq; NP_001121620.1; NM_001128148.2.
DR   RefSeq; NP_001300894.1; NM_001313965.1.
DR   RefSeq; NP_003225.2; NM_003234.3.
DR   PRIDE; Q7Z3E0; -.
DR   ProteomicsDB; 69038; -.
DR   GeneID; 7037; -.
DR   KEGG; hsa:7037; -.
DR   CTD; 7037; -.
DR   KO; K06503; -.
DR   OrthoDB; 804230at2759; -.
DR   GenomeRNAi; 7037; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   13 AA;  1468 MW;  8FE0E6255E80CDC5 CRC64;
     MDQARSAFSN LDL
//
ID   TR150_HUMAN             Reviewed;         955 AA.
AC   Q9Y2W1; D3DPS5; Q5VTK6;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   22-APR-2020, entry version 192.
DE   RecName: Full=Thyroid hormone receptor-associated protein 3;
DE   AltName: Full=BCLAF1 and THRAP3 family member 2 {ECO:0000312|HGNC:HGNC:22964};
DE   AltName: Full=Thyroid hormone receptor-associated protein complex 150 kDa component;
DE            Short=Trap150;
GN   Name=THRAP3 {ECO:0000312|HGNC:HGNC:22964};
GN   Synonyms=BCLAF2 {ECO:0000312|HGNC:HGNC:22964}, TRAP150;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 490-500, TISSUE
RP   SPECIFICITY, IDENTIFICATION IN TRAP COMPLEX, AND VARIANT VAL-201.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10198638; DOI=10.1016/s1097-2765(00)80463-3;
RA   Ito M., Yuan C.-X., Malik S., Gu W., Fondell J.D., Yamamura S., Fu Z.-Y.,
RA   Zhang X., Qin J., Roeder R.G.;
RT   "Identity between TRAP and SMCC complexes indicates novel pathways for the
RT   function of nuclear receptors and diverse mammalian activators.";
RL   Mol. Cell 3:361-370(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-201.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-201.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 186-202; 216-245; 253-261; 314-333; 376-387; 443-451;
RP   468-481; 486-498; 573-591; 609-653; 678-687; 710-718; 792-802; 864-876;
RP   879-893 AND 927-944, METHYLATION AT ARG-17, PHOSPHORYLATION AT SER-243;
RP   SER-320 AND SER-682, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Ovarian carcinoma;
RA   Bienvenut W.V., Heiserich L., Boulahbel H., Gottlieb E., Lilla S.,
RA   von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; SER-243; SER-248;
RP   SER-253; SER-315; SER-320; SER-575; SER-672 AND SER-928, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [11]
RP   SUBUNIT.
RX   PubMed=17095540; DOI=10.1261/rna.336807;
RA   Merz C., Urlaub H., Will C.L., Luhrmann R.;
RT   "Protein composition of human mRNPs spliced in vitro and differential
RT   requirements for mRNP protein recruitment.";
RL   RNA 13:116-128(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [13]
RP   IDENTIFICATION IN THE SNARP COMPLEX.
RX   PubMed=18794151; DOI=10.1158/0008-5472.can-08-1217;
RA   Bracken C.P., Wall S.J., Barre B., Panov K.I., Ajuh P.M., Perkins N.D.;
RT   "Regulation of cyclin D1 RNA stability by SNIP1.";
RL   Cancer Res. 68:7621-7628(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-248 AND SER-253, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232; SER-237; SER-240;
RP   SER-243; SER-248; SER-253; SER-379; SER-406; SER-408; SER-575; SER-682;
RP   THR-874; SER-928 AND SER-939, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-928, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-874; SER-928 AND SER-939, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-221; LYS-455; LYS-519 AND
RP   LYS-811, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH SFPQ.
RX   PubMed=20932480; DOI=10.1016/j.molcel.2010.09.013;
RA   Heyd F., Lynch K.W.;
RT   "Phosphorylation-dependent regulation of PSF by GSK3 controls CD45
RT   alternative splicing.";
RL   Mol. Cell 40:126-137(2010).
RN   [23]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH NXF1.
RX   PubMed=20123736; DOI=10.1093/nar/gkq017;
RA   Lee K.M., Hsu I.W., Tarn W.Y.;
RT   "TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA
RT   degradation.";
RL   Nucleic Acids Res. 38:3340-3350(2010).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232; SER-243; SER-248;
RP   SER-253; SER-257; SER-315; SER-320; SER-379; SER-408; SER-575; SER-622;
RP   SER-682; SER-698; SER-928 AND SER-939, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-253; SER-315;
RP   SER-320; SER-339; SER-379; SER-406; SER-408; SER-535; SER-575; SER-622;
RP   SER-682; SER-698; SER-928 AND SER-939, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [27]
RP   FUNCTION, PHOSPHORYLATION, AND MUTAGENESIS OF SER-406 AND SER-408.
RX   PubMed=22424773; DOI=10.1016/j.molcel.2012.01.026;
RA   Beli P., Lukashchuk N., Wagner S.A., Weinert B.T., Olsen J.V., Baskcomb L.,
RA   Mann M., Jackson S.P., Choudhary C.;
RT   "Proteomic investigations reveal a role for RNA processing factor THRAP3 in
RT   the DNA damage response.";
RL   Mol. Cell 46:212-225(2012).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [29]
RP   IDENTIFICATION IN A MACOM-LIKE COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=24100041; DOI=10.1074/jbc.m113.500397;
RA   Horiuchi K., Kawamura T., Iwanari H., Ohashi R., Naito M., Kodama T.,
RA   Hamakubo T.;
RT   "Identification of Wilms' tumor 1-associating protein complex and its role
RT   in alternative splicing and the cell cycle.";
RL   J. Biol. Chem. 288:33292-33302(2013).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-220; SER-232; SER-237;
RP   SER-240; SER-243; SER-248; SER-253; SER-257; SER-315; SER-320; SER-323;
RP   SER-326; SER-377; SER-379; THR-397; SER-406; SER-408; SER-444; SER-468;
RP   SER-560; SER-562; SER-575; SER-619; SER-682; SER-698; THR-874; SER-928 AND
RP   SER-939, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [31]
RP   ADP-RIBOSYLATION.
RX   PubMed=24055347; DOI=10.1016/j.molcel.2013.08.026;
RA   Jungmichel S., Rosenthal F., Altmeyer M., Lukas J., Hottiger M.O.,
RA   Nielsen M.L.;
RT   "Proteome-wide identification of poly(ADP-Ribosyl)ation targets in
RT   different genotoxic stress responses.";
RL   Mol. Cell 52:272-285(2013).
RN   [32]
RP   FUNCTION, INTERACTION WITH HELZ2 AND PPARG, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=23525231; DOI=10.1210/me.2012-1332;
RA   Katano-Toki A., Satoh T., Tomaru T., Yoshino S., Ishizuka T., Ishii S.,
RA   Ozawa A., Shibusawa N., Tsuchiya T., Saito T., Shimizu H., Hashimoto K.,
RA   Okada S., Yamada M., Mori M.;
RT   "THRAP3 interacts with HELZ2 and plays a novel role in adipocyte
RT   differentiation.";
RL   Mol. Endocrinol. 27:769-780(2013).
RN   [33]
RP   FUNCTION.
RX   PubMed=24043798; DOI=10.1073/pnas.1305980110;
RA   Lande-Diner L., Boyault C., Kim J.Y., Weitz C.J.;
RT   "A positive feedback loop links circadian clock factor CLOCK-BMAL1 to the
RT   basic transcriptional machinery.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:16021-16026(2013).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-248; SER-253; SER-257;
RP   SER-320; SER-377; SER-560; SER-575; SER-682 AND SER-684, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-66; ARG-101; ARG-108 AND LYS-252,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [36]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-451; LYS-467; LYS-470; LYS-486;
RP   LYS-705; LYS-711; LYS-756 AND LYS-759, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [37]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-202; LYS-387 AND LYS-451, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [38]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-486, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [39]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-396; LYS-427; LYS-451; LYS-470;
RP   LYS-486; LYS-527; LYS-697; LYS-705 AND LYS-711, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [40]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-202; LYS-215; LYS-221; LYS-252;
RP   LYS-333; LYS-346; LYS-353; LYS-375; LYS-387; LYS-389; LYS-396; LYS-401;
RP   LYS-421; LYS-427; LYS-451; LYS-455; LYS-461; LYS-467; LYS-470; LYS-481;
RP   LYS-486; LYS-527; LYS-551; LYS-558; LYS-602; LYS-697; LYS-705; LYS-709;
RP   LYS-711; LYS-876 AND LYS-879, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Involved in pre-mRNA splicing. Remains associated with
CC       spliced mRNA after splicing which probably involves interactions with
CC       the exon junction complex (EJC). Can trigger mRNA decay which seems to
CC       be independent of nonsense-mediated decay involving premature stop
CC       codons (PTC) recognition. May be involved in nuclear mRNA decay.
CC       Involved in regulation of signal-induced alternative splicing. During
CC       splicing of PTPRC/CD45 is proposed to sequester phosphorylated SFPQ
CC       from PTPRC/CD45 pre-mRNA in resting T-cells. Involved in cyclin-
CC       D1/CCND1 mRNA stability probably by acting as component of the SNARP
CC       complex which associates with both the 3'end of the CCND1 gene and its
CC       mRNA. Involved in response to DNA damage. Is excluced from DNA damage
CC       sites in a manner that parallels transcription inhibition; the function
CC       may involve the SNARP complex. Initially thought to play a role in
CC       transcriptional coactivation through its association with the TRAP
CC       complex; however, it is not regarded as a stable Mediator complex
CC       subunit. Cooperatively with HELZ2, enhances the transcriptional
CC       activation mediated by PPARG, maybe through the stabilization of the
CC       PPARG binding to DNA in presence of ligand. May play a role in the
CC       terminal stage of adipocyte differentiation. Plays a role in the
CC       positive regulation of the circadian clock. Acts as a coactivator of
CC       the CLOCK-ARNTL/BMAL1 heterodimer and promotes its transcriptional
CC       activator activity and binding to circadian target genes
CC       (PubMed:24043798). {ECO:0000269|PubMed:20123736,
CC       ECO:0000269|PubMed:20932480, ECO:0000269|PubMed:22424773,
CC       ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:24043798}.
CC   -!- SUBUNIT: Associated with the large multiprotein complex TRAP (Mediator
CC       complex-like). Interacts with SFPQ; the interaction is dependent on
CC       SFPQ phosphorylation at 'Thr-687' and inhibits binding of SFPQ to an
CC       ESS1 exonic splicing silencer element-containing RNA. Interacts with
CC       NXF1. Component of the SNARP complex which consists at least of SNIP1,
CC       SNW1, THRAP3, BCLAF1 and PNN. Associated with spliced mRNP complexes.
CC       Interacts with HELZ2 and PPARG. Interacts with CLOCK and ARNTL/BMAL1
CC       (By similarity). Component of a MACOM-like complex, named WTAP complex,
CC       composed of WTAP, ZC3H13, CBLL1, KIAA1429, RBM15, BCLAF1 and THRAP3.
CC       {ECO:0000250|UniProtKB:Q569Z6, ECO:0000269|PubMed:10198638,
CC       ECO:0000269|PubMed:17095540, ECO:0000269|PubMed:18794151,
CC       ECO:0000269|PubMed:20123736, ECO:0000269|PubMed:20932480,
CC       ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:24100041}.
CC   -!- INTERACTION:
CC       Q9Y2W1; P38919: EIF4A3; NbExp=2; IntAct=EBI-352039, EBI-299104;
CC       Q9Y2W1; Q9UBU9: NXF1; NbExp=4; IntAct=EBI-352039, EBI-398874;
CC       Q9Y2W1; P23246: SFPQ; NbExp=6; IntAct=EBI-352039, EBI-355453;
CC       Q9Y2W1; Q13573: SNW1; NbExp=4; IntAct=EBI-352039, EBI-632715;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20123736,
CC       ECO:0000269|PubMed:23525231}. Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:24100041}. Nucleus speckle
CC       {ECO:0000269|PubMed:24100041}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10198638}.
CC   -!- PTM: ADP-ribosylation during genotoxic stress promotes accumulation in
CC       nuclear speckles.
CC   -!- SIMILARITY: Belongs to the BCLAF1/THRAP3 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH37554.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/THRAP3ID42960ch1p34.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF117756; AAD22034.1; -; mRNA.
DR   EMBL; AL591845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07379.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07380.1; -; Genomic_DNA.
DR   EMBL; BC037554; AAH37554.1; ALT_SEQ; mRNA.
DR   EMBL; BC112330; AAI12331.1; -; mRNA.
DR   EMBL; BC112350; AAI12351.1; -; mRNA.
DR   CCDS; CCDS405.1; -.
DR   RefSeq; NP_001308400.1; NM_001321471.1.
DR   RefSeq; NP_001308402.1; NM_001321473.1.
DR   RefSeq; NP_005110.2; NM_005119.3.
DR   BioGrid; 115292; 202.
DR   CORUM; Q9Y2W1; -.
DR   IntAct; Q9Y2W1; 103.
DR   MINT; Q9Y2W1; -.
DR   STRING; 9606.ENSP00000346634; -.
DR   ChEMBL; CHEMBL4105820; -.
DR   iPTMnet; Q9Y2W1; -.
DR   MetOSite; Q9Y2W1; -.
DR   PhosphoSitePlus; Q9Y2W1; -.
DR   SwissPalm; Q9Y2W1; -.
DR   BioMuta; THRAP3; -.
DR   DMDM; 97537467; -.
DR   EPD; Q9Y2W1; -.
DR   jPOST; Q9Y2W1; -.
DR   MassIVE; Q9Y2W1; -.
DR   MaxQB; Q9Y2W1; -.
DR   PaxDb; Q9Y2W1; -.
DR   PeptideAtlas; Q9Y2W1; -.
DR   PRIDE; Q9Y2W1; -.
DR   ProteomicsDB; 85914; -.
DR   TopDownProteomics; Q9Y2W1; -.
DR   Antibodypedia; 1852; 156 antibodies.
DR   DNASU; 9967; -.
DR   Ensembl; ENST00000354618; ENSP00000346634; ENSG00000054118.
DR   Ensembl; ENST00000469141; ENSP00000433825; ENSG00000054118.
DR   GeneID; 9967; -.
DR   KEGG; hsa:9967; -.
DR   UCSC; uc001cae.5; human.
DR   CTD; 9967; -.
DR   DisGeNET; 9967; -.
DR   GeneCards; THRAP3; -.
DR   HGNC; HGNC:22964; THRAP3.
DR   HPA; ENSG00000054118; Low tissue specificity.
DR   MIM; 603809; gene.
DR   neXtProt; NX_Q9Y2W1; -.
DR   OpenTargets; ENSG00000054118; -.
DR   PharmGKB; PA134893249; -.
DR   eggNOG; ENOG410IE11; Eukaryota.
DR   eggNOG; ENOG410ZR5P; LUCA.
DR   GeneTree; ENSGT00950000183163; -.
DR   HOGENOM; CLU_014485_1_0_1; -.
DR   InParanoid; Q9Y2W1; -.
DR   KO; K13112; -.
DR   OMA; SEGSKPW; -.
DR   OrthoDB; 380969at2759; -.
DR   PhylomeDB; Q9Y2W1; -.
DR   TreeFam; TF335939; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   SignaLink; Q9Y2W1; -.
DR   SIGNOR; Q9Y2W1; -.
DR   ChiTaRS; THRAP3; human.
DR   GeneWiki; THRAP3; -.
DR   GenomeRNAi; 9967; -.
DR   Pharos; Q9Y2W1; Tbio.
DR   PRO; PR:Q9Y2W1; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9Y2W1; protein.
DR   Bgee; ENSG00000054118; Expressed in lung and 204 other tissues.
DR   ExpressionAtlas; Q9Y2W1; baseline and differential.
DR   Genevisible; Q9Y2W1; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016592; C:mediator complex; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030374; F:nuclear receptor transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:MGI.
DR   GO; GO:0003712; F:transcription coregulator activity; IDA:UniProtKB.
DR   GO; GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0048255; P:mRNA stabilization; IMP:UniProtKB.
DR   GO; GO:0000956; P:nuclear-transcribed mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0042753; P:positive regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IMP:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB.
DR   InterPro; IPR026667; THRAP3.
DR   InterPro; IPR029199; THRAP3_BCLAF1.
DR   PANTHER; PTHR15268; PTHR15268; 1.
DR   PANTHER; PTHR15268:SF16; PTHR15268:SF16; 1.
DR   Pfam; PF15440; THRAP3_BCLAF1; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; ADP-ribosylation; ATP-binding; Biological rhythms;
KW   Direct protein sequencing; Isopeptide bond; Methylation; mRNA processing;
KW   mRNA splicing; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   CHAIN           2..955
FT                   /note="Thyroid hormone receptor-associated protein 3"
FT                   /id="PRO_0000065583"
FT   NP_BIND         552..559
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   REGION          2..190
FT                   /note="Required for mRNA splicing activation"
FT   REGION          359..955
FT                   /note="Required for mRNA decay activity"
FT   COMPBIAS        7..339
FT                   /note="Ser-rich"
FT   COMPBIAS        12..161
FT                   /note="Arg-rich"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         17
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000269|Ref.5"
FT   MOD_RES         66
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         101
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         108
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         220
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         221
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         232
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         237
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         240
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163"
FT   MOD_RES         243
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:19367720, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|Ref.5"
FT   MOD_RES         248
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         252
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         253
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         315
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         320
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569,
FT                   ECO:0000269|Ref.5"
FT   MOD_RES         323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         324
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q569Z6"
FT   MOD_RES         326
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         328
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q569Z6"
FT   MOD_RES         339
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         346
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q569Z6"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         397
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         406
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         408
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         444
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         455
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         468
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         470
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q569Z6"
FT   MOD_RES         481
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q569Z6"
FT   MOD_RES         519
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         527
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q569Z6"
FT   MOD_RES         535
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         558
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q569Z6"
FT   MOD_RES         560
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         562
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         575
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         619
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         622
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692"
FT   MOD_RES         672
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983"
FT   MOD_RES         682
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569,
FT                   ECO:0000269|Ref.5"
FT   MOD_RES         684
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         698
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         811
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         845
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q569Z6"
FT   MOD_RES         874
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         928
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         939
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   CROSSLNK        202
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        202
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        215
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        221
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        252
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        333
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        346
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        353
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        375
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        387
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        387
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        389
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        396
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        401
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        421
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        427
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        451
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        451
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211,
FT                   ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        455
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        461
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        467
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        470
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        481
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        486
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        527
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        551
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        558
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        602
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        697
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        705
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        709
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        711
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        756
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   CROSSLNK        759
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   CROSSLNK        876
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        879
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VARIANT         201
FT                   /note="A -> V (in dbSNP:rs6425977)"
FT                   /evidence="ECO:0000269|PubMed:10198638,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.3"
FT                   /id="VAR_024552"
FT   MUTAGEN         406
FT                   /note="S->A: Reduces phosphorylation upon DNA damage; when
FT                   associated with A-408."
FT                   /evidence="ECO:0000269|PubMed:22424773"
FT   MUTAGEN         408
FT                   /note="S->A: Reduces phosphorylation upon DNA damage; when
FT                   associated with A-406."
FT                   /evidence="ECO:0000269|PubMed:22424773"
SQ   SEQUENCE   955 AA;  108666 MW;  01131D2479B8C0F4 CRC64;
     MSKTNKSKSG SRSSRSRSAS RSRSRSFSKS RSRSRSLSRS RKRRLSSRSR SRSYSPAHNR
     ERNHPRVYQN RDFRGHNRGY RRPYYFRGRN RGFYPWGQYN RGGYGNYRSN WQNYRQAYSP
     RRGRSRSRSP KRRSPSPRSR SHSRNSDKSS SDRSRRSSSS RSSSNHSRVE SSKRKSAKEK
     KSSSKDSRPS QAAGDNQGDE AKEQTFSGGT SQDTKASESS KPWPDATYGT GSASRASAVS
     ELSPRERSPA LKSPLQSVVV RRRSPRPSPV PKPSPPLSST SQMGSTLPSG AGYQSGTHQG
     QFDHGSGSLS PSKKSPVGKS PPSTGSTYGS SQKEESAASG GAAYTKRYLE EQKTENGKDK
     EQKQTNTDKE KIKEKGSFSD TGLGDGKMKS DSFAPKTDSE KPFRGSQSPK RYKLRDDFEK
     KMADFHKEEM DDQDKDKAKG RKESEFDDEP KFMSKVIGAN KNQEEEKSGK WEGLVYAPPG
     KEKQRKTEEL EEESFPERSK KEDRGKRSEG GHRGFVPEKN FRVTAYKAVQ EKSSSPPPRK
     TSESRDKLGA KGDFPTGKSS FSITREAQVN VRMDSFDEDL ARPSGLLAQE RKLCRDLVHS
     NKKEQEFRSI FQHIQSAQSQ RSPSELFAQH IVTIVHHVKE HHFGSSGMTL HERFTKYLKR
     GTEQEAAKNK KSPEIHRRID ISPSTFRKHG LAHDEMKSPR EPGYKAEGKY KDDPVDLRLD
     IERRKKHKER DLKRGKSRES VDSRDSSHSR ERSAEKTEKT HKGSKKQKKH RRARDRSRSS
     SSSSQSSHSY KAEEYTEETE EREESTTGFD KSRLGTKDFV GPSERGGGRA RGTFQFRARG
     RGWGRGNYSG NNNNNSNNDF QKRNREEEWD PEYTPKSKKY YLHDDREGEG SDKWVSRGRG
     RGAFPRGRGR FMFRKSSTSP KWAHDKFSGE EGEIEDDESG TENREEKDNI QPTTE
//
ID   A0A0A0MR07_HUMAN        Unreviewed;       823 AA.
AC   A0A0A0MR07;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   22-APR-2020, entry version 45.
DE   SubName: Full=Proto-oncogene vav {ECO:0000313|Ensembl:ENSP00000302269};
GN   Name=VAV1 {ECO:0000313|Ensembl:ENSP00000302269};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000302269, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000302269, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:15592455}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000302269}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC010647; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022156; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001245135.1; NM_001258206.1.
DR   jPOST; A0A0A0MR07; -.
DR   PeptideAtlas; A0A0A0MR07; -.
DR   PRIDE; A0A0A0MR07; -.
DR   Antibodypedia; 665; 713 antibodies.
DR   Ensembl; ENST00000304076; ENSP00000302269; ENSG00000141968.
DR   GeneID; 7409; -.
DR   UCSC; uc010dva.3; human.
DR   CTD; 7409; -.
DR   EuPathDB; HostDB:ENSG00000141968.7; -.
DR   HGNC; HGNC:12657; VAV1.
DR   OpenTargets; ENSG00000141968; -.
DR   eggNOG; KOG2996; Eukaryota.
DR   eggNOG; ENOG410XPH6; LUCA.
DR   GeneTree; ENSGT00940000159125; -.
DR   HOGENOM; CLU_013787_0_0_1; -.
DR   ChiTaRS; VAV1; human.
DR   GenomeRNAi; 7409; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000141968; Expressed in blood and 123 other tissues.
DR   ExpressionAtlas; A0A0A0MR07; baseline and differential.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd01223; PH_Vav; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   CDD; cd10405; SH2_Vav1; 1.
DR   CDD; cd11976; SH3_VAV1_2; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR022613; CAMSAP_CH.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR037832; PH_Vav.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR003096; SM22_calponin.
DR   InterPro; IPR028530; Vav1.
DR   InterPro; IPR035879; VAV1_SH2.
DR   InterPro; IPR035729; VAV1_SH3_2.
DR   PANTHER; PTHR45818:SF2; PTHR45818:SF2; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF11971; CAMSAP_CH; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00888; SM22CALPONIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00033; CH; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Guanine-nucleotide releasing factor {ECO:0000256|SAAS:SAAS01163629};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00253054};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MR07,
KW   ECO:0000213|MaxQB:A0A0A0MR07, ECO:0000213|PeptideAtlas:A0A0A0MR07,
KW   ECO:0000213|ProteomicsDB:A0A0A0MR07};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   SH2 domain {ECO:0000256|PROSITE-ProRule:PRU00191};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS01042643}; Zinc {ECO:0000256|SAAS:SAAS00253075}.
FT   DOMAIN          1..119
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000259|PROSITE:PS50021"
FT   DOMAIN          194..373
FT                   /note="DH"
FT                   /evidence="ECO:0000259|PROSITE:PS50010"
FT   DOMAIN          402..504
FT                   /note="PH"
FT                   /evidence="ECO:0000259|PROSITE:PS50003"
FT   DOMAIN          515..564
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50081"
FT   DOMAIN          649..743
FT                   /note="SH2"
FT                   /evidence="ECO:0000259|PROSITE:PS50001"
FT   DOMAIN          760..820
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
SQ   SEQUENCE   823 AA;  95756 MW;  16D1B7D394372FFE CRC64;
     MELWRQCTHW LIQCRVLPPS HRVTWDGAQV CELAQALRDG VLLCQLLNNL LPHAINLREV
     NLRPQMSQFL CLKNIRTFLS TCCEKFGLKR SELFEAFDLF DVQDFGKVIY TLSALSWTPI
     AQNRGIMPFP TEEESVGDED IYSGLSDQID DTVEEDEDLY DCVENEEAEG DEIYEDLMRS
     EPVSMPPKMT EYDKRCCCLR EIQQTEEKYT DTLGSIQQHF LKPLQRFLKP QDIEIIFINI
     EDLLRVHTHF LKEMKEALGT PGAANLYQVF IKYKERFLVY GRYCSQVESA SKHLDRVAAA
     REDVQMKLEE CSQRANNGRF TLRDLLMVPM QRVLKYHLLL QELVKHTQEA MEKENLRLAL
     DAMRDLAQCV NEVKRDNETL RQITNFQLSI ENLDQSLAHY GRPKIDGELK ITSVERRSKM
     DRYAFLLDKA LLICKRRGDS YDLKDFVNLH SFQVRDDSSG DRDNKKWSHM FLLIEDQGAQ
     GYELFFKTRE LKKKWMEQFE MAISNIYPEN ATANGHDFQM FSFEETTSCK ACQMLLRGTF
     YQGYRCHRCR ASAHKECLGR VPPCGRHGQD FPGTMKKDKL HRRAQDKKRN ELGLPKMEVF
     QEYYGLPPPP GAIGPFLRLN PGDIVELTKA EAEQNWWEGP PQDLSVHLWY AGPMERAGAE
     SILANRSDGT FLVRQRVKDA AEFAISIKYN VEVKHIKIMT AEGLYRITEK KAFRGLTELV
     EFYQQNSLKD CFKSLDTTLQ FPFKEPEKRT ISRPAVGSTK YFGTAKARYD FCARDRSELS
     LKEGDIIKIL NKKGQQGWWR GEIYGRVGWF PANYVEEDYS EYC
//
ID   B2R8B5_HUMAN            Unreviewed;       845 AA.
AC   B2R8B5;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   11-DEC-2019, entry version 82.
DE   SubName: Full=cDNA, FLJ93820, highly similar to Homo sapiens vav 1 oncogene (VAV1), mRNA {ECO:0000313|EMBL:BAG36112.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG36112.1};
RN   [1] {ECO:0000313|EMBL:BAG36112.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Spleen {ECO:0000313|EMBL:BAG36112.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK313307; BAG36112.1; -; mRNA.
DR   RefSeq; NP_005419.2; NM_005428.3.
DR   PeptideAtlas; B2R8B5; -.
DR   PRIDE; B2R8B5; -.
DR   GeneID; 7409; -.
DR   KEGG; hsa:7409; -.
DR   CTD; 7409; -.
DR   eggNOG; KOG2996; Eukaryota.
DR   eggNOG; ENOG410XPH6; LUCA.
DR   KO; K05730; -.
DR   OrthoDB; 710582at2759; -.
DR   SignaLink; B2R8B5; -.
DR   GenomeRNAi; 7409; -.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd01223; PH_Vav; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   CDD; cd10405; SH2_Vav1; 1.
DR   CDD; cd11979; SH3_VAV1_1; 1.
DR   CDD; cd11976; SH3_VAV1_2; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR037832; PH_Vav.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR003096; SM22_calponin.
DR   InterPro; IPR028530; Vav1.
DR   InterPro; IPR035879; VAV1_SH2.
DR   InterPro; IPR035730; VAV1_SH3_1.
DR   InterPro; IPR035729; VAV1_SH3_2.
DR   PANTHER; PTHR45818:SF2; PTHR45818:SF2; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00307; CH; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00888; SM22CALPONIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00033; CH; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 2.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 2.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   2: Evidence at transcript level;
KW   Guanine-nucleotide releasing factor {ECO:0000256|SAAS:SAAS01163629};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00253054};
KW   SH2 domain {ECO:0000256|PROSITE-ProRule:PRU00191};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS01042643}; Zinc {ECO:0000256|SAAS:SAAS00253075}.
FT   DOMAIN          1..119
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000259|PROSITE:PS50021"
FT   DOMAIN          194..373
FT                   /note="DH"
FT                   /evidence="ECO:0000259|PROSITE:PS50010"
FT   DOMAIN          402..504
FT                   /note="PH"
FT                   /evidence="ECO:0000259|PROSITE:PS50003"
FT   DOMAIN          515..564
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50081"
FT   DOMAIN          592..660
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
FT   DOMAIN          671..765
FT                   /note="SH2"
FT                   /evidence="ECO:0000259|PROSITE:PS50001"
FT   DOMAIN          782..842
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
SQ   SEQUENCE   845 AA;  98193 MW;  13CC0DA535C844B2 CRC64;
     MELWRQCTHW LIQCRVLPPS HRVTWDGAQA CELAQALRDG VLLCQLLNNL LPHAINLREV
     NLRPQMSQFL CLKNIRTFLS TCCEKFGLKR SELFEAFDLF DVQDFGKVIY TLSALSWTPI
     AQNRGIMPFP TEEESVGDED IYSGLSDQID DTVEEDEDLY DCVENEEAEG DEIYEDLMRS
     EPVSMPPKMT EYDKRCCCLR EIQQTEEKYT DTLGSIQQHF LKPLQRFLKP QDIEIIFINI
     EDLLRVHTHF LKEMKEALGT PGAANLYQVF IKYKERFLVY GRYCSQVESA SKHLDRVAAA
     REDVQMKLEE CSQRANNGRL TLRDLLMVPM QRVLKYHLLL QELVKHTQEA MEKENLRLAL
     DAMRDLAQCV NEVKRDDETL RQITNSQLSI ENLDQSLAHY GRPKIDGELK ITSVERRSKM
     DRYAFLLDKA LLICKRRGDS YDLKDFVNLH SFQVRDDSSG DRDNKKWSHM FLLIEDQGAQ
     GYELFFKTRE LKKKWMEQFE MAISNIYPEN ATANGHDFQM FSFEETTSCK ACQMLLRGTF
     YQGYRCHRCR ASAHKECLGR VPPCGRHGQD FPGTMKKDKL HRRAQDKKRN ELGLPKMEVF
     QEYYGLPPPP GAIGPFLRLN PGDIVELTKA EAEQNWWEGR NTSTNEIGWF PCNRVKPYVH
     GPPQDLSVHL WYAGPMERAG AESILANRSD GTFLVRQRVK DAAEFAISIK YNVEVKHIKI
     MTAEGLYRIT EKKAFRGLTE LVEFYQQNSL KDCFKSLDTT LQFPFKEPEK RTISRPAVGS
     TKYFGTAKAR YDFCARDRSE LSLKEGDIIK ILNKKGQQGW WRGEIYGRVG WFPANYVEED
     YSEYC
//
ID   VAV_HUMAN               Reviewed;         845 AA.
AC   P15498; B4DVK9; M0QXX6; Q15860;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 4.
DT   22-APR-2020, entry version 229.
DE   RecName: Full=Proto-oncogene vav;
GN   Name=VAV1; Synonyms=VAV;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF CYS-529.
RX   PubMed=2069873;
RA   Coppola J., Bryant S., Koda T., Conway D., Barbacid M.;
RT   "Mechanism of activation of the vav protooncogene.";
RL   Cell Growth Differ. 2:95-105(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10760587; DOI=10.1016/s0167-4781(00)00008-7;
RA   Denkinger D.J., Borges C.R., Butler C.L., Cushman A.M., Kawahara R.S.;
RT   "Genomic organization and regulation of the vav proto-oncogene.";
RL   Biochim. Biophys. Acta 1491:253-262(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-61.
RX   PubMed=2005887; DOI=10.1128/mcb.11.4.1912;
RA   Katzav S., Cleveland J.L., Heslop H.E., Pulido D.;
RT   "Loss of the amino-terminal helix-loop-helix domain of the vav proto-
RT   oncogene activates its transforming potential.";
RL   Mol. Cell. Biol. 11:1912-1920(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 51-813 (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 68-845 (ISOFORM 1).
RX   PubMed=2477241; DOI=10.1002/j.1460-2075.1989.tb08354.x;
RA   Katzav S., Martin-Zanca D., Barbacid M.;
RT   "vav, a novel human oncogene derived from a locus ubiquitously expressed in
RT   hematopoietic cells.";
RL   EMBO J. 8:2283-2290(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 299-837 (ISOFORM 1).
RA   Romero F.;
RL   Submitted (JAN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 299-334 (ISOFORM 1).
RX   PubMed=7478592;
RA   Ramos-Morales F., Romero F., Schweighoffer F., Bismuth G., Camonis J.,
RA   Tortolero M., Fischer S.;
RT   "The proline-rich region of Vav binds to Grb2 and Grb3-3.";
RL   Oncogene 11:1665-1669(1995).
RN   [9]
RP   SIMILARITY TO CDC24 FAMILY.
RX   PubMed=1565462;
RA   Adams J.M., Houston H., Allen J., Lints T., Harvey R.;
RT   "The hematopoietically expressed vav proto-oncogene shares homology with
RT   the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24)
RT   involved in cytoskeletal organization.";
RL   Oncogene 7:611-618(1992).
RN   [10]
RP   INTERACTION WITH SYK, AND MUTAGENESIS OF ARG-696.
RX   PubMed=8986718; DOI=10.1016/s1074-7613(00)80273-3;
RA   Deckert M., Tartare-Deckert S., Couture C., Mustelin T., Altman A.;
RT   "Functional and physical interactions of Syk family kinases with the Vav
RT   proto-oncogene product.";
RL   Immunity 5:591-604(1996).
RN   [11]
RP   INTERACTION WITH CBLB.
RX   PubMed=9399639; DOI=10.1038/sj.onc.1201430;
RA   Bustelo X.R., Crespo P., Lopez-Barahona M., Gutkind J.S., Barbacid M.;
RT   "Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated
RT   c-Jun N-terminal kinase activation.";
RL   Oncogene 15:2511-2520(1997).
RN   [12]
RP   INTERACTION WITH BLNK; PLCG1; GRB2 AND NCK1.
RX   PubMed=9697839; DOI=10.1016/s1074-7613(00)80591-9;
RA   Fu C., Turck C.W., Kurosaki T., Chan A.C.;
RT   "BLNK: a central linker protein in B cell activation.";
RL   Immunity 9:93-103(1998).
RN   [13]
RP   INTERACTION WITH SIAH2.
RX   PubMed=10207103; DOI=10.1128/mcb.19.5.3798;
RA   Germani A., Romero F., Houlard M., Camonis J., Gisselbrecht S., Fischer S.,
RA   Varin-Blank N.;
RT   "hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling
RT   pathways.";
RL   Mol. Cell. Biol. 19:3798-3807(1999).
RN   [14]
RP   PHOSPHORYLATION BY FYN.
RX   PubMed=11005864; DOI=10.1073/pnas.97.20.10923;
RA   Huang J., Tilly D., Altman A., Sugie K., Grey H.M.;
RT   "T-cell receptor antagonists induce Vav phosphorylation by selective
RT   activation of Fyn kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:10923-10929(2000).
RN   [15]
RP   INTERACTION WITH DOCK2.
RX   PubMed=12393632; DOI=10.1182/blood-2001-11-0032;
RA   Nishihara H., Maeda M., Oda A., Tsuda M., Sawa H., Nagashima K., Tanaka S.;
RT   "DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell
RT   lines.";
RL   Blood 100:3968-3974(2002).
RN   [16]
RP   INTERACTION WITH SHB.
RX   PubMed=12084069; DOI=10.1046/j.1432-1033.2002.03008.x;
RA   Lindholm C.K., Henriksson M.L., Hallberg B., Welsh M.;
RT   "Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells.";
RL   Eur. J. Biochem. 269:3279-3288(2002).
RN   [17]
RP   INTERACTION WITH APS.
RX   PubMed=12400014; DOI=10.1038/sj.onc.1205927;
RA   Yabana N., Shibuya M.;
RT   "Adaptor protein APS binds the NH2-terminal autoinhibitory domain of
RT   guanine nucleotide exchange factor Vav3 and augments its activity.";
RL   Oncogene 21:7720-7729(2002).
RN   [18]
RP   INTERACTION WITH ITK.
RX   PubMed=15661896; DOI=10.4049/jimmunol.174.3.1385;
RA   Dombroski D., Houghtling R.A., Labno C.M., Precht P., Takesono A.,
RA   Caplen N.J., Billadeau D.D., Wange R.L., Burkhardt J.K., Schwartzberg P.L.;
RT   "Kinase-independent functions for Itk in TCR-induced regulation of Vav and
RT   the actin cytoskeleton.";
RL   J. Immunol. 174:1385-1392(2005).
RN   [19]
RP   INTERACTION WITH NEK3.
RX   PubMed=15618286; DOI=10.1210/me.2004-0443;
RA   Miller S.L., DeMaria J.E., Freier D.O., Riegel A.M., Clevenger C.V.;
RT   "Novel association of Vav2 and Nek3 modulates signaling through the human
RT   prolactin receptor.";
RL   Mol. Endocrinol. 19:939-949(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-826, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [21]
RP   INTERACTION WITH ZNF655/VIK.
RX   PubMed=15558030; DOI=10.1038/sj.onc.1208043;
RA   Houlard M., Romero-Portillo F., Germani A., Depaux A., Regnier-Ricard F.,
RA   Gisselbrecht S., Varin-Blank N.;
RT   "Characterization of VIK-1: a new Vav-interacting Kruppel-like protein.";
RL   Oncogene 24:28-38(2005).
RN   [22]
RP   INTERACTION WITH PTK2B/PYK2.
RX   PubMed=19207108; DOI=10.1042/bj20090037;
RA   Gao C., Blystone S.D.;
RT   "A Pyk2-Vav1 complex is recruited to beta3-adhesion sites to initiate Rho
RT   activation.";
RL   Biochem. J. 420:49-56(2009).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   STRUCTURE BY NMR OF 661-775.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the SH2 domain of human proto-oncogene protein
RT   VAV1.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Couples tyrosine kinase signals with the activation of the
CC       Rho/Rac GTPases, thus leading to cell differentiation and/or
CC       proliferation.
CC   -!- SUBUNIT: Interacts with SHB (PubMed:12084069). Interacts with APS,
CC       GRB2, GRB3, DOCK2, SLA, TEC and ZNF655/VIK (PubMed:12393632,
CC       PubMed:12400014, PubMed:15558030). Interacts with SIAH2; without
CC       leading to its degradation (PubMed:10207103). Associates with BLNK,
CC       PLCG1, GRB2 and NCK1 in a B-cell antigen receptor-dependent fashion
CC       (PubMed:9697839). Interacts with CBLB; which inhibits tyrosine
CC       phosphorylation and down-regulates activity (PubMed:9399639). May
CC       interact with CCPG1. Interacts with CLNK. Interacts with THEMIS2 (By
CC       similarity). Interacts with NEK3 and this interaction is prolactin-
CC       dependent (PubMed:15618286). Interacts with ITK (PubMed:15661896).
CC       Interacts with PTK2B/PYK2 (By similarity). Interacts with HCK.
CC       Interacts with PTK2B/PYK2 (PubMed:19207108). Interacts (via SH2 domain)
CC       with SYK (PubMed:8986718). Interacts with ANKRD54. Interacts with CD6
CC       (By similarity). {ECO:0000250|UniProtKB:P27870,
CC       ECO:0000269|PubMed:10207103, ECO:0000269|PubMed:12084069,
CC       ECO:0000269|PubMed:12393632, ECO:0000269|PubMed:12400014,
CC       ECO:0000269|PubMed:15558030, ECO:0000269|PubMed:15618286,
CC       ECO:0000269|PubMed:15661896, ECO:0000269|PubMed:19207108,
CC       ECO:0000269|PubMed:8986718, ECO:0000269|PubMed:9399639,
CC       ECO:0000269|PubMed:9697839}.
CC   -!- INTERACTION:
CC       P15498; Q8IZP0: ABI1; NbExp=2; IntAct=EBI-625518, EBI-375446;
CC       P15498; P00519: ABL1; NbExp=5; IntAct=EBI-625518, EBI-375543;
CC       P15498; Q13480: GAB1; NbExp=2; IntAct=EBI-625518, EBI-517684;
CC       P15498; P62993: GRB2; NbExp=3; IntAct=EBI-625518, EBI-401755;
CC       P15498; Q07666: KHDRBS1; NbExp=3; IntAct=EBI-625518, EBI-1364;
CC       P15498; Q13094: LCP2; NbExp=9; IntAct=EBI-625518, EBI-346946;
CC       P15498; P08487: PLCG1; Xeno; NbExp=4; IntAct=EBI-625518, EBI-8013886;
CC       P15498; P63000: RAC1; NbExp=2; IntAct=EBI-625518, EBI-413628;
CC       P15498; P78314: SH3BP2; NbExp=8; IntAct=EBI-625518, EBI-727062;
CC       P15498; Q8N720: ZNF655; NbExp=5; IntAct=EBI-625518, EBI-625509;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P15498-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P15498-2; Sequence=VSP_047563;
CC   -!- TISSUE SPECIFICITY: Widely expressed in hematopoietic cells but not in
CC       other cell types.
CC   -!- DOMAIN: The DH domain is involved in interaction with CCPG1.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine residues by HCK in response to IFNG and
CC       bacterial lipopolysaccharide (LPS) (By similarity). Phosphorylated by
CC       FYN. {ECO:0000250, ECO:0000269|PubMed:11005864}.
CC   -!- MISCELLANEOUS: 'Vav' stands for the sixth letter of the Hebrew
CC       alphabet.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG62721.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA34383.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/VAV1ID195ch19p13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF030227; AAC25011.1; -; Genomic_DNA.
DR   EMBL; AF030201; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030202; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030203; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030204; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030205; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030206; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030207; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030208; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030209; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030210; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030211; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030212; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030213; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030214; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030215; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030216; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030217; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030218; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030219; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030220; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030221; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030222; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030223; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030224; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030225; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030226; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AC010647; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022156; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M59834; AAA63267.1; -; Genomic_DNA.
DR   EMBL; AK301128; BAG62721.1; ALT_INIT; mRNA.
DR   EMBL; X16316; CAA34383.1; ALT_FRAME; mRNA.
DR   EMBL; X83931; CAA58783.1; -; mRNA.
DR   CCDS; CCDS12174.1; -. [P15498-1]
DR   CCDS; CCDS59342.1; -. [P15498-2]
DR   PIR; B39576; TVHUVV.
DR   RefSeq; NP_001245136.1; NM_001258207.1. [P15498-2]
DR   RefSeq; NP_005419.2; NM_005428.3. [P15498-1]
DR   PDB; 2CRH; NMR; -; A=629-775.
DR   PDB; 2LCT; NMR; -; A=664-767.
DR   PDB; 2MC1; NMR; -; A=664-767.
DR   PDB; 2ROR; NMR; -; A=629-775.
DR   PDB; 3BJI; X-ray; 2.60 A; A/B=189-565.
DR   PDB; 3KY9; X-ray; 2.73 A; A/B=2-584.
DR   PDB; 6NEW; X-ray; 2.50 A; A=170-575.
DR   PDB; 6NF1; X-ray; 2.60 A; A=2-575.
DR   PDB; 6NFA; X-ray; 2.70 A; A=170-575.
DR   PDBsum; 2CRH; -.
DR   PDBsum; 2LCT; -.
DR   PDBsum; 2MC1; -.
DR   PDBsum; 2ROR; -.
DR   PDBsum; 3BJI; -.
DR   PDBsum; 3KY9; -.
DR   PDBsum; 6NEW; -.
DR   PDBsum; 6NF1; -.
DR   PDBsum; 6NFA; -.
DR   SMR; P15498; -.
DR   BioGrid; 113252; 90.
DR   CORUM; P15498; -.
DR   DIP; DIP-1061N; -.
DR   IntAct; P15498; 139.
DR   MINT; P15498; -.
DR   STRING; 9606.ENSP00000472929; -.
DR   BindingDB; P15498; -.
DR   ChEMBL; CHEMBL3259472; -.
DR   iPTMnet; P15498; -.
DR   PhosphoSitePlus; P15498; -.
DR   BioMuta; VAV1; -.
DR   DMDM; 13124807; -.
DR   CPTAC; CPTAC-1226; -.
DR   CPTAC; CPTAC-1227; -.
DR   EPD; P15498; -.
DR   jPOST; P15498; -.
DR   MassIVE; P15498; -.
DR   MaxQB; P15498; -.
DR   PaxDb; P15498; -.
DR   PeptideAtlas; P15498; -.
DR   PRIDE; P15498; -.
DR   ProteomicsDB; 53143; -. [P15498-1]
DR   Antibodypedia; 665; 713 antibodies.
DR   DNASU; 7409; -.
DR   Ensembl; ENST00000596764; ENSP00000469450; ENSG00000141968. [P15498-2]
DR   Ensembl; ENST00000602142; ENSP00000472929; ENSG00000141968. [P15498-1]
DR   GeneID; 7409; -.
DR   KEGG; hsa:7409; -.
DR   UCSC; uc002mfu.3; human. [P15498-1]
DR   CTD; 7409; -.
DR   DisGeNET; 7409; -.
DR   GeneCards; VAV1; -.
DR   HGNC; HGNC:12657; VAV1.
DR   HPA; ENSG00000141968; Tissue enhanced (blood, bone marrow, lymphoid tissue).
DR   MIM; 164875; gene.
DR   neXtProt; NX_P15498; -.
DR   OpenTargets; ENSG00000141968; -.
DR   PharmGKB; PA37280; -.
DR   eggNOG; KOG2996; Eukaryota.
DR   eggNOG; ENOG410XPH6; LUCA.
DR   GeneTree; ENSGT00940000159125; -.
DR   InParanoid; P15498; -.
DR   KO; K05730; -.
DR   OMA; QPYISRP; -.
DR   PhylomeDB; P15498; -.
DR   TreeFam; TF316171; -.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-1433557; Signaling by SCF-KIT.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-9027284; Erythropoietin activates RAS.
DR   Reactome; R-HSA-912631; Regulation of signaling by CBL.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P15498; -.
DR   SIGNOR; P15498; -.
DR   ChiTaRS; VAV1; human.
DR   EvolutionaryTrace; P15498; -.
DR   GenomeRNAi; 7409; -.
DR   Pharos; P15498; Tchem.
DR   PRO; PR:P15498; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P15498; protein.
DR   Bgee; ENSG00000141968; Expressed in blood and 123 other tissues.
DR   ExpressionAtlas; P15498; baseline and differential.
DR   Genevisible; P15498; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; EXP:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; IPI:CAFA.
DR   GO; GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IEA:Ensembl.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IEA:Ensembl.
DR   GO; GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; TAS:Reactome.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:0008361; P:regulation of cell size; IGI:UniProtKB.
DR   GO; GO:0043087; P:regulation of GTPase activity; IGI:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd01223; PH_Vav; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   CDD; cd10405; SH2_Vav1; 1.
DR   CDD; cd11979; SH3_VAV1_1; 1.
DR   CDD; cd11976; SH3_VAV1_2; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR022613; CAMSAP_CH.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR037832; PH_Vav.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR003096; SM22_calponin.
DR   InterPro; IPR028530; Vav1.
DR   InterPro; IPR035879; VAV1_SH2.
DR   InterPro; IPR035730; VAV1_SH3_1.
DR   InterPro; IPR035729; VAV1_SH3_2.
DR   PANTHER; PTHR45818:SF2; PTHR45818:SF2; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF11971; CAMSAP_CH; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00888; SM22CALPONIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00033; CH; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 2.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 2.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Guanine-nucleotide releasing factor;
KW   Metal-binding; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Repeat; SH2 domain; SH3 domain; Zinc; Zinc-finger.
FT   CHAIN           1..845
FT                   /note="Proto-oncogene vav"
FT                   /id="PRO_0000080980"
FT   DOMAIN          1..119
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          194..373
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          402..504
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          592..660
FT                   /note="SH3 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          671..765
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          782..842
FT                   /note="SH3 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   ZN_FING         515..564
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   COMPBIAS        33..99
FT                   /note="Leu-rich"
FT   MOD_RES         826
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:15592455"
FT   MOD_RES         844
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P27870"
FT   VAR_SEQ         187..218
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047563"
FT   VARIANT         739
FT                   /note="T -> M (in dbSNP:rs36097961)"
FT                   /id="VAR_051997"
FT   MUTAGEN         529
FT                   /note="C->R: Abolishes transforming activity."
FT                   /evidence="ECO:0000269|PubMed:2069873"
FT   MUTAGEN         696
FT                   /note="R->L: Loss of interaction with SYK."
FT                   /evidence="ECO:0000269|PubMed:8986718"
FT   CONFLICT        264
FT                   /note="A -> P (in Ref. 6; CAA34383)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        368
FT                   /note="Q -> R (in Ref. 5; BAG62721)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        718
FT                   /note="I -> TV (in Ref. 6)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..13
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   TURN            22..24
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           30..37
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           41..50
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           57..59
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           68..84
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           96..100
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           105..117
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   TURN            119..121
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           122..124
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           145..149
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           159..162
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           168..178
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           191..218
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           221..224
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   TURN            225..227
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           230..237
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           240..259
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   TURN            260..262
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           267..273
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           276..278
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           279..300
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           302..316
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   STRAND          317..319
FT                   /evidence="ECO:0000244|PDB:3KY9"
FT   HELIX           322..326
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           328..333
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           336..344
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           351..388
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           397..400
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   STRAND          403..412
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   STRAND          420..435
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   STRAND          442..448
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           449..451
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   STRAND          452..456
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   STRAND          469..479
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   STRAND          481..488
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           489..506
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   TURN            509..512
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           513..515
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   STRAND          518..521
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   TURN            530..532
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   STRAND          538..540
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   STRAND          543..546
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   TURN            547..549
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           555..560
FT                   /evidence="ECO:0000244|PDB:3BJI"
FT   HELIX           666..668
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   STRAND          669..672
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   HELIX           678..684
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   TURN            685..687
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   STRAND          692..696
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   STRAND          700..702
FT                   /evidence="ECO:0000244|PDB:2LCT"
FT   STRAND          706..711
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   STRAND          714..719
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   STRAND          721..723
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   STRAND          726..730
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   STRAND          735..737
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   HELIX           738..745
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   HELIX           750..752
FT                   /evidence="ECO:0000244|PDB:2CRH"
FT   STRAND          754..756
FT                   /evidence="ECO:0000244|PDB:2LCT"
FT   STRAND          763..766
FT                   /evidence="ECO:0000244|PDB:2CRH"
SQ   SEQUENCE   845 AA;  98314 MW;  AC3BC9736FD2F138 CRC64;
     MELWRQCTHW LIQCRVLPPS HRVTWDGAQV CELAQALRDG VLLCQLLNNL LPHAINLREV
     NLRPQMSQFL CLKNIRTFLS TCCEKFGLKR SELFEAFDLF DVQDFGKVIY TLSALSWTPI
     AQNRGIMPFP TEEESVGDED IYSGLSDQID DTVEEDEDLY DCVENEEAEG DEIYEDLMRS
     EPVSMPPKMT EYDKRCCCLR EIQQTEEKYT DTLGSIQQHF LKPLQRFLKP QDIEIIFINI
     EDLLRVHTHF LKEMKEALGT PGAANLYQVF IKYKERFLVY GRYCSQVESA SKHLDRVAAA
     REDVQMKLEE CSQRANNGRF TLRDLLMVPM QRVLKYHLLL QELVKHTQEA MEKENLRLAL
     DAMRDLAQCV NEVKRDNETL RQITNFQLSI ENLDQSLAHY GRPKIDGELK ITSVERRSKM
     DRYAFLLDKA LLICKRRGDS YDLKDFVNLH SFQVRDDSSG DRDNKKWSHM FLLIEDQGAQ
     GYELFFKTRE LKKKWMEQFE MAISNIYPEN ATANGHDFQM FSFEETTSCK ACQMLLRGTF
     YQGYRCHRCR ASAHKECLGR VPPCGRHGQD FPGTMKKDKL HRRAQDKKRN ELGLPKMEVF
     QEYYGLPPPP GAIGPFLRLN PGDIVELTKA EAEQNWWEGR NTSTNEIGWF PCNRVKPYVH
     GPPQDLSVHL WYAGPMERAG AESILANRSD GTFLVRQRVK DAAEFAISIK YNVEVKHIKI
     MTAEGLYRIT EKKAFRGLTE LVEFYQQNSL KDCFKSLDTT LQFPFKEPEK RTISRPAVGS
     TKYFGTAKAR YDFCARDRSE LSLKEGDIIK ILNKKGQQGW WRGEIYGRVG WFPANYVEED
     YSEYC
//
ID   Q96D37_HUMAN            Unreviewed;       790 AA.
AC   Q96D37;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2004, sequence version 2.
DT   22-APR-2020, entry version 157.
DE   SubName: Full=Proto-oncogene vav {ECO:0000313|Ensembl:ENSP00000472803};
DE   SubName: Full=VAV1 protein {ECO:0000313|EMBL:AAH13361.2};
GN   Name=VAV1 {ECO:0000313|EMBL:AAH13361.2,
GN   ECO:0000313|Ensembl:ENSP00000472803};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH13361.2};
RN   [1] {ECO:0000313|EMBL:AAH13361.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta {ECO:0000313|EMBL:AAH13361.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000472803, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3] {ECO:0000213|PubMed:15592455}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000472803}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2013) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC010647; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022156; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013361; AAH13361.2; -; mRNA.
DR   RefSeq; NP_001245135.1; NM_001258206.1.
DR   RefSeq; NP_001245136.1; NM_001258207.1.
DR   RefSeq; NP_005419.2; NM_005428.3.
DR   IntAct; Q96D37; 4.
DR   Antibodypedia; 665; 713 antibodies.
DR   Ensembl; ENST00000599806; ENSP00000472803; ENSG00000141968.
DR   GeneID; 7409; -.
DR   KEGG; hsa:7409; -.
DR   UCSC; uc002mfv.2; human.
DR   CTD; 7409; -.
DR   EuPathDB; HostDB:ENSG00000141968.7; -.
DR   HGNC; HGNC:12657; VAV1.
DR   OpenTargets; ENSG00000141968; -.
DR   eggNOG; KOG2996; Eukaryota.
DR   eggNOG; ENOG410XPH6; LUCA.
DR   GeneTree; ENSGT00940000159125; -.
DR   KO; K05730; -.
DR   OrthoDB; 710582at2759; -.
DR   ChiTaRS; VAV1; human.
DR   GenomeRNAi; 7409; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000141968; Expressed in blood and 123 other tissues.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd01223; PH_Vav; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   CDD; cd10405; SH2_Vav1; 1.
DR   CDD; cd11979; SH3_VAV1_1; 1.
DR   CDD; cd11976; SH3_VAV1_2; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR037832; PH_Vav.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR028530; Vav1.
DR   InterPro; IPR035879; VAV1_SH2.
DR   InterPro; IPR035730; VAV1_SH3_1.
DR   InterPro; IPR035729; VAV1_SH3_2.
DR   PANTHER; PTHR45818:SF2; PTHR45818:SF2; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00307; CH; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 2.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 2.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Guanine-nucleotide releasing factor {ECO:0000256|SAAS:SAAS01163629};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00253054};
KW   Proteomics identification {ECO:0000213|EPD:Q96D37,
KW   ECO:0000213|MaxQB:Q96D37, ECO:0000213|PeptideAtlas:Q96D37,
KW   ECO:0000213|ProteomicsDB:Q96D37};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   SH2 domain {ECO:0000256|PROSITE-ProRule:PRU00191};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS01042643}; Zinc {ECO:0000256|SAAS:SAAS00253075}.
FT   DOMAIN          1..64
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000259|PROSITE:PS50021"
FT   DOMAIN          139..318
FT                   /note="DH"
FT                   /evidence="ECO:0000259|PROSITE:PS50010"
FT   DOMAIN          347..449
FT                   /note="PH"
FT                   /evidence="ECO:0000259|PROSITE:PS50003"
FT   DOMAIN          460..509
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50081"
FT   DOMAIN          537..605
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
FT   DOMAIN          616..710
FT                   /note="SH2"
FT                   /evidence="ECO:0000259|PROSITE:PS50001"
FT   DOMAIN          727..787
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
SQ   SEQUENCE   790 AA;  91991 MW;  4A92899AAA3FDCF5 CRC64;
     MIVLPLYSRL DKRFLCLKNI RTFLSTCCEK FGLKRSELFE AFDLFDVQDF GKVIYTLSAL
     SWTPIAQNRG IMPFPTEEES VGDEDIYSGL SDQIDDTVEE DEDLYDCVEN EEAEGDEIYE
     DLMRSEPVSM PPKMTEYDKR CCCLREIQQT EEKYTDTLGS IQQHFLKPLQ RFLKPQDIEI
     IFINIEDLLR VHTHFLKEMK EALGTPGAAN LYQVFIKYKE RFLVYGRYCS QVESASKHLD
     RVAAAREDVQ MKLEECSQRA NNGRFTLRDL LMVPMQRVLK YHLLLQELVK HTQEAMEKEN
     LRLALDAMRD LAQCVNEVKR DNETLRQITN FQLSIENLDQ SLAHYGRPKI DGELKITSVE
     RRSKMDRYAF LLDKALLICK RRGDSYDLKD FVNLHSFQVR DDSSGDRDNK KWSHMFLLIE
     DQGAQGYELF FKTRELKKKW MEQFEMAISN IYPENATANG HDFQMFSFEE TTSCKACQML
     LRGTFYQGYR CHRCRASAHK ECLGRVPPCG RHGQDFPGTM KKDKLHRRAQ DKKRNELGLP
     KMEVFQEYYG LPPPPGAIGP FLRLNPGDIV ELTKAEAEQN WWEGRNTSTN EIGWFPCNRV
     KPYVHGPPQD LSVHLWYAGP MERAGAESIL ANRSDGTFLV RQRVKDAAEF AISIKYNVEV
     KHIKIMTAEG LYRITEKKAF RGLTELVEFY QQNSLKDCFK SLDTTLQFPF KEPEKRTISR
     PAVGSTKYFG TAKARYDFCA RDRSELSLKE GDIIKILNKK GQQGWWRGEI YGRVGWFPAN
     YVEEDYSEYC
//
ID   VTI1A_HUMAN             Reviewed;         217 AA.
AC   Q96AJ9; A2A307; B4E137; Q5W0D7;
DT   25-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   25-JAN-2012, sequence version 2.
DT   22-APR-2020, entry version 151.
DE   RecName: Full=Vesicle transport through interaction with t-SNAREs homolog 1A;
DE   AltName: Full=Vesicle transport v-SNARE protein Vti1-like 2;
DE   AltName: Full=Vti1-rp2;
GN   Name=VTI1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAH17052.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3] {ECO:0000312|EMBL:AAH17052.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=18195106; DOI=10.1083/jcb.200707136;
RA   Ganley I.G., Espinosa E., Pfeffer S.R.;
RT   "A syntaxin 10-SNARE complex distinguishes two distinct transport routes
RT   from endosomes to the trans-Golgi in human cells.";
RL   J. Cell Biol. 180:159-172(2008).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19138172; DOI=10.1042/bj20081736;
RA   Flowerdew S.E., Burgoyne R.D.;
RT   "A VAMP7/Vti1a SNARE complex distinguishes a non-conventional traffic route
RT   to the cell surface used by KChIP1 and Kv4 potassium channels.";
RL   Biochem. J. 418:529-540(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: V-SNARE that mediates vesicle transport pathways through
CC       interactions with t-SNAREs on the target membrane. These interactions
CC       are proposed to mediate aspects of the specificity of vesicle
CC       trafficking and to promote fusion of the lipid bilayers. Involved in
CC       vesicular transport from the late endosomes to the trans-Golgi network.
CC       Along with VAMP7, involved in an non-conventional RAB1-dependent
CC       traffic route to the cell surface used by KCNIP1 and KCND2. May be
CC       involved in increased cytokine secretion associated with cellular
CC       senescence. {ECO:0000269|PubMed:18195106, ECO:0000269|PubMed:19138172}.
CC   -!- SUBUNIT: Interacts with distinct SNARE complexes that contain either
CC       STX5 or STX6. Interacts with NAPA and, to a lesser extent, with NAPG.
CC       Identified in a complex containing STX6, STX12, VAMP4 and VTI1A.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle
CC       {ECO:0000269|PubMed:19138172}. Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type IV membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2;
CC         IsoId=Q96AJ9-2; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q96AJ9-1; Sequence=VSP_039848;
CC   -!- SIMILARITY: Belongs to the VTI1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK303646; BAG64649.1; -; mRNA.
DR   EMBL; AC022018; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL139120; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158212; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49524.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49525.1; -; Genomic_DNA.
DR   EMBL; BC017052; AAH17052.1; -; mRNA.
DR   CCDS; CCDS7575.2; -. [Q96AJ9-2]
DR   RefSeq; NP_001305132.1; NM_001318203.1.
DR   RefSeq; NP_001305134.1; NM_001318205.1.
DR   RefSeq; NP_660207.2; NM_145206.3. [Q96AJ9-2]
DR   RefSeq; XP_005269601.1; XM_005269544.4.
DR   SMR; Q96AJ9; -.
DR   BioGrid; 126789; 17.
DR   CORUM; Q96AJ9; -.
DR   DIP; DIP-44223N; -.
DR   IntAct; Q96AJ9; 14.
DR   MINT; Q96AJ9; -.
DR   STRING; 9606.ENSP00000376792; -.
DR   iPTMnet; Q96AJ9; -.
DR   MetOSite; Q96AJ9; -.
DR   PhosphoSitePlus; Q96AJ9; -.
DR   BioMuta; VTI1A; -.
DR   DMDM; 374095459; -.
DR   EPD; Q96AJ9; -.
DR   jPOST; Q96AJ9; -.
DR   MassIVE; Q96AJ9; -.
DR   PaxDb; Q96AJ9; -.
DR   PeptideAtlas; Q96AJ9; -.
DR   PRIDE; Q96AJ9; -.
DR   ProteomicsDB; 75969; -. [Q96AJ9-2]
DR   ProteomicsDB; 75970; -. [Q96AJ9-1]
DR   Antibodypedia; 31821; 257 antibodies.
DR   DNASU; 143187; -.
DR   GeneID; 143187; -.
DR   KEGG; hsa:143187; -.
DR   UCSC; uc001kzz.5; human. [Q96AJ9-2]
DR   CTD; 143187; -.
DR   DisGeNET; 143187; -.
DR   GeneCards; VTI1A; -.
DR   HGNC; HGNC:17792; VTI1A.
DR   HPA; ENSG00000151532; Low tissue specificity.
DR   MIM; 614316; gene.
DR   neXtProt; NX_Q96AJ9; -.
DR   OpenTargets; ENSG00000151532; -.
DR   PharmGKB; PA134928049; -.
DR   eggNOG; KOG1666; Eukaryota.
DR   eggNOG; ENOG4111J90; LUCA.
DR   GeneTree; ENSGT00950000183192; -.
DR   HOGENOM; CLU_075474_1_0_1; -.
DR   InParanoid; Q96AJ9; -.
DR   KO; K08493; -.
DR   OMA; VESHRAE; -.
DR   OrthoDB; 1195966at2759; -.
DR   PhylomeDB; Q96AJ9; -.
DR   TreeFam; TF312874; -.
DR   Reactome; R-HSA-6811438; Intra-Golgi traffic.
DR   Reactome; R-HSA-6811440; Retrograde transport at the Trans-Golgi-Network.
DR   SIGNOR; Q96AJ9; -.
DR   ChiTaRS; VTI1A; human.
DR   GeneWiki; VTI1A; -.
DR   GenomeRNAi; 143187; -.
DR   Pharos; Q96AJ9; Tbio.
DR   PRO; PR:Q96AJ9; -.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; Q96AJ9; protein.
DR   Bgee; ENSG00000151532; Expressed in corpus callosum and 190 other tissues.
DR   Genevisible; Q96AJ9; HS.
DR   GO; GO:0005776; C:autophagosome; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030136; C:clathrin-coated vesicle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0005768; C:endosome; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031902; C:late endosome membrane; IBA:GO_Central.
DR   GO; GO:0044306; C:neuron projection terminus; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0043025; C:neuronal cell body; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0031201; C:SNARE complex; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0008021; C:synaptic vesicle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0005484; F:SNAP receptor activity; IDA:HGNC-UCL.
DR   GO; GO:0000149; F:SNARE binding; IBA:GO_Central.
DR   GO; GO:0006914; P:autophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0090161; P:Golgi ribbon formation; IMP:UniProtKB.
DR   GO; GO:0006896; P:Golgi to vacuole transport; IBA:GO_Central.
DR   GO; GO:0006891; P:intra-Golgi vesicle-mediated transport; IBA:GO_Central.
DR   GO; GO:0006623; P:protein targeting to vacuole; IBA:GO_Central.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IDA:UniProtKB.
DR   GO; GO:0048280; P:vesicle fusion with Golgi apparatus; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0050882; P:voluntary musculoskeletal movement; IMP:UniProtKB.
DR   Gene3D; 1.20.58.400; -; 1.
DR   InterPro; IPR027027; GOSR2/Membrin/Bos1.
DR   InterPro; IPR010989; SNARE.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   InterPro; IPR038407; v-SNARE_N_sf.
DR   InterPro; IPR007705; Vesicle_trsprt_v-SNARE_N.
DR   Pfam; PF05008; V-SNARE; 1.
DR   PIRSF; PIRSF028865; Membrin-2; 1.
DR   SMART; SM00397; t_SNARE; 1.
DR   SUPFAM; SSF47661; SSF47661; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Cytoplasmic vesicle; Golgi apparatus;
KW   Membrane; Protein transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..217
FT                   /note="Vesicle transport through interaction with t-SNAREs
FT                   homolog 1A"
FT                   /id="PRO_0000218225"
FT   TOPO_DOM        1..192
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        193..213
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        214..217
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   COILED          31..92
FT                   /evidence="ECO:0000255"
FT   COILED          112..178
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         188..217
FT                   /note="IIQNRILLVILGIIVVITILMAITFSVRRH -> GCSVKKQCNLSLAPKA
FT                   (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_039848"
FT   CONFLICT        83
FT                   /note="K -> E (in Ref. 1; BAG64649)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   217 AA;  25218 MW;  3FE5FE787B5958F0 CRC64;
     MSSDFEGYEQ DFAVLTAEIT SKIARVPRLP PDEKKQMVAN VEKQLEEAKE LLEQMDLEVR
     EIPPQSRGMY SNRMRSYKQE MGKLETDFKR SRIAYSDEVR NELLGDDGNS SENQRAHLLD
     NTERLERSSR RLEAGYQIAV ETEQIGQEML ENLSHDREKI QRARERLRET DANLGKSSRI
     LTGMLRRIIQ NRILLVILGI IVVITILMAI TFSVRRH
//
ID   ZCHC8_HUMAN             Reviewed;         707 AA.
AC   Q6NZY4; Q7L2P6; Q8N2K5; Q96SK7; Q9NSS2; Q9NSS3;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 2.
DT   22-APR-2020, entry version 159.
DE   RecName: Full=Zinc finger CCHC domain-containing protein 8;
DE   AltName: Full=TRAMP-like complex RNA-binding factor ZCCHC8;
GN   Name=ZCCHC8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE SPLICEOSOMAL
RP   C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/s1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [5]
RP   FUNCTION, PHOSPHORYLATION AT THR-492, MUTAGENESIS OF THR-492, PTM,
RP   INTERACTION WITH MTREX AND RBM7, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=16263084; DOI=10.1016/j.bbrc.2005.10.090;
RA   Gustafson M.P., Welcker M., Hwang H.C., Clurman B.E.;
RT   "Zcchc8 is a glycogen synthase kinase-3 substrate that interacts with RNA-
RT   binding proteins.";
RL   Biochem. Biophys. Res. Commun. 338:1359-1367(2005).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-598 AND SER-658, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-658, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-479; THR-485 AND SER-658, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION IN A TRAMP-LIKE COMPLEX, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=21855801; DOI=10.1016/j.molcel.2011.06.028;
RA   Lubas M., Christensen M.S., Kristiansen M.S., Domanski M., Falkenby L.G.,
RA   Lykke-Andersen S., Andersen J.S., Dziembowski A., Jensen T.H.;
RT   "Interaction profiling identifies the human nuclear exosome targeting
RT   complex.";
RL   Mol. Cell 43:624-637(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   REVIEW ON RNA EXOSOMES.
RX   PubMed=22817747; DOI=10.1042/bst20120061;
RA   Sloan K.E., Schneider C., Watkins N.J.;
RT   "Comparison of the yeast and human nuclear exosome complexes.";
RL   Biochem. Soc. Trans. 40:850-855(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-342; THR-479; THR-485;
RP   THR-492; THR-577; SER-598; THR-648; SER-649; SER-658 AND SER-695, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-472; THR-479; THR-492 AND
RP   SER-658, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, SUBUNIT, AND INTERACTION WITH RBM7 AND MTREX.
RX   PubMed=27871484; DOI=10.1016/j.molcel.2016.09.025;
RA   Meola N., Domanski M., Karadoulama E., Chen Y., Gentil C., Pultz D.,
RA   Vitting-Seerup K., Lykke-Andersen S., Andersen J.S., Sandelin A.,
RA   Jensen T.H.;
RT   "Identification of a nuclear exosome decay pathway for processed
RT   transcripts.";
RL   Mol. Cell 64:520-533(2016).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-413, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [19] {ECO:0000244|PDB:5LXR, ECO:0000244|PDB:5LXY}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 285-324 IN COMPLEX WITH RBM7 AND
RP   MTREX, SUBUNIT, INTERACTION WITH RBM7 AND MTREX, AND MUTAGENESIS OF
RP   LEU-295; LEU-299; PHE-309 AND MET-313.
RX   PubMed=27905398; DOI=10.1038/ncomms13573;
RA   Falk S., Finogenova K., Melko M., Benda C., Lykke-Andersen S., Jensen T.H.,
RA   Conti E.;
RT   "Structure of the RBM7-ZCCHC8 core of the NEXT complex reveals connections
RT   to splicing factors.";
RL   Nat. Commun. 7:13573-13573(2016).
RN   [20] {ECO:0000244|PDB:6C90}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 659-707 IN COMPLEX WITH MTREX,
RP   INTERACTION WITH MTREX, MUTAGENESIS OF ASP-662; PHE-666; PHE-673; GLU-674;
RP   PHE-675; GLU-676; ILE-688 AND LEU-692, REGION, AND DOMAIN.
RX   PubMed=29844170; DOI=10.1073/pnas.1803530115;
RA   Puno M.R., Lima C.D.;
RT   "Structural basis for MTR4-ZCCHC8 interactions that stimulate the MTR4
RT   helicase in the nuclear exosome-targeting complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 115:E5506-E5515(2018).
CC   -!- FUNCTION: Scaffolding subunit of the trimeric nuclear exosome targeting
CC       (NEXT) complex. NEXT functions as an RNA exosome cofactor that directs
CC       a subset of non-coding short-lived RNAs for exosomal degradation. NEXT
CC       is involved in surveillance and turnover of aberrant transcripts and
CC       non-coding RNAs (PubMed:27871484). May be involved in pre-mRNA splicing
CC       (Probable). {ECO:0000269|PubMed:27871484, ECO:0000305|PubMed:16263084}.
CC   -!- SUBUNIT: Component of a nuclear TRAMP-like complex, an ATP-dependent
CC       exosome regulatory complex consisting of a helicase (MTREX), an
CC       oligadenylate polymerase (TENT4B or TENT4A), and a substrate specific
CC       RNA-binding factor (ZCCHC7 or ZCCHC8). Several TRAMP-like complexes
CC       exist with specific compositions and are associated with nuclear, or
CC       nucleolar RNA exosomes. Identified in the spliceosome C complex.
CC       Component of the nuclear exosome targeting (NEXT) complex composed of
CC       MTREX, ZCCHC8, and RBM7 that directs a subset of non-coding short-lived
CC       RNAs for exosomal degradation (PubMed:27905398, PubMed:27871484).
CC       Interacts with proteins involved in RNA processing and degradation such
CC       as MTREX and RBM7; interaction with MTREX enhances MTREX RNA helicase
CC       activity and bridges between RBM7 and MTREX (PubMed:16263084,
CC       PubMed:27905398, PubMed:27871484). {ECO:0000269|PubMed:11991638,
CC       ECO:0000269|PubMed:16263084, ECO:0000269|PubMed:21855801,
CC       ECO:0000269|PubMed:29844170}.
CC   -!- INTERACTION:
CC       Q6NZY4; P38398: BRCA1; NbExp=2; IntAct=EBI-1263058, EBI-349905;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:16263084, ECO:0000269|PubMed:21855801}. Nucleus
CC       {ECO:0000255|PROSITE-ProRule:PRU00768}. Note=Excluded from nucleolus.
CC       {ECO:0000269|PubMed:21855801}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6NZY4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6NZY4-2; Sequence=VSP_013717;
CC   -!- INDUCTION: Slight accumulation in cells entering S phase of the cell
CC       cycle. {ECO:0000269|PubMed:16263084}.
CC   -!- DOMAIN: The C-terminal part (659-707) contributes to MTREX RNA helicase
CC       activity, in part, by enhancing its RNA-dependent ATPase activity.
CC       {ECO:0000269|PubMed:29844170}.
CC   -!- PTM: Phosphorylation at Thr-492 by GSK3 is triggered in cells entering
CC       mitosis; this phosphorylation is greatly enhanced by nocodazole
CC       treatment, but reduced by lithium. {ECO:0000269|PubMed:16263084}.
CC   -!- SIMILARITY: Belongs to the ZCCHC8 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK027702; BAB55308.1; -; mRNA.
DR   EMBL; AK074638; BAC11105.1; -; mRNA.
DR   EMBL; AL157433; CAB75657.1; -; mRNA.
DR   EMBL; AL157434; CAB75658.1; -; mRNA.
DR   EMBL; BC017704; AAH17704.2; -; mRNA.
DR   EMBL; BC065918; AAH65918.1; -; mRNA.
DR   CCDS; CCDS86340.1; -. [Q6NZY4-2]
DR   PIR; T46929; T46929.
DR   PIR; T46930; T46930.
DR   RefSeq; NP_060082.2; NM_017612.4. [Q6NZY4-1]
DR   PDB; 5LXR; X-ray; 2.00 A; B=285-324.
DR   PDB; 5LXY; X-ray; 2.85 A; C/D/F/H/J/L/N=285-324.
DR   PDB; 6C90; X-ray; 2.20 A; B=659-707.
DR   PDBsum; 5LXR; -.
DR   PDBsum; 5LXY; -.
DR   PDBsum; 6C90; -.
DR   SMR; Q6NZY4; -.
DR   BioGrid; 120739; 72.
DR   CORUM; Q6NZY4; -.
DR   IntAct; Q6NZY4; 45.
DR   MINT; Q6NZY4; -.
DR   STRING; 9606.ENSP00000438993; -.
DR   iPTMnet; Q6NZY4; -.
DR   PhosphoSitePlus; Q6NZY4; -.
DR   BioMuta; ZCCHC8; -.
DR   DMDM; 66774213; -.
DR   CPTAC; CPTAC-1021; -.
DR   EPD; Q6NZY4; -.
DR   jPOST; Q6NZY4; -.
DR   MassIVE; Q6NZY4; -.
DR   MaxQB; Q6NZY4; -.
DR   PaxDb; Q6NZY4; -.
DR   PeptideAtlas; Q6NZY4; -.
DR   PRIDE; Q6NZY4; -.
DR   ProteomicsDB; 66798; -. [Q6NZY4-1]
DR   ProteomicsDB; 66799; -. [Q6NZY4-2]
DR   Antibodypedia; 31655; 106 antibodies.
DR   Ensembl; ENST00000536306; ENSP00000441423; ENSG00000033030. [Q6NZY4-2]
DR   Ensembl; ENST00000543897; ENSP00000438993; ENSG00000033030. [Q6NZY4-2]
DR   Ensembl; ENST00000633063; ENSP00000488055; ENSG00000033030. [Q6NZY4-1]
DR   Ensembl; ENST00000672018; ENSP00000500728; ENSG00000033030. [Q6NZY4-1]
DR   GeneID; 55596; -.
DR   KEGG; hsa:55596; -.
DR   UCSC; uc009zxp.4; human. [Q6NZY4-1]
DR   CTD; 55596; -.
DR   DisGeNET; 55596; -.
DR   GeneCards; ZCCHC8; -.
DR   HGNC; HGNC:25265; ZCCHC8.
DR   HPA; ENSG00000033030; Low tissue specificity.
DR   MIM; 616381; gene.
DR   neXtProt; NX_Q6NZY4; -.
DR   OpenTargets; ENSG00000033030; -.
DR   PharmGKB; PA134889410; -.
DR   eggNOG; KOG2673; Eukaryota.
DR   eggNOG; ENOG410XPDY; LUCA.
DR   GeneTree; ENSGT00390000011475; -.
DR   InParanoid; Q6NZY4; -.
DR   KO; K13128; -.
DR   OMA; DRSSDMD; -.
DR   OrthoDB; 338817at2759; -.
DR   PhylomeDB; Q6NZY4; -.
DR   TreeFam; TF321837; -.
DR   ChiTaRS; ZCCHC8; human.
DR   GeneWiki; ZCCHC8; -.
DR   GenomeRNAi; 55596; -.
DR   Pharos; Q6NZY4; Tdark.
DR   PRO; PR:Q6NZY4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q6NZY4; protein.
DR   Bgee; ENSG00000033030; Expressed in cervix squamous epithelium and 218 other tissues.
DR   ExpressionAtlas; Q6NZY4; baseline and differential.
DR   Genevisible; Q6NZY4; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031499; C:TRAMP complex; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB.
DR   GO; GO:0016076; P:snRNA catabolic process; ISS:UniProtKB.
DR   InterPro; IPR006568; PSP_pro-rich.
DR   InterPro; IPR001878; Znf_CCHC.
DR   Pfam; PF04046; PSP; 1.
DR   Pfam; PF00098; zf-CCHC; 1.
DR   SMART; SM00581; PSP; 1.
DR   SMART; SM00343; ZnF_C2HC; 1.
DR   PROSITE; PS50158; ZF_CCHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Coiled coil;
KW   Isopeptide bond; Metal-binding; mRNA processing; mRNA splicing; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Spliceosome;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   CHAIN           2..707
FT                   /note="Zinc finger CCHC domain-containing protein 8"
FT                   /id="PRO_0000150960"
FT   ZN_FING         227..244
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   REGION          286..299
FT                   /note="RBM7 binding"
FT                   /evidence="ECO:0000244|PDB:5LXR, ECO:0000244|PDB:5LXY,
FT                   ECO:0000269|PubMed:27905398"
FT   REGION          309..324
FT                   /note="RBM7 binding"
FT                   /evidence="ECO:0000244|PDB:5LXR, ECO:0000244|PDB:5LXY,
FT                   ECO:0000269|PubMed:27905398"
FT   REGION          659..707
FT                   /note="MTREX binding"
FT                   /evidence="ECO:0000244|PDB:6C90,
FT                   ECO:0000269|PubMed:29844170"
FT   COILED          45..80
FT                   /evidence="ECO:0000255"
FT   COILED          516..539
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        466..501
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00015"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         342
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         472
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         479
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         485
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         492
FT                   /note="Phosphothreonine; by GSK3"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:16263084"
FT   MOD_RES         577
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         598
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         648
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         649
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         658
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         695
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        413
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..238
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_013717"
FT   VARIANT         672
FT                   /note="P -> A (in dbSNP:rs1063155)"
FT                   /id="VAR_034585"
FT   MUTAGEN         295
FT                   /note="L->E: Impaired interaction with ZCCHC8; when
FT                   associated with E-299."
FT                   /evidence="ECO:0000269|PubMed:27905398"
FT   MUTAGEN         299
FT                   /note="L->E: Impaired interaction with ZCCHC8; when
FT                   associated with E-295."
FT                   /evidence="ECO:0000269|PubMed:27905398"
FT   MUTAGEN         309
FT                   /note="F->A: Reduced interaction with ZCCHC8; when
FT                   associated with E-313."
FT                   /evidence="ECO:0000269|PubMed:27905398"
FT   MUTAGEN         313
FT                   /note="M->E: Reduced interaction with ZCCHC8; when
FT                   associated with A-309."
FT                   /evidence="ECO:0000269|PubMed:27905398"
FT   MUTAGEN         492
FT                   /note="T->A: Impaired phosphorylation by GSK3."
FT                   /evidence="ECO:0000269|PubMed:16263084"
FT   MUTAGEN         662
FT                   /note="D->A: Does not alter RNA helicase activity of NEXT
FT                   complex; when associated with K-666."
FT                   /evidence="ECO:0000269|PubMed:29844170"
FT   MUTAGEN         666
FT                   /note="F->K: Does not alter RNA helicase activity of NEXT
FT                   complex; when associated with A-662."
FT                   /evidence="ECO:0000269|PubMed:29844170"
FT   MUTAGEN         673
FT                   /note="F->A: Does not affect RNA helicase activity of NEXT
FT                   complex; when associated with A-675."
FT                   /evidence="ECO:0000269|PubMed:29844170"
FT   MUTAGEN         674
FT                   /note="E->A: Does not affect RNA helicase activity of NEXT
FT                   complex; when associated with A-676."
FT                   /evidence="ECO:0000269|PubMed:29844170"
FT   MUTAGEN         675
FT                   /note="F->A: Does not affect RNA helicase activity of NEXT
FT                   complex; when associated with A-673."
FT                   /evidence="ECO:0000269|PubMed:29844170"
FT   MUTAGEN         676
FT                   /note="E->A: Does not affect RNA helicase activity of NEXT
FT                   complex; when associated with A-674."
FT                   /evidence="ECO:0000269|PubMed:29844170"
FT   MUTAGEN         688
FT                   /note="I->E: Loss of RNA helicase activity of NEXT complex;
FT                   when associated with E-692."
FT                   /evidence="ECO:0000269|PubMed:29844170"
FT   MUTAGEN         692
FT                   /note="L->E: Loss of RNA helicase activity of NEXT complex;
FT                   when associated with E-688."
FT                   /evidence="ECO:0000269|PubMed:29844170"
FT   CONFLICT        20
FT                   /note="E -> G (in Ref. 1; BAB55308)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        216..219
FT                   /note="QEIQ -> DAWV (in Ref. 3; AAH17704)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        326
FT                   /note="A -> V (in Ref. 3; AAH65918)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        461
FT                   /note="S -> G (in Ref. 1; BAB55308)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        582
FT                   /note="E -> G (in Ref. 1; BAC11105)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        663
FT                   /note="M -> V (in Ref. 2; CAB75658)"
FT                   /evidence="ECO:0000305"
FT   HELIX           293..299
FT                   /evidence="ECO:0000244|PDB:5LXR"
FT   HELIX           308..316
FT                   /evidence="ECO:0000244|PDB:5LXR"
FT   HELIX           320..322
FT                   /evidence="ECO:0000244|PDB:5LXR"
FT   HELIX           663..667
FT                   /evidence="ECO:0000244|PDB:6C90"
FT   HELIX           684..690
FT                   /evidence="ECO:0000244|PDB:6C90"
FT   HELIX           696..699
FT                   /evidence="ECO:0000244|PDB:6C90"
SQ   SEQUENCE   707 AA;  78577 MW;  7BE6E30F919A4771 CRC64;
     MAAEVYFGDL ELFEPFDHPE ESIPKPVHTR FKDDDGDEED ENGVGDAELR ERLRQCEETI
     EQLRAENQEL KRKLNILTRP SGILVNDTKL DGPILQILFM NNAISKQYHQ EIEEFVSNLV
     KRFEEQQKND VEKTSFNLLP QPSSIVLEED HKVEESCAIK NNKEAFSVVG SVLYFTNFCL
     DKLGQPLLNE NPQLSEGWEI PKYHQVFSHI VSLEGQEIQV KAKRPKPHCF NCGSEEHQMK
     DCPMPRNAAR ISEKRKEYMD ACGEANNQNF QQRYHAEEVE ERFGRFKPGV ISEELQDALG
     VTDKSLPPFI YRMRQLGYPP GWLKEAELEN SGLALYDGKD GTDGETEVGE IQQNKSVTYD
     LSKLVNYPGF NISTPRGIPD EWRIFGSIPM QACQQKDVFA NYLTSNFQAP GVKSGNKRSS
     SHSSPGSPKK QKNESNSAGS PADMELDSDM EVPHGSQSSE SFQFQPPLPP DTPPLPRGTP
     PPVFTPPLPK GTPPLTPSDS PQTRTASGAV DEDALTLEEL EEQQRRIWAA LEQAESVNSD
     SDVPVDTPLT GNSVASSPCP NELDLPVPEG KTSEKQTLDE PEVPEIFTKK SEAGHASSPD
     SEVTSLCQKE KAELAPVNTE GALLDNGSVV PNCDISNGGS QKLFPADTSP STATKIHSPI
     PDMSKFATGI TPFEFENMAE STGMYLRIRS LLKNSPRNQQ KNKKASE
//
